data_4by9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4by9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 C5'-C4'-O4' 112.981 2.701 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' C' . . . . . 0.403 " H2'" ' C8 ' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.429 -2.022 1 O4'-C1'-N19 113.121 4.921 . 0.219 1L . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.419 HO2' " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.537 2.049 1 O4'-C1'-N19 113.144 4.944 . 0.334 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.419 " H5'" HO2' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.429 -2.024 1 O4'-C1'-N19 112.325 4.125 . 0.731 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 113.093 4.893 . 0.658 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.576 1 O4'-C1'-N19 112.999 4.799 . 0.688 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.58 -2.228 0 C4'-C3'-C2' 99.15 -3.55 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.325 1 O4'-C1'-N19 113.538 5.338 . 0.297 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.337 1 O4'-C1'-N19 114.713 6.513 . 0.588 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 P-O3'-C3' 124.745 4.204 . 0.619 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.565 0 O3'-P-O5' 97.761 -3.284 . 0.117 4g . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.381 0 C5'-C4'-O4' 114.17 3.55 . 0.628 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.581 -2.133 1 O4'-C1'-N19 112.241 4.041 . 0.218 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ' A' . . . . . 0.547 HO2' ' P ' ' A' ' 15' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 O4'-C1'-N19 111.229 3.029 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ' G' . . . . . 0.547 ' P ' HO2' ' A' ' 14' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.226 2 C1'-O4'-C4' 105.099 -5.001 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.705 2 P-O3'-C3' 126.746 5.872 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 1 O4'-C1'-N19 112.594 4.394 . 0.386 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 C4'-C3'-C2' 98.837 -3.863 . 0.445 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.047 2 O4'-C1'-N19 112.943 4.743 . 0.498 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.354 0 O4'-C1'-N19 111.25 3.05 . 0.523 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 O4'-C1'-N19 111.83 3.63 . 0.64 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 O4'-C1'-N19 111.758 3.558 . 0.562 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.034 2 C4'-C3'-C2' 97.938 -4.762 . 0.401 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 O4'-C1'-N19 111.865 3.665 . 0.263 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.109 1 O4'-C1'-N19 114.549 6.349 . 0.502 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.209 0 C5'-C4'-C3' 110.546 -3.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 113.111 4.911 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.822 0 O4'-C1'-N19 111.419 3.219 . 0.509 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.216 0 C3'-C2'-C1' 104.11 2.899 OUTLIER-DELTA 0.106 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.767 0 O4'-C1'-N19 111.115 2.915 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 C5'-C4'-C3' 110.106 -3.596 . 0.171 0i . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 1 O4'-C1'-N19 113.014 4.814 . 0.806 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.098 0 O4'-C1'-N19 112.144 3.944 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.55 3.111 1 O4'-C1'-N19 112.688 4.488 . 0.538 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.625 3.15 0 O4'-C1'-N19 111.234 3.034 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.995 0 C3'-C2'-C1' 105.094 3.993 . 0.471 1g . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ' A' . . . . . 0.459 " H2'" ' C8 ' ' A' ' 38' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.429 -2.007 1 O4'-C1'-N19 112.265 4.065 . 0.238 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ' A' . . . . . 0.459 ' C8 ' " H2'" ' A' ' 37' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.538 2.122 1 O4'-C1'-N19 113.958 5.758 . 0.37 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.231 1 O4'-C1'-N19 112.308 4.108 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.146 0 O4'-C1'-N19 111.33 3.13 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 O4'-C1'-N19 113.325 5.125 . 0.594 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.669 0 O4'-C1'-N19 111.618 3.418 . 0.541 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.969 0 C5'-C4'-O4' 113.5 3.071 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.159 1 O4'-C1'-N19 114.151 5.951 . 0.536 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.339 0 O4'-C1'-N19 111.789 3.589 . 0.715 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.249 0 C5'-C4'-C3' 111.069 -2.954 . 0.514 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.568 -3.232 0 C4'-C3'-C2' 99.819 -2.881 . 0.136 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ' U' . . . . . 0.409 HO2' " H5'" ' A' ' 49' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.374 1 O4'-C1'-N19 113.455 5.255 . 0.808 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ' G' . . . . . 0.409 " H5'" HO2' ' A' ' 48' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.022 0 N19-C1'-C2' 108.912 -2.805 . 0.584 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ' A' . . . . . 0.404 ' H62' ' NE2' ' I' ' 284' ' ' GLN . . . . . . . . 0 O4'--C4' 1.43 -1.884 1 O4'-C1'-N19 115.506 7.306 . 0.669 1c . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.996 0 O4'-C1'-N19 110.77 2.57 . 0.062 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 1 C3'-C2'-C1' 105.108 4.008 . 0.108 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.221 1 O4'-C1'-N19 114.026 5.826 . 0.022 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 O4'-C1'-N19 111.938 3.738 . 0.392 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 O4'-C1'-N19 112.075 3.875 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ' G' . . . . . 0.435 HO2' " H5'" ' A' ' 57' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.538 2.168 0 O4'-C1'-N19 111.273 3.073 . 0.604 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ' G' . . . . . 0.435 " H5'" HO2' ' A' ' 56' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.538 2.143 1 O4'-C1'-N19 112.725 4.525 . 0.353 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.025 1 O4'-C1'-N19 112.658 4.458 . 0.695 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ' C' . . . . . 0.462 HO2' " H5'" ' A' ' 60' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.539 2.216 1 O4'-C1'-N19 114.604 6.404 . 0.595 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ' G' . . . . . 0.462 " H5'" HO2' ' A' ' 59' ' ' ' C' . . . . . . . . 0 C5'--C4' 1.538 2.171 0 C4'-C3'-C2' 99.17 -3.53 . 0.301 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 110.447 2.247 . 0.795 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.289 0 O4'-C1'-N19 111.972 3.772 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.461 2 O4'-C1'-N19 115.6 7.4 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.05 0 C4'-C3'-C2' 100.299 -2.401 . 0.238 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.902 0 C5'-C4'-C3' 110.281 -3.479 . 0.563 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.793 0 O4'-C1'-N19 111.984 3.784 . 0.225 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.422 0 O5'-C5'-C4' 114.423 3.016 . 0.409 0i . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.382 1 O4'-C1'-N19 112.812 4.612 . 0.731 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.178 1 O4'-C1'-N19 112.511 4.311 . 0.676 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.204 1 O4'-C1'-N19 112.406 4.206 OUTLIER-EPSILON 0.489 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 1 P-O3'-C3' 126.52 5.684 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.013 0 N19-C1'-C2' 109.556 -2.403 . 0.189 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 0 C3'-C2'-C1' 103.903 2.669 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.885 2 C4'-C3'-C2' 96.579 -6.121 . 0.199 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.426 1 O4'-C1'-N19 113.959 5.759 . 0.235 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.884 0 O4'-C1'-N19 111.647 3.447 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 C4'-C3'-C2' 99.145 -3.555 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.087 0 O4'-C1'-N19 112.09 3.89 . 0.698 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.29 0 C4'-C3'-C2' 99.664 -3.036 . 0.701 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.062 1 O4'-C1'-N19 114.561 6.361 . 0.431 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.441 0 O4'-C1'-N19 111.796 3.596 . 0.604 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 P-O3'-C3' 123.325 3.021 . 0.396 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.57 -3.067 0 C4'-C3'-C2' 99.949 -2.751 . 0.074 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.532 0 O4'-C1'-N19 111.568 3.368 . 0.674 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.115 1 O4'-C1'-N19 113.086 4.886 . 0.487 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O5'-C5'-C4' 115.608 3.863 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.554 2.696 3 O4'-C1'-N19 113.773 5.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.566 0 O4'-C1'-N19 111.299 3.099 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ' G' . . . . . 0.408 HO2' " H5'" ' B' ' 18' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.41 -1.881 2 O4'-C1'-N19 113.96 5.76 . 0.027 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ' A' . . . . . 0.408 " H5'" HO2' ' B' ' 17' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.539 2.252 1 C5'-C4'-O4' 116.001 4.858 . 0.188 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.95 1 O4'-C1'-N19 112.816 4.616 . 0.537 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.984 1 O4'-C1'-N19 112.318 4.118 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ' G' . . . . . 0.448 ' P ' ' HZ3' ' C' ' 290' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 O4'-C1'-N19 111.683 3.483 . 0.582 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.427 0 O4'-C1'-N19 111.023 2.823 . 0.267 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ' C' . . . . . 0.4 HO2' " H5'" ' B' ' 24' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.541 2.388 1 O4'-C1'-N19 112.892 4.692 . 0.335 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ' G' . . . . . 0.4 " H5'" HO2' ' B' ' 23' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.293 1 O4'-C1'-N19 112.253 4.053 . 0.622 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.228 1 C3'-C2'-C1' 105.47 4.411 . 0.373 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 1 C3'-C2'-C1' 105.297 4.219 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.94 2 O4'-C1'-N19 112.934 4.734 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 112.377 4.177 . 0.615 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.035 0 O4'-C1'-N19 111.951 3.751 . 0.401 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 O4'-C1'-N19 113.254 5.054 . 0.231 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 1 C5'-C4'-C3' 109.381 -4.079 . 0.527 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 1 O4'-C1'-N19 112.528 4.328 . 0.639 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.173 0 O4'-C1'-N19 112.061 3.861 . 0.866 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.451 0 O4'-C1'-N19 111.323 3.123 . 0.714 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.729 0 C3'-C2'-C1' 104.592 3.436 . 0.427 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 1 C3'-C2'-C1' 106.159 5.176 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ' A' . . . . . 0.445 " H2'" ' C8 ' ' B' ' 38' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 O4'-C1'-N19 112.064 3.864 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ' A' . . . . . 0.445 ' C8 ' " H2'" ' B' ' 37' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.543 2.54 1 O4'-C1'-N19 113.164 4.964 . 0.0 OUTLIER '7D dist 1a' 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 O4'-C1'-N19 111.085 2.885 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.931 2.731 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.201 0 C4'-C3'-C2' 99.132 -3.568 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.96 0 C4'-C3'-C2' 98.94 -3.76 . 0.538 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.081 0 C4'-C3'-C2' 99.027 -3.673 . 0.596 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 1 O4'-C1'-N19 114.494 6.294 . 0.464 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.282 0 O4'-C1'-N19 111.527 3.327 . 0.689 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 P-O3'-C3' 123.679 3.316 . 0.428 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.477 0 O4'-C1'-N19 110.557 2.357 . 0.257 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.884 1 O4'-C1'-N19 112.588 4.388 . 0.397 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.134 2 O4'-C1'-N19 113.975 5.775 OUTLIER-EPSILON 0.444 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 3 P-O3'-C3' 126.25 5.458 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.344 0 C5'-C4'-O4' 113.779 3.271 . 0.029 7d . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.155 1 O4'-C1'-N19 112.734 4.534 . 0.566 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.074 1 O4'-C1'-N19 113.31 5.11 . 0.593 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.198 1 O4'-C1'-N19 113.679 5.479 . 0.314 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.192 1 O4'-C1'-N19 114.118 5.918 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.117 1 C4'-C3'-C2' 97.677 -5.023 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.118 0 O4'-C1'-N19 112.098 3.898 . 0.691 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ' G' . . . . . 0.427 HO2' " H5'" ' B' ' 59' ' ' ' C' . . . . . . . . 0 C5'--C4' 1.542 2.454 1 O4'-C1'-N19 112.946 4.746 . 0.491 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ' C' . . . . . 0.427 " H5'" HO2' ' B' ' 58' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 112.026 3.826 . 0.613 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C4'-C3'-C2' 99.278 -3.422 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.05 0 C4'-C3'-C2' 99.098 -3.602 . 0.618 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 1 C4'-C3'-C2' 98.674 -4.026 . 0.345 1e . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 2.982 5 O4'-C1'-N19 117.483 9.283 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.129 0 O4'-C1'-N19 111.918 3.718 . 0.01 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.583 -2.022 1 C5'-C4'-C3' 108.857 -4.429 . 0.415 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 C3'-C2'-C1' 105.039 3.933 . 0.087 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 1 C5'-C4'-O4' 115.26 4.328 . 0.158 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.821 0 O4'-C1'-N19 111.577 3.377 . 0.893 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.876 1 O4'-C1'-N19 113.939 5.739 . 0.898 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ' C' . . . . . 0.521 HO2' " C5'" ' B' ' 71' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.412 -1.725 1 O4'-C1'-N19 112.676 4.476 OUTLIER-EPSILON 0.504 1a . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ' G' . . . . . 0.521 " C5'" HO2' ' B' ' 70' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.424 1 P-O3'-C3' 126.92 6.017 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 C4'-C3'-C2' 100.974 -1.726 . 0.544 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.76 147.15 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.084 0.856 . . . . 0.0 109.946 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 47.6 t -150.26 159.66 44.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.634 1.974 . . . . 0.0 110.647 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.37 145.46 47.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.584 1.554 . . . . 0.0 110.79 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 179.3 6.71 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.502 0.721 . . . . 0.0 111.995 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -38.35 -33.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -114.2 -8.88 12.93 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.44 -168.12 40.03 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 117.031 1.572 . . . . 0.0 117.031 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -135.01 130.52 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 127.036 2.134 . . . . 0.0 107.92 -165.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 133.95 34.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.614 0.766 . . . . 0.0 112.027 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.59 122.92 49.09 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.164 0.986 . . . . 0.0 111.468 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -122.87 144.19 49.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.385 1.474 . . . . 0.0 110.846 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.28 173.16 11.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.14 -4.25 37.6 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -92.04 -47.07 7.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.938 1.245 . . . . 0.0 111.518 163.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.03 27.58 0.17 Allowed Glycine 0 CA--C 1.534 1.254 0 N-CA-C 117.836 1.894 . . . . 0.0 117.836 163.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -109.53 151.4 26.81 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.536 1.668 . . . . 0.0 112.691 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.03 132.2 45.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 mt -98.18 -54.81 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.617 1.567 . . . . 0.0 109.731 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -152.09 153.58 34.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.996 1.318 . . . . 0.0 111.423 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -133.96 143.86 48.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.259 1.423 . . . . 0.0 112.198 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -124.63 160.4 28.56 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.935 2.094 . . . . 0.0 111.003 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -118.18 155.27 30.78 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.524 1.93 . . . . 0.0 108.368 168.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -71.65 138.2 48.47 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 46.6 p -90.37 9.9 27.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.341 1.457 . . . . 0.0 113.66 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -142.11 167.74 21.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.342 1.457 . . . . 0.0 110.803 165.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.37 130.19 80.6 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.9 1.28 . . . . 0.0 109.994 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.76 -41.22 47.98 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.257 2.638 . . . . 0.0 114.092 -155.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -59.22 -36.91 76.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.299 0.954 . . . . 0.0 112.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -70.53 -31.73 68.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.648 1.179 . . . . 0.0 112.396 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.18 -40.66 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.434 1.494 . . . . 0.0 111.592 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 mt -68.27 -35.14 77.42 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.211 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.35 -43.74 79.41 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 121.041 1.746 . . . . 0.0 112.434 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.13 -49.85 76.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.622 0.769 . . . . 0.0 111.111 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.72 -28.2 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 47.3 mt -76.93 -44.42 31.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.702 1.601 . . . . 0.0 112.057 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.37 -16.03 58.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.187 0.995 . . . . 0.0 113.436 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.81 16.85 4.82 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 167.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -117.61 155.53 29.7 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.629 2.215 . . . . 0.0 113.234 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 9.1 tp -82.81 143.99 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.26 . . . . 0.0 112.352 -170.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 62.1 p -129.32 155.42 45.65 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.772 1.229 . . . . 0.0 110.847 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -55.09 -33.15 62.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -72.46 -39.73 67.54 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.47 1.032 . . . . 0.0 112.466 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 tp -70.65 -37.39 73.73 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.446 171.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.58 -44.17 93.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 0.0 111.542 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 -35.57 77.9 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.794 -1.191 . . . . 0.0 112.424 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.83 -51.59 63.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.753 0.706 . . . . 0.0 111.713 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.48 -26.6 66.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.48 1.036 . . . . 0.0 112.702 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -74.94 -30.8 61.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.707 168.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t -61.59 -42.73 99.28 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.527 1.512 . . . . 0.0 111.746 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.68 -36.78 84.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.659 -1.276 . . . . 0.0 111.945 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.05 -33.17 74.93 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.257 1.023 . . . . 0.0 113.218 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -71.16 -38.33 72.18 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.55 -1.344 . . . . 0.0 110.94 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.65 0.66 14.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.13 1.372 . . . . 0.0 114.546 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.01 24.21 35.65 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -91.33 125.82 36.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.369 1.585 . . . . 0.0 109.883 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.71 -20.54 13.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -174.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.25 140.35 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.831 1.253 . . . . 0.0 111.788 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -130.41 141.99 50.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 111.916 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -131.6 118.12 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.114 1.366 . . . . 0.0 109.437 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -115.31 178.8 4.16 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.951 1.7 . . . . 0.0 111.695 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -91.68 -41.95 10.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -96.58 133.17 25.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.519 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.05 -30.81 83.34 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.906 2.404 . . . . 0.0 113.636 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.41 -33.66 13.75 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.458 -0.776 . . . . 0.0 112.523 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.83 -37.13 75.74 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.924 -0.485 . . . . 0.0 110.354 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -66.23 -37.62 85.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.223 0.609 . . . . 0.0 112.493 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -65.03 -46.34 81.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.234 1.414 . . . . 0.0 111.328 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.14 -36.52 84.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.711 0.804 . . . . 0.0 112.467 172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.87 92.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.341 0.973 . . . . 0.0 113.212 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -72.14 -33.23 67.61 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 119.76 1.163 . . . . 0.0 113.382 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.24 -23.78 65.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.555 -0.716 . . . . 0.0 112.72 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -78.52 -6.49 55.6 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.527 1.531 . . . . 0.0 113.722 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.37 25.43 7.01 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -118.0 147.41 43.22 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 119.043 1.421 . . . . 0.0 112.647 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' SER . . . . . . . . . . . . . 61.2 m -71.7 76.95 0.84 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.223 1.011 . . . . 0.0 111.8 166.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.02 141.35 37.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.55 -1.344 . . . . 0.0 113.226 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' THR . . . . . . . . . . . . . 44.6 p -142.31 175.49 9.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.244 1.818 . . . . 0.0 111.762 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -122.18 130.03 52.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.165 1.386 . . . . 0.0 111.691 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.56 98.27 1.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.697 1.199 . . . . 0.0 108.013 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.24 -37.73 18.06 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.747 -1.22 . . . . 0.0 113.658 -171.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -70.31 14.77 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.823 3.015 . . . . 0.0 116.508 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -72.25 152.81 41.93 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.733 -1.229 . . . . 0.0 113.317 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 70.7 mt -54.82 -36.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.644 1.178 . . . . 0.0 113.78 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.35 81.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.36 0.982 . . . . 0.0 111.977 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.58 -35.97 27.51 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.29 0.471 . . . . 0.0 113.348 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.89 -40.77 98.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.074 0.549 . . . . 0.0 111.385 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -68.61 -53.59 21.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.968 0.907 . . . . 0.0 111.83 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.4 -41.02 75.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -84.66 -18.66 34.67 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.261 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 50.6 m -85.55 -38.51 18.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.323 1.42 . . . . 0.0 113.373 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.05 55.25 17.85 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.038 0.935 . . . . 0.0 111.139 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -58.22 -28.24 83.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.07 2.514 . . . . 0.0 113.306 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -63.71 -18.88 64.46 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.67 -23.7 56.25 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.866 1.266 . . . . 0.0 112.423 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -114.98 -37.23 4.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.476 1.11 . . . . 0.0 113.106 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.44 -4.69 13.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.519 1.528 . . . . 0.0 112.927 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.2 174.04 46.85 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.72 1.145 . . . . 0.0 114.445 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -69.99 2.46 3.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -101.05 1.21 39.24 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.996 1.719 . . . . 0.0 113.728 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -45.84 -36.57 5.36 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -165.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.07 -24.93 67.89 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.602 0.761 . . . . 0.0 112.818 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.34 -32.89 72.27 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.32 -0.863 . . . . 0.0 112.822 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -79.36 -39.1 33.43 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.434 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -53.34 -48.05 68.82 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.735 0.814 . . . . 0.0 111.5 168.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.58 -50.82 71.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.928 1.291 . . . . 0.0 112.36 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -61.05 -29.52 69.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.306 1.042 . . . . 0.0 113.157 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.47 -32.33 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.432 0.693 . . . . 0.0 112.466 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.75 89.29 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.625 1.102 . . . . 0.0 112.785 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.82 -33.31 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 122.061 -0.67 . . . . 0.0 112.346 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.62 -38.66 73.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.59 0.756 . . . . 0.0 112.686 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.84 -42.45 97.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.628 0.771 . . . . 0.0 111.182 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 26.4 m -63.43 -29.89 71.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.278 0.631 . . . . 0.0 112.368 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -75.11 -14.54 60.58 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.921 -1.112 . . . . 0.0 113.85 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' MET . . . . . . . . . . . . . 16.4 ttt -104.52 -26.8 12.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.594 1.958 . . . . 0.0 114.169 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -76.5 32.57 0.13 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 tt -143.38 143.36 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.523 1.929 . . . . 0.0 108.654 170.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -75.22 153.18 38.21 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -133.79 109.66 9.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 109.296 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -146.47 103.86 3.72 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.903 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' SER . . . . . . . . . . . . . 13.8 t -95.22 159.36 15.05 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.075 -1.016 . . . . 0.0 112.467 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.95 -10.04 56.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.513 -1.16 . . . . 0.0 114.552 164.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.88 31.65 0.94 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.23 1.015 . . . . 0.0 112.721 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.16 -42.56 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -165.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.45 -33.86 69.74 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.017 0.826 . . . . 0.0 112.428 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -67.29 -36.41 81.49 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.118 -0.988 . . . . 0.0 111.53 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' MET . . . . . . . . . . . . . 22.5 mmt -65.64 -42.11 91.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.83 0.852 . . . . 0.0 111.145 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.53 -40.09 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.898 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.96 -46.06 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.84 1.2 . . . . 0.0 110.67 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.55 -32.81 74.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.253 0.933 . . . . 0.0 112.474 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.08 -34.57 77.93 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.141 0.882 . . . . 0.0 113.073 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -70.05 -42.88 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.567 1.147 . . . . 0.0 111.687 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.44 -38.18 90.11 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.201 0.455 . . . . 0.0 110.637 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.83 75.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.509 0.723 . . . . 0.0 112.177 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -69.88 -40.67 75.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.549 1.068 . . . . 0.0 111.676 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.21 -39.96 74.85 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.611 -0.681 . . . . 0.0 112.324 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -66.59 -38.16 86.43 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.816 0.734 . . . . 0.0 112.55 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.7 -48.14 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.966 1.306 . . . . 0.0 111.122 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.9 -38.42 85.66 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.27 0.941 . . . . 0.0 111.244 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -66.67 -37.63 85.17 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.238 1.415 . . . . 0.0 113.784 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.24 -29.21 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.088 1.313 . . . . 0.0 113.143 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.37 -49.18 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.958 0.799 . . . . 0.0 109.218 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -55.55 -40.54 72.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.173 0.897 . . . . 0.0 112.501 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.24 -54.06 39.42 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.363 0.665 . . . . 0.0 112.135 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.08 -30.09 68.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.784 -0.573 . . . . 0.0 112.253 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.26 -35.85 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.845 0.858 . . . . 0.0 111.839 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.78 93.26 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.699 1.136 . . . . 0.0 111.989 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -43.48 81.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.46 0.704 . . . . 0.0 111.735 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.299 1.04 . . . . 0.0 112.393 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -59.07 -51.08 71.6 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.871 0.868 . . . . 0.0 111.41 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.54 -44.15 83.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -70.93 -46.04 63.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.982 0.513 . . . . 0.0 111.812 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.12 -24.89 65.06 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.654 -1.279 . . . . 0.0 112.284 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 71.1 m -63.59 -16.91 62.16 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.82 -32.78 74.63 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.056 1.298 . . . . 0.0 111.457 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -106.78 -21.04 13.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.84 1.256 . . . . 0.0 114.039 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.58 72.33 7.44 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-N 119.867 1.212 . . . . 0.0 112.084 172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.12 -20.51 67.42 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.184 3.256 . . . . 0.0 115.342 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -70.79 -16.88 62.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.442 1.097 . . . . 0.0 113.25 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.95 -28.5 62.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.842 1.257 . . . . 0.0 113.348 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.63 -48.45 74.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.931 0.892 . . . . 0.0 113.072 -167.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.62 -24.1 61.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.281 1.032 . . . . 0.0 112.266 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.79 -29.92 23.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.88 1.272 . . . . 0.0 113.665 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.8 mt -117.42 85.17 19.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.282 1.433 . . . . 0.0 110.399 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.1 -32.81 10.34 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.781 2.32 . . . . 0.0 113.527 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -71.94 112.59 8.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.973 1.309 . . . . 0.0 111.199 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -58.01 -51.22 83.33 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -168.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.43 -28.15 71.08 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 122.701 2.0 . . . . 0.0 113.161 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.05 -32.57 69.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.914 -1.116 . . . . 0.0 111.751 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -69.16 -42.1 76.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.067 0.947 . . . . 0.0 111.616 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.59 -55.21 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.147 0.979 . . . . 0.0 110.988 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.7 80.61 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.44 -54.5 44.99 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.588 -0.695 . . . . 0.0 111.041 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.14 -36.65 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.794 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.23 -49.45 69.42 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.334 1.454 . . . . 0.0 112.071 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' THR . . . . . . . . . . . . . 34.4 m -90.42 -29.82 17.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.37 -49.87 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 111.889 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.28 -101.52 0.24 Allowed Glycine 0 CA--C 1.535 1.306 0 CA-C-N 118.928 0.785 . . . . 0.0 111.69 -168.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.55 139.06 45.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.428 -1.043 . . . . 0.0 113.548 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -60.76 -13.52 15.61 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.35 -4.46 57.08 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.715 1.598 . . . . 0.0 113.685 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.75 3.98 17.74 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.515 -0.741 . . . . 0.0 112.993 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -77.23 120.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 120.837 -1.164 . . . . 0.0 109.43 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -140.97 151.4 44.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.437 1.495 . . . . 0.0 109.795 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -49.35 -38.64 28.85 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.082 1.353 . . . . 0.0 112.579 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -62.57 -53.72 50.44 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.99 0.916 . . . . 0.0 112.671 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.03 -30.16 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.528 -0.733 . . . . 0.0 112.938 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.44 -34.81 70.6 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.585 -0.697 . . . . 0.0 111.763 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.35 -28.17 47.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.221 1.009 . . . . 0.0 112.957 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.33 -46.96 75.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.259 0.936 . . . . 0.0 111.398 165.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.61 -5.29 3.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.963 1.305 . . . . 0.0 112.826 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.32 70.65 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.646 -1.085 . . . . 0.0 115.129 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.02 157.41 28.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.794 1.297 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' SER . . . . . . . . . . . . . 85.8 p -80.25 153.63 28.38 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.708 -0.62 . . . . 0.0 112.158 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -54.03 -31.55 51.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -62.71 -52.83 61.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.48 1.112 . . . . 0.0 111.912 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.23 -31.17 72.26 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.817 -0.552 . . . . 0.0 111.273 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.59 -17.82 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 127.033 2.133 . . . . 0.0 112.702 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -71.65 -26.87 62.73 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.853 -1.154 . . . . 0.0 111.774 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.19 -167.69 1.62 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.279 1.431 . . . . 0.0 109.081 159.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' ILE . . . . . . . . . . . . . 43.6 mt 64.22 -64.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.879 1.672 . . . . 0.0 111.995 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.51 -42.43 98.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 111.74 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.19 -37.48 74.85 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.661 -0.65 . . . . 0.0 112.037 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.53 -36.55 52.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 112.578 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -56.88 -34.47 67.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.616 1.166 . . . . 0.0 112.604 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.94 -11.77 60.02 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 4.41 3.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' THR . . . . . . . . . . . . . 8.1 t -49.68 143.13 7.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -94.67 3.17 55.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.927 1.691 . . . . 0.0 113.553 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.86 160.56 41.6 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.951 0.786 . . . . 0.0 114.193 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.71 -165.63 0.65 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.775 1.23 . . . . 0.0 112.024 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -117.31 113.82 22.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.671 1.188 . . . . 0.0 112.024 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 86.9 mtp -93.12 135.18 34.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.53 1.132 . . . . 0.0 109.581 159.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.98 168.4 15.47 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.285 -0.885 . . . . 0.0 111.779 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -55.91 -36.67 67.94 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.548 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' THR . . . . . . . . . . . . . 3.0 m -71.01 -26.28 63.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.858 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.41 -50.11 6.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.629 1.172 . . . . 0.0 111.642 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.73 -22.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.295 -0.878 . . . . 0.0 112.833 -168.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.98 -27.63 68.96 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.549 -0.719 . . . . 0.0 111.964 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.42 -40.35 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 120.376 1.443 . . . . 0.0 110.803 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.33 -30.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.404 0.682 . . . . 0.0 111.266 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -66.51 -41.84 88.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.983 0.913 . . . . 0.0 112.264 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.02 -39.34 90.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.366 1.066 . . . . 0.0 111.373 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.14 -44.15 83.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.62 0.645 . . . . 0.0 111.561 170.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.01 -37.6 84.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.14 -42.63 93.67 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.42 -0.8 . . . . 0.0 112.352 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -24.98 64.01 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 62.6 mt -73.4 -33.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 120.53 -1.356 . . . . 0.0 111.112 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.33 -28.97 63.4 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.846 -1.159 . . . . 0.0 111.98 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -57.89 -50.74 72.32 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.825 -1.172 . . . . 0.0 110.797 162.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.15 -38.59 80.09 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -29.59 68.9 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.041 -1.037 . . . . 0.0 113.154 174.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.12 -41.81 63.61 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.81 0.732 . . . . 0.0 111.301 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.86 -40.45 76.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.059 0.845 . . . . 0.0 111.928 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -53.31 -46.27 69.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.938 0.895 . . . . 0.0 111.679 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.16 -39.47 86.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.502 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -61.67 -33.13 73.43 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 119.915 1.234 . . . . 0.0 112.686 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' LEU . . . . . . . . . . . . . 83.4 mt -66.94 -46.49 74.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 0.0 111.991 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.14 -41.35 98.19 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.61 -31.1 61.9 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.598 1.159 . . . . 0.0 113.14 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.42 -48.79 79.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.108 0.867 . . . . 0.0 110.923 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.55 -37.76 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.974 0.509 . . . . 0.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.61 -25.33 68.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.154 0.982 . . . . 0.0 113.508 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -87.15 -48.73 7.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.645 1.178 . . . . 0.0 112.524 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.66 -29.35 67.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.246 1.018 . . . . 0.0 113.303 -170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' MET . . . . . . . . . . . . . 96.3 mmm -72.18 7.99 1.49 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.3 -24.39 16.78 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.764 1.62 . . . . 0.0 112.857 167.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -88.83 79.41 7.4 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.906 -1.746 . . . . 0.0 111.929 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.09 136.91 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.481 1.512 . . . . 0.0 112.013 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' ALA . . . . . . . . . . . . . . . -156.68 158.66 31.45 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.241 1.416 . . . . 0.0 113.341 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.61 154.41 11.92 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.663 3.575 . . . . 0.0 113.227 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -79.94 -43.85 21.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.76 1.624 . . . . 0.0 113.719 -170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.33 -31.57 70.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.102 -0.999 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.54 -29.77 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.292 1.037 . . . . 0.0 112.702 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ALA . . . . . . . . . . . . . . . -92.74 -38.03 12.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.181 0.992 . . . . 0.0 113.292 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.32 -36.84 66.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.59 -30.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.69 166.81 42.58 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 119.121 0.873 . . . . 0.0 114.811 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' ALA . . . . . . . . . . . . . . . -54.71 -41.9 70.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -163.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.29 -34.48 57.47 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.056 1.342 . . . . 0.0 112.562 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 23.6 tp -101.43 -40.55 7.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.059 0.944 . . . . 0.0 112.282 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.16 70.81 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.089 0.858 . . . . 0.0 112.763 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' ALA . . . . . . . . . . . . . . . -69.91 -25.86 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.518 -0.739 . . . . 0.0 112.522 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -47.23 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.23 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -40.14 96.41 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.841 0.746 . . . . 0.0 111.546 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.97 -46.89 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.365 0.666 . . . . 0.0 110.887 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' SER . . . . . . . . . . . . . 13.1 t -69.82 -32.3 70.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.93 -24.81 37.91 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.338 0.972 . . . . 0.0 112.524 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.13 -1.6 49.33 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 164.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.28 -29.41 1.67 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.111 1.339 . . . . 0.0 114.845 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.44 173.37 43.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.294 1.547 . . . . 0.0 113.91 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.96 -30.34 61.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.326 -1.102 . . . . 0.0 113.152 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -57.62 -49.46 76.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.3 0.955 . . . . 0.0 109.63 167.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -67.49 -42.1 83.44 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.457 1.103 . . . . 0.0 110.548 -173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.3 -40.94 87.77 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.28 0.632 . . . . 0.0 112.302 171.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.29 -29.69 68.52 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.42 -0.8 . . . . 0.0 112.736 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' MET . . . . . . . . . . . . . 13.4 mmt -80.55 -1.64 42.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.702 1.201 . . . . 0.0 113.95 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' MET . . . . . . . . . . . . . 52.2 mtt -94.12 150.36 38.3 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.171 1.35 . . . . 0.0 113.89 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.2 155.42 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.694 2.929 . . . . 0.0 111.992 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' SER . . . . . . . . . . . . . 67.0 p -50.19 -46.38 54.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.683 1.193 . . . . 0.0 112.986 170.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' SER . . . . . . . . . . . . . 7.9 p -73.7 16.23 0.22 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.188 1.795 . . . . 0.0 114.668 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' THR . . . . . . . . . . . . . 97.4 m -124.68 -36.27 2.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.929 -1.732 . . . . 0.0 110.58 158.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.65 -30.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.851 1.26 . . . . 0.0 112.232 171.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.99 -33.27 64.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.581 . . . . 0.0 113.128 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.97 2.5 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.473 1.509 . . . . 0.0 113.933 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' LEU . . . . . . . . . . . . . 40.2 mt -53.7 129.19 32.31 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.471 -0.768 . . . . 0.0 109.954 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 66.76 26.33 73.05 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.291 -0.727 . . . . 0.0 114.29 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.1 -16.86 57.62 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.96 1.38 . . . . 0.0 112.138 159.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.06 -119.88 1.55 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.713 2.005 . . . . 0.0 111.875 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' LYS . . . . . 0.448 ' HZ3' ' P ' ' B' ' 21' ' ' ' G' . 24.5 mtpp -45.42 -27.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' ALA . . . . . . . . . . . . . . . -77.74 -37.53 49.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.162 0.892 . . . . 0.0 113.135 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' LEU . . . . . . . . . . . . . 49.2 tp -73.13 -47.05 47.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.469 0.577 . . . . 0.0 110.138 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -47.84 -52.78 17.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.983 1.313 . . . . 0.0 113.053 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -83.52 -20.01 34.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -61.5 -34.77 76.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.961 0.8 . . . . 0.0 111.45 165.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 -75.88 0.17 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.701 0.8 . . . . 0.0 111.345 167.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -55.88 -42.55 76.11 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -163.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 298' ' ' THR . . . . . . . . . . . . . 75.8 p -108.81 6.68 25.74 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 299' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.96 74.02 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.363 -0.836 . . . . 0.0 114.0 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 300' ' ' ALA . . . . . . . . . . . . . . . -71.46 -173.13 0.86 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.668 1.187 . . . . 0.0 114.024 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 301' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.45 126.2 46.31 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.518 1.527 . . . . 0.0 111.32 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 302' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -59.43 132.1 44.32 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.14 1.893 . . . . 0.0 112.228 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 303' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.28 123.49 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.468 2.112 . . . . 0.0 111.617 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.25 -32.64 68.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.047 0.939 . . . . 0.0 112.662 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 305' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.45 149.62 15.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.286 1.834 . . . . 0.0 110.647 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 306' ' ' GLY . . . . . . . . . . . . . . . -100.18 -136.38 9.32 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.701 1.619 . . . . 0.0 112.386 169.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 307' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.1 -14.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.813 1.245 . . . . 0.0 114.353 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 308' ' ' ILE . . . . . . . . . . . . . 39.0 pt -61.03 -12.27 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.092 1.357 . . . . 0.0 114.144 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 309' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -53.78 -37.78 63.82 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 310' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.49 19.16 1.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 311' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -62.2 146.1 92.91 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.799 -1.188 . . . . 0.0 111.571 170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 312' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -48.41 1.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 1 C-N-CA 127.123 5.215 . . . . 0.0 120.303 176.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 313' ' ' ALA . . . . . . . . . . . . . . . -145.8 22.74 1.42 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.111 1.364 . . . . 0.0 114.421 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 314' ' ' ILE . . . . . . . . . . . . . 68.1 mt -117.94 -70.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.791 -1.193 . . . . 0.0 112.022 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 315' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -64.86 6.51 0.23 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 316' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -135.8 18.86 3.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.756 1.622 . . . . 0.0 114.437 -171.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.4 m -142.3 163.41 39.7 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.127 0.971 . . . . 0.0 112.998 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 318' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -59.69 150.11 78.7 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.47 3.447 . . . . 0.0 114.188 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -55.52 -37.93 68.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 320' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -49.32 -37.44 24.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.191 1.796 . . . . 0.0 113.036 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 321' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.45 -33.06 14.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.155 0.982 . . . . 0.0 111.316 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 322' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -54.72 -39.96 68.75 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 323' ' ' GLY . . . . . . . . . . . . . . . -77.13 -37.65 31.91 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 118.575 0.625 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 324' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -73.43 -43.5 60.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.607 1.163 . . . . 0.0 111.464 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 325' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.35 -34.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.961 0.904 . . . . 0.0 111.636 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.18 -46.83 87.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 327' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -77.96 -35.76 49.87 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 328' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.17 95.78 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.878 0.763 . . . . 0.0 112.259 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 329' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.64 -43.99 89.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.54 1.136 . . . . 0.0 111.496 172.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.78 73.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 331' ' ' GLY . . . . . . . . . . . . . . . -57.44 -59.94 9.92 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.642 1.115 . . . . 0.0 111.645 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 332' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -61.1 -33.08 72.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.583 -0.951 . . . . 0.0 113.379 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 333' ' ' LEU . . . . . . . . . . . . . 36.8 mt -66.98 -38.6 86.36 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.123 0.969 . . . . 0.0 113.356 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 334' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.43 75.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.962 0.801 . . . . 0.0 111.9 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.44 -53.64 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.863 -0.523 . . . . 0.0 110.025 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 336' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.57 87.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.68 -37.31 86.11 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.674 -0.641 . . . . 0.0 112.49 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 338' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -68.96 -38.59 79.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.397 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 339' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.3 -53.07 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.223 0.609 . . . . 0.0 110.996 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 340' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -67.39 -26.83 66.64 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 341' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -86.8 -50.62 6.61 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 342' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.55 -23.98 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 343' ' ' SER . . . . . . . . . . . . . 67.1 m -133.33 -35.7 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 344' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.18 74.28 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.183 0.897 . . . . 0.0 114.75 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 345' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -88.38 145.04 26.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.877 1.271 . . . . 0.0 110.675 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 346' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -95.0 124.14 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.003 -1.06 . . . . 0.0 113.158 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 347' ' ' ILE . . . . . . . . . . . . . 45.4 pt -137.18 6.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.025 1.73 . . . . 0.0 113.09 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 348' ' ' ALA . . . . . . . . . . . . . . . -63.71 -18.59 64.17 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -160.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 349' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.45 -28.56 66.22 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.353 1.433 . . . . 0.0 111.959 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 350' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.55 -40.69 49.06 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.553 -0.717 . . . . 0.0 110.963 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 351' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.64 -33.98 73.6 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.867 -0.521 . . . . 0.0 111.827 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 352' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.3 -51.05 57.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.34 1.056 . . . . 0.0 111.348 169.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 353' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -56.15 -42.14 76.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.68 1.127 . . . . 0.0 112.604 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 354' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.26 -34.93 79.24 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.079 0.854 . . . . 0.0 112.506 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 355' ' ' LEU . . . . . . . . . . . . . 25.1 tp -83.09 -21.44 33.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.95 0.9 . . . . 0.0 113.26 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -50.27 67.04 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.32 -1.487 . . . . 0.0 109.979 158.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 357' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.43 79.91 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.323 1.049 . . . . 0.0 113.183 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 358' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -64.91 -31.85 73.29 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.16 0.891 . . . . 0.0 112.316 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 359' ' ' ILE . . . . . . . . . . . . . 87.3 mt -79.95 -29.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.742 1.155 . . . . 0.0 111.73 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 360' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -64.6 -38.22 90.25 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.702 1.137 . . . . 0.0 111.938 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -43.26 93.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.144 0.978 . . . . 0.0 111.544 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 362' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.25 -27.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.834 0.854 . . . . 0.0 111.195 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 363' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.13 -46.25 21.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.009 -1.057 . . . . 0.0 112.848 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 364' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.93 -26.56 66.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.203 0.911 . . . . 0.0 112.147 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 365' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -77.81 -43.15 31.45 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 366' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.955 1.302 . . . . 0.0 112.752 -168.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 117.484 -1.246 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 156.07 45.26 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.318 2.012 . . . . 0.0 113.047 -172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' SER . . . . . . . . . . . . . 80.9 p -72.45 -13.96 61.57 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -88.45 -17.33 30.64 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.8 60.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 122.353 1.073 . . . . 0.0 111.228 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.82 -10.97 60.64 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -165.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -124.7 145.29 49.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.549 1.068 . . . . 0.0 112.583 170.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.98 119.4 17.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.492 0.717 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.07 126.98 55.35 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.443 0.697 . . . . 0.0 111.487 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.21 177.38 7.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.158 3.239 . . . . 0.0 112.857 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -69.88 20.18 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.38 164.51 29.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.11 2.164 . . . . 0.0 110.24 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' LEU . . . . . . . . . . . . . 43.1 mt 64.85 -35.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.27 74.2 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.891 1.678 . . . . 0.0 111.885 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.39 -26.69 68.86 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.331 -0.856 . . . . 0.0 112.502 174.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tttp -76.11 -31.09 58.5 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.42 1.088 . . . . 0.0 111.688 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.7 69.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.014 0.925 . . . . 0.0 111.696 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -49.57 77.32 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 171.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.11 -39.35 82.0 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.379 1.072 . . . . 0.0 112.619 174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.04 87.82 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.296 -0.878 . . . . 0.0 112.086 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.66 -50.44 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.567 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -53.9 -41.08 67.23 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 pt -95.09 -19.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -30.92 67.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.752 1.16 . . . . 0.0 111.627 167.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -42.2 -39.86 2.19 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.14 2.576 . . . . 0.0 115.835 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.86 1.61 12.71 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 7.2 p -131.85 -17.06 2.85 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.71 -144.06 9.82 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.375 1.464 . . . . 0.0 111.768 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -140.31 128.74 22.68 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.848 1.659 . . . . 0.0 107.103 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 tt -150.2 144.9 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.041 0.936 . . . . 0.0 110.857 -158.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -125.53 154.53 42.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.067 1.347 . . . . 0.0 111.191 170.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.9 34.69 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.76 1.624 . . . . 0.0 111.153 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.74 152.76 19.98 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 123.924 0.765 . . . . 0.0 111.568 -164.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' THR . . . . . . . . . . . . . 13.3 m -78.83 -30.25 45.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.455 -1.259 . . . . 0.0 114.044 -166.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.0 -41.15 60.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 121.974 2.17 . . . . 0.0 111.627 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -65.01 -38.57 91.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.675 -1.266 . . . . 0.0 112.568 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' THR . . . . . . . . . . . . . 51.2 m -53.87 -53.17 56.25 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.951 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 40.2 m -54.11 -49.45 69.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.569 1.148 . . . . 0.0 111.795 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -69.17 -41.14 77.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.541 1.064 . . . . 0.0 113.038 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.92 -8.46 56.56 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.524 1.056 . . . . 0.0 113.815 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.25 -34.82 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.573 1.549 . . . . 0.0 109.753 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -72.28 -53.2 13.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.291 1.405 . . . . 0.0 112.214 167.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -100.11 140.42 34.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.979 1.312 . . . . 0.0 113.141 -158.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.67 -159.47 34.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.971 0.762 . . . . 0.0 112.943 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -108.2 85.37 2.1 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.08 -1.247 . . . . 0.0 111.664 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.85 151.31 18.2 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.572 -0.705 . . . . 0.0 111.368 161.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -108.73 -38.67 5.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.201 1.0 . . . . 0.0 112.547 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 tp -154.13 151.04 28.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.19 2.196 . . . . 0.0 109.92 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -129.0 143.12 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.617 1.167 . . . . 0.0 111.183 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.43 138.08 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.527 1.931 . . . . 0.0 109.083 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -125.41 154.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.627 1.571 . . . . 0.0 109.888 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.81 155.94 27.64 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.284 -1.51 . . . . 0.0 112.655 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.5 -8.01 56.92 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.35 21.58 13.97 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.682 1.193 . . . . 0.0 113.88 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.63 127.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.594 -0.691 . . . . 0.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -150.95 113.15 3.12 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.838 0.855 . . . . 0.0 109.133 -167.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.59 142.83 29.71 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.491 1.211 . . . . 0.0 113.622 0.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.58 -25.58 65.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.652 0.739 . . . . 0.0 112.176 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -54.99 -33.37 62.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.922 2.489 . . . . 0.0 113.461 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -35.54 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 O-C-N 121.488 -0.758 . . . . 0.0 111.358 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -102.2 -9.99 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.19 1.396 . . . . 0.0 113.942 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.46 -18.09 25.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -73.72 -25.79 60.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.422 1.089 . . . . 0.0 113.892 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.67 -40.17 29.89 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.881 -171.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.79 -55.87 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.038 1.825 . . . . 0.0 114.283 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.55 -34.05 65.68 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.776 2.027 . . . . 0.0 112.309 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.23 -29.91 71.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.457 -0.777 . . . . 0.0 112.37 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.17 -25.58 47.27 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.5 -1.375 . . . . 0.0 113.476 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.95 -27.51 57.59 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.433 1.093 . . . . 0.0 113.707 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.62 -25.89 60.53 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.448 1.099 . . . . 0.0 112.317 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -127.52 17.26 6.99 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -168.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 63.8 25.71 14.17 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 167.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 20.6 mm -104.07 140.56 21.18 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.927 1.291 . . . . 0.0 111.488 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.42 152.03 26.37 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.557 2.838 . . . . 0.0 112.764 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -133.36 157.02 46.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.492 1.117 . . . . 0.0 112.121 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -151.8 166.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.585 1.554 . . . . 0.0 109.898 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 158.48 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.17 154.62 80.17 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 126.392 1.877 . . . . 0.0 111.966 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -68.34 -6.45 17.53 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 N-CA-C 119.113 2.697 . . . . 0.0 119.113 -157.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 10.5 t -162.37 134.89 5.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.724 1.602 . . . . 0.0 114.098 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -62.15 -31.52 72.01 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 113.391 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -75.62 -36.97 60.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.62 0.768 . . . . 0.0 111.442 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -70.68 -36.32 73.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.514 0.726 . . . . 0.0 112.052 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -68.03 -37.67 81.63 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 112.212 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.17 -45.97 95.46 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.862 -0.524 . . . . 0.0 112.567 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.49 77.96 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.439 -1.036 . . . . 0.0 113.089 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.0 90.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.676 0.79 . . . . 0.0 111.976 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.59 -21.76 65.4 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.03 30.86 8.02 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.988 1.28 . . . . 0.0 114.521 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' ILE . . . . . . . . . . . . . 35.6 pt -120.2 142.09 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.298 1.439 . . . . 0.0 109.676 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . 0.344 5.5 pt-20 -84.39 1.2 46.35 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.09 -149.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.149 1.78 . . . . 0.0 111.238 166.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.58 171.33 7.55 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.058 1.743 . . . . 0.0 111.9 172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.77 17.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.857 . . . . 0.0 110.239 165.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.92 -31.79 63.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -151.83 163.44 39.19 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -141.67 139.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.814 2.046 . . . . 0.0 110.098 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.0 137.09 54.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.058 1.343 . . . . 0.0 113.173 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -102.24 119.5 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.092 1.357 . . . . 0.0 110.241 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.26 -44.16 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.28 1.432 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -126.83 134.85 26.52 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.889 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -74.02 -21.0 18.74 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.561 1.507 . . . . 0.0 114.932 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.75 -117.6 12.12 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.69 -27.12 68.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.72 1.208 . . . . 0.0 113.47 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.22 7.46 5.12 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 23.6 ttm105 -64.84 -39.81 94.17 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.138 -1.601 . . . . 0.0 113.935 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.09 -30.14 66.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.202 1.001 . . . . 0.0 111.741 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.67 -44.6 70.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.729 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.47 -39.96 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.033 0.933 . . . . 0.0 110.988 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -64.18 -44.03 93.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.667 0.667 . . . . 0.0 112.152 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.79 -42.78 94.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.448 -0.783 . . . . 0.0 112.425 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.22 -48.38 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 110.652 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.79 96.51 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.671 0.669 . . . . 0.0 112.082 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' MET . . . . . . . . . . . . . 19.8 mmt -60.13 -46.68 88.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.186 0.594 . . . . 0.0 112.29 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.01 -35.88 59.38 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.69 -38.59 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.25 -32.87 71.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -91.59 -10.08 41.84 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -77.18 -46.98 21.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.669 1.188 . . . . 0.0 111.145 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp -78.21 6.02 9.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.654 1.582 . . . . 0.0 115.227 -171.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' LYS . . . . . . . . . . . . . 76.0 tttt . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.55 1.54 . . . . 0.0 114.935 -152.386 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -60.45 149.07 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.592 0.633 . . . . 0.0 112.085 164.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -138.96 132.83 30.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.959 1.304 . . . . 0.0 110.053 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.14 132.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.869 1.268 . . . . 0.0 108.312 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -138.05 156.59 47.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.642 1.177 . . . . 0.0 110.407 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.66 145.7 36.51 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.552 -1.342 . . . . 0.0 110.4 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.93 173.7 9.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 110.861 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -74.46 17.05 0.21 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -136.51 132.52 18.78 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.316 1.846 . . . . 0.0 110.097 -176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.17 132.02 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.391 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -12.16 34.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.671 1.129 . . . . 0.0 115.786 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.8 138.08 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.217 1.508 . . . . 0.0 110.65 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -120.06 166.93 12.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.753 1.221 . . . . 0.0 112.166 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.59 145.42 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.365 1.866 . . . . 0.0 108.618 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.21 143.36 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.211 0.605 . . . . 0.0 110.336 164.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.99 151.34 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.072 1.349 . . . . 0.0 108.526 163.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . 0.428 ' CG ' ' HZ2' ' E' ' 23' ' ' LYS . 52.5 p30 -146.74 -154.52 0.55 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -163.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -70.09 -17.64 63.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.995 2.118 . . . . 0.0 115.037 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.403 ' CG ' ' HZ1' ' E' ' 23' ' ' LYS . 0.7 OUTLIER -94.36 -22.68 18.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.726 1.603 . . . . 0.0 112.426 159.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.93 77.43 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.104 1.335 . . . . 0.0 115.387 170.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -69.38 151.17 46.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.312 1.556 . . . . 0.0 111.904 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -69.64 134.53 48.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.813 0.845 . . . . 0.0 111.496 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' LYS . . . . . 0.428 ' HZ2' ' CG ' ' E' ' 17' ' ' ASP . 7.1 mptt -123.74 141.88 51.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.312 1.445 . . . . 0.0 109.919 164.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 pt -77.34 140.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.784 0.833 . . . . 0.0 112.004 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.64 166.42 28.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.846 0.858 . . . . 0.0 113.19 -172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' THR . . . . . . . . . . . . . 44.6 p -137.72 148.48 45.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.349 1.459 . . . . 0.0 111.78 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -82.4 116.16 21.75 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.895 0.878 . . . . 0.0 109.634 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.06 123.87 19.67 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.886 0.851 . . . . 0.0 112.758 -165.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.9 -33.16 73.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.204 1.402 . . . . 0.0 111.642 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.92 85.38 40.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.077 1.751 . . . . 0.0 110.324 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.13 135.31 69.8 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.608 2.872 . . . . 0.0 114.106 -174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -33.39 6.54 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.887 1.708 . . . . 0.0 114.848 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 144.39 33.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.118 1.459 . . . . 0.0 113.807 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' ARG . . . . . 0.413 HH22 ' CD ' ' E' ' 47' ' ' GLU . 0.4 OUTLIER -103.89 161.6 13.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.975 1.71 . . . . 0.0 110.082 174.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.23 -50.93 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.815 1.246 . . . . 0.0 111.447 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -128.51 6.24 5.7 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.73 30.33 18.55 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.892 -1.13 . . . . 0.0 113.451 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -53.3 158.14 1.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.533 1.933 . . . . 0.0 115.75 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -76.61 137.5 39.53 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 162.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' VAL . . . . . . . . . . . . . 84.3 t -137.02 155.05 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.86 1.264 . . . . 0.0 110.927 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 58.2 mt -136.4 119.5 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.262 1.825 . . . . 0.0 108.717 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -78.58 142.11 37.55 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.418 -0.801 . . . . 0.0 109.43 162.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -139.77 179.18 6.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.237 1.015 . . . . 0.0 112.042 -169.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -57.34 90.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.504 1.922 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.07 9.39 85.42 Favored Glycine 0 CA--C 1.545 1.95 0 C-N-CA 125.397 1.475 . . . . 0.0 115.427 -177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -142.73 171.5 13.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.511 1.656 . . . . 0.0 113.081 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' GLU . . . . . 0.413 ' CD ' HH22 ' E' ' 34' ' ' ARG . 27.3 tt0 -139.45 138.24 36.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.132 1.373 . . . . 0.0 110.1 168.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -124.68 137.27 54.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.422 1.489 . . . . 0.0 111.166 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -125.04 142.53 51.43 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.362 1.465 . . . . 0.0 111.553 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.66 145.47 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.078 1.351 . . . . 0.0 110.157 -172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -105.05 114.44 28.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.431 1.093 . . . . 0.0 108.544 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -76.36 122.29 86.46 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.171 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.36 -27.1 47.77 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.563 2.175 . . . . 0.0 113.647 -169.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -71.2 -1.96 14.34 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -100.14 -23.06 14.95 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.46 1.104 . . . . 0.0 113.481 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.56 129.39 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.977 0.911 . . . . 0.0 111.051 174.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -50.29 -34.81 24.75 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.308 1.843 . . . . 0.0 114.434 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.67 -32.56 74.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.813 0.733 . . . . 0.0 111.922 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.71 -48.61 65.72 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 118.298 0.499 . . . . 0.0 111.97 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.902 -0.763 . . . . 0.0 112.997 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.68 94.34 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 112.923 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' ILE . . . . . . . . . . . . . 90.5 mt -68.2 -34.98 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.299 1.039 . . . . 0.0 111.106 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.47 -41.17 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.057 0.943 . . . . 0.0 111.702 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -65.32 -48.23 73.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.0 0.92 . . . . 0.0 111.645 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.03 11.62 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.62 118.86 3.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.183 1.992 . . . . 0.0 111.027 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -106.9 -37.32 6.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.434 1.093 . . . . 0.0 112.775 -167.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -86.91 57.48 4.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.575 1.15 . . . . 0.0 112.878 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -84.08 120.2 74.41 Favored Pre-proline 0 CA--C 1.55 0.962 0 O-C-N 121.237 -0.915 . . . . 0.0 112.045 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -97.55 -17.55 0.23 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 115.194 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.3 114.17 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.478 1.036 . . . . 0.0 109.1 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -143.22 158.35 58.39 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.292 1.437 . . . . 0.0 111.078 -166.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -46.1 125.25 8.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.496 3.464 . . . . 0.0 114.817 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.47 87.07 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.11 1.604 . . . . 0.0 117.11 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -75.98 163.85 26.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.344 2.072 . . . . 0.0 113.071 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -105.54 132.74 51.32 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.558 1.143 . . . . 0.0 111.789 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.79 145.09 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.474 1.11 . . . . 0.0 111.927 -173.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' LEU . . . . . . . . . . . . . 10.6 tt -119.5 129.95 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.773 1.229 . . . . 0.0 109.167 169.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.4 136.14 53.83 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.701 1.601 . . . . 0.0 109.062 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.19 131.79 55.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.491 1.116 . . . . 0.0 109.968 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.1 59.34 1.11 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 124.873 1.225 . . . . 0.0 112.523 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 tt -103.99 -28.45 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 127.292 2.237 . . . . 0.0 112.936 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 83' ' ' ALA . . . . . . . . . . . . . . . 40.2 -124.11 0.43 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.908 1.283 . . . . 0.0 112.568 -167.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -79.72 -3.94 49.68 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.65 33.49 10.06 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 119.214 2.446 . . . . 0.0 119.214 159.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -46.78 88.93 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.732 2.266 . . . . 0.0 111.946 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -48.36 -52.82 19.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.253 1.821 . . . . 0.0 112.126 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.01 -32.16 72.61 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.113 1.365 . . . . 0.0 112.618 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 89' ' ' SER . . . . . . . . . . . . . 14.3 p -61.92 -39.49 92.21 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 90' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.69 -36.26 37.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.584 -0.697 . . . . 0.0 112.249 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.99 -28.38 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 120.189 1.358 . . . . 0.0 112.791 170.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' SER . . . . . . . . . . . . . 12.8 t -58.83 -41.98 88.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.5 1.12 . . . . 0.0 112.007 168.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.06 -45.11 82.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.661 0.785 . . . . 0.0 112.859 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.68 -38.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.352 1.461 . . . . 0.0 112.118 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 74.0 t -81.74 -36.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.946 0.898 . . . . 0.0 111.719 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.47 -170.46 45.5 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.673 1.13 . . . . 0.0 114.738 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -67.75 -18.04 64.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.01 -23.31 55.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.975 1.31 . . . . 0.0 113.851 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.74 -165.73 27.17 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.303 0.954 . . . . 0.0 114.117 -172.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -146.73 126.42 13.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.274 1.429 . . . . 0.0 109.777 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mt -125.71 123.7 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.099 0.96 . . . . 0.0 110.077 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 102' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.7 138.39 40.41 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.201 1.0 . . . . 0.0 109.891 164.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.46 115.72 2.22 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.886 1.232 . . . . 0.0 111.356 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.46 133.54 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.554 1.542 . . . . 0.0 109.276 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -132.83 144.28 50.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.072 0.949 . . . . 0.0 112.689 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 106' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -98.98 -33.58 10.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.483 1.513 . . . . 0.0 112.877 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 107' ' ' SER . . . . . . . . . . . . . 45.5 t -71.53 114.76 30.93 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 119.469 1.031 . . . . 0.0 110.553 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.6 -38.92 2.18 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.518 1.479 . . . . 0.0 113.899 -159.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -82.98 -31.05 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.95 -25.82 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.273 0.942 . . . . 0.0 112.835 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.86 -27.58 66.81 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.217 -0.927 . . . . 0.0 112.956 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -54.67 -36.96 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.759 1.224 . . . . 0.0 112.494 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -69.63 -22.81 63.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.038 . . . . 0.0 112.82 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 tp -77.16 -21.15 54.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.002 1.721 . . . . 0.0 112.945 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.05 -43.87 99.44 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.338 1.455 . . . . 0.0 114.6 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -29.38 5.2 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 122.509 1.932 . . . . 0.0 113.158 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' ILE . . . . . . . . . . . . . 58.5 mt -66.21 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.65 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -73.61 -7.13 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -71.42 -22.65 61.82 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.704 1.593 . . . . 0.0 112.197 167.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -92.88 -47.92 6.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.775 0.716 . . . . 0.0 111.947 164.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -83.02 57.29 3.84 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.866 1.266 . . . . 0.0 112.662 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 -69.55 10.16 0.39 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.96 -6.09 51.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 165.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.99 139.79 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.814 2.045 . . . . 0.0 110.284 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' ILE . . . . . . . . . . . . . 59.3 mt -119.66 115.92 33.49 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.084 1.353 . . . . 0.0 109.262 165.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -85.04 135.11 5.38 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.872 3.048 . . . . 0.0 111.351 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' ILE . . . . . . . . . . . . . 59.1 mt -134.98 124.93 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.13 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.77 121.71 33.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.86 0.864 . . . . 0.0 110.927 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.72 21.91 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.665 1.126 . . . . 0.0 114.471 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.23 115.58 5.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.306 1.05 . . . . 0.0 111.972 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.12 -23.66 48.63 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.119 1.368 . . . . 0.0 113.623 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' THR . . . . . . . . . . . . . 1.1 m -78.43 -12.1 59.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.036 1.735 . . . . 0.0 113.277 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -128.76 77.63 77.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.944 1.698 . . . . 0.0 110.789 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.16 -31.81 47.11 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.034 3.156 . . . . 0.0 115.013 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -60.13 -23.12 63.63 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.869 1.268 . . . . 0.0 112.552 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -74.66 -6.9 51.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.28 1.832 . . . . 0.0 114.685 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.66 7.11 3.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.841 1.656 . . . . 0.0 113.816 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -45.7 -26.3 0.61 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 118.253 2.686 . . . . 0.0 118.253 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.47 -19.07 30.11 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.926 1.29 . . . . 0.0 114.224 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 73.7 mt -116.44 17.36 15.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.3 1.44 . . . . 0.0 113.439 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.91 164.06 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.541 1.536 . . . . 0.0 111.47 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' THR . . . . . . . . . . . . . 72.0 p -135.01 176.34 8.75 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.332 1.453 . . . . 0.0 111.686 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.31 141.92 58.58 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.35 -0.844 . . . . 0.0 111.181 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -129.08 160.01 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.282 1.433 . . . . 0.0 113.162 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.46 -30.64 42.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.514 1.526 . . . . 0.0 113.042 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.89 142.81 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.44 1.496 . . . . 0.0 110.352 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 147' ' ' ILE . . . . . . . . . . . . . 83.2 mt -117.41 142.32 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.102 0.961 . . . . 0.0 110.217 161.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -128.56 136.34 50.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.055 1.342 . . . . 0.0 110.477 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -126.36 120.75 30.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.998 1.319 . . . . 0.0 110.532 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -149.19 31.13 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.549 1.54 . . . . 0.0 112.411 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 t -70.15 -45.14 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 123.438 1.59 . . . . 0.0 106.95 157.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . 0.256 . . 50.78 48.5 22.73 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.934 2.094 . . . . 0.0 112.166 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 153' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -67.92 166.82 20.31 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.819 2.048 . . . . 0.0 110.528 166.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 154' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.4 -28.36 53.44 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.653 2.235 . . . . 0.0 113.356 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 155' ' ' THR . . . . . . . . . . . . . 68.8 p -80.48 2.3 25.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.366 1.866 . . . . 0.0 114.523 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 156' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -60.37 -27.62 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -161.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.21 85.64 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.865 -1.147 . . . . 0.0 112.025 172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 158' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -72.19 -38.06 69.14 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.751 -1.119 . . . . 0.0 111.728 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 159' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.53 -55.53 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.008 0.822 . . . . 0.0 110.202 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 160' ' ' LEU . . . . . . . . . . . . . 26.7 tp -63.26 -49.24 74.9 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.985 -0.447 . . . . 0.0 112.176 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 161' ' ' ILE . . . . . . . . . . . . . 51.4 mt -64.7 -47.92 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.478 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -37.17 62.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.739 1.154 . . . . 0.0 112.333 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 163' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -61.38 -34.09 74.76 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.048 -1.032 . . . . 0.0 111.571 167.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 164' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.42 58.07 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.568 -1.333 . . . . 0.0 114.553 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -71.64 -50.48 30.3 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.136 1.334 . . . . 0.0 110.025 162.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.25 25.28 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -112.88 -24.97 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -160.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.53 126.9 31.8 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.155 1.343 . . . . 0.0 111.795 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 169' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.87 161.21 26.82 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -60.33 136.06 57.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 171' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.6 62.6 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.074 -1.403 . . . . 0.0 116.045 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -76.84 166.35 54.01 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.622 1.582 . . . . 0.0 115.026 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 173' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -107.79 156.94 18.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.985 1.314 . . . . 0.0 113.9 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.69 150.11 20.02 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.694 1.14 . . . . 0.0 112.114 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mtm -136.32 139.17 42.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.516 1.526 . . . . 0.0 109.935 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 176' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.45 131.77 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.263 0.625 . . . . 0.0 112.572 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 177' ' ' ALA . . . . . . . . . . . . . . . -92.82 89.89 6.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.86 1.264 . . . . 0.0 110.991 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 178' ' ' VAL . . . . . . . . . . . . . 23.2 t -72.51 102.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.374 1.469 . . . . 0.0 111.888 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 179' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -84.54 75.3 10.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.902 2.081 . . . . 0.0 109.424 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -41.94 -48.83 4.57 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.827 1.251 . . . . 0.0 113.898 -169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -18.96 64.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 182' ' ' SER . . . . . . . . . . . . . 50.2 m -99.16 -11.82 21.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.954 1.252 . . . . 0.0 113.363 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -88.87 -46.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.134 0.879 . . . . 0.0 110.474 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -157.07 114.1 3.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.431 0.692 . . . . 0.0 110.544 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 185' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.65 -1.08 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -6.21 57.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.323 1.449 . . . . 0.0 113.391 -171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 187' ' ' LYS . . . . . 0.406 ' HE2' HG22 ' E' ' 192' ' ' VAL . 18.6 pttt -143.37 158.32 43.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.293 1.437 . . . . 0.0 113.63 -173.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -55.39 134.43 70.03 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.872 1.269 . . . . 0.0 110.469 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 189' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.9 -33.88 53.48 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.523 2.815 . . . . 0.0 115.807 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 190' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.47 -25.95 66.41 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.684 -1.26 . . . . 0.0 113.806 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 191' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -73.19 -38.44 66.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.664 1.12 . . . . 0.0 111.744 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 192' ' ' VAL . . . . . 0.406 HG22 ' HE2' ' E' ' 187' ' ' LYS . 12.6 t -65.12 -49.33 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.279 1.031 . . . . 0.0 109.871 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 193' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.19 -33.33 72.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.282 1.033 . . . . 0.0 112.575 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 194' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -72.57 -35.6 67.99 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.165 0.893 . . . . 0.0 113.278 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 195' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.2 -39.88 71.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.582 1.083 . . . . 0.0 112.571 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 196' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.1 -41.62 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.655 0.661 . . . . 0.0 110.415 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 197' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.15 -42.7 96.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.794 -1.192 . . . . 0.0 112.812 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.31 -22.73 47.73 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -78.85 -46.51 18.47 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.486 1.039 . . . . 0.0 110.912 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.67 -35.66 81.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.148 -0.97 . . . . 0.0 111.915 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 201' ' ' SER . . . . . . . . . . . . . 77.6 p -78.46 11.15 2.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 202' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.48 12.24 31.65 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.653 1.181 . . . . 0.0 113.15 162.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 203' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -143.78 -45.28 0.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 204' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -98.48 170.99 8.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.072 1.749 . . . . 0.0 111.689 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 205' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.52 134.65 41.18 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.43 -0.794 . . . . 0.0 109.76 153.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 206' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.51 131.04 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 207' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.41 -29.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -157.6 146.57 19.65 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.499 1.045 . . . . 0.0 113.041 174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 209' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -134.5 132.07 38.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.593 1.957 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 210' ' ' LEU . . . . . . . . . . . . . 65.6 tp -137.94 123.31 19.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.245 1.418 . . . . 0.0 111.636 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 211' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -79.77 139.33 37.31 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 161.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 212' ' ' LEU . . . . . . . . . . . . . 73.0 mt -79.41 -3.48 46.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.88 148.04 92.75 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 121.057 -1.027 . . . . 0.0 111.892 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 214' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.68 27.64 17.35 Favored 'Cis proline' 0 CA--C 1.546 1.12 0 CA-C-N 119.928 1.01 . . . . 0.0 114.191 2.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 215' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -92.15 -52.42 4.71 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.472 -0.767 . . . . 0.0 109.824 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 216' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -129.68 -173.5 3.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.966 1.306 . . . . 0.0 111.235 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 217' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.7 145.98 50.39 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.861 -1.149 . . . . 0.0 113.566 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 218' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 55.6 0.75 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 128.445 2.698 . . . . 0.0 117.669 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 219' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.26 143.04 32.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.157 1.783 . . . . 0.0 109.886 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.5 156.63 42.96 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.353 -0.842 . . . . 0.0 112.847 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.69 126.9 55.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.078 1.351 . . . . 0.0 109.601 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 222' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -112.78 140.37 47.62 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.769 1.228 . . . . 0.0 109.388 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.28 137.97 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 122.214 1.006 . . . . 0.0 111.322 171.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 17.1 m -142.19 167.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 111.896 -162.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -136.58 135.66 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.597 1.159 . . . . 0.0 111.75 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 226' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.03 133.61 54.16 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.852 1.661 . . . . 0.0 108.451 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 227' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 122.838 2.359 . . . . 0.0 113.896 178.412 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' ILE . . . . . . . . . . . . . 71.1 mt -119.27 146.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.584 1.084 . . . . 0.0 110.795 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' SER . . . . . . . . . . . . . 9.0 t -151.8 166.21 32.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.941 1.697 . . . . 0.0 110.151 165.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -137.92 157.45 46.37 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 112.504 -167.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -139.91 -178.64 5.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 112.06 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' VAL . . . . . . . . . . . . . 69.9 t -54.76 -18.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.095 1.758 . . . . 0.0 115.511 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -108.01 -16.72 14.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.102 1.361 . . . . 0.0 114.095 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.97 38.16 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.29 131.6 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.095 2.158 . . . . 0.0 108.744 -166.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -135.99 139.55 43.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 112.352 -166.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.07 134.87 55.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.187 0.995 . . . . 0.0 112.149 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -134.9 148.36 50.06 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 113.834 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.65 13.36 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.567 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.22 6.93 5.76 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.34 0.16 14.72 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.884 1.674 . . . . 0.0 112.377 165.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.74 63.52 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.115 1.816 . . . . 0.0 115.47 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -71.01 139.84 50.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.996 1.398 . . . . 0.0 110.709 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' LEU . . . . . . . . . . . . . 19.7 tp -68.46 149.16 49.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.479 0.582 . . . . 0.0 111.055 170.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.72 -55.27 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 109.706 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.86 158.66 38.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.3 1.44 . . . . 0.0 110.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -139.85 143.1 36.6 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.784 2.033 . . . . 0.0 111.266 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -131.4 154.69 48.37 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.736 1.615 . . . . 0.0 110.789 171.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.49 150.23 38.24 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.164 1.386 . . . . 0.0 112.143 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -73.58 144.89 45.84 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' THR . . . . . . . . . . . . . 69.5 p -127.59 0.69 6.19 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -113.72 170.05 8.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.545 1.938 . . . . 0.0 109.261 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -56.19 112.44 4.38 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.394 1.478 . . . . 0.0 109.546 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.51 -19.7 14.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.83 2.353 . . . . 0.0 114.362 -154.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' GLU . . . . . . . . . . . . . 10.7 pm0 -57.03 -36.44 70.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.636 1.107 . . . . 0.0 112.509 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -65.78 -49.22 69.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.419 1.088 . . . . 0.0 111.539 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.98 -38.84 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.346 1.459 . . . . 0.0 110.208 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 mt -64.39 -49.31 72.09 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.793 1.237 . . . . 0.0 112.015 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.66 -35.8 80.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.939 1.7 . . . . 0.0 112.972 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -57.24 -58.27 8.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.72 0.808 . . . . 0.0 111.189 168.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.03 -33.5 75.89 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -66.94 -34.36 77.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.028 1.331 . . . . 0.0 111.787 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -94.53 12.67 26.59 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.777 1.631 . . . . 0.0 113.846 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.35 85.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -89.87 143.14 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.583 1.191 . . . . 0.0 111.496 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 tt -91.88 136.24 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.872 0.844 . . . . 0.0 112.333 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -114.8 160.31 19.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.932 1.693 . . . . 0.0 110.411 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -63.38 -36.17 82.82 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.133 -0.979 . . . . 0.0 113.357 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.42 -28.62 68.76 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.89 -39.5 50.73 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.121 -0.987 . . . . 0.0 111.503 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.64 -38.33 84.44 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.646 1.179 . . . . 0.0 111.909 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -74.67 -36.76 62.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.88 -46.74 83.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.831 0.852 . . . . 0.0 111.713 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.06 -29.76 67.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.618 -0.676 . . . . 0.0 112.43 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -65.14 -46.68 79.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.042 -0.504 . . . . 0.0 111.302 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 5.3 t -60.39 -37.94 82.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.392 0.677 . . . . 0.0 111.87 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.35 -42.53 87.94 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.121 -0.987 . . . . 0.0 113.096 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.076 1.307 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.62 -34.6 78.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.343 1.457 . . . . 0.0 112.222 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -86.04 -0.94 56.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.376 1.87 . . . . 0.0 114.063 171.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.39 34.83 11.41 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 117.265 1.666 . . . . 0.0 117.265 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.11 141.33 36.85 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.425 1.612 . . . . 0.0 112.699 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -135.89 -15.56 1.77 Allowed 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 -171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -81.54 50.21 1.44 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 119.411 -2.055 . . . . 0.0 115.331 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -63.71 87.3 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 p -101.41 127.59 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.566 1.146 . . . . 0.0 112.185 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.12 170.16 8.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.866 2.067 . . . . 0.0 112.107 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.58 -42.06 15.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.06 134.93 20.08 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-N 119.395 0.998 . . . . 0.0 112.017 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 64' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.75 -42.89 62.8 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.093 2.529 . . . . 0.0 114.368 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.81 -18.84 60.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.581 -0.699 . . . . 0.0 112.598 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 66' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.94 -41.64 67.58 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.518 -0.739 . . . . 0.0 110.757 171.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -60.1 -33.58 72.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.157 0.583 . . . . 0.0 111.353 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 68' ' ' ARG . . . . . 0.463 HH12 ' CD ' ' F' ' 72' ' ' GLU . 0.4 OUTLIER -68.77 -47.35 66.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.901 1.68 . . . . 0.0 112.158 177.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -64.46 -34.98 79.47 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.975 0.807 . . . . 0.0 112.02 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.75 93.33 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.308 0.958 . . . . 0.0 113.082 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.91 -21.75 59.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 72' ' ' GLU . . . . . 0.463 ' CD ' HH12 ' F' ' 68' ' ' ARG . 23.9 tt0 -70.7 -34.99 72.54 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.804 0.841 . . . . 0.0 113.01 165.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 73' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.72 0.13 13.89 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.761 1.224 . . . . 0.0 112.684 168.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.78 -17.61 52.36 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.874 2.178 . . . . 0.0 115.221 173.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.18 130.92 35.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.98 1.39 . . . . 0.0 112.052 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p -71.26 88.6 0.85 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.05 -1.031 . . . . 0.0 112.634 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.75 42.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 78' ' ' THR . . . . . . . . . . . . . 45.0 p -126.14 176.99 6.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.316 1.846 . . . . 0.0 111.913 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -130.86 131.21 44.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 0.0 112.331 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -155.95 123.59 5.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.911 1.684 . . . . 0.0 109.307 163.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 81' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.07 -49.66 9.79 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.167 -0.958 . . . . 0.0 113.324 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 82' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.38 22.92 0.32 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 123.226 2.617 . . . . 0.0 115.763 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -69.8 162.16 28.42 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.333 1.053 . . . . 0.0 113.832 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 84' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.05 -28.35 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.098 0.959 . . . . 0.0 113.182 -168.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.48 72.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.21 0.914 . . . . 0.0 112.397 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.01 -34.99 90.04 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 112.014 -0.435 . . . . 0.0 112.014 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -65.65 -48.28 72.7 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.778 . . . . 0.0 112.541 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 88' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -59.88 -51.58 69.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.787 0.835 . . . . 0.0 111.164 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.29 -53.32 59.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.81 1.644 . . . . 0.0 111.614 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 90' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 -75.48 -17.12 60.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -86.45 -28.17 23.65 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 92' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -125.46 62.97 42.58 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.244 0.929 . . . . 0.0 111.576 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 93' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.68 -31.14 86.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.947 2.432 . . . . 0.0 113.51 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.49 -26.12 67.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.71 1.204 . . . . 0.0 113.451 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.06 -27.07 64.34 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 119.817 1.189 . . . . 0.0 113.201 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 96' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -119.45 -19.18 8.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -163.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 97' ' ' LEU . . . . . . . . . . . . . 13.3 tp -134.67 -2.48 2.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.171 1.389 . . . . 0.0 114.178 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 -169.72 46.12 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.407 1.004 . . . . 0.0 114.591 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.48 -48.38 70.05 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 121.741 -0.858 . . . . 0.0 112.159 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.51 35.96 0.52 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.95 1.3 . . . . 0.0 113.1 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 101' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -54.45 -41.11 69.07 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -69.22 -27.75 65.75 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 103' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.69 -34.21 69.46 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.945 -1.097 . . . . 0.0 112.113 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.3 -43.06 64.76 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.673 -0.642 . . . . 0.0 111.027 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -55.8 -43.8 77.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.304 169.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.63 -50.75 70.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.637 0.775 . . . . 0.0 112.092 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 107' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -54.62 -42.89 71.72 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.796 1.238 . . . . 0.0 112.348 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.82 -31.68 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.373 0.669 . . . . 0.0 112.132 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.88 -44.2 96.18 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 119.182 0.901 . . . . 0.0 112.935 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.92 -32.42 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.304 1.052 . . . . 0.0 112.76 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.12 -43.97 69.88 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.477 -0.764 . . . . 0.0 111.72 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.55 -43.83 97.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.657 1.183 . . . . 0.0 111.353 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -59.58 -34.7 73.04 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.939 0.896 . . . . 0.0 112.647 171.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -73.11 -33.54 65.63 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.196 0.907 . . . . 0.0 113.275 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' MET . . . . . . . . . . . . . 22.9 ptm -78.9 -24.32 44.2 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.873 1.215 . . . . 0.0 113.659 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -76.03 10.41 1.92 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' ILE . . . . . . . . . . . . . 90.1 mt -67.68 95.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.81 1.186 . . . . 0.0 109.55 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -75.06 152.0 38.65 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -156.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -127.68 172.98 10.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.176 1.791 . . . . 0.0 110.135 152.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.89 129.39 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.58 1.552 . . . . 0.0 114.162 -149.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' SER . . . . . . . . . . . . . 60.1 p -145.1 147.98 33.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.037 0.935 . . . . 0.0 113.386 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.75 -1.85 68.22 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.767 1.467 . . . . 0.0 116.767 -169.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.47 6.8 8.95 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.956 1.378 . . . . 0.0 114.109 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -68.04 -22.8 64.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.218 -0.926 . . . . 0.0 113.24 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 -39.9 86.63 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.419 1.008 . . . . 0.0 112.48 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -63.9 -33.59 76.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.686 0.795 . . . . 0.0 111.065 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' MET . . . . . . . . . . . . . 27.3 mtt -73.72 -38.38 64.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.73 1.212 . . . . 0.0 111.946 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.21 -48.14 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 110.449 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.61 -43.93 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.433 0.56 . . . . 0.0 111.143 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.66 -36.93 81.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.596 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.68 78.79 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.661 1.119 . . . . 0.0 112.739 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.97 -50.76 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.621 1.169 . . . . 0.0 111.366 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -69.12 -26.77 65.07 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.514 1.052 . . . . 0.0 111.645 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.0 75.61 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.655 -1.278 . . . . 0.0 112.677 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -44.24 90.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.167 0.894 . . . . 0.0 109.587 171.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.47 -43.29 88.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.961 1.304 . . . . 0.0 112.341 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.99 -46.3 68.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.175 1.39 . . . . 0.0 112.504 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.92 -39.84 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.331 -1.48 . . . . 0.0 111.764 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.24 -32.8 70.31 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.771 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -74.66 -40.83 61.2 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 117.462 -1.256 . . . . 0.0 113.597 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.61 -37.18 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 121.038 1.745 . . . . 0.0 111.133 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.13 -48.51 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.522 0.729 . . . . 0.0 109.973 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -58.03 -39.79 79.24 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.616 1.098 . . . . 0.0 112.865 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.82 -47.66 71.33 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.035 -1.041 . . . . 0.0 112.492 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 145' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.73 -34.85 72.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.363 0.665 . . . . 0.0 111.977 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 146' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.63 -35.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.44 -0.787 . . . . 0.0 111.435 171.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.8 -40.6 92.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.021 1.282 . . . . 0.0 112.255 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -46.06 91.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.754 0.822 . . . . 0.0 111.092 171.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.4 -41.19 88.87 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.798 1.239 . . . . 0.0 112.309 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 150' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -64.71 -48.54 74.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.279 1.032 . . . . 0.0 111.907 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 151' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.44 -35.02 79.65 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.297 0.499 . . . . 0.0 112.025 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 152' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -74.74 -46.49 37.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 153' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -68.82 -20.51 64.31 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.623 -1.298 . . . . 0.0 112.625 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 70.2 m -65.02 -9.56 22.83 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 155' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.92 -8.71 59.11 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.097 0.959 . . . . 0.0 113.185 167.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 156' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -121.6 -30.34 4.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.47 1.508 . . . . 0.0 113.104 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.09 70.54 6.34 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 125.416 1.486 . . . . 0.0 110.953 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 158' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.27 -25.92 81.36 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.862 3.041 . . . . 0.0 114.508 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -66.85 -20.18 65.88 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.001 -1.062 . . . . 0.0 113.014 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.67 -35.42 72.82 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.283 -0.886 . . . . 0.0 112.76 -171.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 161' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.61 -31.13 70.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.585 -0.697 . . . . 0.0 111.937 171.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 162' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -82.15 4.47 23.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.177 1.391 . . . . 0.0 112.799 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 163' ' ' LEU . . . . . . . . . . . . . 37.8 tp -128.43 -31.34 2.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.188 1.395 . . . . 0.0 114.283 -172.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 164' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.31 87.2 39.82 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.672 1.189 . . . . 0.0 112.097 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 165' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -74.21 -16.04 22.56 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.145 2.564 . . . . 0.0 115.343 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 166' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -82.98 136.94 34.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.445 1.098 . . . . 0.0 111.06 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 167' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -83.13 -45.92 0.84 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 116.867 -1.54 . . . . 0.0 114.717 -168.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 168' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -59.79 -43.12 40.09 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.55 2.167 . . . . 0.0 113.631 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 169' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.6 -39.18 73.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.885 1.274 . . . . 0.0 112.717 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 170' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.06 -22.29 64.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.86 0.864 . . . . 0.0 113.007 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 171' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.07 -41.48 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.28 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.117 0.967 . . . . 0.0 112.602 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 173' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -56.46 -43.09 79.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.59 -34.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.722 0.809 . . . . 0.0 111.983 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -59.94 -41.24 91.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.544 1.137 . . . . 0.0 111.641 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 176' ' ' THR . . . . . . . . . . . . . 6.6 m -87.48 -50.05 6.8 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 177' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.28 -59.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.967 0.907 . . . . 0.0 111.65 -172.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 178' ' ' GLY . . . . . . . . . . . . . . . 68.28 -34.67 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.81 1.671 . . . . 0.0 116.802 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 179' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -80.91 114.68 19.95 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.824 1.812 . . . . 0.0 111.16 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -52.72 -33.24 46.96 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 181' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.42 -5.17 59.23 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 182' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -98.56 12.85 33.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 112.706 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 183' ' ' ILE . . . . . . . . . . . . . 73.6 mt -84.07 141.72 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.076 1.35 . . . . 0.0 110.943 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 184' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -150.95 165.4 33.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.546 2.738 . . . . 0.0 109.339 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 185' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -51.96 -44.18 63.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.832 1.196 . . . . 0.0 113.408 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 186' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -60.36 -42.9 96.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.693 1.197 . . . . 0.0 112.13 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 187' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.81 -7.99 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 188' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.25 -26.83 17.98 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.94 -1.1 . . . . 0.0 112.564 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 189' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -66.49 -50.76 62.19 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.618 1.167 . . . . 0.0 110.752 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.16 -31.94 73.38 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.291 -0.881 . . . . 0.0 113.272 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 191' ' ' LEU . . . . . . . . . . . . . 40.1 tp -64.78 -6.95 9.17 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.547 1.539 . . . . 0.0 113.283 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.66 33.58 27.31 Favored Glycine 0 CA--C 1.527 0.829 0 O-C-N 120.905 -1.122 . . . . 0.0 113.307 172.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.96 178.64 6.77 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 122.194 0.997 . . . . 0.0 110.583 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 194' ' ' SER . . . . . . . . . . . . . 44.0 p -116.18 152.41 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.602 1.961 . . . . 0.0 109.129 168.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 195' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.51 -40.88 62.91 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.505 1.048 . . . . 0.0 113.455 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 196' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.4 -13.47 58.72 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 114.221 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 197' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -99.93 -29.2 12.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.959 2.104 . . . . 0.0 111.984 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 198' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.72 -28.0 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.873 1.269 . . . . 0.0 113.035 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 199' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.96 -32.92 74.49 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.042 0.837 . . . . 0.0 112.444 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 200' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.38 164.51 26.32 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.379 -1.451 . . . . 0.0 108.707 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 201' ' ' ILE . . . . . . . . . . . . . 15.4 mt 67.66 -62.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 120.919 -1.113 . . . . 0.0 110.717 -151.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 202' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.63 -39.67 94.94 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.715 1.143 . . . . 0.0 113.281 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 203' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -54.65 -25.53 27.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.532 1.533 . . . . 0.0 113.099 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 204' ' ' ALA . . . . . . . . . . . . . . . -109.9 9.91 24.45 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.179 1.791 . . . . 0.0 113.481 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -47.57 -49.68 25.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.819 1.648 . . . . 0.0 114.484 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 206' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.56 -35.6 12.18 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.957 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 207' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -100.82 20.94 14.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -162.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 208' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.67 142.14 35.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.433 0.693 . . . . 0.0 110.584 162.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 209' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -78.13 8.22 5.15 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 210' ' ' GLY . . . . . . . . . . . . . . . -85.03 163.39 37.89 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.196 0.903 . . . . 0.0 114.668 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.33 -131.39 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.699 1.599 . . . . 0.0 113.73 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 212' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -137.54 108.24 6.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.108 1.363 . . . . 0.0 110.435 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 213' ' ' MET . . . . . . . . . . . . . 60.5 ttm -77.12 124.53 27.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.738 1.215 . . . . 0.0 108.969 162.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 214' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -65.09 156.98 29.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.941 0.896 . . . . 0.0 112.526 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 215' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -56.51 -21.67 27.63 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.653 1.181 . . . . 0.0 112.114 166.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 216' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.75 -14.07 25.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.448 1.499 . . . . 0.0 114.391 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 217' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.35 -42.05 14.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.534 1.061 . . . . 0.0 110.487 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 218' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.33 -23.38 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.61 -0.681 . . . . 0.0 111.717 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 219' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.37 -46.64 87.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.79 -33.73 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.468 1.031 . . . . 0.0 111.136 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 221' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.56 -36.52 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.93 0.892 . . . . 0.0 111.337 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 222' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -70.24 -46.08 65.17 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.707 1.203 . . . . 0.0 111.946 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 223' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -60.51 -33.01 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.629 1.104 . . . . 0.0 112.682 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 224' ' ' LEU . . . . . . . . . . . . . 9.9 tt -66.62 -46.48 75.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.712 0.805 . . . . 0.0 111.915 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.17 82.46 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 226' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -62.77 -37.32 86.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.11 1.364 . . . . 0.0 111.497 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 227' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.82 -33.36 75.45 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.394 -0.816 . . . . 0.0 112.248 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 228' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.21 -31.34 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.275 -0.891 . . . . 0.0 111.202 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 229' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.77 -43.71 98.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.029 1.74 . . . . 0.0 111.316 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 230' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -63.45 -33.34 75.34 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.55 -1.344 . . . . 0.0 111.779 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 231' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.51 -34.18 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 171.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 232' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -63.85 -36.02 82.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.588 1.54 . . . . 0.0 111.292 168.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 233' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -67.85 -39.83 83.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.645 172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 234' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.48 -44.86 95.49 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 121.104 1.775 . . . . 0.0 112.408 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 235' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -56.07 -42.19 76.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.37 0.668 . . . . 0.0 110.455 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 236' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -71.55 -36.44 70.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.557 0.743 . . . . 0.0 112.881 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 237' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -57.75 -41.35 81.75 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.549 1.14 . . . . 0.0 110.871 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 238' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.84 -41.36 64.9 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.351 1.06 . . . . 0.0 112.635 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.64 -21.44 63.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.668 1.587 . . . . 0.0 113.535 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 240' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.63 -40.76 33.39 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.327 1.451 . . . . 0.0 111.595 163.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 241' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -76.0 -28.39 57.78 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 242' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.5 -39.35 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.506 1.048 . . . . 0.0 111.941 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 243' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -38.38 51.99 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.791 -0.568 . . . . 0.0 111.214 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 244' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -59.36 -22.8 61.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.008 1.723 . . . . 0.0 114.33 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 245' ' ' ALA . . . . . . . . . . . . . . . -97.39 -11.29 24.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.056 1.342 . . . . 0.0 113.448 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 246' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.83 -31.19 15.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.51 1.124 . . . . 0.0 112.182 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 247' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.61 12.8 0.43 Allowed 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -167.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 248' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -70.12 -2.84 14.14 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 120.393 -1.442 . . . . 0.0 113.201 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 249' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.5 79.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 152.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.94 118.68 48.06 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -160.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 251' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.98 164.77 32.45 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.0 3.133 . . . . 0.0 113.045 166.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 252' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -64.23 -40.31 95.77 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.33 -0.856 . . . . 0.0 111.498 174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 253' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.91 -37.75 80.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 254' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -63.8 -60.28 3.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.659 0.784 . . . . 0.0 110.063 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 255' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.83 65.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -165.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 256' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.7 -27.59 66.95 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 257' ' ' VAL . . . . . . . . . . . . . 15.6 m -140.88 -46.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.0 150.23 5.18 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.68 1.127 . . . . 0.0 114.024 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 259' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.98 79.79 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 260' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.42 -27.96 68.92 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.849 -1.157 . . . . 0.0 112.529 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 261' ' ' LEU . . . . . . . . . . . . . 18.8 tp -75.12 -45.55 40.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.263 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 262' ' ' ALA . . . . . . . . . . . . . . . -59.36 -45.67 90.76 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.303 0.956 . . . . 0.0 112.573 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 263' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.44 84.17 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.579 0.752 . . . . 0.0 111.939 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 264' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -70.65 -35.36 72.84 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.133 -0.979 . . . . 0.0 113.527 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 265' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.92 -46.25 85.29 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.769 1.168 . . . . 0.0 111.249 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 266' ' ' ILE . . . . . . . . . . . . . 88.6 mt -71.32 -39.97 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 122.968 0.507 . . . . 0.0 110.951 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 267' ' ' SER . . . . . . . . . . . . . 22.7 t -58.05 -40.07 80.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.463 1.105 . . . . 0.0 113.026 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.42 -28.74 41.73 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.36 -33.46 61.06 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.388 0.995 . . . . 0.0 112.966 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.29 -4.73 77.53 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.743 1.639 . . . . 0.0 114.262 -172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.47 160.2 20.53 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.468 1.033 . . . . 0.0 112.86 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 272' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.09 -31.39 70.98 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.089 -0.654 . . . . 0.0 111.975 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 273' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -58.99 -48.83 80.18 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.0 0.92 . . . . 0.0 111.039 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 274' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -61.19 -46.45 90.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.335 1.054 . . . . 0.0 111.227 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -64.86 -38.29 90.49 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.697 -0.627 . . . . 0.0 112.397 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.49 -6.39 43.43 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.662 1.185 . . . . 0.0 113.715 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 277' ' ' MET . . . . . . . . . . . . . 53.1 mtt -103.95 -27.53 12.11 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 112.958 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 278' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.82 144.77 97.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 119.468 1.031 . . . . 0.0 112.773 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 279' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.61 165.1 16.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.202 3.268 . . . . 0.0 113.354 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 280' ' ' SER . . . . . . . . . . . . . 84.4 p -55.38 -45.79 76.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 111.691 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 281' ' ' SER . . . . . . . . . . . . . 4.9 m -74.67 22.09 0.1 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.505 1.522 . . . . 0.0 114.888 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 282' ' ' THR . . . . . . . . . . . . . 53.9 m -128.28 -42.79 1.49 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.846 1.659 . . . . 0.0 109.905 159.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 283' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.25 -28.51 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.062 0.945 . . . . 0.0 111.561 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 284' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.19 -39.18 43.25 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.0 112.567 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.63 6.19 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.699 1.6 . . . . 0.0 113.45 -170.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 286' ' ' LEU . . . . . . . . . . . . . 57.1 tp -57.26 124.21 18.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.947 0.899 . . . . 0.0 110.99 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 287' ' ' GLY . . . . . . . . . . . . . . . 95.66 -16.59 60.92 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.471 -1.183 . . . . 0.0 115.273 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 288' ' ' ALA . . . . . . . . . . . . . . . -75.18 36.58 0.12 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.968 1.884 . . . . 0.0 113.585 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 289' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -66.14 -37.48 85.79 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.002 -1.686 . . . . 0.0 112.988 -165.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 290' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -68.76 -10.47 56.74 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.659 -1.276 . . . . 0.0 113.562 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 291' ' ' ALA . . . . . . . . . . . . . . . -92.23 -41.87 10.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.73 1.15 . . . . 0.0 111.553 167.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 292' ' ' LEU . . . . . . . . . . . . . 59.9 tp -55.41 -45.86 76.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.606 0.762 . . . . 0.0 111.517 172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 293' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -52.64 -58.8 5.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.586 1.555 . . . . 0.0 112.542 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 294' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -66.05 -31.81 72.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 295' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -71.71 -45.52 61.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.331 0.652 . . . . 0.0 112.616 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -58.94 -40.4 84.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.499 1.119 . . . . 0.0 111.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 297' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -70.76 -7.25 43.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.348 2.259 . . . . 0.0 114.879 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 298' ' ' THR . . . . . . . . . . . . . 77.4 p -140.95 -24.81 0.75 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 61.26 23.9 62.74 Favored Glycine 0 CA--C 1.54 1.626 0 O-C-N 120.637 -1.289 . . . . 0.0 113.893 -166.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.17 -135.41 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.079 1.352 . . . . 0.0 112.585 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 301' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.81 124.65 90.99 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 120.514 -1.366 . . . . 0.0 110.707 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 302' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.9 157.62 34.82 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.466 2.777 . . . . 0.0 113.727 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.03 136.85 58.76 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.407 2.738 . . . . 0.0 112.506 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 304' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -95.78 -45.74 6.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.907 0.883 . . . . 0.0 113.239 -166.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 305' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.13 142.12 20.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.413 2.285 . . . . 0.0 111.697 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 306' ' ' GLY . . . . . . . . . . . . . . . -92.9 -144.7 15.15 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.57 1.081 . . . . 0.0 112.385 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 307' ' ' VAL . . . . . . . . . . . . . 9.8 p -47.45 -25.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.095 2.158 . . . . 0.0 114.818 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 308' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.07 -9.84 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.574 1.55 . . . . 0.0 114.613 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 309' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -58.24 -44.09 88.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.501 1.046 . . . . 0.0 113.316 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 310' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -74.94 31.06 0.09 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.901 1.28 . . . . 0.0 114.374 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 311' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -119.1 139.81 27.94 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.685 1.994 . . . . 0.0 110.511 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -53.12 -33.07 62.19 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.345 2.697 . . . . 0.0 116.735 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.79 63.22 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.448 1.022 . . . . 0.0 113.62 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 314' ' ' ILE . . . . . . . . . . . . . 33.5 mt -111.97 -53.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.749 1.219 . . . . 0.0 111.124 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 315' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -76.02 -2.09 28.94 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.66 1.573 . . . . 0.0 115.24 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 316' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.55 58.19 1.71 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.471 1.508 . . . . 0.0 112.805 158.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 317' ' ' SER . . . . . . . . . . . . . 27.9 m -136.87 146.59 55.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 125.936 1.694 . . . . 0.0 109.983 159.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -52.11 143.57 40.95 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.459 2.772 . . . . 0.0 113.672 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 319' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -56.58 -32.91 65.68 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 320' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -50.91 -26.21 5.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.068 1.747 . . . . 0.0 114.659 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 321' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -119.12 0.22 11.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.255 1.422 . . . . 0.0 114.183 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 322' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -67.27 -12.25 59.62 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 323' ' ' GLY . . . . . . . . . . . . . . . -92.83 -48.8 2.84 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.399 1.0 . . . . 0.0 111.967 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 324' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -58.1 -36.66 73.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.636 1.574 . . . . 0.0 113.617 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 325' ' ' ILE . . . . . . . . . . . . . 95.5 mt -73.1 -36.45 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.07 -1.019 . . . . 0.0 110.997 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.03 82.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 327' ' ' ARG . . . . . . . . . . . . . 34.4 mtt85 -65.6 -53.79 36.87 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.38 0.991 . . . . 0.0 111.593 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.18 -34.21 70.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 329' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.49 -40.03 96.0 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.88 -1.137 . . . . 0.0 111.167 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.64 72.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 331' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.89 79.61 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 119.398 0.999 . . . . 0.0 113.613 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 332' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -70.23 -28.02 64.92 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.012 -1.287 . . . . 0.0 112.33 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 333' ' ' LEU . . . . . . . . . . . . . 70.7 mt -68.67 -38.52 80.44 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.027 0.83 . . . . 0.0 113.081 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 334' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.64 87.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.858 0.863 . . . . 0.0 111.733 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 335' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.32 -47.42 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.358 1.063 . . . . 0.0 110.357 170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 336' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.29 77.77 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.711 1.141 . . . . 0.0 113.043 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.13 84.28 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 338' ' ' ARG . . . . . 0.482 HH21 ' CD2' ' G' ' 63' ' ' HIS . 67.1 mtt85 -71.93 -37.23 70.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 111.97 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -61.37 -47.54 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.704 0.801 . . . . 0.0 110.374 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 340' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -68.0 -27.63 66.73 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 341' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.31 -38.14 14.4 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 342' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -108.62 -33.65 6.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 343' ' ' SER . . . . . . . . . . . . . 1.9 t -105.56 -48.93 3.54 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.865 0.757 . . . . 0.0 112.886 -162.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 344' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.65 52.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.258 1.409 . . . . 0.0 116.241 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 345' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.02 151.01 35.76 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.113 1.456 . . . . 0.0 111.271 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 346' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -101.83 117.69 35.37 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.416 -0.802 . . . . 0.0 110.837 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 347' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.44 16.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.233 1.413 . . . . 0.0 113.297 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 348' ' ' ALA . . . . . . . . . . . . . . . -52.74 -39.01 61.73 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 349' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' F' ' 352' ' ' LYS . 19.5 mm-40 -69.09 -26.8 65.11 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.44 -0.787 . . . . 0.0 113.056 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 350' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -79.65 -39.35 31.65 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.24 -0.913 . . . . 0.0 111.226 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 351' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.21 -34.39 73.58 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.565 0.621 . . . . 0.0 111.661 169.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 352' ' ' LYS . . . . . 0.449 ' HZ1' ' CD ' ' F' ' 349' ' ' GLU . 51.0 mtpt -69.16 -44.87 71.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.773 1.229 . . . . 0.0 112.251 171.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 353' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -57.64 -38.51 75.14 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.322 0.964 . . . . 0.0 111.741 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 354' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.6 -42.96 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.292 1.437 . . . . 0.0 112.589 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 355' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.61 -42.56 91.45 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.962 -1.087 . . . . 0.0 111.698 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 356' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.79 -24.23 67.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.341 -0.849 . . . . 0.0 112.373 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 357' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.74 80.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 121.07 1.759 . . . . 0.0 112.722 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 358' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -71.47 -37.54 71.34 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.897 0.771 . . . . 0.0 111.858 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 359' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.59 -42.69 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.033 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 360' ' ' ARG . . . . . . . . . . . . . 24.9 mtp-105 -54.01 -44.76 71.19 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.63 1.105 . . . . 0.0 112.019 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 361' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.38 -45.69 90.75 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.813 0.279 . . . . 0.0 111.353 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 362' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.86 -14.19 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.565 1.146 . . . . 0.0 112.82 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 363' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -95.91 -8.36 34.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 168.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 364' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.08 -34.64 8.35 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.204 1.365 . . . . 0.0 112.374 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 365' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -69.28 -30.53 68.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 113.31 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 366' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.624 1.57 . . . . 0.0 113.85 -172.905 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.17 141.3 56.79 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.725 2.283 . . . . 0.0 111.465 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -96.36 -16.24 21.39 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -78.21 -7.82 57.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.093 1.357 . . . . 0.0 114.462 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 m -81.23 70.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.537 1.535 . . . . 0.0 111.283 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -73.26 2.02 8.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -144.1 142.67 30.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.075 0.852 . . . . 0.0 111.689 164.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.45 140.06 37.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.074 0.95 . . . . 0.0 109.659 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.81 146.72 36.14 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.89 -179.73 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.331 2.687 . . . . 0.0 111.494 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.01 27.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -138.67 178.37 7.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.072 2.549 . . . . 0.0 110.09 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt 61.81 -41.04 0.14 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.383 2.273 . . . . 0.0 117.131 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.56 69.18 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 121.319 1.872 . . . . 0.0 113.247 -173.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.91 -30.96 71.24 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.211 -0.931 . . . . 0.0 110.992 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -70.84 -30.54 66.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.434 1.094 . . . . 0.0 112.755 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.87 -35.95 67.28 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.195 -0.941 . . . . 0.0 111.906 171.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.19 -46.21 81.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.233 0.613 . . . . 0.0 110.534 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.03 -39.51 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.056 1.342 . . . . 0.0 112.2 171.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.4 68.52 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.69 -48.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.039 0.836 . . . . 0.0 110.43 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -55.72 -38.62 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.342 0.973 . . . . 0.0 113.453 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 pt -88.25 -14.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.96 -29.24 25.25 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.281 -0.887 . . . . 0.0 112.468 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -35.56 -59.66 0.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.308 2.643 . . . . 0.0 114.13 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -101.47 6.4 42.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.029 1.332 . . . . 0.0 114.517 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -121.73 -11.51 8.6 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.04 -162.67 9.21 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.748 1.166 . . . . 0.0 115.402 -169.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -118.57 122.4 42.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.65 1.58 . . . . 0.0 109.671 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.76 150.34 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.496 1.919 . . . . 0.0 109.252 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -127.07 130.7 50.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.36 1.464 . . . . 0.0 108.975 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.31 143.4 50.49 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.48 1.112 . . . . 0.0 112.037 -166.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.56 153.21 22.85 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 124.456 1.098 . . . . 0.0 111.615 -163.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -73.01 -24.6 60.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.847 -1.384 . . . . 0.0 113.88 -169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 35' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -79.55 -41.2 27.76 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 111.978 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.87 -32.81 71.37 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.187 -0.946 . . . . 0.0 112.401 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -58.32 -45.93 87.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.215 0.916 . . . . 0.0 110.43 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 38' ' ' THR . . . . . . . . . . . . . 92.6 m -63.58 -42.35 98.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.938 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.68 -44.68 90.3 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.556 1.071 . . . . 0.0 112.287 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.09 -31.32 69.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 41' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.19 -47.91 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.004 0.921 . . . . 0.0 110.572 170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -59.86 -43.65 94.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.007 0.923 . . . . 0.0 112.369 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -80.31 6.24 12.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.802 1.241 . . . . 0.0 113.011 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.38 29.67 60.69 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.775 -1.203 . . . . 0.0 114.152 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 45' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -88.59 -31.04 18.81 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.146 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.26 57.84 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.585 0.754 . . . . 0.0 112.711 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 47' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -108.89 -22.05 12.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.317 1.847 . . . . 0.0 111.933 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 tp -149.73 142.29 24.45 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.277 2.231 . . . . 0.0 108.126 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.63 141.63 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.389 1.076 . . . . 0.0 111.216 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.72 133.4 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.995 1.718 . . . . 0.0 109.069 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 mt -125.54 142.17 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.981 1.313 . . . . 0.0 109.689 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.6 150.64 30.97 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 53' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.15 -7.54 59.62 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.57 23.29 12.47 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.44 1.496 . . . . 0.0 114.004 -171.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 t -80.06 128.03 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.423 1.089 . . . . 0.0 110.289 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -146.34 118.64 4.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.482 1.513 . . . . 0.0 107.532 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.99 151.91 86.65 Favored 'Cis proline' 0 CA--C 1.538 0.705 0 CA-C-N 120.956 1.377 . . . . 0.0 113.037 0.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 58' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.32 -24.57 62.15 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.147 -0.971 . . . . 0.0 112.428 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -71.07 16.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.071 1.748 . . . . 0.0 114.955 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.13 -34.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.131 -0.981 . . . . 0.0 111.559 161.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 61' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.43 -14.45 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.231 1.412 . . . . 0.0 114.441 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.91 -20.34 5.88 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 63' ' ' HIS . . . . . 0.482 ' CD2' HH21 ' F' ' 338' ' ' ARG . 27.1 p-80 -83.29 -19.83 35.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 114.369 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 64' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.99 -44.75 85.88 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.763 -1.589 . . . . 0.0 114.022 -170.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 65' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.74 -54.82 3.27 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 CA-C-N 122.333 1.869 . . . . 0.0 114.621 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.41 -29.71 37.46 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.077 1.777 . . . . 0.0 113.376 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 67' ' ' LEU . . . . . . . . . . . . . 61.5 tp -71.7 -32.78 68.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.603 0.761 . . . . 0.0 113.017 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 68' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.89 -29.34 19.7 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 69' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -64.27 -46.54 83.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.638 0.775 . . . . 0.0 111.48 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.73 -4.48 6.53 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.181 -0.949 . . . . 0.0 113.06 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -121.24 11.38 10.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.473 1.909 . . . . 0.0 114.487 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 72' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 53.11 54.58 10.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.952 1.301 . . . . 0.0 113.115 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.87 135.78 22.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.39 1.476 . . . . 0.0 110.327 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -67.21 136.97 42.33 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.158 2.572 . . . . 0.0 112.732 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 75' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -132.56 148.92 52.38 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.38 1.072 . . . . 0.0 113.569 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 tt -151.49 166.94 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.203 1.401 . . . . 0.0 111.575 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -118.25 149.96 40.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 111.596 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.94 156.53 72.53 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 124.994 1.318 . . . . 0.0 112.073 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -67.61 -31.4 33.3 Favored 'Trans proline' 0 C--N 1.35 0.626 0 N-CA-C 117.257 1.984 . . . . 0.0 117.257 -160.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 80' ' ' SER . . . . . . . . . . . . . 74.7 m -154.02 142.61 20.8 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -68.05 -29.85 68.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.074 2.149 . . . . 0.0 114.829 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 82' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -72.41 -44.2 62.8 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.71 0.687 . . . . 0.0 111.33 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 83' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -64.3 -42.67 96.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.682 1.193 . . . . 0.0 111.864 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -61.55 -43.32 99.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.217 0.607 . . . . 0.0 112.316 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.89 -45.16 96.74 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.835 -0.541 . . . . 0.0 112.846 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.97 93.09 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.42 90.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.187 0.595 . . . . 0.0 111.676 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.23 15.11 0.47 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.152 1.381 . . . . 0.0 114.68 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.84 -3.11 87.61 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.194 1.378 . . . . 0.0 116.295 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 pt -104.81 152.55 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.326 1.563 . . . . 0.0 111.774 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.6 -16.75 35.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -82.19 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.368 1.067 . . . . 0.0 111.001 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.74 169.97 8.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.007 1.723 . . . . 0.0 111.153 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.16 124.35 19.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.569 0.748 . . . . 0.0 109.664 165.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.06 71.46 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 96' ' ' SER . . . . . . . . . . . . . 67.2 p -149.11 161.71 41.42 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.423 1.089 . . . . 0.0 113.274 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 88.4 t -141.13 145.35 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.882 1.673 . . . . 0.0 109.976 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.71 141.03 52.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 111.935 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 99' ' ' ILE . . . . . . . . . . . . . 24.7 mt -102.91 121.46 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.223 1.009 . . . . 0.0 108.524 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.01 -43.07 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.91 1.284 . . . . 0.0 110.851 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 101' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -131.25 109.79 15.13 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 163.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -67.66 -3.48 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 N-CA-C 116.633 1.743 . . . . 0.0 116.633 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.58 -114.55 6.06 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.867 1.212 . . . . 0.0 112.026 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.88 -26.46 66.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.497 1.519 . . . . 0.0 113.351 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.77 4.14 23.16 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 106' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -54.36 -43.58 71.45 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.625 1.557 . . . . 0.0 114.348 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.16 -28.05 59.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.719 1.208 . . . . 0.0 113.506 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 108' ' ' LEU . . . . . . . . . . . . . 47.3 tp -77.12 -38.23 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 111.542 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 109' ' ' VAL . . . . . . . . . . . . . 44.7 t -61.59 -36.58 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.437 -0.79 . . . . 0.0 110.885 170.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 110' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -70.75 -33.45 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 111' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -62.81 -49.01 76.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.551 1.069 . . . . 0.0 110.89 170.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 112' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.38 -51.3 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 110.243 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.57 -45.55 91.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.603 0.638 . . . . 0.0 112.178 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 114' ' ' MET . . . . . . . . . . . . . 34.6 mmt -70.91 -34.98 72.08 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.72 -36.38 37.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.348 0.976 . . . . 0.0 112.91 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 116' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.95 -42.94 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.351 0.978 . . . . 0.0 110.478 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.75 54.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.588 1.155 . . . . 0.0 113.843 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -87.36 -12.81 45.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 pp -101.29 -11.98 19.03 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.549 1.522 . . . . 0.0 114.089 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 120' ' ' MET . . . . . . . . . . . . . 91.3 mtp -75.64 40.4 0.18 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.92 1.288 . . . . 0.0 112.489 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 121' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.949 2.099 . . . . 0.0 110.892 -171.551 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.73 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 m -150.76 155.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 127.28 2.232 . . . . 0.0 109.676 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -138.8 164.97 28.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.714 1.206 . . . . 0.0 111.182 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 t -136.45 137.66 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.974 0.91 . . . . 0.0 111.779 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -138.72 161.4 37.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.92 2.088 . . . . 0.0 111.548 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -74.75 153.58 38.75 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.771 -1.205 . . . . 0.0 111.644 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' H' ' 8' ' ' LYS . 14.8 t-80 -94.26 -171.46 2.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.415 1.086 . . . . 0.0 111.333 170.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' H' ' 7' ' ' HIS . 54.9 pttt -79.56 -17.72 53.34 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 173.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' PHE . . . . . 0.461 ' CZ ' ' HE3' ' H' ' 8' ' ' LYS . 21.6 m-85 -103.68 144.62 29.03 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.435 1.094 . . . . 0.0 112.343 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -62.99 131.86 34.47 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.958 2.439 . . . . 0.0 111.894 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -6.99 29.11 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 115.574 0.99 . . . . 0.0 115.574 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 t -91.2 141.05 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.932 1.366 . . . . 0.0 110.037 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -127.97 166.43 18.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.633 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.13 136.98 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.58 1.952 . . . . 0.0 108.022 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.76 146.76 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.374 1.07 . . . . 0.0 110.249 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' ILE . . . . . . . . . . . . . 10.3 mm -106.41 127.42 61.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.699 1.6 . . . . 0.0 108.051 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.65 175.71 6.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 113.305 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' ASP . . . . . . . . . . . . 0.304 0.4 OUTLIER -72.2 -3.46 23.58 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -167.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -91.29 -28.27 17.88 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.664 1.186 . . . . 0.0 113.549 163.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.51 -0.18 21.91 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 127.024 2.25 . . . . 0.0 115.728 -168.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' SER . . . . . . . . . . . . . 85.2 p -74.98 147.35 40.9 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.108 1.954 . . . . 0.0 113.891 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.36 137.41 32.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.982 1.313 . . . . 0.0 111.473 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -143.66 148.34 35.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.518 1.527 . . . . 0.0 110.865 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.25 148.07 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.04 14.47 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.667 1.587 . . . . 0.0 113.62 -169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' THR . . . . . . . . . . . . . 24.6 p -138.71 160.8 38.77 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.639 1.576 . . . . 0.0 112.269 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -79.26 123.77 27.75 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.98 1.312 . . . . 0.0 110.425 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -65.11 122.95 18.25 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.906 0.776 . . . . 0.0 112.26 -174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.27 -27.23 68.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.286 1.434 . . . . 0.0 113.252 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.39 89.73 11.96 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 125.088 1.355 . . . . 0.0 111.714 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 31' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.71 133.14 56.11 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.668 2.912 . . . . 0.0 115.164 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.55 -29.36 12.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.123 1.821 . . . . 0.0 113.575 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -66.39 140.27 58.05 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.179 -1.189 . . . . 0.0 111.345 175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -104.09 140.36 37.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.176 1.39 . . . . 0.0 107.509 158.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.28 -30.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -159.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 36' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -143.31 27.4 1.57 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 171.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.27 37.08 48.98 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.931 0.777 . . . . 0.0 113.152 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -104.28 172.41 6.81 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -166.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -77.35 123.65 26.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.922 1.289 . . . . 0.0 110.907 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 40' ' ' VAL . . . . . . . . . . . . . 22.9 t -137.43 137.62 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.205 1.402 . . . . 0.0 110.136 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 41' ' ' ILE . . . . . . . . . . . . . 46.2 pt -138.0 158.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.225 1.81 . . . . 0.0 112.061 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -105.83 147.96 28.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.819 1.248 . . . . 0.0 111.3 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 43' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -133.49 -146.41 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.233 1.813 . . . . 0.0 109.956 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.95 93.9 0.12 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.519 -1.363 . . . . 0.0 111.533 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.3 -15.62 1.93 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.812 1.672 . . . . 0.0 116.206 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -126.33 165.48 18.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.11 1.364 . . . . 0.0 112.826 -164.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.81 138.37 52.75 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.658 1.183 . . . . 0.0 111.651 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 48' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -132.66 140.39 48.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.027 1.731 . . . . 0.0 111.282 -170.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -131.16 138.55 49.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.301 1.44 . . . . 0.0 112.946 -168.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 50' ' ' ILE . . . . . . . . . . . . . 8.8 tp -69.61 142.29 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.309 1.044 . . . . 0.0 112.339 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 51' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -100.79 97.85 8.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.044 0.938 . . . . 0.0 109.305 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -77.87 118.53 72.73 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 121.227 -0.921 . . . . 0.0 110.778 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 53' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.23 -22.35 34.64 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 113.96 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 54' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -79.48 -34.24 41.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.294 0.952 . . . . 0.0 112.758 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 55' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -102.0 -29.27 11.89 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -170.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -118.83 63.55 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 108.906 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 57' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -46.04 -34.28 3.99 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 127.89 2.476 . . . . 0.0 116.658 -148.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tt -48.81 -33.74 11.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.631 1.573 . . . . 0.0 112.289 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.49 -33.77 72.9 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.819 -1.176 . . . . 0.0 114.294 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.2 -36.77 85.22 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.939 1.37 . . . . 0.0 112.099 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.51 -38.19 80.71 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.638 -0.664 . . . . 0.0 112.087 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 62' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.61 -40.9 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.588 0.755 . . . . 0.0 111.023 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 63' ' ' VAL . . . . . . . . . . . . . 90.8 t -74.31 -41.88 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 118.586 0.63 . . . . 0.0 112.155 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 64' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -78.92 -24.69 43.91 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.55 9.55 0.03 OUTLIER Glycine 0 N--CA 1.477 1.369 0 N-CA-C 119.554 2.582 . . . . 0.0 119.554 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.62 120.76 12.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.904 1.852 . . . . 0.0 111.535 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -103.38 -40.09 6.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.747 1.619 . . . . 0.0 111.179 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -83.31 85.93 7.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.525 1.13 . . . . 0.0 111.461 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -109.32 91.43 9.78 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.319 1.448 . . . . 0.0 110.516 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.0 -16.1 10.13 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.673 2.249 . . . . 0.0 115.445 -163.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 71' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.15 150.95 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.296 0.953 . . . . 0.0 113.318 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -143.65 160.09 51.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.786 2.034 . . . . 0.0 109.602 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -54.65 146.43 54.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.063 1.842 . . . . 0.0 111.673 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 6.02 85.3 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 75' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -94.53 169.28 10.31 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.01 1.405 . . . . 0.0 113.431 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 76' ' ' SER . . . . . . . . . . . . . 89.6 p -111.65 130.32 55.81 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 111.932 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -140.0 140.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.765 0.826 . . . . 0.0 112.962 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 78' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.66 127.81 49.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.734 1.614 . . . . 0.0 109.15 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.75 118.33 32.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.849 1.26 . . . . 0.0 109.995 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 mt -103.22 122.92 45.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.862 1.265 . . . . 0.0 108.922 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.89 5.31 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.738 0.685 . . . . 0.0 112.61 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 82' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.66 -18.31 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.592 -0.946 . . . . 0.0 113.551 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 83' ' ' ALA . . . . . . . . . . . . . . . 47.25 -135.26 0.97 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.998 1.319 . . . . 0.0 111.945 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 84' ' ' SER . . . . . . . . . . . . . 18.3 m -89.08 22.54 2.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.055 -1.028 . . . . 0.0 112.666 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.27 75.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.98 1.276 . . . . 0.0 116.13 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 86' ' ' THR . . . . . . . . . . . . . 34.5 p -50.42 -59.06 4.38 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.336 1.568 . . . . 0.0 112.989 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 87' ' ' THR . . . . . . . . . . . . . 18.6 m -77.83 -48.09 17.32 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.457 -0.777 . . . . 0.0 111.692 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.2 64.14 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -168.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 89' ' ' SER . . . . . . . . . . . . . 61.0 p -54.94 -33.09 61.92 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.93 -1.107 . . . . 0.0 112.592 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 90' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -74.06 -33.08 63.55 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 m -73.89 -32.94 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 120.149 1.34 . . . . 0.0 111.654 171.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.92 -36.88 80.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.226 1.01 . . . . 0.0 112.539 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.39 -37.3 84.94 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 94' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.03 -39.06 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.22 1.408 . . . . 0.0 112.546 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -77.58 -22.77 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.72 1.208 . . . . 0.0 112.592 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.39 -164.79 54.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.413 1.006 . . . . 0.0 114.521 172.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 97' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -89.21 -28.24 20.1 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -174.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 98' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.18 -22.21 58.21 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.352 0.661 . . . . 0.0 112.218 171.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 165.33 33.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.579 1.085 . . . . 0.0 113.428 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 100' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -130.05 128.4 41.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.559 1.144 . . . . 0.0 111.627 -168.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 118.76 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.696 1.198 . . . . 0.0 110.427 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 102' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.6 124.79 42.02 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.561 0.744 . . . . 0.0 109.487 168.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.18 108.99 1.71 Allowed Glycine 0 N--CA 1.468 0.812 0 CA-C-N 118.88 0.764 . . . . 0.0 113.302 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.06 132.75 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.744 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -145.89 143.87 29.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.081 1.353 . . . . 0.0 109.981 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 106' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -90.23 -34.18 15.88 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 112.211 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 107' ' ' SER . . . . . . . . . . . . . 3.5 m -79.88 100.44 0.61 Allowed Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.152 1.781 . . . . 0.0 111.383 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 108' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -64.51 -44.01 12.3 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.397 1.535 . . . . 0.0 114.359 -157.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 109' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -62.93 -24.86 68.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.607 1.163 . . . . 0.0 113.191 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -77.04 -44.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.654 1.116 . . . . 0.0 110.463 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 111' ' ' LEU . . . . . . . . . . . . . 34.3 tp -67.46 -31.54 71.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.061 0.944 . . . . 0.0 111.816 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 112' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -57.67 -34.29 69.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.83 1.252 . . . . 0.0 113.12 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 113' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -79.38 -9.47 59.6 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -92.8 -28.09 16.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.774 1.23 . . . . 0.0 112.142 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 115' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.53 -47.01 99.01 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.348 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 116' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.36 -33.34 58.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.469 2.112 . . . . 0.0 113.713 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 117' ' ' ILE . . . . . . . . . . . . . 31.5 mt -69.32 -37.81 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.071 -1.018 . . . . 0.0 111.317 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.26 -0.9 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.204 1.002 . . . . 0.0 113.618 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -68.65 -17.59 64.13 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.884 0.873 . . . . 0.0 111.273 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -108.47 -46.4 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.407 1.883 . . . . 0.0 112.896 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 121' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 -77.24 62.22 2.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.628 1.571 . . . . 0.0 112.784 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 122' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -73.36 9.98 1.15 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 123' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -87.68 -8.38 56.2 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 163.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 124' ' ' ILE . . . . . . . . . . . . . 23.2 mt -103.57 135.03 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.38 123.34 39.89 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.913 0.885 . . . . 0.0 109.696 166.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 126' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.86 123.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.499 2.799 . . . . 0.0 111.238 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -125.37 117.3 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.153 1.381 . . . . 0.0 109.856 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 119.02 22.46 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.766 -0.584 . . . . 0.0 110.595 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.77 157.43 18.59 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.927 0.775 . . . . 0.0 114.483 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 130' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -77.57 123.62 26.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.552 0.741 . . . . 0.0 109.276 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.03 -16.91 62.71 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.03 -7.92 55.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.354 1.862 . . . . 0.0 112.712 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -124.36 55.53 10.18 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.982 2.113 . . . . 0.0 111.2 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 134' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.31 -23.56 72.05 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.23 2.62 . . . . 0.0 114.487 -167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -54.81 -32.83 60.83 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.917 -1.115 . . . . 0.0 112.4 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.35 3.72 4.45 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 137' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -132.42 18.04 4.4 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 163.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 138' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -53.61 -30.03 40.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.9 -2.32 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.114 1.366 . . . . 0.0 114.459 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 140' ' ' LEU . . . . . . . . . . . . . 71.6 mt -106.55 -2.89 21.4 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 141' ' ' VAL . . . . . . . . . . . . . 13.2 m -142.22 158.0 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.618 1.167 . . . . 0.0 111.526 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 142' ' ' THR . . . . . . . . . . . . . 71.6 p -85.95 -177.82 6.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.633 1.173 . . . . 0.0 111.99 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -64.96 157.96 26.75 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.048 -1.033 . . . . 0.0 109.6 154.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 144' ' ' VAL . . . . . . . . . . . . . 24.8 m -134.44 158.97 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.357 1.463 . . . . 0.0 113.198 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 145' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.32 -34.72 59.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.981 1.312 . . . . 0.0 112.635 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 146' ' ' VAL . . . . . . . . . . . . . 57.0 t -140.51 146.39 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.041 1.337 . . . . 0.0 111.486 -171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 147' ' ' ILE . . . . . . . . . . . . . 57.3 mt -116.02 137.68 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.764 1.225 . . . . 0.0 109.681 164.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 148' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -118.93 142.49 47.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.675 1.19 . . . . 0.0 110.486 164.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -131.01 130.33 43.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.195 0.998 . . . . 0.0 113.114 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 150' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.51 9.88 2.69 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 128.442 2.697 . . . . 0.0 111.056 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.75 -26.89 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.57 -1.331 . . . . 0.0 112.363 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 152' ' ' ALA . . . . . . . . . . . . . . . 54.49 48.47 20.43 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.176 1.391 . . . . 0.0 114.117 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 153' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -96.44 161.83 25.53 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.501 1.521 . . . . 0.0 113.557 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 154' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -58.07 -23.27 60.01 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.503 2.802 . . . . 0.0 116.423 -171.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 155' ' ' THR . . . . . . . . . . . . . 27.2 p -119.42 22.41 11.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.856 1.662 . . . . 0.0 112.788 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 156' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -56.58 -25.49 52.68 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.11 77.52 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.477 -1.39 . . . . 0.0 112.978 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 158' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -71.39 -36.67 71.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.812 0.845 . . . . 0.0 111.951 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 159' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.54 -46.54 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 160' ' ' LEU . . . . . . . . . . . . . 49.4 tp -62.16 -44.68 96.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.204 0.602 . . . . 0.0 112.325 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 161' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.76 -50.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.809 0.844 . . . . 0.0 111.484 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 162' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -76.93 -30.99 56.33 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.402 -0.811 . . . . 0.0 112.215 -172.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 163' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -66.13 -34.42 78.02 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.534 -1.354 . . . . 0.0 111.511 166.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.53 63.15 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.298 -1.501 . . . . 0.0 113.704 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 165' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.94 -55.6 21.36 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.506 1.048 . . . . 0.0 110.354 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.36 68.88 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 167' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.21 -30.52 2.65 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 -165.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 168' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.95 134.25 36.25 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.004 1.729 . . . . 0.0 112.49 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 169' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -72.83 160.44 32.16 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.166 0.986 . . . . 0.0 112.599 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -49.93 132.14 22.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.499 1.52 . . . . 0.0 111.3 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 171' ' ' GLY . . . . . . . . . . . . . . . 65.99 4.14 20.04 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.36 162.31 54.22 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-N 119.798 1.799 . . . . 0.0 113.581 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 173' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -105.71 153.71 21.47 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.49 145.19 16.19 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.948 1.261 . . . . 0.0 111.679 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 175' ' ' MET . . . . . . . . . . . . . 69.5 mtp -136.64 142.8 43.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.503 1.521 . . . . 0.0 109.51 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 176' ' ' ILE . . . . . . . . . . . . . 12.1 tt -151.42 127.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -169.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 177' ' ' ALA . . . . . . . . . . . . . . . -97.6 120.83 38.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 111.087 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 178' ' ' VAL . . . . . . . . . . . . . 40.8 t -113.53 121.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 111.478 -168.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 179' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -105.72 101.38 10.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.851 1.66 . . . . 0.0 109.796 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 180' ' ' SER . . . . . . . . . . . . . 25.0 t -51.93 -49.35 63.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.315 0.646 . . . . 0.0 112.551 -168.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 181' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -66.81 -3.47 6.89 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 182' ' ' SER . . . . . . . . . . . . . 10.0 t -80.39 -36.99 33.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.653 0.781 . . . . 0.0 111.322 165.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.38 -49.31 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.065 1.346 . . . . 0.0 110.325 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 184' ' ' ASP . . . . . 0.43 ' CG ' ' HE3' ' H' ' 187' ' ' LYS . 7.1 t70 -156.91 140.33 15.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.449 1.5 . . . . 0.0 111.793 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 185' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.31 2.37 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.73 1.612 . . . . 0.0 113.131 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 186' ' ' THR . . . . . . . . . . . . . 53.7 m -99.64 -33.69 10.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.511 1.524 . . . . 0.0 111.858 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 187' ' ' LYS . . . . . 0.43 ' HE3' ' CG ' ' H' ' 184' ' ' ASP . 16.1 ptpt -93.62 170.26 9.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.295 1.438 . . . . 0.0 114.181 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 188' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.6 123.48 81.36 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.343 1.457 . . . . 0.0 110.868 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 189' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.34 -32.34 51.1 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.848 3.032 . . . . 0.0 116.199 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 190' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -62.92 -23.12 67.22 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 113.227 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 191' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -73.8 -36.21 64.99 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.618 -1.301 . . . . 0.0 112.277 170.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.01 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.319 0.647 . . . . 0.0 109.88 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 193' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -65.67 -26.52 67.82 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.411 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 194' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -70.01 -32.99 71.44 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.131 1.332 . . . . 0.0 113.611 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.45 -36.71 74.08 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.927 -1.108 . . . . 0.0 111.237 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 196' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.72 -39.93 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 119.887 -1.758 . . . . 0.0 111.332 171.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 197' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -55.42 -43.32 75.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.068 1.347 . . . . 0.0 112.002 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 198' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.13 -19.4 47.37 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -87.61 -44.4 11.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.452 1.024 . . . . 0.0 111.694 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.68 -40.81 89.07 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.013 -1.054 . . . . 0.0 111.039 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 201' ' ' SER . . . . . . . . . . . . . 87.1 p -76.42 8.43 3.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 202' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -97.52 -6.65 33.16 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.759 -1.213 . . . . 0.0 112.29 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 203' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -142.33 -18.15 0.71 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 204' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.99 169.77 9.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.905 -1.122 . . . . 0.0 113.512 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 205' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -89.92 128.55 36.24 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 154.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 206' ' ' VAL . . . . . . . . . . . . . 27.3 t -100.07 133.31 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.246 -0.909 . . . . 0.0 109.901 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 207' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.42 -12.78 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -149.16 143.76 26.17 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.385 0.993 . . . . 0.0 111.366 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 138.14 27.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 109.391 164.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 210' ' ' LEU . . . . . . . . . . . . . 87.4 mt -139.6 175.25 9.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.021 1.329 . . . . 0.0 112.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 211' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -124.84 141.87 51.82 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.322 2.649 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 1.2 36.66 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 213' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.14 141.53 76.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 120.645 -1.284 . . . . 0.0 111.121 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 214' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.27 -0.07 66.1 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 120.362 1.165 . . . . 0.0 114.245 1.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 215' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -68.88 -34.84 76.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.265 0.939 . . . . 0.0 112.805 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 216' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -117.84 175.71 5.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.533 1.533 . . . . 0.0 112.149 171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 217' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -123.5 141.29 52.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.35 1.46 . . . . 0.0 110.199 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 218' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.46 35.52 26.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.127 1.771 . . . . 0.0 114.364 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -134.18 135.42 43.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -161.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.21 174.2 9.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.244 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 221' ' ' LEU . . . . . . . . . . . . . 7.9 tt -144.43 147.18 33.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.226 1.411 . . . . 0.0 110.415 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 222' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.89 158.98 35.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.039 1.336 . . . . 0.0 111.866 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 223' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.0 139.07 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.033 1.333 . . . . 0.0 110.219 167.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 224' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.86 164.85 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.125 1.77 . . . . 0.0 112.117 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 225' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -124.12 139.86 53.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.275 1.43 . . . . 0.0 110.83 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 226' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -72.5 144.71 86.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.006 1.323 . . . . 0.0 109.808 165.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 227' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo . . . . . 0 C--O 1.257 1.428 0 C-N-CA 123.566 2.844 . . . . 0.0 114.573 179.58 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 mp -78.13 145.83 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 119.137 0.88 . . . . 0.0 109.623 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 3' ' ' SER . . . . . . . . . . . . . 34.4 t -132.76 145.1 50.73 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.611 1.164 . . . . 0.0 111.383 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -114.93 114.01 24.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.665 1.586 . . . . 0.0 109.616 -161.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -145.53 165.94 27.14 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -166.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.91 -38.86 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.279 1.832 . . . . 0.0 114.4 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -87.37 52.44 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.892 1.224 . . . . 0.0 110.677 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.75 -179.29 52.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.518 1.532 . . . . 0.0 114.034 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -109.39 145.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.657 1.583 . . . . 0.0 111.245 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -127.66 147.85 50.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.612 1.165 . . . . 0.0 112.693 -161.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 130.86 45.74 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.769 1.228 . . . . 0.0 112.17 173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.57 154.8 46.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.695 1.998 . . . . 0.0 112.003 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.5 172.06 11.28 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.362 1.465 . . . . 0.0 114.335 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -56.02 -27.63 53.88 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -88.55 -5.1 58.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.683 1.193 . . . . 0.0 113.753 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.37 27.88 31.85 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.743 -1.223 . . . . 0.0 115.352 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -98.57 151.71 20.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.004 1.321 . . . . 0.0 109.792 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' LEU . . . . . . . . . . . . . 23.6 tp -72.52 144.01 48.14 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 111.119 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.48 -58.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.229 1.412 . . . . 0.0 109.56 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -157.2 158.04 35.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.303 1.441 . . . . 0.0 110.423 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -140.64 146.78 38.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.407 1.083 . . . . 0.0 110.994 164.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 22' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -128.83 145.43 51.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.948 1.299 . . . . 0.0 111.622 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 23' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -92.76 158.83 15.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 24' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -80.87 152.08 28.32 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 25' ' ' THR . . . . . . . . . . . . . 77.6 p -116.73 12.92 15.03 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -130.89 170.36 14.53 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.899 1.679 . . . . 0.0 108.729 156.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -51.14 114.52 4.97 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.462 1.505 . . . . 0.0 110.699 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.31 -31.02 65.23 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.575 2.85 . . . . 0.0 116.032 -168.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.26 -36.26 79.53 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.833 0.742 . . . . 0.0 112.721 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -77.03 -30.16 55.6 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.397 -0.814 . . . . 0.0 112.619 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.41 -39.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.78 -0.575 . . . . 0.0 110.758 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.1 -39.56 93.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.645 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 33' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.15 -36.92 83.3 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.905 1.229 . . . . 0.0 112.708 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 34' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -67.33 -53.35 30.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.024 0.93 . . . . 0.0 111.538 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.16 -33.84 76.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 36' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.05 -42.3 66.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.732 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 37' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' K' ' 136' ' ' GLU . 59.0 mmtt -84.98 11.32 9.69 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.6 22.31 40.5 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 161.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 39' ' ' GLU . . . . . . . . . . . . 0.352 13.0 pt-20 -113.38 139.14 49.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.488 2.144 . . . . 0.0 113.865 165.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 40' ' ' ILE . . . . . . . . . . . . . 14.7 tt -85.34 154.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.974 1.31 . . . . 0.0 112.215 -165.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 41' ' ' THR . . . . . . . . . . . . . 72.9 p -131.21 157.77 42.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.165 0.986 . . . . 0.0 113.557 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -53.41 -34.92 59.63 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.43 1.892 . . . . 0.0 115.287 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.82 -28.12 58.16 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.89 -0.506 . . . . 0.0 111.946 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.15 -34.27 32.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.243 1.017 . . . . 0.0 111.245 173.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.59 -42.79 67.98 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.056 0.844 . . . . 0.0 110.774 165.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.68 -42.08 67.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.344 -0.847 . . . . 0.0 112.64 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.7 -39.4 94.21 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.244 -0.91 . . . . 0.0 112.425 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.8 -28.19 60.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.549 1.068 . . . . 0.0 112.677 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -66.64 -38.56 87.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.311 0.96 . . . . 0.0 112.084 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 50' ' ' SER . . . . . . . . . . . . . 23.5 t -60.71 -46.84 88.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.591 0.756 . . . . 0.0 110.788 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 51' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.95 -36.43 83.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.97 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 52' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -66.66 -45.03 80.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.198 1.399 . . . . 0.0 111.791 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -70.42 -24.61 62.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.579 1.151 . . . . 0.0 113.33 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.75 -24.43 64.45 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.495 1.118 . . . . 0.0 112.875 167.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.75 5.29 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 115.464 0.946 . . . . 0.0 115.464 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 56' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.6 155.07 20.53 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.696 1.198 . . . . 0.0 110.887 168.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -131.24 -25.67 2.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 58' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -80.91 64.44 5.68 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.33 1.452 . . . . 0.0 112.084 -168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 59' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -76.26 72.2 3.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.795 1.238 . . . . 0.0 113.53 -167.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 p -76.15 118.54 22.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 170.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 61' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.15 171.78 8.72 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.075 2.55 . . . . 0.0 111.517 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -79.45 -41.4 27.63 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.904 -0.497 . . . . 0.0 112.152 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 63' ' ' HIS . . . . . 0.401 ' CD2' ' HD2' ' I' ' 64' ' ' PRO . 49.1 t-80 -101.08 139.53 20.56 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -167.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 64' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' I' ' 63' ' ' HIS . 56.0 Cg_endo -68.8 -38.84 9.47 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.773 2.316 . . . . 0.0 113.81 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -89.11 -29.44 19.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.379 0.99 . . . . 0.0 112.36 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.35 -43.62 88.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.086 0.555 . . . . 0.0 110.562 163.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 67' ' ' SER . . . . . . . . . . . . . 9.5 t -65.82 -34.13 77.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.622 0.769 . . . . 0.0 112.333 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -60.35 -55.46 33.3 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.2 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 69' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.83 -37.43 71.23 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.377 1.444 . . . . 0.0 111.306 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.99 69.73 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 71' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -79.74 -23.45 42.27 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.87 -34.34 75.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.557 1.543 . . . . 0.0 111.632 168.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 73' ' ' LEU . . . . . . . . . . . . . 47.9 tp -77.34 -30.15 53.81 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.659 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.46 2.69 1.98 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 169.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 75' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -81.53 160.23 23.94 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.941 1.371 . . . . 0.0 112.909 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 76' ' ' SER . . . . . . . . . . . . . 4.5 p -83.47 57.29 3.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.085 1.754 . . . . 0.0 112.204 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.48 141.26 30.76 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 78' ' ' THR . . . . . . . . . . . . . 41.8 p -133.62 -175.98 4.01 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.751 1.62 . . . . 0.0 111.236 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 79' ' ' THR . . . . . . . . . . . . . 40.7 m -139.46 126.38 20.93 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.091 -1.005 . . . . 0.0 112.794 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -149.73 108.28 3.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.974 1.31 . . . . 0.0 109.104 162.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 81' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -56.53 -43.5 99.35 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.362 1.065 . . . . 0.0 113.779 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.54 20.22 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.282 2.655 . . . . 0.0 114.971 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -62.4 158.02 18.62 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.085 1.311 . . . . 0.0 112.732 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 tp -60.61 -22.5 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -167.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.04 -55.1 20.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.835 0.743 . . . . 0.0 111.798 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.51 -38.15 90.42 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.367 0.508 . . . . 0.0 112.491 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 87' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' K' ' 143' ' ' LYS . 20.0 tp10 -62.95 -26.3 68.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.041 0.937 . . . . 0.0 112.88 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -86.12 -56.88 3.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.957 1.253 . . . . 0.0 111.736 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.97 -45.48 90.44 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.928 1.291 . . . . 0.0 112.293 -171.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 90' ' ' ARG . . . . . . . . . . . . . 92.9 mtm-85 -82.35 -9.66 59.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 91' ' ' SER . . . . . . . . . . . . . 75.3 m -82.38 -44.24 16.37 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.153 1.342 . . . . 0.0 111.958 173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 92' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -141.28 89.45 9.52 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.42 -21.73 68.84 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.668 2.245 . . . . 0.0 114.266 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.66 -37.77 76.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.879 1.272 . . . . 0.0 112.368 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 95' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.44 -16.51 63.71 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.649 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 96' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -131.16 -39.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -166.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.38 -27.35 13.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.157 1.383 . . . . 0.0 113.753 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.01 159.84 31.52 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.272 1.415 . . . . 0.0 112.839 -166.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.22 -26.29 66.53 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 100' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -86.86 19.01 3.16 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 101' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -48.18 -32.15 6.66 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 102' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.85 -24.44 66.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.944 0.897 . . . . 0.0 113.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 103' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.31 -39.04 91.96 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 119.576 1.08 . . . . 0.0 111.0 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 104' ' ' GLU . . . . . 0.429 ' HA ' ' HE2' ' I' ' 107' ' ' LYS . 0.9 OUTLIER -77.47 -37.08 52.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.555 0.742 . . . . 0.0 112.183 -178.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 105' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.38 -50.44 72.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.405 0.682 . . . . 0.0 111.22 166.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.52 -53.5 56.73 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.951 0.901 . . . . 0.0 112.187 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 107' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' I' ' 104' ' ' GLU . 55.9 pttt -67.16 -26.57 66.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.77 -37.7 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.763 0.825 . . . . 0.0 111.632 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.42 -46.65 93.93 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.345 0.975 . . . . 0.0 113.114 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 110' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.78 -32.08 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.829 -0.806 . . . . 0.0 112.283 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.33 68.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.553 0.741 . . . . 0.0 112.001 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.83 -47.5 82.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.006 0.922 . . . . 0.0 111.078 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 113' ' ' THR . . . . . . . . . . . . . 64.5 m -65.66 -36.17 82.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 114' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -69.16 -22.42 63.93 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.102 -0.999 . . . . 0.0 112.727 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 115' ' ' MET . . . . . . . . . . . . . 54.8 ttp -95.5 -20.04 19.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.504 1.522 . . . . 0.0 114.851 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -72.27 37.14 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 117' ' ' ILE . . . . . . . . . . . . . 19.0 tt -137.72 124.46 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.182 1.393 . . . . 0.0 111.125 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 118' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -74.8 157.67 34.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.659 . . . . 0.0 112.468 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 119' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.04 128.7 44.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.606 1.562 . . . . 0.0 114.274 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 120' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -156.21 68.01 0.6 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.128 0.971 . . . . 0.0 111.639 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m -70.82 163.61 26.95 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.936 -1.102 . . . . 0.0 111.747 165.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.24 -30.71 13.27 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.809 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.69 58.7 1.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 111.467 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 124' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -66.98 -23.88 65.99 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -160.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.17 -39.92 95.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.593 1.542 . . . . 0.0 111.635 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 126' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -66.19 -40.68 90.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.825 1.25 . . . . 0.0 111.79 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 127' ' ' MET . . . . . . . . . . . . . 21.0 mtt -73.91 -4.5 35.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.098 1.359 . . . . 0.0 113.317 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 128' ' ' VAL . . . . . . . . . . . . . 71.8 t -105.89 -31.9 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.56 1.544 . . . . 0.0 111.722 168.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 129' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.57 -40.99 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.431 1.469 . . . . 0.0 110.958 169.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 130' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -63.59 -28.96 70.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.82 -29.36 50.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.036 0.834 . . . . 0.0 112.844 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.12 -41.38 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.463 -0.773 . . . . 0.0 110.527 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -65.89 -34.26 77.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.868 0.758 . . . . 0.0 112.218 167.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.48 75.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.924 1.238 . . . . 0.0 112.046 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.18 -39.08 78.92 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.982 0.81 . . . . 0.0 111.205 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.78 -44.7 80.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.701 0.8 . . . . 0.0 112.019 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.92 -29.62 65.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.261 1.424 . . . . 0.0 112.541 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 138' ' ' VAL . . . . . . . . . . . . . 10.9 t -71.47 -47.75 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 119.937 -1.727 . . . . 0.0 111.932 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 139' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -62.46 -33.91 75.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.484 1.038 . . . . 0.0 111.028 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 140' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -62.61 -40.01 95.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.588 1.155 . . . . 0.0 113.316 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.77 -34.31 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.73 1.15 . . . . 0.0 112.877 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 142' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.05 -46.73 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 110.216 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 143' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -70.43 -3.81 19.49 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.373 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.55 -56.29 2.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.638 1.575 . . . . 0.0 110.654 172.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 145' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.93 -34.4 77.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.164 -0.96 . . . . 0.0 112.881 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 146' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.76 -25.38 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.423 -0.798 . . . . 0.0 111.913 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.04 -43.88 86.28 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.101 1.319 . . . . 0.0 111.039 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -42.86 99.37 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.713 0.805 . . . . 0.0 111.537 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 149' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.26 -42.72 99.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.011 0.925 . . . . 0.0 112.321 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 150' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -61.52 -52.02 66.22 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.499 1.12 . . . . 0.0 111.382 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 151' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.04 -38.88 92.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.172 0.589 . . . . 0.0 112.58 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 152' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -72.71 -47.99 42.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.748 0.819 . . . . 0.0 111.906 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.2 -30.9 70.09 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.732 -1.23 . . . . 0.0 112.712 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 48.7 m -67.46 -8.85 36.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 155' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.55 -30.73 71.76 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.02 -1.05 . . . . 0.0 111.779 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 156' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -107.69 -33.76 7.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.025 1.73 . . . . 0.0 113.468 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 157' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -149.75 72.03 9.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.321 1.048 . . . . 0.0 111.773 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.18 -13.0 38.08 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.856 3.037 . . . . 0.0 114.593 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 159' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -71.52 6.26 1.94 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.221 1.408 . . . . 0.0 114.472 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 160' ' ' LEU . . . . . . . . . . . . . 18.4 tp -111.17 -26.35 9.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.405 1.882 . . . . 0.0 114.187 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.03 -50.05 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.492 1.117 . . . . 0.0 113.564 -165.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 162' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.71 -6.44 55.81 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.337 1.055 . . . . 0.0 113.594 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 163' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.91 -31.49 11.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.36 1.464 . . . . 0.0 112.47 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 164' ' ' LEU . . . . . . . . . . . . . 53.3 mt -115.92 68.36 3.23 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.973 1.709 . . . . 0.0 110.693 168.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 165' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.55 -27.79 18.36 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.562 2.174 . . . . 0.0 113.63 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 166' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -69.31 115.33 8.47 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.485 -1.385 . . . . 0.0 109.665 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 167' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -40.1 81.5 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -164.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 168' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.78 -35.77 87.3 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.065 1.843 . . . . 0.0 113.927 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 169' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -71.85 -35.15 69.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.71 -0.619 . . . . 0.0 111.491 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 170' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.64 -43.73 83.85 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.572 0.749 . . . . 0.0 111.524 172.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 171' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.92 -44.6 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.475 -0.766 . . . . 0.0 111.251 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.71 -37.73 87.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.813 0.733 . . . . 0.0 112.537 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 173' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -61.27 -49.47 76.95 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.582 -0.699 . . . . 0.0 111.557 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.16 -32.73 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 118.527 -0.749 . . . . 0.0 112.062 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 175' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -68.54 -57.74 5.32 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.61 1.095 . . . . 0.0 111.537 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 176' ' ' THR . . . . . . . . . . . . . 36.2 m -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -164.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 177' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.12 -50.69 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.043 -1.036 . . . . 0.0 110.784 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.3 -107.83 2.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.82 0.724 . . . . 0.0 114.111 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 179' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -67.24 134.18 51.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.584 -0.95 . . . . 0.0 112.11 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 180' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -59.02 -30.01 67.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 181' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.01 -0.83 50.68 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 182' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.7 -23.74 60.91 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 112.494 165.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 183' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.84 122.14 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.809 1.244 . . . . 0.0 111.034 -169.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 184' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -140.93 172.2 13.02 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.518 1.927 . . . . 0.0 110.301 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 185' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -67.46 -29.71 69.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 186' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -80.68 -45.96 16.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.126 0.97 . . . . 0.0 111.176 -172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 187' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.72 -22.36 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 188' ' ' LEU . . . . . . . . . . . . . 86.1 mt -75.82 -29.2 58.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.3 -0.875 . . . . 0.0 112.254 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 189' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 -78.54 -32.67 48.01 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.037 170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.78 -11.42 58.44 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 167.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 191' ' ' LEU . . . . . . . . . . . . . 47.8 tp -99.18 -7.36 26.68 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.676 1.99 . . . . 0.0 112.644 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.13 25.96 46.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.631 1.11 . . . . 0.0 115.863 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 193' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.27 150.46 25.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.45 1.625 . . . . 0.0 111.598 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 194' ' ' SER . . . . . . . . . . . . . 13.4 p -91.83 157.14 17.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.255 1.422 . . . . 0.0 112.703 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 195' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -52.27 -39.52 60.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.007 1.323 . . . . 0.0 113.721 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 196' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -57.71 -28.13 63.58 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.351 2.26 . . . . 0.0 114.516 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 197' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -93.17 -26.77 17.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.513 1.925 . . . . 0.0 111.181 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 198' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.43 -17.86 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.003 2.121 . . . . 0.0 113.026 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 199' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.53 -51.67 66.48 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.612 -1.305 . . . . 0.0 110.796 162.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 200' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -68.43 175.54 3.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.96 0.904 . . . . 0.0 109.677 161.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 201' ' ' ILE . . . . . . . . . . . . . 21.5 mt 64.59 -61.79 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.005 1.322 . . . . 0.0 112.292 -166.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 202' ' ' LEU . . . . . . . . . . . . . 46.9 mt -63.58 -34.73 78.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.705 1.139 . . . . 0.0 112.022 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -47.14 -37.7 10.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.436 1.094 . . . . 0.0 113.164 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.83 -16.09 30.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 113.737 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 205' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.09 -34.13 65.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.549 1.139 . . . . 0.0 112.752 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 206' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -92.36 -9.47 41.68 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.934 1.293 . . . . 0.0 114.274 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 207' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' N' ' 216' ' ' GLU . 15.5 pttm -148.91 10.41 0.81 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -167.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 208' ' ' THR . . . . . . . . . . . . . 4.4 t -47.33 153.05 0.54 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.884 1.22 . . . . 0.0 113.554 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 209' ' ' MET . . . . . . . . . . . . . 11.6 ptp -105.11 -0.48 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.49 1.516 . . . . 0.0 114.022 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.06 154.37 52.84 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-N 118.84 0.746 . . . . 0.0 114.136 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 211' ' ' ALA . . . . . . . . . . . . . . . -101.52 150.01 23.5 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.673 1.989 . . . . 0.0 111.984 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 212' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -70.55 131.42 43.95 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 213' ' ' MET . . . . . . . . . . . . . 64.7 mtt -95.36 134.7 37.87 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.913 1.685 . . . . 0.0 110.674 155.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 214' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' I' ' 215' ' ' GLN 0.263 13.8 t0 -87.55 172.99 9.34 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 172.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 215' ' ' GLN . . . . . 0.411 ' H ' ' CG ' ' I' ' 214' ' ' ASP . 40.3 tp60 -54.81 -33.14 61.21 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -164.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 216' ' ' THR . . . . . 0.418 ' CB ' HH12 ' L' ' 244' ' ' ARG 0.263 23.7 p -114.31 18.41 16.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 175.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 217' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -84.71 -49.16 8.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.3 0.64 . . . . 0.0 109.89 155.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 218' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.36 -25.49 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.576 . . . . 0.0 112.11 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.98 -47.7 84.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.173 -0.918 . . . . 0.0 112.439 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -29.96 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.62 1.555 . . . . 0.0 112.038 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.24 -34.96 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 0.0 110.676 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 222' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -70.09 -37.59 75.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 118.196 -0.906 . . . . 0.0 113.052 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 223' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -60.01 -45.21 93.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.411 1.005 . . . . 0.0 110.604 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 224' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.57 -43.18 93.68 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.817 -0.552 . . . . 0.0 111.902 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.9 -34.07 75.94 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 226' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.85 -35.48 74.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.149 1.38 . . . . 0.0 112.112 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 227' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.8 -35.16 60.16 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.118 -0.989 . . . . 0.0 112.756 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 228' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 -32.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.564 -1.335 . . . . 0.0 111.477 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 229' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.71 -42.79 68.4 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 230' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -68.17 -27.95 66.86 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.367 -0.833 . . . . 0.0 112.952 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 231' ' ' LEU . . . . . . . . . . . . . 98.9 mt -68.94 -30.42 68.86 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.886 1.221 . . . . 0.0 112.537 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 232' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -71.71 -34.89 69.99 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.012 -1.055 . . . . 0.0 112.393 168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 233' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.0 -39.04 92.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.862 0.755 . . . . 0.0 111.606 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 234' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.17 -37.02 83.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.637 1.175 . . . . 0.0 112.044 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 235' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -62.28 -40.9 97.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.528 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 236' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.46 -44.05 97.33 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.599 1.09 . . . . 0.0 111.995 171.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 237' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -56.54 -39.34 73.22 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.285 1.034 . . . . 0.0 111.854 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 238' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.1 -42.91 62.45 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 239' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.03 -43.63 95.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.505 1.048 . . . . 0.0 111.741 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 240' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -70.46 -28.44 65.01 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.069 1.348 . . . . 0.0 113.166 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 241' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -72.6 -46.96 51.65 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.854 0.862 . . . . 0.0 111.686 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 242' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.14 -41.19 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.784 0.834 . . . . 0.0 111.098 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 243' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.39 -15.56 62.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.356 1.063 . . . . 0.0 113.805 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -46.16 4.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.837 1.655 . . . . 0.0 113.127 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 245' ' ' ALA . . . . . . . . . . . . . . . -91.38 -23.75 19.97 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 246' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.96 -2.81 49.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.693 1.133 . . . . 0.0 113.955 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 247' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.74 -0.42 51.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 113.56 172.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 248' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -73.09 147.19 45.19 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.926 -1.109 . . . . 0.0 112.434 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 249' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.46 135.02 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.216 1.807 . . . . 0.0 109.732 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 250' ' ' ALA . . . . . . . . . . . . . . . -147.73 134.5 10.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.868 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 251' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -75.93 148.62 32.03 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.736 2.291 . . . . 0.0 113.58 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 252' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -82.33 -48.65 10.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.41 1.484 . . . . 0.0 112.314 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 253' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.77 -40.63 76.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.882 0.873 . . . . 0.0 111.497 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 254' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -56.06 -27.42 53.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.775 2.03 . . . . 0.0 113.635 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 255' ' ' ALA . . . . . . . . . . . . . . . -100.93 -35.24 9.47 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.9 1.28 . . . . 0.0 113.694 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 256' ' ' LEU . . . . . . . . . . . . . 67.5 tp -72.47 -43.53 63.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.225 0.921 . . . . 0.0 113.095 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 257' ' ' VAL . . . . . . . . . . . . . 18.0 m -117.71 -6.41 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.4 142.91 6.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.505 1.05 . . . . 0.0 112.532 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 259' ' ' ALA . . . . . . . . . . . . . . . -52.15 -48.92 64.65 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -166.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 260' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -67.14 -38.98 86.47 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.49 0.716 . . . . 0.0 112.776 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 261' ' ' LEU . . . . . . . . . . . . . 44.0 tp -72.25 -41.03 67.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.51 0.724 . . . . 0.0 111.589 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 262' ' ' ALA . . . . . . . . . . . . . . . -57.8 -50.64 72.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.447 0.699 . . . . 0.0 111.556 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.39 82.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.791 0.837 . . . . 0.0 112.276 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 264' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -66.92 -51.53 54.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 118.941 0.791 . . . . 0.0 111.776 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 265' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.32 -36.3 73.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.165 0.986 . . . . 0.0 113.022 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 266' ' ' ILE . . . . . . . . . . . . . 44.5 mt -57.8 -27.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.825 1.25 . . . . 0.0 113.039 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 267' ' ' SER . . . . . . . . . . . . . 11.9 t -96.77 -28.92 14.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 268' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.4 -23.5 66.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.802 0.728 . . . . 0.0 112.254 170.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.92 -2.99 56.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.935 1.294 . . . . 0.0 113.677 169.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.67 -36.42 2.65 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.768 -1.208 . . . . 0.0 114.107 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 271' ' ' GLY . . . . . . . . . . . . . . . -170.3 171.29 43.49 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 118.531 1.166 . . . . 0.0 114.942 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 272' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.64 -30.96 71.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.399 -1.059 . . . . 0.0 111.736 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -54.86 39.52 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.096 1.358 . . . . 0.0 110.491 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 274' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.42 -42.9 96.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.266 0.627 . . . . 0.0 112.475 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 275' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.43 -25.09 67.78 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 119.482 1.037 . . . . 0.0 112.948 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 276' ' ' ALA . . . . . . . . . . . . . . . -91.52 -4.54 55.34 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.929 1.692 . . . . 0.0 114.249 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 277' ' ' MET . . . . . . . . . . . . . 20.0 mmt -107.31 -51.04 2.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.046 1.339 . . . . 0.0 111.451 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 278' ' ' MET . . . . . . . . . . . . . 56.4 mtt -54.14 154.37 7.99 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.907 2.083 . . . . 0.0 114.286 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 279' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.58 154.12 27.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.776 2.984 . . . . 0.0 112.445 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 280' ' ' SER . . . . . . . . . . . . . 96.8 p -53.85 -38.31 64.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.776 0.831 . . . . 0.0 113.095 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 281' ' ' SER . . . . . . . . . . . . . 18.4 m -57.54 -29.55 64.47 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 282' ' ' THR . . . . . . . . . . . . . 87.4 m -90.2 -41.87 11.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.11 0.964 . . . . 0.0 110.429 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 283' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.06 -28.98 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.738 1.215 . . . . 0.0 111.622 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 284' ' ' GLN . . . . . 0.404 ' NE2' ' H62' ' A' ' 50' ' ' ' A' . 50.3 tt0 -59.86 -33.49 71.86 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.911 1.685 . . . . 0.0 113.602 172.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 285' ' ' VAL . . . . . . . . . . . . . 32.0 m -113.27 -0.98 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 286' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.45 125.15 10.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.662 1.185 . . . . 0.0 112.329 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 287' ' ' GLY . . . . . . . . . . . . . . . 63.06 32.21 83.37 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.68 -4.85 25.62 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 119.67 1.735 . . . . 0.0 114.314 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 289' ' ' GLU . . . . . . . . . . . . 0.25 43.4 mt-10 49.77 -139.81 0.82 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.225 1.81 . . . . 0.0 111.061 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 290' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -61.15 -10.57 6.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.85 74.09 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.216 -0.927 . . . . 0.0 112.386 170.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 292' ' ' LEU . . . . . . . . . . . . . 48.4 tp -73.03 -43.03 62.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.51 -0.744 . . . . 0.0 110.918 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 293' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -50.4 -53.0 32.57 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.359 1.063 . . . . 0.0 112.174 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 294' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -72.93 -21.86 60.82 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 295' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -67.76 -41.56 83.15 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.168 0.895 . . . . 0.0 112.386 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 296' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.13 -70.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.675 0.671 . . . . 0.0 110.881 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 297' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -38.28 88.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.683 1.593 . . . . 0.0 113.463 -167.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 298' ' ' THR . . . . . . . . . . . . . 3.7 m -105.56 -4.11 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.201 1.0 . . . . 0.0 113.165 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 299' ' ' GLY . . . . . . . . . . . . . . . 68.94 28.18 73.26 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.674 -1.266 . . . . 0.0 115.501 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 300' ' ' ALA . . . . . . . . . . . . . . . -68.95 178.3 2.26 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.11 1.364 . . . . 0.0 113.112 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 301' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -61.55 137.8 94.89 Favored Pre-proline 0 CA--C 1.55 0.965 0 O-C-N 120.85 -1.157 . . . . 0.0 110.285 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 302' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -54.11 143.82 60.98 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.803 2.335 . . . . 0.0 112.959 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 303' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.16 136.52 37.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.047 1.831 . . . . 0.0 111.453 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 304' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -67.69 -25.06 65.5 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.862 -1.149 . . . . 0.0 113.518 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 305' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.58 145.7 9.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.066 1.346 . . . . 0.0 111.336 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 306' ' ' GLY . . . . . . . . . . . . . . . -95.22 -136.8 8.72 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.126 1.346 . . . . 0.0 112.007 164.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 307' ' ' VAL . . . . . . . . . . . . . 54.8 t -54.99 -21.62 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.466 1.506 . . . . 0.0 113.546 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 308' ' ' ILE . . . . . . . . . . . . . 26.3 pt -59.39 -13.86 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.863 -1.148 . . . . 0.0 114.01 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 309' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -59.4 -31.37 69.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.773 1.17 . . . . 0.0 112.407 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 310' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.62 -0.91 7.56 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 311' ' ' TYR . . . . . 0.403 ' CD2' ' HD2' ' I' ' 312' ' ' PRO . 70.0 t80 -65.7 133.33 95.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 120.076 -1.64 . . . . 0.0 110.861 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 312' ' ' PRO . . . . . 0.403 ' HD2' ' CD2' ' I' ' 311' ' ' TYR . 43.1 Cg_endo -67.91 -0.87 5.99 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.248 2.632 . . . . 0.0 116.824 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 313' ' ' ALA . . . . . . . . . . . . . . . -113.2 10.42 18.57 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.057 1.343 . . . . 0.0 113.778 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 314' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.2 -45.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 315' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -51.61 -46.26 63.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.743 1.217 . . . . 0.0 114.214 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -87.44 -10.3 52.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 317' ' ' SER . . . . . . . . . . . . . 15.8 m -88.96 152.44 48.43 Favored Pre-proline 0 N--CA 1.473 0.675 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -155.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 318' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.11 157.28 46.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.927 2.418 . . . . 0.0 113.155 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 319' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -60.32 -39.08 85.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 320' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -50.19 -32.32 16.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.387 1.875 . . . . 0.0 113.418 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 321' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.23 -26.16 9.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.409 1.884 . . . . 0.0 114.114 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 322' ' ' ARG . . . . . 0.459 ' NH2' HO2' ' W' ' 11' ' ' ' C' . 57.7 mtt180 -50.62 -42.58 56.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 120.557 1.526 . . . . 0.0 113.844 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 323' ' ' GLY . . . . . . . . . . . . . . . -70.92 -44.18 56.31 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.772 0.715 . . . . 0.0 113.877 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 324' ' ' LYS . . . . . 0.479 ' HE2' ' CE1' ' I' ' 366' ' ' TYR . 55.7 mttp -62.1 -44.27 97.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.861 1.265 . . . . 0.0 111.199 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 325' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.51 -41.05 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.998 0.919 . . . . 0.0 110.734 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.71 80.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.821 1.191 . . . . 0.0 113.518 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 327' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -67.78 -50.61 56.14 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.696 0.799 . . . . 0.0 111.865 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.36 83.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 112.786 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 329' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.17 -46.03 91.09 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.377 -0.827 . . . . 0.0 110.479 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.02 -37.09 85.8 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.383 0.992 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 331' ' ' GLY . . . . . . . . . . . . . . . -63.62 -54.43 31.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.699 0.666 . . . . 0.0 112.547 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 332' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -64.23 -31.86 73.22 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.046 -1.267 . . . . 0.0 113.188 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 333' ' ' LEU . . . . . . . . . . . . . 49.9 tp -65.66 -45.0 84.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.384 1.873 . . . . 0.0 111.94 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.13 85.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.255 0.622 . . . . 0.0 111.924 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 335' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.04 -51.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.417 1.087 . . . . 0.0 110.834 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 336' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.62 82.97 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.893 0.77 . . . . 0.0 112.944 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.83 97.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.879 0.472 . . . . 0.0 112.095 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 338' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -38.43 87.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.689 0.796 . . . . 0.0 112.534 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 339' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.16 -49.37 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.314 0.961 . . . . 0.0 111.676 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 340' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -60.92 -33.79 73.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.805 0.73 . . . . 0.0 112.784 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 341' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -91.22 -43.66 9.7 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 342' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.05 -25.3 18.0 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 343' ' ' SER . . . . . . . . . . . . . 22.8 t -119.72 -44.04 2.55 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 344' ' ' GLY . . . . . . . . . . . . . . . 66.43 30.31 76.36 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.24 -0.912 . . . . 0.0 113.416 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 345' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -110.02 170.61 7.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.567 1.947 . . . . 0.0 108.983 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 346' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -123.87 125.32 44.45 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.743 -1.223 . . . . 0.0 111.731 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 347' ' ' ILE . . . . . . . . . . . . . 40.1 pt -137.94 14.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.781 1.633 . . . . 0.0 112.616 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 348' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.63 70.06 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 119.797 -1.815 . . . . 0.0 114.885 -162.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 349' ' ' GLU . . . . . 0.443 ' CD ' ' HZ2' ' I' ' 352' ' ' LYS . 54.8 mm-40 -75.6 -21.64 57.61 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.348 -0.845 . . . . 0.0 112.669 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 350' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.04 -48.15 46.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.184 0.902 . . . . 0.0 110.095 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 351' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.56 -37.01 74.82 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.16 0.584 . . . . 0.0 111.988 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 352' ' ' LYS . . . . . 0.443 ' HZ2' ' CD ' ' I' ' 349' ' ' GLU . 54.7 mtpt -65.58 -46.55 79.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.07 0.948 . . . . 0.0 112.441 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 353' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.18 -39.65 79.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.219 1.008 . . . . 0.0 112.253 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 354' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -68.52 -46.36 69.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.186 0.594 . . . . 0.0 112.566 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 355' ' ' LEU . . . . . . . . . . . . . 40.6 tp -64.56 -31.61 72.9 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.205 -0.934 . . . . 0.0 111.648 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 356' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.91 -36.45 75.38 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.899 1.28 . . . . 0.0 112.783 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 357' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.52 87.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.798 0.727 . . . . 0.0 111.309 168.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 358' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -61.73 -37.75 85.38 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.503 -0.748 . . . . 0.0 112.654 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 359' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.91 -41.18 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.829 1.195 . . . . 0.0 111.312 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 360' ' ' ARG . . . . . 0.439 HH12 ' CD ' ' L' ' 206' ' ' GLU . 25.7 mtp180 -62.14 -42.1 98.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.96 0.8 . . . . 0.0 111.506 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 361' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.79 -37.39 87.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.416 0.687 . . . . 0.0 112.083 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 362' ' ' ILE . . . . . . . . . . . . . 46.1 mt -60.52 -40.42 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.066 -1.022 . . . . 0.0 111.058 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 363' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -43.15 88.61 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.753 1.161 . . . . 0.0 111.257 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.37 -19.02 64.61 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.516 1.126 . . . . 0.0 113.379 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 365' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -99.39 -24.56 14.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 366' ' ' TYR . . . . . 0.479 ' CE1' ' HE2' ' I' ' 324' ' ' LYS . 46.8 m-85 . . . . . 0 C--O 1.253 1.271 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -164.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 1' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 2' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.42 165.11 21.08 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.253 2.635 . . . . 0.0 113.988 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 3' ' ' SER . . . . . . . . . . . . . 87.8 p -69.96 -37.68 75.87 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.944 2.097 . . . . 0.0 113.902 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 4' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -72.59 -11.5 60.67 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -164.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.0 144.44 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.505 1.048 . . . . 0.0 112.361 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -116.41 -25.75 7.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.84 1.256 . . . . 0.0 113.764 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -139.13 151.17 46.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.309 1.843 . . . . 0.0 110.405 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.33 148.63 33.7 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 110.93 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.31 145.19 28.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.372 1.069 . . . . 0.0 111.722 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.61 -163.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.874 3.049 . . . . 0.0 111.316 160.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -65.31 -13.42 58.44 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.448 -1.408 . . . . 0.0 114.108 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.46 146.52 53.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.712 1.205 . . . . 0.0 111.545 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' LEU . . . . . . . . . . . . . 50.0 mt 59.82 -47.36 0.08 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.509 1.924 . . . . 0.0 114.531 -162.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.02 83.57 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.1 1.318 . . . . 0.0 113.256 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.61 -29.68 70.3 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.872 -1.143 . . . . 0.0 111.719 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.71 -33.51 62.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.917 0.887 . . . . 0.0 112.411 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.43 70.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.827 0.851 . . . . 0.0 112.368 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.93 -43.34 99.07 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.327 0.512 . . . . 0.0 110.448 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.32 -36.52 75.8 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.445 -0.784 . . . . 0.0 112.945 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.57 90.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.01 0.823 . . . . 0.0 112.518 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' VAL . . . . . . . . . . . . . 77.6 t -59.03 -41.65 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.015 0.825 . . . . 0.0 110.764 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.06 -7.15 15.71 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.5 -21.73 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.23 67.52 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.635 -1.29 . . . . 0.0 111.794 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -57.38 -34.76 69.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -125.64 4.51 7.51 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 25.6 p -115.75 -13.95 11.4 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.55 -139.91 4.1 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.859 1.695 . . . . 0.0 113.957 -171.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -134.16 127.58 32.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.334 1.454 . . . . 0.0 110.792 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 tt -143.13 153.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.722 1.209 . . . . 0.0 112.069 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 31' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -133.59 156.78 47.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.765 1.226 . . . . 0.0 111.445 164.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 144.69 41.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.209 1.803 . . . . 0.0 112.0 -169.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.22 154.58 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.397 0.998 . . . . 0.0 112.16 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 34' ' ' THR . . . . . . . . . . . . . 28.6 m -77.97 -28.12 49.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 35' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -76.44 -32.31 58.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 122.165 2.257 . . . . 0.0 112.744 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -72.18 -40.15 68.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.771 -1.206 . . . . 0.0 112.506 168.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -55.55 -45.53 77.26 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 168.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 38' ' ' THR . . . . . . . . . . . . . 85.5 m -67.82 -38.34 83.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.848 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 39' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -58.67 -49.9 75.83 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.457 1.481 . . . . 0.0 112.215 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.91 -16.61 62.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 41' ' ' VAL . . . . . 0.438 HG12 ' HE2' ' J' ' 71' ' ' LYS . 2.7 t -84.34 -52.92 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 117.275 -1.345 . . . . 0.0 110.956 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -61.46 -48.09 82.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.429 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 43' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -84.77 25.04 0.96 Allowed 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.051 -1.031 . . . . 0.0 113.318 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.63 -30.18 0.48 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.509 2.004 . . . . 0.0 118.052 168.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -56.55 -20.53 21.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.609 2.363 . . . . 0.0 116.629 -162.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.44 115.72 12.04 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.638 -1.289 . . . . 0.0 111.477 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -27.37 51.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.614 1.966 . . . . 0.0 112.758 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -148.93 139.39 22.51 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.22 1.808 . . . . 0.0 108.348 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -121.7 138.91 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 111.274 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.19 128.16 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.066 1.746 . . . . 0.0 108.199 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 51' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.01 156.0 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 111.778 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.06 158.47 20.43 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.735 -1.228 . . . . 0.0 114.164 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 53' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.15 -5.09 55.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.654 1.582 . . . . 0.0 114.351 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -128.66 22.4 5.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.34 1.456 . . . . 0.0 114.339 -169.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.46 138.06 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.801 0.84 . . . . 0.0 110.034 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -152.47 102.47 2.74 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.881 0.873 . . . . 0.0 110.807 -165.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -60.21 143.65 34.4 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.176 1.099 . . . . 0.0 112.875 -0.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.49 -21.91 65.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -66.6 -23.19 66.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.255 1.422 . . . . 0.0 114.654 -169.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.958 1.254 . . . . 0.0 113.581 -174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.1 -1.76 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.937 1.295 . . . . 0.0 114.164 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.92 -16.14 63.59 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -167.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 63' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -77.31 -25.82 51.6 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.951 1.7 . . . . 0.0 114.226 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.12 -42.31 80.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.104 -1.427 . . . . 0.0 113.458 -169.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -63.03 -55.23 0.83 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 CA-C-N 122.105 1.787 . . . . 0.0 115.144 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 66' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.81 -34.28 50.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 122.505 1.93 . . . . 0.0 112.991 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.86 -27.45 66.69 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.525 -0.734 . . . . 0.0 112.32 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 68' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.52 -17.63 55.94 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.09 -43.67 56.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.33 0.968 . . . . 0.0 111.695 162.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.6 -31.59 72.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.833 1.653 . . . . 0.0 113.287 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 71' ' ' LYS . . . . . 0.45 ' HE3' ' HB ' ' J' ' 73' ' ' ILE . 1.6 pttt -103.95 -7.85 20.07 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 115.485 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 63.47 68.78 0.59 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.737 1.615 . . . . 0.0 114.943 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 73' ' ' ILE . . . . . 0.45 ' HB ' ' HE3' ' J' ' 71' ' ' LYS . 20.4 mm -138.3 145.07 45.59 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.843 2.057 . . . . 0.0 110.678 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 74' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.55 146.48 39.21 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.499 2.799 . . . . 0.0 114.333 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 75' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.22 147.66 47.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.904 1.682 . . . . 0.0 112.057 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.4 159.3 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.344 1.057 . . . . 0.0 112.014 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.28 155.67 30.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.844 1.258 . . . . 0.0 113.871 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 m -139.03 152.02 69.21 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 126.403 1.881 . . . . 0.0 112.571 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.81 -12.92 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 N-CA-C 118.557 2.483 . . . . 0.0 118.557 -157.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -155.67 126.14 6.78 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.008 1.731 . . . . 0.0 113.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -61.77 -32.57 72.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.03 2.132 . . . . 0.0 114.834 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -69.08 -41.68 77.21 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.343 -0.848 . . . . 0.0 111.851 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.42 -33.03 70.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.655 0.782 . . . . 0.0 111.78 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.81 -41.18 92.21 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.551 -0.718 . . . . 0.0 112.072 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.47 95.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 118.412 0.551 . . . . 0.0 112.595 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.08 83.16 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.64 87.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.338 -0.851 . . . . 0.0 111.88 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.04 6.58 4.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.888 1.275 . . . . 0.0 114.189 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -15.47 30.07 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.599 1.571 . . . . 0.0 116.008 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 90' ' ' ILE . . . . . . . . . . . . . 43.0 pt -77.15 162.85 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.156 1.478 . . . . 0.0 112.027 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 91' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -97.54 -10.58 24.99 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 92' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.09 -155.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.742 1.617 . . . . 0.0 111.185 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.18 173.29 6.44 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.842 -1.161 . . . . 0.0 112.513 171.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.66 125.16 15.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.438 -0.789 . . . . 0.0 110.379 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -27.22 63.35 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 96' ' ' SER . . . . . . . . . . . . . 87.3 p -153.44 163.54 39.75 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 73.8 t -139.0 143.67 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.165 2.186 . . . . 0.0 109.931 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 130.52 52.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.082 1.353 . . . . 0.0 112.708 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.93 118.81 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.597 1.159 . . . . 0.0 109.322 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.01 -39.92 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 109.942 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 101' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -142.6 121.73 7.68 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.058 0.943 . . . . 0.0 109.562 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 102' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -64.39 -12.09 31.44 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.714 2.276 . . . . 0.0 116.057 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.48 -120.03 20.83 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 119.1 0.864 . . . . 0.0 111.206 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -72.05 -20.98 61.6 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.92 23.78 0.98 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -64.23 -51.01 65.74 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.452 -1.405 . . . . 0.0 113.608 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -33.2 66.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.006 0.821 . . . . 0.0 112.096 174.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 108' ' ' LEU . . . . . . . . . . . . . 17.1 tp -75.36 -44.94 42.36 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.772 1.229 . . . . 0.0 112.108 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 109' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.59 -34.2 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.577 0.751 . . . . 0.0 111.056 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.74 -36.43 78.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.739 0.7 . . . . 0.0 112.208 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 111' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -61.45 -47.54 85.25 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.475 1.034 . . . . 0.0 111.416 169.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 112' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.97 -48.65 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.228 0.611 . . . . 0.0 110.025 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.11 91.67 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.033 0.833 . . . . 0.0 112.219 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 114' ' ' MET . . . . . . . . . . . . . 60.4 ttm -64.61 -36.88 85.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.711 0.804 . . . . 0.0 112.846 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.56 -26.86 29.72 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.866 0.866 . . . . 0.0 113.127 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 116' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.58 -33.26 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.043 1.292 . . . . 0.0 111.129 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 117' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -69.4 -4.11 17.09 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.648 -1.283 . . . . 0.0 113.859 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 118' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -81.63 -17.16 49.09 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.178 -1.576 . . . . 0.0 113.353 163.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 119' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.53 -31.18 7.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.487 1.515 . . . . 0.0 113.378 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 120' ' ' MET . . . . . . . . . . . . . 40.6 mtm -76.62 48.46 0.56 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.914 1.686 . . . . 0.0 112.119 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 121' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 125.481 1.513 . . . . 0.0 113.609 -161.151 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.88 167.38 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.129 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 3' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -119.7 127.06 52.52 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.329 1.052 . . . . 0.0 110.697 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.01 136.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.221 1.008 . . . . 0.0 111.508 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.49 161.82 37.43 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.098 1.759 . . . . 0.0 112.547 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -80.21 152.62 29.04 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.258 1.023 . . . . 0.0 112.198 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -99.74 176.08 5.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.516 1.127 . . . . 0.0 112.595 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' LYS . . . . . 0.449 ' HE3' ' CZ ' ' K' ' 9' ' ' PHE . 48.1 pttt -66.05 -16.86 64.29 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' K' ' 8' ' ' LYS . 14.1 m-85 -112.3 137.72 21.63 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.218 1.407 . . . . 0.0 110.447 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.92 145.66 80.69 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.661 2.241 . . . . 0.0 111.508 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.2 -15.78 8.37 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.289 0.947 . . . . 0.0 114.867 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.34 140.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.807 1.303 . . . . 0.0 110.325 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -124.49 166.84 15.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.766 1.626 . . . . 0.0 111.431 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.45 145.23 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.264 1.826 . . . . 0.0 108.546 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.48 142.53 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.617 0.767 . . . . 0.0 110.389 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 164.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -85.03 163.6 18.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.525 0.73 . . . . 0.0 112.542 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.04 -25.55 68.17 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.829 -1.169 . . . . 0.0 113.078 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.97 -12.88 61.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.836 1.655 . . . . 0.0 115.086 171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.49 28.59 29.51 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.125 -0.984 . . . . 0.0 113.428 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -121.48 152.8 38.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.872 2.069 . . . . 0.0 111.738 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.91 129.3 34.93 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.818 0.847 . . . . 0.0 109.594 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 23' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.17 141.89 51.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.671 0.788 . . . . 0.0 111.662 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -89.12 144.15 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.824 0.85 . . . . 0.0 112.998 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.67 170.64 19.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.247 1.019 . . . . 0.0 113.134 -169.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 26' ' ' THR . . . . . . . . . . . . . 69.0 p -133.91 157.18 46.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.293 1.437 . . . . 0.0 110.899 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -80.14 122.08 26.36 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.429 -0.795 . . . . 0.0 108.957 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -62.29 126.39 27.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.573 0.749 . . . . 0.0 111.233 -166.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -46.25 -45.73 17.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.319 1.847 . . . . 0.0 112.781 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 30' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.98 141.45 39.54 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 125.375 1.47 . . . . 0.0 109.091 158.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 31' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.36 143.87 31.97 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 111.866 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.57 -10.34 74.27 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.01 1.29 . . . . 0.0 114.6 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -77.53 139.66 39.62 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.068 1.434 . . . . 0.0 112.242 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.84 148.84 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.951 1.7 . . . . 0.0 108.881 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.86 -33.24 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 117.84 -1.076 . . . . 0.0 113.649 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 36' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -142.57 38.39 1.51 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.626 1.203 . . . . 0.0 112.042 169.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.89 23.89 64.02 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.172 1.368 . . . . 0.0 114.27 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -81.95 167.09 19.28 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -156.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -67.73 92.62 0.34 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.944 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.71 145.81 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 111.219 167.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 41' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.76 114.79 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 108.654 -170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 42' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -78.81 139.07 38.44 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.246 1.018 . . . . 0.0 109.773 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -129.45 -175.34 3.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.441 1.496 . . . . 0.0 110.777 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.87 66.86 2.19 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.94 1.296 . . . . 0.0 113.625 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.38 10.86 43.48 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.866 1.222 . . . . 0.0 114.271 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -138.06 163.17 32.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.258 1.423 . . . . 0.0 110.434 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 47' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.63 140.21 45.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.996 -1.065 . . . . 0.0 110.51 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 48' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.83 156.8 40.75 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.031 1.732 . . . . 0.0 111.534 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -131.1 138.43 49.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.278 1.431 . . . . 0.0 111.097 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 tt -74.02 152.32 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.975 0.91 . . . . 0.0 111.661 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 51' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -119.33 87.92 2.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.797 1.639 . . . . 0.0 108.456 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 52' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -71.17 108.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -159.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 53' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.29 -12.41 33.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.874 1.716 . . . . 0.0 113.846 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -81.76 -6.89 59.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.819 1.19 . . . . 0.0 112.535 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 55' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -151.45 43.45 0.76 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.308 1.443 . . . . 0.0 111.283 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 56' ' ' SER . . . . . . . . . . . . . 67.7 m -159.94 110.81 1.93 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.371 -1.456 . . . . 0.0 111.711 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -60.05 -34.64 73.69 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.79 -45.29 86.9 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.767 0.712 . . . . 0.0 111.292 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.82 -44.87 88.15 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.266 0.46 . . . . 0.0 112.582 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.13 96.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.12 0.968 . . . . 0.0 112.168 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -38.98 92.9 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.036 -1.04 . . . . 0.0 112.418 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 62' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.71 -42.02 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.43 -0.794 . . . . 0.0 110.651 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -67.97 -35.76 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.076 0.853 . . . . 0.0 112.229 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -69.02 -3.7 14.07 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.312 1.045 . . . . 0.0 113.27 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.72 34.96 7.05 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.56 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -50.34 129.49 21.75 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.477 1.511 . . . . 0.0 111.082 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 67' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -93.88 -44.63 8.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.294 1.438 . . . . 0.0 113.59 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 68' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.7 98.2 8.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.181 1.793 . . . . 0.0 112.235 -171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 69' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -113.21 109.06 52.12 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 121.504 -0.748 . . . . 0.0 110.921 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 70' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -89.05 -11.95 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.245 2.63 . . . . 0.0 114.523 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 71' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.59 125.27 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.157 0.89 . . . . 0.0 109.083 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -145.48 161.46 41.09 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.94 1.696 . . . . 0.0 109.934 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 73' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.46 143.75 34.31 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.479 2.786 . . . . 0.0 114.734 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.7 -11.5 10.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 75' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -73.16 172.77 10.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.385 1.474 . . . . 0.0 113.74 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 76' ' ' SER . . . . . . . . . . . . . 90.1 p -113.7 133.2 55.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.957 1.303 . . . . 0.0 112.164 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.24 148.19 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.401 1.08 . . . . 0.0 112.492 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 tp -116.48 130.64 56.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.542 1.937 . . . . 0.0 109.498 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.47 133.35 56.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.805 1.242 . . . . 0.0 109.381 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -117.33 112.88 21.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.922 1.689 . . . . 0.0 108.884 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.51 68.37 1.52 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -167.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 tt -98.62 -30.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.63 1.172 . . . . 0.0 113.738 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 83' ' ' ALA . . . . . . . . . . . . . . . 43.8 -87.08 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.955 1.702 . . . . 0.0 114.367 -160.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -141.61 -58.83 0.48 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.35 1.86 . . . . 0.0 110.328 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.85 89.95 0.83 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.887 1.232 . . . . 0.0 116.173 148.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -53.12 -46.14 68.62 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.424 1.112 . . . . 0.0 110.598 153.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 87' ' ' THR . . . . . . . . . . . . . 3.9 t -85.71 -34.89 21.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.011 1.725 . . . . 0.0 112.598 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.2 -34.22 9.76 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -163.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 89' ' ' SER . . . . . . . . . . . . . 88.2 p -60.45 -25.49 66.04 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -165.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 90' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -60.44 -20.31 59.38 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.581 1.952 . . . . 0.0 114.016 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.85 -30.98 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.244 0.929 . . . . 0.0 111.99 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -65.63 -39.21 91.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.806 0.842 . . . . 0.0 112.127 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.13 -40.51 74.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.564 0.746 . . . . 0.0 111.845 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 94' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.12 -40.17 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.991 1.317 . . . . 0.0 111.628 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 95' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.88 -35.02 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 111.25 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 -173.84 38.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.134 1.349 . . . . 0.0 115.391 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 97' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -59.48 -21.03 59.52 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -97.94 -3.9 37.48 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.34 -172.75 18.4 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.87 1.224 . . . . 0.0 114.605 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 100' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -139.94 131.93 27.8 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.378 1.071 . . . . 0.0 112.343 -168.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.91 125.77 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.122 1.369 . . . . 0.0 109.79 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 102' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -99.29 124.09 44.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.639 0.776 . . . . 0.0 109.382 164.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.6 109.31 2.94 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.3 136.23 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.626 1.17 . . . . 0.0 109.493 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -139.42 138.81 36.82 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.849 0.86 . . . . 0.0 111.948 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 106' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -95.32 -32.83 12.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 111.683 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 107' ' ' SER . . . . . . . . . . . . . 5.5 m -65.48 115.26 20.41 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.069 1.748 . . . . 0.0 111.018 -173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.86 2.96 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.692 2.928 . . . . 0.0 116.789 -156.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 109' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -120.26 -55.99 2.02 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 110' ' ' VAL . . . . . . . . . . . . . 26.4 m -56.31 -34.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -160.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 111' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.34 -19.78 56.77 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.238 -0.914 . . . . 0.0 112.969 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 112' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -62.0 -24.08 66.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.941 1.296 . . . . 0.0 113.319 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 113' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -86.39 -17.6 33.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.145 0.884 . . . . 0.0 113.153 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -76.75 -31.64 57.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.604 -1.31 . . . . 0.0 112.225 169.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 t -50.21 -44.63 81.39 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.915 1.686 . . . . 0.0 115.008 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 116' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.38 -39.81 4.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 CA-C-N 122.883 2.066 . . . . 0.0 113.072 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 117' ' ' ILE . . . . . . . . . . . . . 35.2 mt -60.91 -33.96 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.413 1.085 . . . . 0.0 111.09 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 118' ' ' VAL . . . . . . . . . . . . . 20.6 m -76.7 -1.34 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 119' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.26 -14.1 62.76 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 120.301 1.41 . . . . 0.0 112.261 165.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 120' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.22 -27.07 4.2 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 159.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -76.77 55.99 1.13 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 121.007 1.73 . . . . 0.0 112.944 171.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 122' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -71.16 9.71 0.69 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.954 2.102 . . . . 0.0 115.01 -173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 123' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -92.84 -10.53 36.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 113.067 164.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.85 144.85 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.489 1.516 . . . . 0.0 110.295 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 125' ' ' ILE . . . . . . . . . . . . . 45.5 mt -124.79 123.25 25.62 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.447 1.099 . . . . 0.0 108.976 163.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 126' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.44 130.66 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.788 2.992 . . . . 0.0 112.022 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.63 124.52 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.961 1.304 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.83 121.05 27.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.623 0.769 . . . . 0.0 111.719 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.29 155.13 12.08 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 126.419 1.961 . . . . 0.0 112.924 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 130' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.61 115.06 7.56 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.193 -1.18 . . . . 0.0 112.725 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.82 60.9 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 132' ' ' THR . . . . . . . . . . . . . 19.1 m -66.93 -26.27 66.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.349 1.46 . . . . 0.0 112.236 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 133' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.17 78.06 17.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.166 1.786 . . . . 0.0 108.46 -171.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 134' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.29 -16.7 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.188 3.259 . . . . 0.0 115.297 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -67.34 -22.64 65.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.646 1.978 . . . . 0.0 114.226 171.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 136' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' I' ' 37' ' ' LYS . 43.7 mm-40 -60.33 -28.43 68.14 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 121.011 1.732 . . . . 0.0 114.327 -173.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -121.37 14.88 11.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.166 1.386 . . . . 0.0 113.915 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -51.46 -25.6 6.72 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.37 -12.85 51.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -121.55 13.45 10.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.262 1.425 . . . . 0.0 113.594 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 141' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.66 173.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.137 1.375 . . . . 0.0 112.307 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 142' ' ' THR . . . . . . . . . . . . . 68.3 p -139.41 -179.45 5.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.127 1.771 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 143' ' ' LYS . . . . . 0.413 ' HZ1' ' CD ' ' I' ' 87' ' ' GLU . 33.4 mmtp -56.14 144.47 29.33 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 154.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.42 171.34 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.593 1.957 . . . . 0.0 111.64 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 145' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.65 -31.07 21.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 112.991 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.58 143.54 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.691 1.596 . . . . 0.0 111.266 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 147' ' ' ILE . . . . . . . . . . . . . 45.3 mt -123.43 139.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.079 1.352 . . . . 0.0 110.077 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 148' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -127.19 142.68 51.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.58 1.552 . . . . 0.0 111.678 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -134.99 134.01 40.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.832 1.653 . . . . 0.0 109.94 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 150' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -139.22 -1.98 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . . . . . . . . . 96.9 t -90.84 -23.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.243 -1.535 . . . . 0.0 111.876 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.74 48.32 5.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.539 1.536 . . . . 0.0 114.324 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -61.5 158.11 41.66 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.454 1.502 . . . . 0.0 111.84 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 154' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.62 -20.26 26.81 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.816 3.011 . . . . 0.0 115.604 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 155' ' ' THR . . . . . . . . . . . . . 59.1 p -95.63 1.73 53.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.064 1.746 . . . . 0.0 113.564 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -57.24 -31.27 65.37 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 -161.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.65 97.42 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.947 -1.096 . . . . 0.0 111.885 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 158' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.15 -38.55 72.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.794 -1.098 . . . . 0.0 111.756 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 159' ' ' ILE . . . . . . . . . . . . . 60.9 mt -50.48 -56.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 109.908 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 160' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 -45.69 65.68 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.424 1.011 . . . . 0.0 112.705 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 161' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.53 -48.63 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 119.241 0.928 . . . . 0.0 112.101 -170.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -32.13 35.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.907 1.23 . . . . 0.0 112.38 -173.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -57.14 -39.07 74.45 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.559 -1.338 . . . . 0.0 111.022 163.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.49 -6.74 48.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 165' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -81.74 -44.65 16.76 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.482 1.492 . . . . 0.0 111.888 166.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.41 -37.85 24.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 167' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.07 -4.56 11.02 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -163.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 168' ' ' LEU . . . . . . . . . . . . . 19.8 tp -105.17 131.25 52.89 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.447 1.93 . . . . 0.0 113.228 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 169' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -76.1 164.27 26.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.726 1.61 . . . . 0.0 113.714 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -64.81 132.23 48.93 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.325 1.05 . . . . 0.0 109.725 165.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.1 32.78 81.39 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.571 1.082 . . . . 0.0 113.7 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.51 167.23 21.07 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.496 1.522 . . . . 0.0 112.687 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 173' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.98 171.56 13.44 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.535 -0.979 . . . . 0.0 112.465 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.93 166.2 35.5 Favored Glycine 0 CA--C 1.527 0.828 0 O-C-N 121.225 -0.922 . . . . 0.0 113.718 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 175' ' ' MET . . . . . . . . . . . . . 98.5 mtp -142.21 146.98 35.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.64 1.576 . . . . 0.0 110.512 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 176' ' ' ILE . . . . . . . . . . . . . 18.6 tt -149.62 132.53 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.679 0.791 . . . . 0.0 111.746 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 177' ' ' ALA . . . . . . . . . . . . . . . -96.56 102.83 14.68 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.73 0.812 . . . . 0.0 110.914 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 178' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.84 129.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.867 1.667 . . . . 0.0 111.8 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 179' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -120.08 135.69 54.85 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.84 0.746 . . . . 0.0 111.544 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 180' ' ' SER . . . . . . . . . . . . . 94.4 p -66.66 -39.77 88.33 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 181' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -57.23 -28.33 62.82 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 182' ' ' SER . . . . . . . . . . . . . 11.6 m -73.72 -13.97 61.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.1 -40.2 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.005 1.322 . . . . 0.0 110.45 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 184' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -156.86 128.02 6.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.688 0.795 . . . . 0.0 111.514 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 185' ' ' VAL . . . . . . . . . . . . . 4.2 p -88.23 0.37 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 186' ' ' THR . . . . . . . . . . . . . 8.7 m -115.65 -40.86 3.31 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.467 -1.396 . . . . 0.0 113.927 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -84.0 162.75 20.3 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.866 0.757 . . . . 0.0 112.289 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 188' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -62.72 138.71 96.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 121.578 -0.702 . . . . 0.0 112.675 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 189' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.79 -44.98 43.85 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.846 2.364 . . . . 0.0 114.077 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 190' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -65.18 -25.38 67.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.273 -0.892 . . . . 0.0 113.251 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 191' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -75.88 -47.2 26.38 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.54 1.136 . . . . 0.0 110.835 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 192' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.87 -40.53 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.91 1.232 . . . . 0.0 110.829 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 193' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -61.74 -26.46 68.08 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.059 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 194' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -71.37 -41.44 69.68 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.978 1.717 . . . . 0.0 111.86 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 195' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.079 0.399 . . . . 0.0 110.586 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 196' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.2 -43.25 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 118.581 -0.724 . . . . 0.0 111.363 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 197' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.63 -38.48 72.16 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.631 1.56 . . . . 0.0 112.359 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.42 -23.32 40.42 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -81.53 -41.84 21.07 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.305 0.957 . . . . 0.0 111.33 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.4 -39.19 91.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.949 1.3 . . . . 0.0 111.119 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 201' ' ' SER . . . . . . . . . . . . . 80.0 p -75.53 -2.42 28.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -80.73 -3.67 51.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.83 -1.169 . . . . 0.0 112.753 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 203' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -139.11 -34.11 0.6 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 204' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -111.85 162.99 14.7 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.52 116.84 19.18 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 150.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 206' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.99 111.74 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 207' ' ' ILE . . . . . . . . . . . . . 36.6 pt -97.48 -22.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.598 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 208' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -153.95 151.78 29.81 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.844 1.202 . . . . 0.0 113.635 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 209' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -138.26 137.17 37.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.481 2.712 . . . . 0.0 108.862 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 210' ' ' LEU . . . . . . . . . . . . . 7.2 tt -143.01 136.17 28.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.896 1.678 . . . . 0.0 110.276 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 211' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -93.23 142.95 26.74 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.109 0.964 . . . . 0.0 109.829 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 212' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.11 -4.42 49.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 213' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -57.97 141.27 81.24 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 120.714 -1.241 . . . . 0.0 109.892 162.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 214' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -97.04 20.3 29.03 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.839 1.335 . . . . 0.0 114.225 11.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 215' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.08 -77.38 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.15 0.886 . . . . 0.0 109.824 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 216' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -117.01 134.6 54.54 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.637 -0.665 . . . . 0.0 111.371 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 217' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -97.39 142.1 29.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -164.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 218' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 60.2 17.85 7.32 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.411 1.884 . . . . 0.0 114.391 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.33 143.13 39.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.03 2.132 . . . . 0.0 109.326 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 220' ' ' ALA . . . . . . . . . . . . . . . -135.96 160.08 39.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.747 1.619 . . . . 0.0 110.873 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.75 129.35 51.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 222' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -113.31 147.55 37.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.434 1.494 . . . . 0.0 111.159 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 223' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.54 137.83 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.756 1.223 . . . . 0.0 110.01 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 224' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.92 156.44 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.866 1.267 . . . . 0.0 113.956 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 225' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -119.56 137.45 53.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.423 1.889 . . . . 0.0 110.819 167.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 226' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -92.7 128.15 45.2 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.706 1.602 . . . . 0.0 107.494 158.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 227' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.871 3.047 . . . . 0.0 114.501 -160.092 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 16.1 t80 . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.65 147.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.471 1.032 . . . . 0.0 111.243 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' SER . . . . . . . . . . . . . 13.2 t -150.57 159.62 44.37 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.972 2.109 . . . . 0.0 110.212 169.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -136.32 151.65 49.83 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.991 -1.068 . . . . 0.0 113.034 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -136.16 -179.06 5.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.581 1.153 . . . . 0.0 111.533 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -49.66 -23.48 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.777 2.031 . . . . 0.0 115.735 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -101.8 -20.79 14.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.27 -163.02 36.57 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 117.766 1.866 . . . . 0.0 117.766 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.36 134.32 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 127.839 2.456 . . . . 0.0 109.585 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.14 137.42 47.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 110.14 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.79 54.1 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.84 0.856 . . . . 0.0 112.549 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.17 151.25 48.59 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.477 1.511 . . . . 0.0 112.308 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -178.1 4.36 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.35 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.83 -20.6 65.92 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -88.79 -35.0 16.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.974 1.309 . . . . 0.0 112.392 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 19.12 4.3 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.172 1.844 . . . . 0.0 114.856 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -92.83 140.07 29.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.155 1.382 . . . . 0.0 111.23 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.87 131.98 43.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.244 1.018 . . . . 0.0 111.664 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' ILE . . . . . . . . . . . . . 81.4 mt -97.74 -50.43 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.55 1.94 . . . . 0.0 110.797 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -161.02 154.7 22.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.729 1.611 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 152.26 49.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.403 1.081 . . . . 0.0 112.548 164.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -140.39 145.05 36.58 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.018 1.327 . . . . 0.0 110.491 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -107.72 156.94 18.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.449 1.1 . . . . 0.0 112.126 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.06 138.67 57.33 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' THR . . . . . . . . . . . . . 77.8 p -90.42 -37.05 14.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.016 2.126 . . . . 0.0 112.852 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -87.58 -178.47 6.12 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.375 1.87 . . . . 0.0 111.236 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -65.67 123.0 83.46 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.124 -1.61 . . . . 0.0 108.374 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.85 -33.51 84.39 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.615 2.21 . . . . 0.0 114.753 -156.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -61.81 -29.2 70.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.621 1.1 . . . . 0.0 113.392 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -68.01 -35.76 78.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.268 1.027 . . . . 0.0 111.707 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 31' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.79 -39.76 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.832 0.853 . . . . 0.0 110.715 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.29 -43.21 98.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.146 -0.93 . . . . 0.0 112.03 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -58.84 -41.99 88.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.384 1.447 . . . . 0.0 112.117 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 34' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -62.49 -52.43 63.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.154 0.982 . . . . 0.0 111.625 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 35' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.59 -26.49 65.41 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 36' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.0 -28.8 63.63 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.342 0.973 . . . . 0.0 112.182 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 37' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' N' ' 136' ' ' GLU . 70.3 mmtt -87.89 -11.55 47.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 167.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.81 13.37 69.75 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.8 1.667 . . . . 0.0 114.969 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.09 136.29 46.54 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.768 1.284 . . . . 0.0 110.177 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -95.17 137.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.493 0.717 . . . . 0.0 112.218 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -122.7 167.04 13.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.608 1.563 . . . . 0.0 112.594 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 42' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -40.85 -40.91 1.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.258 2.223 . . . . 0.0 113.928 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.22 -38.39 90.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.051 1.74 . . . . 0.0 112.089 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -88.29 -34.6 17.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.043 0.937 . . . . 0.0 111.685 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 45' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -55.86 -31.94 63.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.277 1.031 . . . . 0.0 112.596 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.45 -45.25 88.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.601 0.76 . . . . 0.0 111.81 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tt -73.52 -39.25 64.92 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.693 0.797 . . . . 0.0 112.096 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 48' ' ' LEU . . . . . . . . . . . . 0.301 1.1 pp -72.15 -24.42 61.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.842 1.201 . . . . 0.0 113.596 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 49' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.37 -41.12 57.19 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 111.551 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 50' ' ' SER . . . . . . . . . . . . . 28.7 t -53.61 -47.89 69.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 0.0 111.861 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.44 -23.26 46.69 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.628 -1.295 . . . . 0.0 113.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 52' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.36 -45.57 90.57 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.126 0.876 . . . . 0.0 110.651 164.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.23 -31.74 69.28 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.201 1.401 . . . . 0.0 112.996 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 54' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -74.98 1.2 13.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.611 1.565 . . . . 0.0 113.696 168.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.03 59.5 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 163.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 56' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.98 148.83 27.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.071 1.435 . . . . 0.0 113.314 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -121.77 -23.18 5.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.344 1.857 . . . . 0.0 114.043 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 58' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -84.43 44.73 1.06 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.991 1.316 . . . . 0.0 114.515 -163.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 59' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.61 78.4 0.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.037 1.735 . . . . 0.0 114.503 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.78 116.95 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.297 -0.877 . . . . 0.0 111.534 166.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.7 169.41 9.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.56 1.544 . . . . 0.0 111.409 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -95.79 3.04 54.1 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 63' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -136.5 128.32 17.06 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.597 1.09 . . . . 0.0 112.166 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.62 -37.96 53.99 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.945 2.43 . . . . 0.0 115.447 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.99 -34.07 61.92 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.526 -0.734 . . . . 0.0 111.293 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 66' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.66 -41.0 98.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.771 0.429 . . . . 0.0 111.192 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 67' ' ' SER . . . . . . . . . . . . . 26.1 m -62.14 -37.6 85.78 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.456 -0.777 . . . . 0.0 112.472 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 68' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -63.74 -53.59 48.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.114 0.87 . . . . 0.0 111.578 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -58.52 -34.03 70.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.169 0.895 . . . . 0.0 112.19 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.65 76.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 71' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -81.8 -16.4 51.05 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.808 -1.183 . . . . 0.0 114.024 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -70.29 -34.42 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.419 1.488 . . . . 0.0 111.752 161.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 73' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.81 10.26 2.35 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.693 1.597 . . . . 0.0 112.657 166.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.95 82.92 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.899 1.714 . . . . 0.0 116.576 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -70.68 154.39 41.9 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.546 1.673 . . . . 0.0 112.896 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 76' ' ' SER . . . . . . . . . . . . . 24.5 m -71.77 41.99 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.953 1.701 . . . . 0.0 113.81 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.65 142.91 31.34 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -163.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 78' ' ' THR . . . . . . . . . . . . . 67.9 p -136.07 178.79 6.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.825 2.05 . . . . 0.0 111.163 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -137.2 133.63 35.38 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -155.82 122.49 5.25 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.092 1.357 . . . . 0.0 110.128 158.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 81' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -64.08 -52.98 51.78 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.77 24.73 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.686 2.924 . . . . 0.0 114.792 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -72.15 151.52 42.93 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.654 -1.279 . . . . 0.0 111.601 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 84' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.02 -26.91 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.37 -51.06 69.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.752 0.706 . . . . 0.0 111.831 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.21 69.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.482 0.563 . . . . 0.0 112.663 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 87' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -64.6 -42.78 95.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.589 0.756 . . . . 0.0 111.795 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 88' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -69.9 -52.85 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.408 1.083 . . . . 0.0 112.293 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.39 -41.45 76.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.972 1.309 . . . . 0.0 112.255 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 mtm-85 -88.48 -6.69 57.47 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -95.81 -32.5 12.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.412 1.005 . . . . 0.0 113.51 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 92' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -116.66 53.26 1.13 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.745 1.218 . . . . 0.0 112.26 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 93' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -57.52 -30.99 90.3 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.312 2.008 . . . . 0.0 112.479 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 94' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.56 -21.9 65.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.743 1.617 . . . . 0.0 113.353 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 95' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -76.12 -26.56 56.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 0.0 111.915 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 96' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.41 -20.97 12.72 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -168.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 97' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.07 -0.27 1.68 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.823 1.649 . . . . 0.0 114.519 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -172.37 55.18 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.827 -1.171 . . . . 0.0 113.986 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -71.84 -28.5 63.6 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.876 -1.367 . . . . 0.0 113.318 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 100' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -81.28 16.41 1.62 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.501 1.52 . . . . 0.0 112.424 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 101' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -57.86 -34.58 69.89 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.827 -1.171 . . . . 0.0 113.461 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.62 -29.18 61.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -64.58 -40.86 96.29 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.174 -0.954 . . . . 0.0 111.172 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -67.56 -47.89 68.51 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -58.27 -45.1 88.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.157 0.983 . . . . 0.0 111.636 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 106' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -59.05 -52.61 65.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.374 0.67 . . . . 0.0 110.956 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 107' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -58.95 -45.8 89.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.351 1.46 . . . . 0.0 112.257 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.48 -34.63 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.646 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.09 -47.62 90.2 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.2 0.909 . . . . 0.0 112.627 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.23 -6.96 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.467 -1.02 . . . . 0.0 113.443 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.89 -49.35 6.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.324 1.05 . . . . 0.0 111.232 166.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 112' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.74 -41.28 95.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.577 1.151 . . . . 0.0 111.866 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 113' ' ' THR . . . . . . . . . . . . . 18.8 m -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.647 1.179 . . . . 0.0 113.392 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 114' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -87.18 -25.48 24.04 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.437 1.017 . . . . 0.0 113.055 168.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 115' ' ' MET . . . . . . . . . . . . . 54.5 ttp -81.48 -37.65 27.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.44 1.096 . . . . 0.0 113.588 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -63.12 122.88 17.19 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.923 0.783 . . . . 0.0 111.298 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.34 146.37 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.889 1.676 . . . . 0.0 107.455 167.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 118' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -114.79 153.2 30.8 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.81 161.04 19.91 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.624 2.769 . . . . 0.0 111.663 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 57.4 171.27 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.061 1.745 . . . . 0.0 114.299 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 121' ' ' SER . . . . . . . . . . . . . 39.1 t -155.9 137.32 14.01 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.038 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.41 -40.58 97.79 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -158.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.39 2.97 54.79 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -68.02 -29.42 68.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -159.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -28.11 68.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.049 1.295 . . . . 0.0 112.954 174.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -76.15 -33.82 59.39 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.137 -0.977 . . . . 0.0 111.086 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 127' ' ' MET . . . . . . . . . . . . . 73.1 mtm -69.07 -22.91 63.98 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.413 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 128' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.04 -47.99 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.123 1.329 . . . . 0.0 110.284 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 129' ' ' ILE . . . . . . . . . . . . . 25.9 mt -66.55 -47.45 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.786 0.835 . . . . 0.0 109.799 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 130' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -64.04 -35.17 79.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.809 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.23 73.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.394 0.997 . . . . 0.0 112.732 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 132' ' ' ILE . . . . . . . . . . . . . 16.9 mm -63.8 -47.83 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.749 0.82 . . . . 0.0 110.903 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 133' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.62 -37.63 88.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.207 0.458 . . . . 0.0 111.364 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.86 78.94 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.185 -0.947 . . . . 0.0 112.804 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.29 -43.05 82.72 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.766 0.712 . . . . 0.0 110.587 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 136' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.14 -36.32 72.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.847 0.749 . . . . 0.0 112.303 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -64.47 -44.4 91.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.258 1.023 . . . . 0.0 111.637 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.83 -40.22 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.205 -0.934 . . . . 0.0 111.236 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 139' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.32 -36.61 82.72 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.293 -0.879 . . . . 0.0 112.454 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 140' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -70.07 -42.79 72.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.775 1.23 . . . . 0.0 112.336 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 141' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.99 -32.06 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 119.639 1.109 . . . . 0.0 112.963 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 142' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.48 -47.47 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.091 0.86 . . . . 0.0 109.913 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 143' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -60.08 -38.4 82.77 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.887 0.767 . . . . 0.0 111.821 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.98 -53.83 33.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.973 1.309 . . . . 0.0 112.683 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 145' ' ' LEU . . . . . . . . . . . . . 59.0 mt -68.15 -31.11 70.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.145 0.884 . . . . 0.0 112.302 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 146' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.73 -30.28 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.136 0.88 . . . . 0.0 111.831 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.85 99.88 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.415 1.461 . . . . 0.0 111.383 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.8 96.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.607 0.763 . . . . 0.0 111.989 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 tp -62.16 -41.39 98.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.355 1.062 . . . . 0.0 112.101 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 150' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -64.23 -49.26 72.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 111.431 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 151' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -66.26 -34.61 78.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.66 0.663 . . . . 0.0 112.522 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -75.18 -50.56 15.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.596 0.758 . . . . 0.0 112.069 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 153' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.66 -18.39 64.27 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.096 -1.003 . . . . 0.0 112.667 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 61.6 m -61.22 -16.48 45.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 168.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 155' ' ' LEU . . . . . . . . . . . . . 77.9 mt -74.94 -9.89 58.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.552 1.069 . . . . 0.0 113.05 170.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -123.93 -36.78 2.67 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.993 1.317 . . . . 0.0 113.284 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 157' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -158.02 70.86 4.08 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.385 1.074 . . . . 0.0 113.834 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 158' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.16 -20.13 33.36 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.343 3.362 . . . . 0.0 115.701 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -50.66 -27.21 6.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.99 1.316 . . . . 0.0 113.947 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 160' ' ' LEU . . . . . . . . . . . . . 12.5 tp -68.74 -24.55 64.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.35 1.06 . . . . 0.0 113.563 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 161' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.01 -31.9 64.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -166.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 162' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.11 -14.5 20.41 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.231 -0.918 . . . . 0.0 112.863 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 163' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.5 -45.49 30.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.435 -0.791 . . . . 0.0 111.734 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 164' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.52 89.0 6.81 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.023 1.329 . . . . 0.0 112.04 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 165' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.54 -22.01 21.67 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.565 2.177 . . . . 0.0 112.96 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 166' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -76.59 97.24 4.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.63 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 167' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -40.09 -47.83 5.83 Favored Pre-proline 0 N--CA 1.477 0.917 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.82 -28.73 76.04 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 122.696 1.998 . . . . 0.0 114.883 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 169' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -71.6 -35.65 70.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.236 1.38 . . . . 0.0 111.634 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 170' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -64.37 -40.74 96.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.675 -0.641 . . . . 0.0 111.367 172.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 171' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.33 -48.11 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.485 -0.759 . . . . 0.0 111.335 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.0 78.96 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -58.38 -53.76 54.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.415 0.686 . . . . 0.0 110.868 170.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.97 -30.25 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.13 -0.981 . . . . 0.0 112.559 -176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 175' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -63.24 -49.15 75.25 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.11 0.868 . . . . 0.0 112.034 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 176' ' ' THR . . . . . . . . . . . . . 8.4 m -85.72 -37.4 19.42 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -167.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 177' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.73 -44.41 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.742 1.217 . . . . 0.0 111.324 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.71 -88.44 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 O-C-N 121.413 -0.804 . . . . 0.0 112.451 -171.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 179' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -85.51 123.43 30.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.417 1.487 . . . . 0.0 111.736 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -16.83 60.37 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.02 -5.8 58.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 182' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -104.13 18.66 21.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.978 1.311 . . . . 0.0 114.533 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 183' ' ' ILE . . . . . . . . . . . . . 23.2 pt -65.26 151.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.919 1.288 . . . . 0.0 113.677 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 184' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -151.81 -169.12 3.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.481 2.312 . . . . 0.0 109.431 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 185' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.4 -39.01 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.834 -1.166 . . . . 0.0 113.786 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.87 -46.25 81.95 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.354 1.061 . . . . 0.0 111.347 -172.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 187' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.88 -11.22 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 188' ' ' LEU . . . . . . . . . . . . . 40.4 mt -101.6 -49.86 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.255 1.422 . . . . 0.0 110.307 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 189' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -66.8 -43.33 84.13 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.623 1.569 . . . . 0.0 111.865 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -33.64 74.96 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.674 -0.641 . . . . 0.0 111.687 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 191' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.83 -6.9 35.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.023 1.329 . . . . 0.0 112.822 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.18 27.36 60.1 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.672 -1.267 . . . . 0.0 113.644 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.83 143.0 53.0 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.863 1.332 . . . . 0.0 108.004 158.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 194' ' ' SER . . . . . . . . . . . . . 67.6 p -78.02 163.11 26.22 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.655 -0.653 . . . . 0.0 111.197 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 195' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.11 -29.72 63.77 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.873 0.844 . . . . 0.0 110.797 170.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 196' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -67.06 -12.83 61.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.751 1.621 . . . . 0.0 113.561 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 197' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -100.94 -28.91 12.5 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.604 1.962 . . . . 0.0 112.432 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 198' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' L' ' 200' ' ' LYS . 97.0 mt -73.01 -23.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.852 1.261 . . . . 0.0 111.787 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 199' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -71.85 21.43 0.05 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.196 -1.565 . . . . 0.0 113.894 164.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 200' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' L' ' 198' ' ' ILE . 73.8 mmtt -147.9 -175.85 5.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 131.171 3.789 . . . . 0.0 106.657 167.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 201' ' ' ILE . . . . . . . . . . . . . 88.8 mt 66.75 -66.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.4 -1.437 . . . . 0.0 112.216 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 202' ' ' LEU . . . . . . . . . . . . . 69.8 mt -61.1 -42.93 99.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.262 1.025 . . . . 0.0 112.598 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 203' ' ' GLU . . . . . 0.429 ' O ' ' HE3' ' L' ' 207' ' ' LYS . 0.4 OUTLIER -63.45 -11.91 27.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 174.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 204' ' ' ALA . . . . . . . . . . . . . . . -96.58 3.47 52.58 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.036 -1.04 . . . . 0.0 113.544 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -39.62 -45.73 1.69 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.967 2.107 . . . . 0.0 114.717 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 206' ' ' GLU . . . . . 0.439 ' CD ' HH12 ' I' ' 360' ' ' ARG . 48.9 mt-10 -116.87 -23.01 8.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.883 1.273 . . . . 0.0 114.205 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 207' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' L' ' 203' ' ' GLU . 17.0 pttp -111.85 16.43 20.41 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.151 1.781 . . . . 0.0 114.642 -173.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 208' ' ' THR . . . . . . . . . . . . . 2.3 t -49.47 143.38 6.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.94 0.896 . . . . 0.0 110.251 158.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 209' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -71.44 -7.95 50.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 210' ' ' GLY . . . . . . . . . . . . . . . -76.19 172.81 54.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.934 1.254 . . . . 0.0 115.058 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 211' ' ' ALA . . . . . . . . . . . . . . . -96.65 -125.71 0.13 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.071 1.348 . . . . 0.0 112.177 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 212' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -147.91 107.35 3.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.185 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 213' ' ' MET . . . . . . . . . . . . . 59.2 mtp -81.06 146.55 30.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.359 0.6 . . . . 0.0 109.462 153.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 214' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 151.69 34.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 215' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -51.66 -33.05 31.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.559 1.944 . . . . 0.0 112.885 168.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 216' ' ' THR . . . . . . . . . . . . . 26.0 m -82.14 -33.83 29.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.54 1.536 . . . . 0.0 113.407 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 217' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.7 -35.1 27.05 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.689 0.795 . . . . 0.0 111.843 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -68.74 -11.54 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 113.189 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 219' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -50.69 -42.41 56.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.22 1.408 . . . . 0.0 112.118 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 220' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.32 -27.91 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.536 -0.727 . . . . 0.0 112.024 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 221' ' ' VAL . . . . . . . . . . . . . 3.3 t -83.71 -33.53 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.238 1.015 . . . . 0.0 110.934 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 222' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.78 -46.4 90.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.887 1.275 . . . . 0.0 111.148 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 223' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.57 -43.69 89.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 112.021 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 224' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.54 -41.66 66.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.789 0.835 . . . . 0.0 112.033 171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.48 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 226' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.58 -34.66 76.19 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.585 1.084 . . . . 0.0 112.765 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -45.15 92.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.728 0.811 . . . . 0.0 111.281 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 228' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.01 -32.32 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.838 -1.164 . . . . 0.0 111.928 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 229' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.33 -31.83 73.09 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.53 -1.356 . . . . 0.0 112.382 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -28.95 69.99 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.76 -1.212 . . . . 0.0 112.493 169.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 231' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.48 -28.88 63.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.144 -0.973 . . . . 0.0 113.238 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 232' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.73 -35.38 79.98 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.536 1.516 . . . . 0.0 111.446 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 233' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.9 -42.22 99.7 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.269 169.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 234' ' ' LEU . . . . . . . . . . . . . 62.4 tp -59.19 -45.26 91.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.076 1.307 . . . . 0.0 112.519 172.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 235' ' ' ARG . . . . . . . . . . . . . 49.7 ttt-85 -57.89 -40.43 80.26 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.364 -0.835 . . . . 0.0 111.111 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -41.1 69.11 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.528 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 237' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -58.43 -37.25 75.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.299 1.44 . . . . 0.0 111.795 172.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 238' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.46 -40.02 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.379 0.672 . . . . 0.0 112.576 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 239' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.32 -36.33 83.76 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.604 1.093 . . . . 0.0 112.248 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 240' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.29 -25.06 66.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.925 0.89 . . . . 0.0 112.651 171.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 241' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -94.48 -30.29 14.5 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 242' ' ' ILE . . . . . . . . . . . . . 41.9 mt -57.39 -42.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.9 1.227 . . . . 0.0 110.543 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -50.75 72.66 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.47 0.308 . . . . 0.0 110.857 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 244' ' ' ARG . . . . . 0.418 HH12 ' CB ' ' I' ' 216' ' ' THR . 65.0 ttt180 -58.31 -32.12 68.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 114.281 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.679 -0.638 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 246' ' ' MET . . . . . . . . . . . . . 23.6 mmt -80.84 -34.17 34.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.88 0.872 . . . . 0.0 113.135 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 247' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -92.52 16.68 11.42 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 248' ' ' ASP . . . . . . . . . . . . 0.273 6.8 t0 -74.64 31.42 0.09 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.97 -156.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.406 1.482 . . . . 0.0 109.112 145.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 250' ' ' ALA . . . . . . . . . . . . . . . -116.19 78.73 8.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 120.854 -1.154 . . . . 0.0 113.084 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 251' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -64.35 149.36 90.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.22 2.613 . . . . 0.0 111.594 161.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 252' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -67.72 -41.26 83.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.879 0.872 . . . . 0.0 111.579 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 253' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.31 -46.51 89.63 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.467 0.707 . . . . 0.0 111.92 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 254' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -62.25 -37.72 86.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.852 1.261 . . . . 0.0 112.313 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.3 58.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 256' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.21 -53.22 10.26 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 112.205 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 257' ' ' VAL . . . . . . . . . . . . . 17.8 m -114.23 -2.57 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.79 143.68 6.34 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 122.113 0.84 . . . . 0.0 112.986 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 259' ' ' ALA . . . . . . . . . . . . . . . -54.69 -44.09 73.08 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -167.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 260' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.25 -33.0 72.8 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.997 -1.064 . . . . 0.0 112.767 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 261' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.56 -33.86 25.34 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.865 -0.522 . . . . 0.0 111.713 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.39 -48.88 79.85 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.401 0.546 . . . . 0.0 111.67 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 263' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.57 84.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.504 1.121 . . . . 0.0 112.215 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 264' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -62.92 -45.94 90.11 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.227 -0.921 . . . . 0.0 112.743 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 265' ' ' LEU . . . . . . . . . . . . . 66.7 mt -59.3 -44.99 92.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.366 0.985 . . . . 0.0 111.596 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 266' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.87 -43.14 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.725 0.81 . . . . 0.0 110.767 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 267' ' ' SER . . . . . . . . . . . . . 35.2 t -65.69 -34.15 77.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.688 1.195 . . . . 0.0 113.825 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 268' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.01 -30.14 26.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.299 0.64 . . . . 0.0 112.073 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.73 61.85 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 168.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.71 -10.38 66.49 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.897 1.713 . . . . 0.0 114.593 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.05 172.87 38.36 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.995 1.283 . . . . 0.0 112.798 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 272' ' ' LEU . . . . . . . . . . . . . 54.3 tp -77.88 -33.14 52.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.483 -1.01 . . . . 0.0 113.1 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 273' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -62.47 -44.78 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.916 0.78 . . . . 0.0 109.45 171.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 274' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -64.49 -45.19 88.38 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.077 2.151 . . . . 0.0 110.351 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 275' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.37 -46.23 84.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.393 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.43 -24.22 67.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 277' ' ' MET . . . . . . . . . . . . . 27.3 mmm -82.85 -3.17 56.48 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.719 1.608 . . . . 0.0 113.957 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 278' ' ' MET . . . . . . . . . . . . . 65.5 mtt -91.06 155.33 44.9 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 279' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -82.38 159.93 17.29 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.584 2.856 . . . . 0.0 112.076 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -45.42 -48.02 13.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.575 1.55 . . . . 0.0 111.651 166.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 281' ' ' SER . . . . . . . . . . . . . 1.4 m -61.96 -5.46 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 282' ' ' THR . . . . . . . . . . . . . 62.6 m -113.72 -41.96 3.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.126 1.37 . . . . 0.0 111.206 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 283' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.83 -32.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.462 1.105 . . . . 0.0 111.667 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 284' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -56.44 -32.84 65.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.531 1.532 . . . . 0.0 113.927 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 285' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.74 6.81 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.089 1.356 . . . . 0.0 114.41 -165.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 286' ' ' LEU . . . . . . . . . . . . . 32.8 mt -52.41 125.83 17.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.547 0.739 . . . . 0.0 111.499 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 287' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.73 90.0 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.459 -1.189 . . . . 0.0 115.839 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 288' ' ' ALA . . . . . . . . . . . . . . . -75.59 27.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.106 1.453 . . . . 0.0 112.937 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 289' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -42.96 80.84 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.692 -1.255 . . . . 0.0 113.065 -159.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 290' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -63.68 -21.93 66.64 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.84 -39.9 12.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.354 1.061 . . . . 0.0 112.151 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 292' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.51 -33.01 74.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.428 0.691 . . . . 0.0 112.447 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 293' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.83 -49.95 68.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.385 0.674 . . . . 0.0 111.971 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 294' ' ' ARG . . . . . . . . . . . . . 21.9 ptt-85 -68.84 -24.82 64.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 295' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -62.39 -50.0 73.26 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.469 0.708 . . . . 0.0 110.382 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.82 -27.38 57.89 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 297' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -78.85 -40.75 31.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.888 1.275 . . . . 0.0 112.581 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 298' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.77 2.99 2.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -156.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 299' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.82 65.34 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 121.131 -0.981 . . . . 0.0 114.184 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.27 150.03 48.93 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 301' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -45.7 128.55 6.65 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.418 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 302' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.56 152.83 31.81 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.545 2.83 . . . . 0.0 115.414 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 303' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.68 127.89 18.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.677 2.252 . . . . 0.0 112.253 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 304' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.55 -25.51 35.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.095 1.758 . . . . 0.0 113.028 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 305' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -164.72 162.48 21.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 111.468 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 306' ' ' GLY . . . . . . . . . . . . . . . -121.0 -136.49 5.09 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.271 1.415 . . . . 0.0 111.371 165.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 307' ' ' VAL . . . . . . . . . . . . . 28.6 m -51.1 -24.34 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 308' ' ' ILE . . . . . . . . . . . . . 47.0 pt -61.03 -11.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.601 1.56 . . . . 0.0 114.936 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 309' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.0 -23.31 53.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.519 1.508 . . . . 0.0 112.815 168.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 310' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.34 -13.11 60.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 311' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -77.92 126.35 84.08 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 120.046 1.293 . . . . 0.0 110.469 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 312' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.04 -30.64 71.0 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.745 2.296 . . . . 0.0 116.042 -164.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 313' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.66 72.04 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 314' ' ' ILE . . . . . . . . . . . . . 46.0 mt -82.13 -28.88 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 315' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -88.81 26.67 1.47 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.203 1.401 . . . . 0.0 114.044 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 316' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -143.64 48.14 1.44 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.799 1.639 . . . . 0.0 111.978 163.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 317' ' ' SER . . . . . . . . . . . . . 62.4 m -150.98 132.22 7.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.001 1.32 . . . . 0.0 112.825 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 318' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.62 152.93 31.71 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.453 3.435 . . . . 0.0 115.133 169.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 319' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -56.93 -39.66 74.91 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 320' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -43.91 -53.06 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.147 1.379 . . . . 0.0 112.152 168.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 321' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -91.15 -11.09 39.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 322' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -56.01 -49.95 72.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.594 1.543 . . . . 0.0 111.968 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 323' ' ' GLY . . . . . . . . . . . . . . . -68.87 -34.9 78.23 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.387 0.539 . . . . 0.0 113.768 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -68.29 -42.69 79.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.137 0.968 . . . . 0.0 111.506 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 325' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.63 -33.49 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.758 0.823 . . . . 0.0 110.869 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 326' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.02 99.22 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.2 0.909 . . . . 0.0 112.463 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 327' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -58.78 -48.56 80.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.867 0.867 . . . . 0.0 111.945 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 328' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.19 91.37 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 329' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.97 -44.56 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 111.224 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.59 84.22 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 331' ' ' GLY . . . . . . . . . . . . . . . -62.18 -38.09 95.6 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.697 0.665 . . . . 0.0 113.358 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 -36.63 44.35 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.953 0.877 . . . . 0.0 112.865 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 333' ' ' LEU . . . . . . . . . . . . . 36.4 mt -60.72 -37.86 83.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.198 0.908 . . . . 0.0 112.392 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.951 0.9 . . . . 0.0 113.075 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 335' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.18 -52.04 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.377 0.671 . . . . 0.0 109.71 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 336' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.29 77.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.12 72.76 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 338' ' ' ARG . . . . . . . . . . . . . 54.5 mtm-85 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.155 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 339' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.91 -48.82 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.202 0.91 . . . . 0.0 110.118 165.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 340' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.39 -28.93 70.03 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 341' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -98.43 -39.46 8.76 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 342' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -100.05 -32.08 11.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 343' ' ' SER . . . . . . . . . . . . . 97.1 p -117.41 -28.77 6.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 344' ' ' GLY . . . . . . . . . . . . . . . 70.1 23.42 77.19 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 119.839 1.199 . . . . 0.0 115.138 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 345' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -107.22 -177.88 3.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.425 1.89 . . . . 0.0 110.74 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 346' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -129.5 133.05 47.06 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.484 -1.385 . . . . 0.0 112.889 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 347' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.76 4.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.505 1.522 . . . . 0.0 113.758 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 348' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.46 65.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -158.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 349' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -67.77 -41.22 83.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.193 1.36 . . . . 0.0 111.709 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 350' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.78 -35.53 80.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 111.99 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 351' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.79 -43.24 99.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.459 1.027 . . . . 0.0 111.78 171.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 352' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -62.17 -37.44 85.28 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.059 0.944 . . . . 0.0 111.156 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 353' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -70.69 -40.94 72.61 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.126 1.37 . . . . 0.0 113.182 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 354' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -65.91 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.851 0.751 . . . . 0.0 110.917 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 355' ' ' LEU . . . . . . . . . . . . . 56.5 tp -63.35 -43.77 96.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.67 -0.644 . . . . 0.0 112.048 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 356' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.04 -37.36 84.65 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.973 0.806 . . . . 0.0 112.127 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 357' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.14 85.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.868 0.758 . . . . 0.0 112.561 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 358' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -66.75 -34.5 77.98 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.131 -0.981 . . . . 0.0 111.758 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 359' ' ' ILE . . . . . . . . . . . . . 65.8 mt -66.04 -46.03 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.392 -0.818 . . . . 0.0 111.048 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 360' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -62.19 -29.12 70.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 0.0 113.378 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 361' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.34 -47.53 19.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.805 1.642 . . . . 0.0 111.609 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 362' ' ' ILE . . . . . . . . . . . . . 88.5 mt -60.54 -37.32 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.901 -1.124 . . . . 0.0 111.024 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 363' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -64.88 -13.66 57.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.404 1.481 . . . . 0.0 114.988 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 364' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -99.65 -32.0 11.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.319 0.963 . . . . 0.0 112.027 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 365' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -70.38 -40.27 74.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 366' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 116.928 -1.511 . . . . 0.0 114.526 -167.653 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' M' M ' 1' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' M' M ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.06 160.63 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.978 2.452 . . . . 0.0 112.875 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 3' ' ' SER . . . . . . . . . . . . . 85.2 p -74.74 -8.66 57.09 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.571 1.949 . . . . 0.0 115.456 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -92.23 -17.15 25.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 m -84.08 91.59 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.51 1.05 . . . . 0.0 109.828 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -76.04 -38.88 56.65 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 7' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.4 147.88 38.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.325 1.05 . . . . 0.0 111.154 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.76 119.18 21.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.17 139.05 42.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.626 0.77 . . . . 0.0 111.74 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.3 178.92 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.347 2.698 . . . . 0.0 114.13 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -74.46 -29.99 61.69 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.318 -0.864 . . . . 0.0 112.722 163.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.35 176.1 7.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.304 0.642 . . . . 0.0 111.368 161.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 13' ' ' LEU . . . . . . . . . . . . . 51.2 mt 63.96 -55.06 0.23 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.5 1.92 . . . . 0.0 114.734 -168.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.63 80.91 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.138 1.336 . . . . 0.0 113.216 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -60.61 -32.56 71.69 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.44 -0.788 . . . . 0.0 111.654 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -76.7 -31.46 57.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.921 1.289 . . . . 0.0 112.271 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.1 90.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.467 0.707 . . . . 0.0 111.355 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.58 -46.06 91.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.906 0.883 . . . . 0.0 110.522 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -64.17 -25.86 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.96 67.71 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.817 -1.177 . . . . 0.0 112.26 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 21' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.25 -37.29 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.006 0.922 . . . . 0.0 111.082 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 22' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.24 -10.68 11.49 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 23' ' ' ILE . . . . . . . . . . . . . 94.4 mt -120.98 -46.0 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.108 1.322 . . . . 0.0 112.762 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.35 69.63 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.885 -1.134 . . . . 0.0 113.069 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 25' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -45.0 -51.45 9.86 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 128.545 2.738 . . . . 0.0 114.803 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -113.33 -14.63 12.79 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 27' ' ' THR . . . . . . . . . . . . . 34.1 p -95.08 -8.01 37.84 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.56 -123.32 0.99 Allowed Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.046 1.308 . . . . 0.0 113.2 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 29' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -143.26 125.08 15.08 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.598 1.559 . . . . 0.0 111.498 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 30' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.06 155.63 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.044 1.738 . . . . 0.0 111.985 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -130.26 142.08 50.58 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.732 1.213 . . . . 0.0 110.127 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 145.35 37.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.966 1.306 . . . . 0.0 112.147 -166.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.77 151.48 14.09 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 123.909 0.755 . . . . 0.0 111.439 -164.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 34' ' ' THR . . . . . . . . . . . . . 4.3 m -70.39 -31.94 69.37 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.972 -1.311 . . . . 0.0 113.851 -170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 35' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -73.12 -36.64 66.77 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.031 1.287 . . . . 0.0 112.175 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 36' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.6 -33.67 58.41 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.663 -1.273 . . . . 0.0 113.706 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 37' ' ' THR . . . . . . . . . . . . . 81.9 m -53.47 -46.55 69.99 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.877 0.762 . . . . 0.0 109.777 167.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 38' ' ' THR . . . . . . . . . . . . . 69.5 m -63.93 -48.14 77.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.626 1.17 . . . . 0.0 111.466 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -58.27 -38.92 77.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.75 1.159 . . . . 0.0 113.193 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.81 -34.09 71.39 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.51 -41.48 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 110.508 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.97 -33.97 76.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.081 -1.012 . . . . 0.0 113.616 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -75.71 0.41 17.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.548 1.139 . . . . 0.0 113.366 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.04 10.28 61.56 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.558 1.075 . . . . 0.0 115.163 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 45' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -96.0 -20.05 19.0 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.9 139.9 56.49 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.749 0.704 . . . . 0.0 112.122 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -106.88 -21.02 13.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.372 1.469 . . . . 0.0 113.506 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 48' ' ' LEU . . . . . . . . . . . . . 46.7 tp -159.1 143.25 15.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.094 2.558 . . . . 0.0 108.628 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.54 139.25 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.255 1.022 . . . . 0.0 112.425 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.33 132.34 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.781 2.032 . . . . 0.0 109.161 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.54 142.78 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.994 1.318 . . . . 0.0 110.77 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.63 145.8 36.52 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.581 -1.324 . . . . 0.0 113.431 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 53' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.31 -2.41 45.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -122.84 24.62 8.98 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -166.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.59 135.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.109 1.364 . . . . 0.0 112.472 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.04 122.23 5.79 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.701 1.6 . . . . 0.0 111.186 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -64.66 140.16 40.77 Favored 'Cis proline' 0 C--N 1.351 0.679 0 CA-C-N 120.984 1.387 . . . . 0.0 113.235 -1.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.33 -24.29 67.23 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -67.53 -20.7 65.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.599 1.16 . . . . 0.0 114.102 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -37.03 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 120.212 1.369 . . . . 0.0 111.312 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 m -94.2 -14.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.94 -23.83 34.34 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -24.03 66.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.52 -43.7 85.07 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 116.83 -1.557 . . . . 0.0 112.972 -166.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 65' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.08 -55.62 2.15 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.15 1.9 . . . . 0.0 114.411 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 66' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.21 -32.86 51.15 Favored 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 122.561 1.951 . . . . 0.0 113.13 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -69.98 -31.12 68.66 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 113.494 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -84.79 -31.26 24.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.807 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 69' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.92 -39.06 90.19 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.684 1.129 . . . . 0.0 113.126 172.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.17 -24.4 67.38 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.804 0.729 . . . . 0.0 112.382 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 71' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -109.56 10.22 25.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.554 1.942 . . . . 0.0 114.482 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 57.81 32.75 22.35 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.35 1.46 . . . . 0.0 114.862 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm -98.22 131.53 26.15 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.993 1.317 . . . . 0.0 110.115 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.2 144.37 46.3 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.956 2.437 . . . . 0.0 112.943 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -129.95 139.28 51.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.761 1.625 . . . . 0.0 112.724 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 tp -143.16 151.82 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.566 1.146 . . . . 0.0 111.633 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.32 148.91 34.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.368 1.067 . . . . 0.0 112.078 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.29 152.89 75.96 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.898 1.279 . . . . 0.0 113.161 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -62.0 -27.54 79.63 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 119.296 2.768 . . . . 0.0 119.296 -162.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 80' ' ' SER . . . . . . . . . . . . . 44.4 m -158.49 136.88 10.89 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 121.852 2.115 . . . . 0.0 115.417 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 81' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -59.97 -32.75 71.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.022 1.729 . . . . 0.0 115.509 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -75.46 -39.17 59.04 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.298 -0.876 . . . . 0.0 111.786 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -67.57 -36.37 80.79 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.304 0.642 . . . . 0.0 111.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.16 -40.48 90.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.492 0.717 . . . . 0.0 112.371 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.52 97.71 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.359 0.527 . . . . 0.0 112.661 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.94 95.94 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.989 -0.712 . . . . 0.0 112.537 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.13 99.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.349 -0.845 . . . . 0.0 112.069 174.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -8.66 34.82 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.82 3.31 77.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.469 1.509 . . . . 0.0 115.447 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -88.53 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.23 1.515 . . . . 0.0 111.609 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -92.61 -29.52 16.1 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -84.31 -152.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.499 1.519 . . . . 0.0 111.77 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.9 171.16 8.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.698 1.599 . . . . 0.0 112.349 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.95 125.58 20.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.44 0.696 . . . . 0.0 110.211 164.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.73 69.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.46 0.704 . . . . 0.0 112.258 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 96' ' ' SER . . . . . . . . . . . . . 90.0 p -153.49 162.38 41.32 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -141.88 145.1 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.805 2.042 . . . . 0.0 109.843 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.63 140.65 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.383 1.473 . . . . 0.0 112.223 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 99' ' ' ILE . . . . . . . . . . . . . 19.6 mm -97.18 124.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.619 1.168 . . . . 0.0 109.502 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.01 -52.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.16 0.891 . . . . 0.0 110.415 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -118.91 112.6 36.42 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 108.165 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -61.94 -13.99 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.054 2.503 . . . . 0.0 116.167 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.7 -124.69 36.92 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 118.927 0.785 . . . . 0.0 112.165 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -9.03 57.93 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.91 18.08 9.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.004 1.322 . . . . 0.0 114.16 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 106' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -52.61 -49.48 64.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.439 1.472 . . . . 0.0 114.171 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.61 -42.25 74.64 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.385 0.993 . . . . 0.0 111.964 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 108' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.92 -36.23 78.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.997 1.319 . . . . 0.0 113.05 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -72.17 -30.38 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 110' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -73.22 -41.55 63.63 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.889 1.222 . . . . 0.0 112.175 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.62 -35.38 80.34 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.364 0.984 . . . . 0.0 112.867 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 112' ' ' ILE . . . . . . . . . . . . . 19.4 tt -74.65 -42.56 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.3 0.955 . . . . 0.0 111.993 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.61 91.7 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.883 1.22 . . . . 0.0 112.177 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 114' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.27 -47.79 78.2 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.819 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.84 -22.27 61.56 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.24 -38.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.776 1.231 . . . . 0.0 111.373 168.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 117' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -65.56 -29.49 70.11 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.149 -0.969 . . . . 0.0 113.303 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -55.46 -31.79 62.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.842 0.857 . . . . 0.0 112.976 165.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 119' ' ' LEU . . . . . . . . . . . . . 28.4 tp -93.12 -29.58 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.992 1.317 . . . . 0.0 113.47 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 120' ' ' MET . . . . . . . . . . . . . 49.2 mtp -60.91 -15.72 34.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.476 1.511 . . . . 0.0 114.443 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 126.438 1.895 . . . . 0.0 114.521 -168.151 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 m -147.65 149.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.648 1.179 . . . . 0.0 110.303 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 3' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -138.49 143.86 39.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.521 1.129 . . . . 0.0 110.728 169.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.58 131.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.643 1.177 . . . . 0.0 110.242 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 5' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.01 157.69 40.99 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.277 2.631 . . . . 0.0 109.897 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.15 153.25 40.81 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.368 -1.457 . . . . 0.0 112.512 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 7' ' ' HIS . . . . . 0.464 ' CG ' ' H ' ' N' ' 8' ' ' LYS . 44.9 t-80 -107.43 176.95 4.99 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.431 1.092 . . . . 0.0 110.599 160.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 8' ' ' LYS . . . . . 0.464 ' H ' ' CG ' ' N' ' 7' ' ' HIS . 50.2 pttt -88.05 2.67 51.33 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 9' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -113.52 146.85 36.26 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.566 1.546 . . . . 0.0 110.796 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 10' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.29 142.4 85.86 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.416 2.077 . . . . 0.0 111.134 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.39 -7.73 4.59 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.81 139.55 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.407 1.483 . . . . 0.0 110.934 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -136.29 156.7 48.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.909 1.683 . . . . 0.0 110.642 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 140.95 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.274 1.83 . . . . 0.0 107.702 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.63 152.02 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.115 0.871 . . . . 0.0 112.693 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 16' ' ' ILE . . . . . . . . . . . . . 34.6 mm -113.43 142.04 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.785 1.634 . . . . 0.0 108.668 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -136.22 -176.89 4.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.695 1.998 . . . . 0.0 109.427 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 18' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -75.89 6.08 5.58 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -172.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -27.36 40.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.658 -1.276 . . . . 0.0 111.767 158.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.36 -12.8 68.19 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.863 1.697 . . . . 0.0 116.094 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -81.42 147.45 29.77 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.205 2.002 . . . . 0.0 112.967 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 22' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -69.83 115.91 9.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.515 1.126 . . . . 0.0 110.47 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -101.75 170.49 8.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.83 1.652 . . . . 0.0 110.505 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 pt -118.73 150.79 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.239 1.016 . . . . 0.0 113.096 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.77 171.8 18.32 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.783 1.633 . . . . 0.0 112.645 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 26' ' ' THR . . . . . . . . . . . . . 19.9 p -129.36 156.73 43.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.651 1.58 . . . . 0.0 111.126 168.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -76.08 129.86 37.45 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.356 -0.84 . . . . 0.0 109.898 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -71.94 121.69 19.53 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.819 0.736 . . . . 0.0 112.035 -169.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.14 -37.83 23.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.392 1.877 . . . . 0.0 114.103 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.46 143.08 28.56 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.898 1.279 . . . . 0.0 109.372 152.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.78 157.19 55.83 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.892 3.061 . . . . 0.0 114.022 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.73 -21.98 43.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.163 1.839 . . . . 0.0 114.746 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.68 141.68 31.31 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.151 1.475 . . . . 0.0 113.353 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 34' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -109.45 150.07 28.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.486 1.514 . . . . 0.0 108.683 153.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.27 -26.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.671 0.788 . . . . 0.0 112.976 -168.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -145.53 25.13 1.36 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.97 38.21 36.28 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.682 -1.261 . . . . 0.0 113.315 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -92.51 159.34 15.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.134 1.374 . . . . 0.0 114.586 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 39' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -70.53 137.84 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.004 1.322 . . . . 0.0 110.216 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.08 149.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.213 1.005 . . . . 0.0 111.638 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.74 115.25 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.621 1.569 . . . . 0.0 107.607 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 42' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -82.86 144.18 30.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 43' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -136.9 172.21 13.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.73 1.212 . . . . 0.0 110.543 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 44' ' ' GLU . . . . . . . . . . . . 0.251 6.4 pt-20 -67.29 90.17 0.22 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 123.055 1.407 . . . . 0.0 112.441 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.37 5.83 66.9 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 126.933 2.206 . . . . 0.0 115.621 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 46' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -145.17 169.91 17.26 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 119.887 1.844 . . . . 0.0 113.397 -166.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.36 136.96 33.7 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.468 -1.395 . . . . 0.0 111.451 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.15 143.51 50.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.007 1.723 . . . . 0.0 111.396 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.58 132.51 49.83 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.35 1.46 . . . . 0.0 111.818 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.11 144.93 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.042 0.937 . . . . 0.0 111.782 -168.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 51' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -111.74 73.16 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.914 1.685 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -65.25 126.9 92.29 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 121.317 -0.864 . . . . 0.0 111.616 -172.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 53' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.0 -36.64 9.81 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.54 2.16 . . . . 0.0 113.213 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -62.76 -15.09 51.91 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.532 1.133 . . . . 0.0 113.639 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 55' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -130.16 22.52 5.26 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.796 2.038 . . . . 0.0 112.448 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 56' ' ' SER . . . . . . . . . . . . . 2.3 m -161.93 103.96 1.17 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.566 1.146 . . . . 0.0 111.515 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 57' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -60.34 -30.04 69.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.06 1.344 . . . . 0.0 113.653 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -38.28 71.48 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.239 -0.913 . . . . 0.0 111.916 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -40.51 98.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.203 -0.935 . . . . 0.0 112.163 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.61 79.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 117.747 0.773 . . . . 0.0 112.495 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.59 76.1 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.245 -0.909 . . . . 0.0 113.327 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 62' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.27 -37.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.235 -0.916 . . . . 0.0 111.176 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 63' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.95 -36.14 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.277 -0.889 . . . . 0.0 111.16 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 64' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -77.03 8.48 3.81 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.1 26.11 53.61 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 166.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -47.27 126.18 9.04 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.438 1.495 . . . . 0.0 111.521 171.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -94.62 -45.8 7.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.097 0.959 . . . . 0.0 112.366 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 68' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -92.9 81.69 4.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 69' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.07 115.98 65.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.063 -1.023 . . . . 0.0 110.31 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 70' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -90.3 -15.91 1.83 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.351 2.034 . . . . 0.0 115.747 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -77.59 143.7 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.32 0.964 . . . . 0.0 110.695 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 72' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.19 154.79 72.48 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 126.048 1.739 . . . . 0.0 111.072 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -60.52 154.38 54.38 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.72 2.28 . . . . 0.0 111.898 166.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.41 -12.71 7.14 Favored Glycine 0 CA--C 1.539 1.569 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 75' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.83 -174.26 2.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.799 1.64 . . . . 0.0 111.346 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 76' ' ' SER . . . . . . . . . . . . . 95.9 p -131.19 146.04 52.18 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 114.092 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.77 137.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.832 0.853 . . . . 0.0 112.71 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 78' ' ' LEU . . . . . . . . . . . . . 49.4 tp -97.96 113.41 25.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.713 1.605 . . . . 0.0 109.216 170.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 79' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' N' ' 82' ' ' ILE . 1.7 t80 -99.33 128.87 45.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.608 1.163 . . . . 0.0 109.845 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 80' ' ' LEU . . . . . . . . . . . . . 62.9 mt -115.03 118.74 34.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.315 1.446 . . . . 0.0 110.562 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.35 39.24 5.71 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.982 1.277 . . . . 0.0 114.313 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 82' ' ' ILE . . . . . 0.482 ' HA ' ' CE2' ' N' ' 79' ' ' TYR . 16.7 tt -64.67 -28.83 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -166.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 83' ' ' ALA . . . . . . . . . . . . . . . 40.47 -130.07 0.38 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.56 1.544 . . . . 0.0 112.742 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -73.78 7.54 2.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.306 1.443 . . . . 0.0 114.787 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.32 18.39 74.14 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.424 1.33 . . . . 0.0 116.424 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 86' ' ' THR . . . . . . . . . . . . . 13.4 m -47.3 -66.43 0.41 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.388 1.594 . . . . 0.0 113.298 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 87' ' ' THR . . . . . . . . . . . . . 25.2 p -80.73 -23.87 39.16 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.995 -1.065 . . . . 0.0 112.079 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.33 -31.35 71.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 89' ' ' SER . . . . . . . . . . . . . 82.7 p -57.01 -42.81 81.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 112.543 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 90' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -75.98 -34.34 59.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.386 0.674 . . . . 0.0 112.181 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 m -71.84 -27.29 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.583 -1.323 . . . . 0.0 112.699 170.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 92' ' ' SER . . . . . . . . . . . . . 12.6 t -66.45 -34.06 77.09 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.742 1.155 . . . . 0.0 112.882 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 93' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.04 -47.68 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 0.697 . . . . 0.0 111.593 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 94' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.76 -36.74 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.135 1.374 . . . . 0.0 112.882 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.67 -26.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.674 1.19 . . . . 0.0 112.496 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.75 -167.89 40.81 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.232 0.92 . . . . 0.0 114.893 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 97' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -84.8 -16.72 40.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -101.25 9.63 41.59 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.238 1.015 . . . . 0.0 113.192 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.07 173.07 14.53 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.236 1.874 . . . . 0.0 112.276 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 100' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -139.63 135.74 33.61 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -165.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 101' ' ' ILE . . . . . . . . . . . . . 20.0 mt -127.88 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.556 1.142 . . . . 0.0 111.438 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 102' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -102.01 136.9 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.894 0.878 . . . . 0.0 109.884 163.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.91 108.04 1.12 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.004 0.811 . . . . 0.0 111.857 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.41 136.37 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.329 1.051 . . . . 0.0 109.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 105' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -139.11 157.09 46.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 106' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -84.27 -35.87 23.06 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 107' ' ' SER . . . . . . . . . . . . . 13.4 t -120.96 136.98 26.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-N 119.658 1.117 . . . . 0.0 113.216 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 108' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.12 -32.93 63.11 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.237 2.625 . . . . 0.0 112.035 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -70.8 -29.49 65.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.642 0.656 . . . . 0.0 112.584 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -77.87 -39.05 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 110.497 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 111' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.67 -24.52 53.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.376 1.07 . . . . 0.0 113.761 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 112' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -48.74 -40.49 28.76 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.74 1.616 . . . . 0.0 112.47 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.06 -21.89 66.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 113.014 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 114' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.94 -22.83 22.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.416 1.487 . . . . 0.0 113.092 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 115' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.78 -44.68 99.86 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.422 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 116' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.09 -32.01 22.28 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.334 1.869 . . . . 0.0 112.641 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 117' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.51 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.919 -1.113 . . . . 0.0 110.577 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.28 -10.3 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -77.74 2.42 16.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.072 1.305 . . . . 0.0 111.98 167.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 120' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -123.36 -49.96 1.9 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.575 1.55 . . . . 0.0 111.859 162.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 121' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -81.81 65.91 7.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.127 1.371 . . . . 0.0 112.305 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -67.34 5.05 0.81 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 123' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -85.82 -3.53 58.93 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 119.631 1.105 . . . . 0.0 113.903 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mt -109.42 139.85 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 110.209 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 125' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.38 124.57 29.92 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.323 1.049 . . . . 0.0 110.023 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.29 127.02 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.117 3.212 . . . . 0.0 111.652 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 127' ' ' ILE . . . . . . . . . . . . . 71.9 mt -131.72 136.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.102 1.361 . . . . 0.0 110.305 -171.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 128' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.03 115.77 30.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.368 1.067 . . . . 0.0 112.531 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.4 167.71 34.23 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.968 0.794 . . . . 0.0 114.489 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -70.55 106.79 3.59 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.63 -0.923 . . . . 0.0 111.891 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.17 19.61 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 132' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.7 -7.94 59.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.319 1.448 . . . . 0.0 112.588 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 133' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -132.93 73.48 75.54 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.0 2.12 . . . . 0.0 108.661 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 134' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -57.78 -13.9 16.03 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.065 3.177 . . . . 0.0 115.315 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 135' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -54.74 -31.58 58.62 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.444 1.898 . . . . 0.0 113.575 167.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 136' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' L' ' 37' ' ' LYS . 1.5 mm-40 -55.02 -23.87 21.7 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.481 1.912 . . . . 0.0 115.085 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 137' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.47 15.96 6.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.691 1.196 . . . . 0.0 113.012 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 138' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -52.07 -31.78 31.85 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.95 -2.66 46.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 140' ' ' LEU . . . . . . . . . . . . . 68.9 mt -110.7 -1.52 16.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.996 1.718 . . . . 0.0 113.641 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 141' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.89 179.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.659 1.183 . . . . 0.0 112.469 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 142' ' ' THR . . . . . . . . . . . . . 66.1 p -133.38 -179.93 5.81 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.276 1.831 . . . . 0.0 110.5 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 143' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -57.7 150.05 20.5 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.23 -0.919 . . . . 0.0 110.485 155.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 144' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.23 164.72 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.169 1.788 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -85.74 -30.81 22.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.581 1.152 . . . . 0.0 113.04 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 t -139.73 150.58 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.974 1.31 . . . . 0.0 112.188 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 147' ' ' ILE . . . . . . . . . . . . . 95.1 mt -115.14 142.94 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.99 1.316 . . . . 0.0 110.628 163.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 148' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -128.78 149.34 50.76 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.485 1.514 . . . . 0.0 111.15 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.18 135.41 41.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.346 1.458 . . . . 0.0 111.643 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -145.12 31.31 1.12 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.823 1.249 . . . . 0.0 111.36 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 151' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.42 -28.42 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.113 -1.617 . . . . 0.0 113.803 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.36 24.35 6.51 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 153' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -87.54 160.21 48.23 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 0.0 112.723 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 154' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.93 -27.93 37.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.536 2.824 . . . . 0.0 113.965 173.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 155' ' ' THR . . . . . . . . . . . . . 23.3 p -88.9 2.25 54.06 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.454 1.502 . . . . 0.0 114.61 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 156' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -57.06 -36.38 70.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.209 1.822 . . . . 0.0 114.535 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.84 74.76 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.908 -1.12 . . . . 0.0 113.078 174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 158' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -64.05 -40.43 96.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.492 1.117 . . . . 0.0 111.672 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 159' ' ' ILE . . . . . . . . . . . . . 67.4 mt -57.09 -50.56 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.24 1.416 . . . . 0.0 110.317 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 160' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.79 -44.76 96.42 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.853 0.751 . . . . 0.0 112.108 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 161' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.07 -50.3 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.134 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -31.38 69.17 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.603 1.547 . . . . 0.0 112.053 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 163' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.31 -1.494 . . . . 0.0 112.683 169.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 164' ' ' ALA . . . . . . . . . . . . . . . -84.47 -13.42 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.654 -1.279 . . . . 0.0 113.941 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 165' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -79.56 -36.82 37.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.379 1.472 . . . . 0.0 110.922 162.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.33 -55.51 4.85 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 167' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.5 -21.25 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -159.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 168' ' ' LEU . . . . . . . . . . . . . 23.7 tp -80.86 129.27 34.44 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.046 1.294 . . . . 0.0 112.485 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 169' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.18 154.01 42.04 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.845 0.858 . . . . 0.0 112.23 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 170' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.44 137.6 58.29 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.325 -0.86 . . . . 0.0 109.731 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 171' ' ' GLY . . . . . . . . . . . . . . . 72.9 4.0 61.27 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -166.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 172' ' ' GLY . . . . . . . . . . . . . . . -78.25 168.0 53.66 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.595 1.198 . . . . 0.0 112.476 167.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 173' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.84 166.74 15.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.398 1.079 . . . . 0.0 113.243 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 174' ' ' GLY . . . . . . . . . . . . . . . -146.16 153.79 25.54 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.123 -0.986 . . . . 0.0 113.208 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 175' ' ' MET . . . . . . . . . . . . . 23.9 mtt -132.97 144.12 49.91 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.816 1.646 . . . . 0.0 110.64 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 176' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.25 135.04 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.282 1.433 . . . . 0.0 110.617 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 177' ' ' ALA . . . . . . . . . . . . . . . -108.6 75.1 0.95 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.965 1.306 . . . . 0.0 110.616 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 178' ' ' VAL . . . . . . . . . . . . . 24.7 t -67.99 107.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.93 1.292 . . . . 0.0 111.188 -166.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -95.11 85.2 4.26 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.653 1.581 . . . . 0.0 108.916 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 180' ' ' SER . . . . . . . . . . . . . 5.3 t -48.98 -46.54 43.89 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -152.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -14.93 54.62 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 182' ' ' SER . . . . . . . . . . . . . 26.7 m -72.03 -25.12 61.69 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.357 0.98 . . . . 0.0 112.804 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 183' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.66 -44.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 110.637 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 184' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -158.62 152.09 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.838 1.255 . . . . 0.0 110.458 166.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 185' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.84 19.04 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.2 1.4 . . . . 0.0 112.208 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 186' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 -39.62 15.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.415 . . . . 0.0 112.15 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -111.89 177.99 4.46 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.687 1.595 . . . . 0.0 113.62 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 188' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.89 133.5 95.28 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.972 0.909 . . . . 0.0 111.591 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 189' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -57.98 -30.33 89.59 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.834 2.356 . . . . 0.0 115.926 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 190' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -61.01 -37.47 82.63 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.31 0.959 . . . . 0.0 112.35 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 191' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -78.7 -30.59 46.11 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.323 -0.86 . . . . 0.0 111.671 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 192' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.68 -44.68 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.783 0.719 . . . . 0.0 110.46 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -58.21 -38.91 77.7 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.028 0.831 . . . . 0.0 112.043 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 194' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.53 -32.93 74.59 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 195' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -76.42 -30.4 57.42 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.925 0.784 . . . . 0.0 112.917 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 196' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.45 -39.74 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.713 -1.242 . . . . 0.0 110.463 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 197' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.4 -34.43 78.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.286 1.034 . . . . 0.0 112.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -22.51 60.07 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.686 1.13 . . . . 0.0 113.948 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.2 -43.66 27.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.165 0.986 . . . . 0.0 110.372 170.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 200' ' ' LEU . . . . . . . . . . . . . 21.8 tp -68.44 -46.15 70.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.121 . . . . 0.0 112.241 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 201' ' ' SER . . . . . . . . . . . . . 88.5 p -76.34 -6.96 53.89 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 202' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -68.92 -23.92 64.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.044 0.937 . . . . 0.0 111.622 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 203' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -120.93 -29.79 4.53 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 204' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -117.21 157.15 26.48 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 205' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -78.68 108.17 11.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 156.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 206' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.97 128.27 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.952 0.901 . . . . 0.0 109.355 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 207' ' ' ILE . . . . . . . . . . . . . 39.9 pt -116.81 -26.81 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 208' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -157.52 142.66 16.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.095 -1.003 . . . . 0.0 112.205 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.56 134.07 42.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.49 2.316 . . . . 0.0 109.074 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 210' ' ' LEU . . . . . . . . . . . . . 34.1 tp -142.3 138.5 31.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.146 0.979 . . . . 0.0 112.872 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 211' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -75.44 144.53 42.09 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.283 1.833 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 mp -104.38 5.43 34.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.78 1.232 . . . . 0.0 113.88 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 213' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.91 144.6 46.75 Favored Pre-proline 0 CA--C 1.55 0.959 0 O-C-N 120.511 -1.368 . . . . 0.0 111.112 162.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 214' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.79 -2.84 60.39 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 120.108 1.074 . . . . 0.0 114.4 0.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 215' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -71.91 -33.96 68.71 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.33 1.052 . . . . 0.0 113.092 -171.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 216' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' I' ' 207' ' ' LYS . 4.2 mm-40 -124.12 176.29 6.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.889 1.676 . . . . 0.0 112.733 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -126.93 132.11 50.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.564 1.546 . . . . 0.0 111.163 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 218' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 48.82 44.48 21.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.574 1.549 . . . . 0.0 113.181 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 219' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -133.59 131.69 39.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.244 1.417 . . . . 0.0 110.644 -167.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 220' ' ' ALA . . . . . . . . . . . . . . . -142.7 135.43 28.0 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 221' ' ' LEU . . . . . . . . . . . . . 62.4 tp -86.51 128.93 35.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.932 0.893 . . . . 0.0 109.72 170.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 222' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -113.32 147.12 38.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.214 1.006 . . . . 0.0 109.779 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 223' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.82 140.17 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.484 1.114 . . . . 0.0 111.369 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 224' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.2 162.98 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 113.632 -164.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 225' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -128.89 144.6 51.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.182 2.193 . . . . 0.0 111.538 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 226' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.3 117.88 69.18 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 117.055 -1.45 . . . . 0.0 111.158 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 227' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.185 3.257 . . . . 0.0 115.564 -179.726 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' W' W ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.163 1 O4'-C1'-N19 113.543 5.343 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' W' W ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.043 1 O4'-C1'-N19 113.192 4.992 . 0.387 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' W' W ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.954 1 O4'-C1'-N19 112.55 4.35 . 0.168 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' W' W ' 4' ' ' ' C' . . . . . 0.408 HO2' " H5'" ' W' ' 5' ' ' ' C' . . . . . . . . 0 C5'--C4' 1.536 1.975 1 O4'-C1'-N19 115.416 7.216 . 0.371 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' W' W ' 5' ' ' ' C' . . . . . 0.408 " H5'" HO2' ' W' ' 4' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.414 -3.29 1 O4'-C1'-N19 113.076 4.876 . 0.097 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' W' W ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.339 1 O4'-C1'-N19 112.962 4.762 . 0.166 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' W' W ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 0 O5'-C5'-C4' 114.811 3.293 . 0.525 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' W' W ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 1 O4'-C1'-N19 113.361 5.161 . 0.439 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' W' W ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.404 0 O4'-C1'-N19 111.943 3.743 . 0.604 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' W' W ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 0 C5'-C4'-C3' 111.249 -2.834 . 0.651 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' W' W ' 11' ' ' ' C' . . . . . 0.459 HO2' ' NH2' ' I' ' 322' ' ' ARG . . . . . . . . 0 O4'--C4' 1.423 -2.535 0 O4'-C1'-N19 110.418 2.218 . 0.591 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.3 1 O4'-C1'-N19 113.161 4.961 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.733 1 O4'-C1'-N19 113.19 4.99 . 0.188 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.26 1 C5'-C4'-O4' 115.504 4.503 . 0.286 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.407 -2.034 1 O4'-C1'-N19 112.966 4.766 . 0.572 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.433 -1.691 2 C4'-C3'-C2' 98.325 -4.375 . 0.441 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 1 O4'-C1'-N19 113.825 5.625 . 0.631 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.546 2.751 0 O4'-C1'-N19 111.507 3.307 . 0.256 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.201 1 O4'-C1'-N19 112.903 4.703 . 0.659 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.053 1 O4'-C1'-N19 113.815 5.615 . 0.647 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.006 1 O4'-C1'-N19 114.289 6.089 . 0.485 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.276 1 O4'-C1'-N19 112.781 4.581 . 0.414 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.178 0 O4'-C1'-N19 111.463 3.263 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' Y' Y ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.157 3 O4'-C1'-N19 113.457 5.257 . 0.234 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.455 1 O4'-C1'-N19 113.702 5.502 . 0.154 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.881 1 O4'-C1'-N19 112.864 4.664 . 0.625 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.37 1 O4'-C1'-N19 113.327 5.127 . 0.545 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.411 -1.827 1 O4'-C1'-N19 115.449 7.249 . 0.367 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.268 1 O4'-C1'-N19 113.679 5.479 . 0.404 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 O4'-C1'-N19 113.657 5.457 . 0.698 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Y' Y ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.088 0 O4'-C1'-N19 112.032 3.832 . 0.542 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' Y' Y ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.311 0 C4'-C3'-C2' 98.879 -3.821 . 0.592 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' Y' Y ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.221 1 O4'-C1'-N19 112.871 4.671 . 0.637 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.293 0 O4'-C1'-N19 111.585 3.385 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' Z' Z ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.292 2 O4'-C1'-N19 114.286 6.086 . 0.234 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.423 1 O4'-C1'-N19 113.695 5.495 . 0.015 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.111 1 O4'-C1'-N19 113.095 4.895 . 0.06 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.436 1.829 2 O4'-C1'-N19 112.775 4.575 . 0.609 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.432 -1.766 1 O4'-C1'-N19 113.498 5.298 . 0.567 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.231 1 C3'-C2'-C1' 105.302 4.225 . 0.01 1L . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 1 O4'-C1'-N19 113.972 5.772 . 0.313 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.256 2 O4'-C1'-N19 115.032 6.832 . 0.608 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' Z' Z ' 10' ' ' ' A' . . . . . 0.407 HO2' " H5'" ' Z' ' 11' ' ' ' C' . . . . . . . . 0 C5'--C4' 1.542 2.499 0 O4'-C1'-N19 111.64 3.44 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' Z' Z ' 11' ' ' ' C' . . . . . 0.407 " H5'" HO2' ' Z' ' 10' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.443 1 O4'-C1'-N19 114.202 6.002 . 0.694 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 C5'-C4'-O4' 112.981 2.701 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.429 -2.022 1 O4'-C1'-N19 113.121 4.921 . 0.219 1L . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.423 ' C8 ' " H2'" ' A' ' 2' ' ' ' C' . . . . . . . . 0 C5'--C4' 1.537 2.049 1 O4'-C1'-N19 113.144 4.944 . 0.334 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.024 1 O4'-C1'-N19 112.325 4.125 . 0.731 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 113.093 4.893 . 0.658 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.576 1 O4'-C1'-N19 112.999 4.799 . 0.688 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.58 -2.228 0 C4'-C3'-C2' 99.15 -3.55 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.325 1 O4'-C1'-N19 113.538 5.338 . 0.297 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.337 1 O4'-C1'-N19 114.713 6.513 . 0.588 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 P-O3'-C3' 124.745 4.204 . 0.619 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.565 0 O3'-P-O5' 97.761 -3.284 . 0.117 4g . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.381 0 C5'-C4'-O4' 114.17 3.55 . 0.628 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.581 -2.133 1 O4'-C1'-N19 112.241 4.041 . 0.218 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 O4'-C1'-N19 111.229 3.029 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.226 2 C1'-O4'-C4' 105.099 -5.001 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.705 2 P-O3'-C3' 126.746 5.872 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 1 O4'-C1'-N19 112.594 4.394 . 0.386 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 C4'-C3'-C2' 98.837 -3.863 . 0.445 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.047 2 O4'-C1'-N19 112.943 4.743 . 0.498 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.354 0 O4'-C1'-N19 111.25 3.05 . 0.523 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 O4'-C1'-N19 111.83 3.63 . 0.64 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 O4'-C1'-N19 111.758 3.558 . 0.562 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.034 2 C4'-C3'-C2' 97.938 -4.762 . 0.401 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 O4'-C1'-N19 111.865 3.665 . 0.263 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.109 1 O4'-C1'-N19 114.549 6.349 . 0.502 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.209 0 C5'-C4'-C3' 110.546 -3.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 113.111 4.911 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.822 0 O4'-C1'-N19 111.419 3.219 . 0.509 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.216 0 C3'-C2'-C1' 104.11 2.899 OUTLIER-DELTA 0.106 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.767 0 O4'-C1'-N19 111.115 2.915 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 C5'-C4'-C3' 110.106 -3.596 . 0.171 0i . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 1 O4'-C1'-N19 113.014 4.814 . 0.806 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.098 0 O4'-C1'-N19 112.144 3.944 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.55 3.111 1 O4'-C1'-N19 112.688 4.488 . 0.538 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.625 3.15 0 O4'-C1'-N19 111.234 3.034 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.995 0 C3'-C2'-C1' 105.094 3.993 . 0.471 1g . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ' A' . . . . . 0.451 " H2'" ' C8 ' ' A' ' 38' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.429 -2.007 1 O4'-C1'-N19 112.265 4.065 . 0.238 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ' A' . . . . . 0.451 ' C8 ' " H2'" ' A' ' 37' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.538 2.122 1 O4'-C1'-N19 113.958 5.758 . 0.37 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.231 1 O4'-C1'-N19 112.308 4.108 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.146 0 O4'-C1'-N19 111.33 3.13 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 O4'-C1'-N19 113.325 5.125 . 0.594 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.669 0 O4'-C1'-N19 111.618 3.418 . 0.541 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.969 0 C5'-C4'-O4' 113.5 3.071 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.159 1 O4'-C1'-N19 114.151 5.951 . 0.536 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.339 0 O4'-C1'-N19 111.789 3.589 . 0.715 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.249 0 C5'-C4'-C3' 111.069 -2.954 . 0.514 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.568 -3.232 0 C4'-C3'-C2' 99.819 -2.881 . 0.136 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 1 O4'-C1'-N19 113.455 5.255 . 0.808 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.022 0 N19-C1'-C2' 108.912 -2.805 . 0.584 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ' A' . . . . . 0.405 ' H62' ' NE2' ' I' ' 284' ' ' GLN . . . . . . . . 0 O4'--C4' 1.43 -1.884 1 O4'-C1'-N19 115.506 7.306 . 0.669 1c . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.996 0 O4'-C1'-N19 110.77 2.57 . 0.062 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 1 C3'-C2'-C1' 105.108 4.008 . 0.108 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.221 1 O4'-C1'-N19 114.026 5.826 . 0.022 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 O4'-C1'-N19 111.938 3.738 . 0.392 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ' U' . . . . . 0.409 " H2'" ' C8 ' ' A' ' 56' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 O4'-C1'-N19 112.075 3.875 . 0.773 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ' G' . . . . . 0.409 ' C8 ' " H2'" ' A' ' 55' ' ' ' U' . . . . . . . . 0 C5'--C4' 1.538 2.168 0 O4'-C1'-N19 111.273 3.073 . 0.604 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.143 1 O4'-C1'-N19 112.725 4.525 . 0.353 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.025 1 O4'-C1'-N19 112.658 4.458 . 0.695 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.216 1 O4'-C1'-N19 114.604 6.404 . 0.595 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.171 0 C4'-C3'-C2' 99.17 -3.53 . 0.301 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 110.447 2.247 . 0.795 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.289 0 O4'-C1'-N19 111.972 3.772 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.461 2 O4'-C1'-N19 115.6 7.4 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.05 0 C4'-C3'-C2' 100.299 -2.401 . 0.238 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.902 0 C5'-C4'-C3' 110.281 -3.479 . 0.563 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.793 0 O4'-C1'-N19 111.984 3.784 . 0.225 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.422 0 O5'-C5'-C4' 114.423 3.016 . 0.409 0i . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.382 1 O4'-C1'-N19 112.812 4.612 . 0.731 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.178 1 O4'-C1'-N19 112.511 4.311 . 0.676 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.204 1 O4'-C1'-N19 112.406 4.206 OUTLIER-EPSILON 0.489 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 1 P-O3'-C3' 126.52 5.684 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.013 0 N19-C1'-C2' 109.556 -2.403 . 0.189 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 0 C3'-C2'-C1' 103.903 2.669 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.885 2 C4'-C3'-C2' 96.579 -6.121 . 0.199 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.426 1 O4'-C1'-N19 113.959 5.759 . 0.235 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.884 0 O4'-C1'-N19 111.647 3.447 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 C4'-C3'-C2' 99.145 -3.555 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.087 0 O4'-C1'-N19 112.09 3.89 . 0.698 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.29 0 C4'-C3'-C2' 99.664 -3.036 . 0.701 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.062 1 O4'-C1'-N19 114.561 6.361 . 0.431 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.441 0 O4'-C1'-N19 111.796 3.596 . 0.604 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 P-O3'-C3' 123.325 3.021 . 0.396 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.57 -3.067 0 C4'-C3'-C2' 99.949 -2.751 . 0.074 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.532 0 O4'-C1'-N19 111.568 3.368 . 0.674 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.115 1 O4'-C1'-N19 113.086 4.886 . 0.487 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O5'-C5'-C4' 115.608 3.863 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.554 2.696 3 O4'-C1'-N19 113.773 5.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.566 0 O4'-C1'-N19 111.299 3.099 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.41 -1.881 2 O4'-C1'-N19 113.96 5.76 . 0.027 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ' A' . . . . . 0.413 " H4'" ' HD3' ' L' ' 294' ' ' ARG . . . . . . . . 0 C5'--C4' 1.539 2.252 1 C5'-C4'-O4' 116.001 4.858 . 0.188 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.95 1 O4'-C1'-N19 112.816 4.616 . 0.537 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.984 1 O4'-C1'-N19 112.318 4.118 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 O4'-C1'-N19 111.683 3.483 . 0.582 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.427 0 O4'-C1'-N19 111.023 2.823 . 0.267 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.388 1 O4'-C1'-N19 112.892 4.692 . 0.335 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.293 1 O4'-C1'-N19 112.253 4.053 . 0.622 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.228 1 C3'-C2'-C1' 105.47 4.411 . 0.373 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 1 C3'-C2'-C1' 105.297 4.219 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.94 2 O4'-C1'-N19 112.934 4.734 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 112.377 4.177 . 0.615 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.035 0 O4'-C1'-N19 111.951 3.751 . 0.401 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 O4'-C1'-N19 113.254 5.054 . 0.231 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 1 C5'-C4'-C3' 109.381 -4.079 . 0.527 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 1 O4'-C1'-N19 112.528 4.328 . 0.639 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.173 0 O4'-C1'-N19 112.061 3.861 . 0.866 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.451 0 O4'-C1'-N19 111.323 3.123 . 0.714 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.729 0 C3'-C2'-C1' 104.592 3.436 . 0.427 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 1 C3'-C2'-C1' 106.159 5.176 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ' A' . . . . . 0.493 " H2'" ' C8 ' ' B' ' 38' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 O4'-C1'-N19 112.064 3.864 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ' A' . . . . . 0.493 ' C8 ' " H2'" ' B' ' 37' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.543 2.54 1 O4'-C1'-N19 113.164 4.964 . 0.0 OUTLIER '7D dist 1a' 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 O4'-C1'-N19 111.085 2.885 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.931 2.731 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.201 0 C4'-C3'-C2' 99.132 -3.568 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.96 0 C4'-C3'-C2' 98.94 -3.76 . 0.538 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.081 0 C4'-C3'-C2' 99.027 -3.673 . 0.596 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 1 O4'-C1'-N19 114.494 6.294 . 0.464 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.282 0 O4'-C1'-N19 111.527 3.327 . 0.689 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 P-O3'-C3' 123.679 3.316 . 0.428 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.477 0 O4'-C1'-N19 110.557 2.357 . 0.257 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.884 1 O4'-C1'-N19 112.588 4.388 . 0.397 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.134 2 O4'-C1'-N19 113.975 5.775 OUTLIER-EPSILON 0.444 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 3 P-O3'-C3' 126.25 5.458 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.344 0 C5'-C4'-O4' 113.779 3.271 . 0.029 7d . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.155 1 O4'-C1'-N19 112.734 4.534 . 0.566 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.074 1 O4'-C1'-N19 113.31 5.11 . 0.593 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.198 1 O4'-C1'-N19 113.679 5.479 . 0.314 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.192 1 O4'-C1'-N19 114.118 5.918 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.117 1 C4'-C3'-C2' 97.677 -5.023 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.118 0 O4'-C1'-N19 112.098 3.898 . 0.691 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.454 1 O4'-C1'-N19 112.946 4.746 . 0.491 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 112.026 3.826 . 0.613 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C4'-C3'-C2' 99.278 -3.422 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.05 0 C4'-C3'-C2' 99.098 -3.602 . 0.618 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 1 C4'-C3'-C2' 98.674 -4.026 . 0.345 1e . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ' C' . . . . . 0.443 " H4'" ' OP2' ' B' ' 63' ' ' ' C' . . . . . . . . 0 P--O5' 1.623 2.982 5 O4'-C1'-N19 117.483 9.283 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.129 0 O4'-C1'-N19 111.918 3.718 . 0.01 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.583 -2.022 1 C5'-C4'-C3' 108.857 -4.429 . 0.415 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 C3'-C2'-C1' 105.039 3.933 . 0.087 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 1 C5'-C4'-O4' 115.26 4.328 . 0.158 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.821 0 O4'-C1'-N19 111.577 3.377 . 0.893 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.876 1 O4'-C1'-N19 113.939 5.739 . 0.898 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.412 -1.725 1 O4'-C1'-N19 112.676 4.476 OUTLIER-EPSILON 0.504 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 1 P-O3'-C3' 126.92 6.017 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 C4'-C3'-C2' 100.974 -1.726 . 0.544 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.76 147.15 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.084 0.856 . . . . 0.0 109.946 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 47.6 t -150.26 159.66 44.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.634 1.974 . . . . 0.0 110.647 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.37 145.46 47.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.584 1.554 . . . . 0.0 110.79 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 179.3 6.71 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.502 0.721 . . . . 0.0 111.995 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -38.35 -33.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -114.2 -8.88 12.93 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.44 -168.12 40.03 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 117.031 1.572 . . . . 0.0 117.031 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -135.01 130.52 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 127.036 2.134 . . . . 0.0 107.92 -165.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 133.95 34.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.614 0.766 . . . . 0.0 112.027 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.59 122.92 49.09 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.164 0.986 . . . . 0.0 111.468 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -122.87 144.19 49.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.385 1.474 . . . . 0.0 110.846 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.28 173.16 11.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.14 -4.25 37.6 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -92.04 -47.07 7.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.938 1.245 . . . . 0.0 111.518 163.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.03 27.58 0.17 Allowed Glycine 0 CA--C 1.534 1.254 0 N-CA-C 117.836 1.894 . . . . 0.0 117.836 163.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -109.53 151.4 26.81 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.536 1.668 . . . . 0.0 112.691 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.03 132.2 45.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 mt -98.18 -54.81 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.617 1.567 . . . . 0.0 109.731 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -152.09 153.58 34.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.996 1.318 . . . . 0.0 111.423 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -133.96 143.86 48.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.259 1.423 . . . . 0.0 112.198 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -124.63 160.4 28.56 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.935 2.094 . . . . 0.0 111.003 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -118.18 155.27 30.78 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.524 1.93 . . . . 0.0 108.368 168.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -71.65 138.2 48.47 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 46.6 p -90.37 9.9 27.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.341 1.457 . . . . 0.0 113.66 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -142.11 167.74 21.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.342 1.457 . . . . 0.0 110.803 165.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.37 130.19 80.6 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.9 1.28 . . . . 0.0 109.994 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.76 -41.22 47.98 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.257 2.638 . . . . 0.0 114.092 -155.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -59.22 -36.91 76.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.299 0.954 . . . . 0.0 112.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -70.53 -31.73 68.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.648 1.179 . . . . 0.0 112.396 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.18 -40.66 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.434 1.494 . . . . 0.0 111.592 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 mt -68.27 -35.14 77.42 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.211 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.35 -43.74 79.41 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 121.041 1.746 . . . . 0.0 112.434 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.13 -49.85 76.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.622 0.769 . . . . 0.0 111.111 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.72 -28.2 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.541 HD21 ' H ' ' E' ' 139' ' ' ALA . 47.3 mt -76.93 -44.42 31.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.702 1.601 . . . . 0.0 112.057 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.37 -16.03 58.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.187 0.995 . . . . 0.0 113.436 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.81 16.85 4.82 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 167.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -117.61 155.53 29.7 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.629 2.215 . . . . 0.0 113.234 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 9.1 tp -82.81 143.99 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.26 . . . . 0.0 112.352 -170.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 62.1 p -129.32 155.42 45.65 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.772 1.229 . . . . 0.0 110.847 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -55.09 -33.15 62.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -72.46 -39.73 67.54 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.47 1.032 . . . . 0.0 112.466 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 tp -70.65 -37.39 73.73 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.446 171.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.58 -44.17 93.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 0.0 111.542 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 -35.57 77.9 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.794 -1.191 . . . . 0.0 112.424 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.83 -51.59 63.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.753 0.706 . . . . 0.0 111.713 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.48 -26.6 66.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.48 1.036 . . . . 0.0 112.702 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -74.94 -30.8 61.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.707 168.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t -61.59 -42.73 99.28 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.527 1.512 . . . . 0.0 111.746 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.68 -36.78 84.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.659 -1.276 . . . . 0.0 111.945 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.05 -33.17 74.93 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.257 1.023 . . . . 0.0 113.218 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -71.16 -38.33 72.18 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.55 -1.344 . . . . 0.0 110.94 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.65 0.66 14.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.13 1.372 . . . . 0.0 114.546 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.01 24.21 35.65 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -91.33 125.82 36.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.369 1.585 . . . . 0.0 109.883 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.71 -20.54 13.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -174.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.25 140.35 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.831 1.253 . . . . 0.0 111.788 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -130.41 141.99 50.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 111.916 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -131.6 118.12 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.114 1.366 . . . . 0.0 109.437 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -115.31 178.8 4.16 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.951 1.7 . . . . 0.0 111.695 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -91.68 -41.95 10.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -96.58 133.17 25.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.519 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.05 -30.81 83.34 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.906 2.404 . . . . 0.0 113.636 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.41 -33.66 13.75 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.458 -0.776 . . . . 0.0 112.523 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.83 -37.13 75.74 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.924 -0.485 . . . . 0.0 110.354 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -66.23 -37.62 85.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.223 0.609 . . . . 0.0 112.493 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -65.03 -46.34 81.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.234 1.414 . . . . 0.0 111.328 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.14 -36.52 84.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.711 0.804 . . . . 0.0 112.467 172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.87 92.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.341 0.973 . . . . 0.0 113.212 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -72.14 -33.23 67.61 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 119.76 1.163 . . . . 0.0 113.382 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.24 -23.78 65.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.555 -0.716 . . . . 0.0 112.72 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -78.52 -6.49 55.6 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.527 1.531 . . . . 0.0 113.722 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.37 25.43 7.01 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -118.0 147.41 43.22 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 119.043 1.421 . . . . 0.0 112.647 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' SER . . . . . . . . . . . . . 61.2 m -71.7 76.95 0.84 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.223 1.011 . . . . 0.0 111.8 166.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.02 141.35 37.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.55 -1.344 . . . . 0.0 113.226 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' THR . . . . . . . . . . . . . 44.6 p -142.31 175.49 9.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.244 1.818 . . . . 0.0 111.762 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -122.18 130.03 52.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.165 1.386 . . . . 0.0 111.691 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.56 98.27 1.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.697 1.199 . . . . 0.0 108.013 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.24 -37.73 18.06 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.747 -1.22 . . . . 0.0 113.658 -171.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -70.31 14.77 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.823 3.015 . . . . 0.0 116.508 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -72.25 152.81 41.93 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.733 -1.229 . . . . 0.0 113.317 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 70.7 mt -54.82 -36.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.644 1.178 . . . . 0.0 113.78 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.35 81.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.36 0.982 . . . . 0.0 111.977 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.58 -35.97 27.51 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.29 0.471 . . . . 0.0 113.348 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.89 -40.77 98.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.074 0.549 . . . . 0.0 111.385 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -68.61 -53.59 21.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.968 0.907 . . . . 0.0 111.83 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.4 -41.02 75.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -84.66 -18.66 34.67 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.261 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 50.6 m -85.55 -38.51 18.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.323 1.42 . . . . 0.0 113.373 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.05 55.25 17.85 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.038 0.935 . . . . 0.0 111.139 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -58.22 -28.24 83.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.07 2.514 . . . . 0.0 113.306 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -63.71 -18.88 64.46 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.67 -23.7 56.25 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.866 1.266 . . . . 0.0 112.423 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -114.98 -37.23 4.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.476 1.11 . . . . 0.0 113.106 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.44 -4.69 13.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.519 1.528 . . . . 0.0 112.927 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.2 174.04 46.85 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.72 1.145 . . . . 0.0 114.445 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -69.99 2.46 3.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -101.05 1.21 39.24 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.996 1.719 . . . . 0.0 113.728 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -45.84 -36.57 5.36 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -165.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.07 -24.93 67.89 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.602 0.761 . . . . 0.0 112.818 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.34 -32.89 72.27 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.32 -0.863 . . . . 0.0 112.822 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -79.36 -39.1 33.43 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.434 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -53.34 -48.05 68.82 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.735 0.814 . . . . 0.0 111.5 168.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.58 -50.82 71.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.928 1.291 . . . . 0.0 112.36 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -61.05 -29.52 69.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.306 1.042 . . . . 0.0 113.157 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.47 -32.33 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.432 0.693 . . . . 0.0 112.466 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.75 89.29 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.625 1.102 . . . . 0.0 112.785 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.82 -33.31 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 122.061 -0.67 . . . . 0.0 112.346 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.62 -38.66 73.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.59 0.756 . . . . 0.0 112.686 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.84 -42.45 97.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.628 0.771 . . . . 0.0 111.182 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 26.4 m -63.43 -29.89 71.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.278 0.631 . . . . 0.0 112.368 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -75.11 -14.54 60.58 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.921 -1.112 . . . . 0.0 113.85 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' MET . . . . . . . . . . . . . 16.4 ttt -104.52 -26.8 12.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.594 1.958 . . . . 0.0 114.169 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -76.5 32.57 0.13 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 tt -143.38 143.36 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.523 1.929 . . . . 0.0 108.654 170.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -75.22 153.18 38.21 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -133.79 109.66 9.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 109.296 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -146.47 103.86 3.72 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.903 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' SER . . . . . . . . . . . . . 13.8 t -95.22 159.36 15.05 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.075 -1.016 . . . . 0.0 112.467 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.95 -10.04 56.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.513 -1.16 . . . . 0.0 114.552 164.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.88 31.65 0.94 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.23 1.015 . . . . 0.0 112.721 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.16 -42.56 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -165.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.45 -33.86 69.74 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.017 0.826 . . . . 0.0 112.428 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -67.29 -36.41 81.49 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.118 -0.988 . . . . 0.0 111.53 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' MET . . . . . . . . . . . . . 22.5 mmt -65.64 -42.11 91.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.83 0.852 . . . . 0.0 111.145 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.53 -40.09 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.898 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.96 -46.06 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.84 1.2 . . . . 0.0 110.67 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.55 -32.81 74.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.253 0.933 . . . . 0.0 112.474 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.08 -34.57 77.93 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.141 0.882 . . . . 0.0 113.073 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -70.05 -42.88 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.567 1.147 . . . . 0.0 111.687 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.44 -38.18 90.11 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.201 0.455 . . . . 0.0 110.637 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.83 75.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.509 0.723 . . . . 0.0 112.177 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -69.88 -40.67 75.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.549 1.068 . . . . 0.0 111.676 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.21 -39.96 74.85 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.611 -0.681 . . . . 0.0 112.324 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' C' ' 140' ' ' LYS . 89.5 m-20 -66.59 -38.16 86.43 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.816 0.734 . . . . 0.0 112.55 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.7 -48.14 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.966 1.306 . . . . 0.0 111.122 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.9 -38.42 85.66 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.27 0.941 . . . . 0.0 111.244 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' C' ' 137' ' ' ASP . 35.7 ttpt -66.67 -37.63 85.17 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.238 1.415 . . . . 0.0 113.784 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.24 -29.21 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.088 1.313 . . . . 0.0 113.143 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.37 -49.18 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.958 0.799 . . . . 0.0 109.218 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -55.55 -40.54 72.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.173 0.897 . . . . 0.0 112.501 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.24 -54.06 39.42 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.363 0.665 . . . . 0.0 112.135 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.08 -30.09 68.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.784 -0.573 . . . . 0.0 112.253 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.26 -35.85 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.845 0.858 . . . . 0.0 111.839 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.78 93.26 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.699 1.136 . . . . 0.0 111.989 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -43.48 81.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.46 0.704 . . . . 0.0 111.735 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.299 1.04 . . . . 0.0 112.393 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -59.07 -51.08 71.6 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.871 0.868 . . . . 0.0 111.41 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.54 -44.15 83.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -70.93 -46.04 63.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.982 0.513 . . . . 0.0 111.812 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.12 -24.89 65.06 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.654 -1.279 . . . . 0.0 112.284 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 71.1 m -63.59 -16.91 62.16 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.82 -32.78 74.63 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.056 1.298 . . . . 0.0 111.457 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 156' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -106.78 -21.04 13.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.84 1.256 . . . . 0.0 114.039 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.58 72.33 7.44 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-N 119.867 1.212 . . . . 0.0 112.084 172.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 158' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.12 -20.51 67.42 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.184 3.256 . . . . 0.0 115.342 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -70.79 -16.88 62.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.442 1.097 . . . . 0.0 113.25 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 160' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.95 -28.5 62.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.842 1.257 . . . . 0.0 113.348 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 161' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.63 -48.45 74.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.931 0.892 . . . . 0.0 113.072 -167.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 162' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.62 -24.1 61.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.281 1.032 . . . . 0.0 112.266 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 163' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.79 -29.92 23.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.88 1.272 . . . . 0.0 113.665 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.8 mt -117.42 85.17 19.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.282 1.433 . . . . 0.0 110.399 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.1 -32.81 10.34 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.781 2.32 . . . . 0.0 113.527 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 166' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -71.94 112.59 8.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.973 1.309 . . . . 0.0 111.199 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -58.01 -51.22 83.33 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -168.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 168' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.43 -28.15 71.08 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 122.701 2.0 . . . . 0.0 113.161 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 169' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.05 -32.57 69.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.914 -1.116 . . . . 0.0 111.751 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 170' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -69.16 -42.1 76.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.067 0.947 . . . . 0.0 111.616 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 171' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.59 -55.21 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.147 0.979 . . . . 0.0 110.988 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.7 80.61 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.44 -54.5 44.99 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.588 -0.695 . . . . 0.0 111.041 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.14 -36.65 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.794 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 175' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.23 -49.45 69.42 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.334 1.454 . . . . 0.0 112.071 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 176' ' ' THR . . . . . . . . . . . . . 34.4 m -90.42 -29.82 17.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.37 -49.87 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 111.889 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.28 -101.52 0.24 Allowed Glycine 0 CA--C 1.535 1.306 0 CA-C-N 118.928 0.785 . . . . 0.0 111.69 -168.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 179' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.55 139.06 45.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.428 -1.043 . . . . 0.0 113.548 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 180' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -60.76 -13.52 15.61 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.35 -4.46 57.08 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.715 1.598 . . . . 0.0 113.685 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 182' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.75 3.98 17.74 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.515 -0.741 . . . . 0.0 112.993 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -77.23 120.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 120.837 -1.164 . . . . 0.0 109.43 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 184' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -140.97 151.4 44.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.437 1.495 . . . . 0.0 109.795 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -49.35 -38.64 28.85 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.082 1.353 . . . . 0.0 112.579 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 186' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -62.57 -53.72 50.44 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.99 0.916 . . . . 0.0 112.671 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 187' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.03 -30.16 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.528 -0.733 . . . . 0.0 112.938 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.44 -34.81 70.6 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.585 -0.697 . . . . 0.0 111.763 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 189' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.35 -28.17 47.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.221 1.009 . . . . 0.0 112.957 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.33 -46.96 75.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.259 0.936 . . . . 0.0 111.398 165.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 191' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.61 -5.29 3.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.963 1.305 . . . . 0.0 112.826 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.32 70.65 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.646 -1.085 . . . . 0.0 115.129 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.02 157.41 28.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.794 1.297 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 194' ' ' SER . . . . . . . . . . . . . 85.8 p -80.25 153.63 28.38 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.708 -0.62 . . . . 0.0 112.158 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 195' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -54.03 -31.55 51.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 196' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -62.71 -52.83 61.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.48 1.112 . . . . 0.0 111.912 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 197' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.23 -31.17 72.26 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.817 -0.552 . . . . 0.0 111.273 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 198' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.59 -17.82 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 127.033 2.133 . . . . 0.0 112.702 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -71.65 -26.87 62.73 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.853 -1.154 . . . . 0.0 111.774 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 200' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.19 -167.69 1.62 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.279 1.431 . . . . 0.0 109.081 159.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 201' ' ' ILE . . . . . . . . . . . . . 43.6 mt 64.22 -64.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.879 1.672 . . . . 0.0 111.995 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 202' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.51 -42.43 98.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 111.74 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.19 -37.48 74.85 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.661 -0.65 . . . . 0.0 112.037 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.53 -36.55 52.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 112.578 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -56.88 -34.47 67.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.616 1.166 . . . . 0.0 112.604 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 206' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.94 -11.77 60.02 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 4.41 3.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 208' ' ' THR . . . . . . . . . . . . . 8.1 t -49.68 143.13 7.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -94.67 3.17 55.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.927 1.691 . . . . 0.0 113.553 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.86 160.56 41.6 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.951 0.786 . . . . 0.0 114.193 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.71 -165.63 0.65 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.775 1.23 . . . . 0.0 112.024 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -117.31 113.82 22.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.671 1.188 . . . . 0.0 112.024 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 86.9 mtp -93.12 135.18 34.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.53 1.132 . . . . 0.0 109.581 159.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.98 168.4 15.47 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.285 -0.885 . . . . 0.0 111.779 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -55.91 -36.67 67.94 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.548 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' THR . . . . . . . . . . . . . 3.0 m -71.01 -26.28 63.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.858 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.41 -50.11 6.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.629 1.172 . . . . 0.0 111.642 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.73 -22.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.295 -0.878 . . . . 0.0 112.833 -168.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.98 -27.63 68.96 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.549 -0.719 . . . . 0.0 111.964 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.42 -40.35 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 120.376 1.443 . . . . 0.0 110.803 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.33 -30.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.404 0.682 . . . . 0.0 111.266 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -66.51 -41.84 88.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.983 0.913 . . . . 0.0 112.264 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.02 -39.34 90.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.366 1.066 . . . . 0.0 111.373 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.14 -44.15 83.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.62 0.645 . . . . 0.0 111.561 170.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.01 -37.6 84.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.14 -42.63 93.67 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.42 -0.8 . . . . 0.0 112.352 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -24.98 64.01 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 62.6 mt -73.4 -33.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 120.53 -1.356 . . . . 0.0 111.112 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.33 -28.97 63.4 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.846 -1.159 . . . . 0.0 111.98 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -57.89 -50.74 72.32 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.825 -1.172 . . . . 0.0 110.797 162.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.15 -38.59 80.09 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -29.59 68.9 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.041 -1.037 . . . . 0.0 113.154 174.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.12 -41.81 63.61 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.81 0.732 . . . . 0.0 111.301 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.86 -40.45 76.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.059 0.845 . . . . 0.0 111.928 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -53.31 -46.27 69.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.938 0.895 . . . . 0.0 111.679 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.16 -39.47 86.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.502 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -61.67 -33.13 73.43 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 119.915 1.234 . . . . 0.0 112.686 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' LEU . . . . . . . . . . . . . 83.4 mt -66.94 -46.49 74.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 0.0 111.991 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 239' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.14 -41.35 98.19 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.61 -31.1 61.9 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.598 1.159 . . . . 0.0 113.14 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 241' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.42 -48.79 79.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.108 0.867 . . . . 0.0 110.923 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.55 -37.76 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.974 0.509 . . . . 0.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 243' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.61 -25.33 68.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.154 0.982 . . . . 0.0 113.508 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -87.15 -48.73 7.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.645 1.178 . . . . 0.0 112.524 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.66 -29.35 67.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.246 1.018 . . . . 0.0 113.303 -170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 246' ' ' MET . . . . . . . . . . . . . 96.3 mmm -72.18 7.99 1.49 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 247' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.3 -24.39 16.78 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.764 1.62 . . . . 0.0 112.857 167.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -88.83 79.41 7.4 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.906 -1.746 . . . . 0.0 111.929 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.09 136.91 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.481 1.512 . . . . 0.0 112.013 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 250' ' ' ALA . . . . . . . . . . . . . . . -156.68 158.66 31.45 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.241 1.416 . . . . 0.0 113.341 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 251' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.61 154.41 11.92 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.663 3.575 . . . . 0.0 113.227 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 252' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -79.94 -43.85 21.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.76 1.624 . . . . 0.0 113.719 -170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.33 -31.57 70.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.102 -0.999 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 254' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.54 -29.77 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.292 1.037 . . . . 0.0 112.702 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ALA . . . . . . . . . . . . . . . -92.74 -38.03 12.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.181 0.992 . . . . 0.0 113.292 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 256' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.32 -36.84 66.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.59 -30.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.69 166.81 42.58 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 119.121 0.873 . . . . 0.0 114.811 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 259' ' ' ALA . . . . . . . . . . . . . . . -54.71 -41.9 70.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -163.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 260' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.29 -34.48 57.47 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.056 1.342 . . . . 0.0 112.562 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 23.6 tp -101.43 -40.55 7.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.059 0.944 . . . . 0.0 112.282 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.16 70.81 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.089 0.858 . . . . 0.0 112.763 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 263' ' ' ALA . . . . . . . . . . . . . . . -69.91 -25.86 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.518 -0.739 . . . . 0.0 112.522 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -47.23 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.23 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 265' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -40.14 96.41 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.841 0.746 . . . . 0.0 111.546 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.97 -46.89 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.365 0.666 . . . . 0.0 110.887 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 267' ' ' SER . . . . . . . . . . . . . 13.1 t -69.82 -32.3 70.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.93 -24.81 37.91 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.338 0.972 . . . . 0.0 112.524 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.13 -1.6 49.33 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 164.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.28 -29.41 1.67 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.111 1.339 . . . . 0.0 114.845 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.44 173.37 43.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.294 1.547 . . . . 0.0 113.91 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.96 -30.34 61.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.326 -1.102 . . . . 0.0 113.152 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 273' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -57.62 -49.46 76.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.3 0.955 . . . . 0.0 109.63 167.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -67.49 -42.1 83.44 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.457 1.103 . . . . 0.0 110.548 -173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.3 -40.94 87.77 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.28 0.632 . . . . 0.0 112.302 171.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.29 -29.69 68.52 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.42 -0.8 . . . . 0.0 112.736 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 277' ' ' MET . . . . . . . . . . . . . 13.4 mmt -80.55 -1.64 42.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.702 1.201 . . . . 0.0 113.95 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 278' ' ' MET . . . . . . . . . . . . . 52.2 mtt -94.12 150.36 38.3 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.171 1.35 . . . . 0.0 113.89 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 279' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.2 155.42 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.694 2.929 . . . . 0.0 111.992 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 280' ' ' SER . . . . . . . . . . . . . 67.0 p -50.19 -46.38 54.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.683 1.193 . . . . 0.0 112.986 170.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 281' ' ' SER . . . . . . . . . . . . . 7.9 p -73.7 16.23 0.22 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.188 1.795 . . . . 0.0 114.668 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 282' ' ' THR . . . . . . . . . . . . . 97.4 m -124.68 -36.27 2.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.929 -1.732 . . . . 0.0 110.58 158.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 283' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.65 -30.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.851 1.26 . . . . 0.0 112.232 171.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.99 -33.27 64.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.581 . . . . 0.0 113.128 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 285' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.97 2.5 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.473 1.509 . . . . 0.0 113.933 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' LEU . . . . . . . . . . . . . 40.2 mt -53.7 129.19 32.31 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.471 -0.768 . . . . 0.0 109.954 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 66.76 26.33 73.05 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.291 -0.727 . . . . 0.0 114.29 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.1 -16.86 57.62 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.96 1.38 . . . . 0.0 112.138 159.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.06 -119.88 1.55 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.713 2.005 . . . . 0.0 111.875 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 290' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -45.42 -27.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 291' ' ' ALA . . . . . . . . . . . . . . . -77.74 -37.53 49.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.162 0.892 . . . . 0.0 113.135 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 292' ' ' LEU . . . . . . . . . . . . . 49.2 tp -73.13 -47.05 47.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.469 0.577 . . . . 0.0 110.138 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 293' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -47.84 -52.78 17.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.983 1.313 . . . . 0.0 113.053 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 294' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -83.52 -20.01 34.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -61.5 -34.77 76.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.961 0.8 . . . . 0.0 111.45 165.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 -75.88 0.17 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.701 0.8 . . . . 0.0 111.345 167.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -55.88 -42.55 76.11 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -163.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 298' ' ' THR . . . . . . . . . . . . . 75.8 p -108.81 6.68 25.74 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 299' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.96 74.02 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.363 -0.836 . . . . 0.0 114.0 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 300' ' ' ALA . . . . . . . . . . . . . . . -71.46 -173.13 0.86 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.668 1.187 . . . . 0.0 114.024 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 301' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.45 126.2 46.31 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.518 1.527 . . . . 0.0 111.32 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 302' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -59.43 132.1 44.32 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.14 1.893 . . . . 0.0 112.228 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 303' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.28 123.49 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.468 2.112 . . . . 0.0 111.617 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.25 -32.64 68.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.047 0.939 . . . . 0.0 112.662 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 305' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.45 149.62 15.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.286 1.834 . . . . 0.0 110.647 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 306' ' ' GLY . . . . . . . . . . . . . . . -100.18 -136.38 9.32 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.701 1.619 . . . . 0.0 112.386 169.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 307' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.1 -14.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.813 1.245 . . . . 0.0 114.353 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 308' ' ' ILE . . . . . . . . . . . . . 39.0 pt -61.03 -12.27 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.092 1.357 . . . . 0.0 114.144 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 309' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -53.78 -37.78 63.82 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 310' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.49 19.16 1.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 311' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' C' ' 312' ' ' PRO . 85.2 t80 -62.2 146.1 92.91 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.799 -1.188 . . . . 0.0 111.571 170.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 312' ' ' PRO . . . . . 0.418 ' HD2' ' CD2' ' C' ' 311' ' ' TYR . 20.0 Cg_exo -48.41 1.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 1 C-N-CA 127.123 5.215 . . . . 0.0 120.303 176.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 313' ' ' ALA . . . . . . . . . . . . . . . -145.8 22.74 1.42 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.111 1.364 . . . . 0.0 114.421 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 314' ' ' ILE . . . . . . . . . . . . . 68.1 mt -117.94 -70.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.791 -1.193 . . . . 0.0 112.022 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 315' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -64.86 6.51 0.23 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 316' ' ' ARG . . . . . 0.411 ' CZ ' ' HA ' ' C' ' 312' ' ' PRO . 16.8 ptp180 -135.8 18.86 3.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.756 1.622 . . . . 0.0 114.437 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.4 m -142.3 163.41 39.7 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.127 0.971 . . . . 0.0 112.998 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 318' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -59.69 150.11 78.7 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.47 3.447 . . . . 0.0 114.188 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -55.52 -37.93 68.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 320' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -49.32 -37.44 24.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.191 1.796 . . . . 0.0 113.036 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 321' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.45 -33.06 14.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.155 0.982 . . . . 0.0 111.316 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 322' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -54.72 -39.96 68.75 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 323' ' ' GLY . . . . . . . . . . . . . . . -77.13 -37.65 31.91 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 118.575 0.625 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 324' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -73.43 -43.5 60.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.607 1.163 . . . . 0.0 111.464 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 325' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.35 -34.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.961 0.904 . . . . 0.0 111.636 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.18 -46.83 87.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 327' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -77.96 -35.76 49.87 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 328' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.17 95.78 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.878 0.763 . . . . 0.0 112.259 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 329' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.64 -43.99 89.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.54 1.136 . . . . 0.0 111.496 172.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.78 73.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 331' ' ' GLY . . . . . . . . . . . . . . . -57.44 -59.94 9.92 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.642 1.115 . . . . 0.0 111.645 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 332' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -61.1 -33.08 72.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.583 -0.951 . . . . 0.0 113.379 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 333' ' ' LEU . . . . . . . . . . . . . 36.8 mt -66.98 -38.6 86.36 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.123 0.969 . . . . 0.0 113.356 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 334' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.43 75.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.962 0.801 . . . . 0.0 111.9 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.44 -53.64 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.863 -0.523 . . . . 0.0 110.025 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 336' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.57 87.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.68 -37.31 86.11 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.674 -0.641 . . . . 0.0 112.49 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 338' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -68.96 -38.59 79.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.397 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 339' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.3 -53.07 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.223 0.609 . . . . 0.0 110.996 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 340' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -67.39 -26.83 66.64 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 341' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -86.8 -50.62 6.61 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 342' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.55 -23.98 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 343' ' ' SER . . . . . . . . . . . . . 67.1 m -133.33 -35.7 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 344' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.18 74.28 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.183 0.897 . . . . 0.0 114.75 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 345' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -88.38 145.04 26.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.877 1.271 . . . . 0.0 110.675 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 346' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -95.0 124.14 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.003 -1.06 . . . . 0.0 113.158 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 347' ' ' ILE . . . . . . . . . . . . . 45.4 pt -137.18 6.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.025 1.73 . . . . 0.0 113.09 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 348' ' ' ALA . . . . . . . . . . . . . . . -63.71 -18.59 64.17 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -160.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 349' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.45 -28.56 66.22 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.353 1.433 . . . . 0.0 111.959 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 350' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.55 -40.69 49.06 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.553 -0.717 . . . . 0.0 110.963 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 351' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.64 -33.98 73.6 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.867 -0.521 . . . . 0.0 111.827 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 352' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.3 -51.05 57.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.34 1.056 . . . . 0.0 111.348 169.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 353' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -56.15 -42.14 76.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.68 1.127 . . . . 0.0 112.604 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 354' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.26 -34.93 79.24 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.079 0.854 . . . . 0.0 112.506 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 355' ' ' LEU . . . . . . . . . . . . . 25.1 tp -83.09 -21.44 33.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.95 0.9 . . . . 0.0 113.26 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -50.27 67.04 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.32 -1.487 . . . . 0.0 109.979 158.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 357' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.43 79.91 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.323 1.049 . . . . 0.0 113.183 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 358' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -64.91 -31.85 73.29 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.16 0.891 . . . . 0.0 112.316 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 359' ' ' ILE . . . . . . . . . . . . . 87.3 mt -79.95 -29.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.742 1.155 . . . . 0.0 111.73 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 360' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -64.6 -38.22 90.25 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.702 1.137 . . . . 0.0 111.938 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -43.26 93.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.144 0.978 . . . . 0.0 111.544 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 362' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.25 -27.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.834 0.854 . . . . 0.0 111.195 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 363' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.13 -46.25 21.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.009 -1.057 . . . . 0.0 112.848 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 364' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.93 -26.56 66.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.203 0.911 . . . . 0.0 112.147 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 365' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -77.81 -43.15 31.45 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 366' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.955 1.302 . . . . 0.0 112.752 -168.6 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 117.484 -1.246 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 156.07 45.26 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.318 2.012 . . . . 0.0 113.047 -172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' SER . . . . . . . . . . . . . 80.9 p -72.45 -13.96 61.57 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -88.45 -17.33 30.64 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.8 60.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 122.353 1.073 . . . . 0.0 111.228 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.82 -10.97 60.64 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -165.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -124.7 145.29 49.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.549 1.068 . . . . 0.0 112.583 170.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.98 119.4 17.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.492 0.717 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.07 126.98 55.35 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.443 0.697 . . . . 0.0 111.487 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.21 177.38 7.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.158 3.239 . . . . 0.0 112.857 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -69.88 20.18 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.38 164.51 29.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.11 2.164 . . . . 0.0 110.24 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' LEU . . . . . . . . . . . . . 43.1 mt 64.85 -35.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.27 74.2 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.891 1.678 . . . . 0.0 111.885 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.39 -26.69 68.86 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.331 -0.856 . . . . 0.0 112.502 174.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tttp -76.11 -31.09 58.5 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.42 1.088 . . . . 0.0 111.688 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.7 69.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.014 0.925 . . . . 0.0 111.696 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -49.57 77.32 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 171.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.11 -39.35 82.0 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.379 1.072 . . . . 0.0 112.619 174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.04 87.82 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.296 -0.878 . . . . 0.0 112.086 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.66 -50.44 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.567 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -53.9 -41.08 67.23 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 pt -95.09 -19.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -30.92 67.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.752 1.16 . . . . 0.0 111.627 167.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -42.2 -39.86 2.19 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.14 2.576 . . . . 0.0 115.835 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.86 1.61 12.71 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 7.2 p -131.85 -17.06 2.85 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.71 -144.06 9.82 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.375 1.464 . . . . 0.0 111.768 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -140.31 128.74 22.68 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.848 1.659 . . . . 0.0 107.103 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 tt -150.2 144.9 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.041 0.936 . . . . 0.0 110.857 -158.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -125.53 154.53 42.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.067 1.347 . . . . 0.0 111.191 170.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.9 34.69 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.76 1.624 . . . . 0.0 111.153 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.74 152.76 19.98 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 123.924 0.765 . . . . 0.0 111.568 -164.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' THR . . . . . . . . . . . . . 13.3 m -78.83 -30.25 45.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.455 -1.259 . . . . 0.0 114.044 -166.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.0 -41.15 60.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 121.974 2.17 . . . . 0.0 111.627 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -65.01 -38.57 91.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.675 -1.266 . . . . 0.0 112.568 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' THR . . . . . . . . . . . . . 51.2 m -53.87 -53.17 56.25 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.951 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 40.2 m -54.11 -49.45 69.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.569 1.148 . . . . 0.0 111.795 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -69.17 -41.14 77.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.541 1.064 . . . . 0.0 113.038 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.92 -8.46 56.56 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.524 1.056 . . . . 0.0 113.815 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' VAL . . . . . 0.441 HG13 ' HE2' ' D' ' 71' ' ' LYS . 5.6 t -88.25 -34.82 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.573 1.549 . . . . 0.0 109.753 172.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -72.28 -53.2 13.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.291 1.405 . . . . 0.0 112.214 167.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -100.11 140.42 34.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.979 1.312 . . . . 0.0 113.141 -158.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.67 -159.47 34.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.971 0.762 . . . . 0.0 112.943 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -108.2 85.37 2.1 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.08 -1.247 . . . . 0.0 111.664 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.85 151.31 18.2 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.572 -0.705 . . . . 0.0 111.368 161.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -108.73 -38.67 5.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.201 1.0 . . . . 0.0 112.547 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 tp -154.13 151.04 28.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.19 2.196 . . . . 0.0 109.92 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -129.0 143.12 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.617 1.167 . . . . 0.0 111.183 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.43 138.08 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.527 1.931 . . . . 0.0 109.083 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -125.41 154.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.627 1.571 . . . . 0.0 109.888 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.81 155.94 27.64 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.284 -1.51 . . . . 0.0 112.655 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.5 -8.01 56.92 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.35 21.58 13.97 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.682 1.193 . . . . 0.0 113.88 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.63 127.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.594 -0.691 . . . . 0.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -150.95 113.15 3.12 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.838 0.855 . . . . 0.0 109.133 -167.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.59 142.83 29.71 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.491 1.211 . . . . 0.0 113.622 0.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.58 -25.58 65.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.652 0.739 . . . . 0.0 112.176 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -54.99 -33.37 62.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.922 2.489 . . . . 0.0 113.461 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -35.54 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 O-C-N 121.488 -0.758 . . . . 0.0 111.358 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -102.2 -9.99 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.19 1.396 . . . . 0.0 113.942 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.46 -18.09 25.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -73.72 -25.79 60.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.422 1.089 . . . . 0.0 113.892 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.67 -40.17 29.89 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.881 -171.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.79 -55.87 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.038 1.825 . . . . 0.0 114.283 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.55 -34.05 65.68 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.776 2.027 . . . . 0.0 112.309 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.23 -29.91 71.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.457 -0.777 . . . . 0.0 112.37 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.17 -25.58 47.27 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.5 -1.375 . . . . 0.0 113.476 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.95 -27.51 57.59 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.433 1.093 . . . . 0.0 113.707 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.62 -25.89 60.53 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.448 1.099 . . . . 0.0 112.317 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' LYS . . . . . 0.441 ' HE2' HG13 ' D' ' 41' ' ' VAL . 13.9 pttp -127.52 17.26 6.99 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -168.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 63.8 25.71 14.17 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 167.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 20.6 mm -104.07 140.56 21.18 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.927 1.291 . . . . 0.0 111.488 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.42 152.03 26.37 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.557 2.838 . . . . 0.0 112.764 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -133.36 157.02 46.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.492 1.117 . . . . 0.0 112.121 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -151.8 166.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.585 1.554 . . . . 0.0 109.898 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 158.48 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.17 154.62 80.17 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 126.392 1.877 . . . . 0.0 111.966 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -68.34 -6.45 17.53 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 N-CA-C 119.113 2.697 . . . . 0.0 119.113 -157.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 10.5 t -162.37 134.89 5.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.724 1.602 . . . . 0.0 114.098 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -62.15 -31.52 72.01 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 113.391 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -75.62 -36.97 60.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.62 0.768 . . . . 0.0 111.442 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -70.68 -36.32 73.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.514 0.726 . . . . 0.0 112.052 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -68.03 -37.67 81.63 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 112.212 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.17 -45.97 95.46 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.862 -0.524 . . . . 0.0 112.567 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.49 77.96 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.439 -1.036 . . . . 0.0 113.089 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.0 90.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.676 0.79 . . . . 0.0 111.976 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.59 -21.76 65.4 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.03 30.86 8.02 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.988 1.28 . . . . 0.0 114.521 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' ILE . . . . . . . . . . . . . 35.6 pt -120.2 142.09 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.298 1.439 . . . . 0.0 109.676 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . 0.344 5.5 pt-20 -84.39 1.2 46.35 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.09 -149.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.149 1.78 . . . . 0.0 111.238 166.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.58 171.33 7.55 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.058 1.743 . . . . 0.0 111.9 172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.77 17.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.857 . . . . 0.0 110.239 165.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.92 -31.79 63.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -151.83 163.44 39.19 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -141.67 139.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.814 2.046 . . . . 0.0 110.098 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.0 137.09 54.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.058 1.343 . . . . 0.0 113.173 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -102.24 119.5 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.092 1.357 . . . . 0.0 110.241 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.26 -44.16 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.28 1.432 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -126.83 134.85 26.52 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.889 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -74.02 -21.0 18.74 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.561 1.507 . . . . 0.0 114.932 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.75 -117.6 12.12 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 104' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.69 -27.12 68.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.72 1.208 . . . . 0.0 113.47 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.22 7.46 5.12 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 23.6 ttm105 -64.84 -39.81 94.17 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.138 -1.601 . . . . 0.0 113.935 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.09 -30.14 66.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.202 1.001 . . . . 0.0 111.741 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.67 -44.6 70.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.729 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.47 -39.96 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.033 0.933 . . . . 0.0 110.988 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -64.18 -44.03 93.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.667 0.667 . . . . 0.0 112.152 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.79 -42.78 94.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.448 -0.783 . . . . 0.0 112.425 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.22 -48.38 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 110.652 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.79 96.51 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.671 0.669 . . . . 0.0 112.082 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' MET . . . . . . . . . . . . . 19.8 mmt -60.13 -46.68 88.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.186 0.594 . . . . 0.0 112.29 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.01 -35.88 59.38 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.69 -38.59 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.25 -32.87 71.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -91.59 -10.08 41.84 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -77.18 -46.98 21.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.669 1.188 . . . . 0.0 111.145 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp -78.21 6.02 9.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.654 1.582 . . . . 0.0 115.227 -171.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' LYS . . . . . . . . . . . . . 76.0 tttt . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.55 1.54 . . . . 0.0 114.935 -152.386 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -60.45 149.07 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.592 0.633 . . . . 0.0 112.085 164.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -138.96 132.83 30.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.959 1.304 . . . . 0.0 110.053 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.14 132.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.869 1.268 . . . . 0.0 108.312 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -138.05 156.59 47.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.642 1.177 . . . . 0.0 110.407 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.66 145.7 36.51 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.552 -1.342 . . . . 0.0 110.4 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.93 173.7 9.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 110.861 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -74.46 17.05 0.21 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -136.51 132.52 18.78 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.316 1.846 . . . . 0.0 110.097 -176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.17 132.02 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.391 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -12.16 34.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.671 1.129 . . . . 0.0 115.786 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.8 138.08 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.217 1.508 . . . . 0.0 110.65 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -120.06 166.93 12.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.753 1.221 . . . . 0.0 112.166 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.59 145.42 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.365 1.866 . . . . 0.0 108.618 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.21 143.36 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.211 0.605 . . . . 0.0 110.336 164.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.99 151.34 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.072 1.349 . . . . 0.0 108.526 163.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.74 -154.52 0.55 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -163.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -70.09 -17.64 63.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.995 2.118 . . . . 0.0 115.037 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.36 -22.68 18.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.726 1.603 . . . . 0.0 112.426 159.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.93 77.43 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.104 1.335 . . . . 0.0 115.387 170.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -69.38 151.17 46.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.312 1.556 . . . . 0.0 111.904 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -69.64 134.53 48.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.813 0.845 . . . . 0.0 111.496 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -123.74 141.88 51.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.312 1.445 . . . . 0.0 109.919 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 pt -77.34 140.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.784 0.833 . . . . 0.0 112.004 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.64 166.42 28.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.846 0.858 . . . . 0.0 113.19 -172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' THR . . . . . . . . . . . . . 44.6 p -137.72 148.48 45.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.349 1.459 . . . . 0.0 111.78 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -82.4 116.16 21.75 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.895 0.878 . . . . 0.0 109.634 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 28' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.06 123.87 19.67 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.886 0.851 . . . . 0.0 112.758 -165.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.9 -33.16 73.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.204 1.402 . . . . 0.0 111.642 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.92 85.38 40.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.077 1.751 . . . . 0.0 110.324 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.13 135.31 69.8 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.608 2.872 . . . . 0.0 114.106 -174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -33.39 6.54 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.887 1.708 . . . . 0.0 114.848 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 144.39 33.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.118 1.459 . . . . 0.0 113.807 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 34' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' E' ' 47' ' ' GLU . 0.4 OUTLIER -103.89 161.6 13.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.975 1.71 . . . . 0.0 110.082 174.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.23 -50.93 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.815 1.246 . . . . 0.0 111.447 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -128.51 6.24 5.7 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.73 30.33 18.55 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.892 -1.13 . . . . 0.0 113.451 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -53.3 158.14 1.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.533 1.933 . . . . 0.0 115.75 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -76.61 137.5 39.53 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 162.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' VAL . . . . . . . . . . . . . 84.3 t -137.02 155.05 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.86 1.264 . . . . 0.0 110.927 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 58.2 mt -136.4 119.5 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.262 1.825 . . . . 0.0 108.717 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -78.58 142.11 37.55 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.418 -0.801 . . . . 0.0 109.43 162.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 43' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -139.77 179.18 6.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.237 1.015 . . . . 0.0 112.042 -169.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -57.34 90.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.504 1.922 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.07 9.39 85.42 Favored Glycine 0 CA--C 1.545 1.95 0 C-N-CA 125.397 1.475 . . . . 0.0 115.427 -177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -142.73 171.5 13.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.511 1.656 . . . . 0.0 113.081 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' E' ' 34' ' ' ARG . 27.3 tt0 -139.45 138.24 36.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.132 1.373 . . . . 0.0 110.1 168.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 48' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -124.68 137.27 54.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.422 1.489 . . . . 0.0 111.166 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -125.04 142.53 51.43 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.362 1.465 . . . . 0.0 111.553 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.66 145.47 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.078 1.351 . . . . 0.0 110.157 -172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -105.05 114.44 28.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.431 1.093 . . . . 0.0 108.544 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -76.36 122.29 86.46 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.171 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.36 -27.1 47.77 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.563 2.175 . . . . 0.0 113.647 -169.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -71.2 -1.96 14.34 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -100.14 -23.06 14.95 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.46 1.104 . . . . 0.0 113.481 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.56 129.39 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.977 0.911 . . . . 0.0 111.051 174.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -50.29 -34.81 24.75 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.308 1.843 . . . . 0.0 114.434 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.67 -32.56 74.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.813 0.733 . . . . 0.0 111.922 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.71 -48.61 65.72 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 118.298 0.499 . . . . 0.0 111.97 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.902 -0.763 . . . . 0.0 112.997 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.68 94.34 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 112.923 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' ILE . . . . . . . . . . . . . 90.5 mt -68.2 -34.98 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.299 1.039 . . . . 0.0 111.106 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.47 -41.17 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.057 0.943 . . . . 0.0 111.702 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -65.32 -48.23 73.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.0 0.92 . . . . 0.0 111.645 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.03 11.62 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.62 118.86 3.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.183 1.992 . . . . 0.0 111.027 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -106.9 -37.32 6.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.434 1.093 . . . . 0.0 112.775 -167.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -86.91 57.48 4.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.575 1.15 . . . . 0.0 112.878 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -84.08 120.2 74.41 Favored Pre-proline 0 CA--C 1.55 0.962 0 O-C-N 121.237 -0.915 . . . . 0.0 112.045 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 70' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -97.55 -17.55 0.23 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 115.194 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 71' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.3 114.17 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.478 1.036 . . . . 0.0 109.1 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -143.22 158.35 58.39 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.292 1.437 . . . . 0.0 111.078 -166.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -46.1 125.25 8.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.496 3.464 . . . . 0.0 114.817 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.47 87.07 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.11 1.604 . . . . 0.0 117.11 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -75.98 163.85 26.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.344 2.072 . . . . 0.0 113.071 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -105.54 132.74 51.32 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.558 1.143 . . . . 0.0 111.789 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.79 145.09 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.474 1.11 . . . . 0.0 111.927 -173.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 78' ' ' LEU . . . . . . . . . . . . . 10.6 tt -119.5 129.95 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.773 1.229 . . . . 0.0 109.167 169.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.4 136.14 53.83 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.701 1.601 . . . . 0.0 109.062 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 80' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.19 131.79 55.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.491 1.116 . . . . 0.0 109.968 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.1 59.34 1.11 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 124.873 1.225 . . . . 0.0 112.523 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 tt -103.99 -28.45 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 127.292 2.237 . . . . 0.0 112.936 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 83' ' ' ALA . . . . . . . . . . . . . . . 40.2 -124.11 0.43 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.908 1.283 . . . . 0.0 112.568 -167.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -79.72 -3.94 49.68 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.65 33.49 10.06 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 119.214 2.446 . . . . 0.0 119.214 159.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -46.78 88.93 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.732 2.266 . . . . 0.0 111.946 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -48.36 -52.82 19.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.253 1.821 . . . . 0.0 112.126 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.01 -32.16 72.61 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.113 1.365 . . . . 0.0 112.618 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 89' ' ' SER . . . . . . . . . . . . . 14.3 p -61.92 -39.49 92.21 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 90' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.69 -36.26 37.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.584 -0.697 . . . . 0.0 112.249 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 91' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.99 -28.38 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 120.189 1.358 . . . . 0.0 112.791 170.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 92' ' ' SER . . . . . . . . . . . . . 12.8 t -58.83 -41.98 88.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.5 1.12 . . . . 0.0 112.007 168.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.06 -45.11 82.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.661 0.785 . . . . 0.0 112.859 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.68 -38.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.352 1.461 . . . . 0.0 112.118 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 74.0 t -81.74 -36.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.946 0.898 . . . . 0.0 111.719 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.47 -170.46 45.5 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.673 1.13 . . . . 0.0 114.738 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 97' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -67.75 -18.04 64.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.01 -23.31 55.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.975 1.31 . . . . 0.0 113.851 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.74 -165.73 27.17 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.303 0.954 . . . . 0.0 114.117 -172.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -146.73 126.42 13.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.274 1.429 . . . . 0.0 109.777 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mt -125.71 123.7 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.099 0.96 . . . . 0.0 110.077 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 102' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.7 138.39 40.41 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.201 1.0 . . . . 0.0 109.891 164.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.46 115.72 2.22 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.886 1.232 . . . . 0.0 111.356 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.46 133.54 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.554 1.542 . . . . 0.0 109.276 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -132.83 144.28 50.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.072 0.949 . . . . 0.0 112.689 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 106' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -98.98 -33.58 10.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.483 1.513 . . . . 0.0 112.877 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 107' ' ' SER . . . . . . . . . . . . . 45.5 t -71.53 114.76 30.93 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 119.469 1.031 . . . . 0.0 110.553 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 108' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.6 -38.92 2.18 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.518 1.479 . . . . 0.0 113.899 -159.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -82.98 -31.05 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.95 -25.82 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.273 0.942 . . . . 0.0 112.835 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.86 -27.58 66.81 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.217 -0.927 . . . . 0.0 112.956 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 112' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -54.67 -36.96 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.759 1.224 . . . . 0.0 112.494 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 113' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -69.63 -22.81 63.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.038 . . . . 0.0 112.82 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 tp -77.16 -21.15 54.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.002 1.721 . . . . 0.0 112.945 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.05 -43.87 99.44 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.338 1.455 . . . . 0.0 114.6 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -29.38 5.2 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 122.509 1.932 . . . . 0.0 113.158 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 117' ' ' ILE . . . . . . . . . . . . . 58.5 mt -66.21 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.65 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -73.61 -7.13 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -71.42 -22.65 61.82 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.704 1.593 . . . . 0.0 112.197 167.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 120' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -92.88 -47.92 6.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.775 0.716 . . . . 0.0 111.947 164.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 121' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -83.02 57.29 3.84 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.866 1.266 . . . . 0.0 112.662 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 122' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 -69.55 10.16 0.39 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 123' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.96 -6.09 51.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 165.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.99 139.79 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.814 2.045 . . . . 0.0 110.284 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 125' ' ' ILE . . . . . . . . . . . . . 59.3 mt -119.66 115.92 33.49 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.084 1.353 . . . . 0.0 109.262 165.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 126' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -85.04 135.11 5.38 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.872 3.048 . . . . 0.0 111.351 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 127' ' ' ILE . . . . . . . . . . . . . 59.1 mt -134.98 124.93 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.13 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.77 121.71 33.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.86 0.864 . . . . 0.0 110.927 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.72 21.91 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.665 1.126 . . . . 0.0 114.471 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 130' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.23 115.58 5.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.306 1.05 . . . . 0.0 111.972 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.12 -23.66 48.63 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.119 1.368 . . . . 0.0 113.623 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 132' ' ' THR . . . . . . . . . . . . . 1.1 m -78.43 -12.1 59.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.036 1.735 . . . . 0.0 113.277 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 133' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -128.76 77.63 77.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.944 1.698 . . . . 0.0 110.789 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 134' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.16 -31.81 47.11 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.034 3.156 . . . . 0.0 115.013 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -60.13 -23.12 63.63 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.869 1.268 . . . . 0.0 112.552 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -74.66 -6.9 51.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.28 1.832 . . . . 0.0 114.685 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.66 7.11 3.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.841 1.656 . . . . 0.0 113.816 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 138' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -45.7 -26.3 0.61 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 118.253 2.686 . . . . 0.0 118.253 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.541 ' H ' HD21 ' C' ' 36' ' ' LEU . . . -86.47 -19.07 30.11 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.926 1.29 . . . . 0.0 114.224 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 73.7 mt -116.44 17.36 15.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.3 1.44 . . . . 0.0 113.439 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 141' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.91 164.06 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.541 1.536 . . . . 0.0 111.47 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 142' ' ' THR . . . . . . . . . . . . . 72.0 p -135.01 176.34 8.75 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.332 1.453 . . . . 0.0 111.686 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 143' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.31 141.92 58.58 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.35 -0.844 . . . . 0.0 111.181 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -129.08 160.01 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.282 1.433 . . . . 0.0 113.162 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.46 -30.64 42.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.514 1.526 . . . . 0.0 113.042 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.89 142.81 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.44 1.496 . . . . 0.0 110.352 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 147' ' ' ILE . . . . . . . . . . . . . 83.2 mt -117.41 142.32 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.102 0.961 . . . . 0.0 110.217 161.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -128.56 136.34 50.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.055 1.342 . . . . 0.0 110.477 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -126.36 120.75 30.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.998 1.319 . . . . 0.0 110.532 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -149.19 31.13 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.549 1.54 . . . . 0.0 112.411 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 t -70.15 -45.14 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 123.438 1.59 . . . . 0.0 106.95 157.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . 0.256 . . 50.78 48.5 22.73 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.934 2.094 . . . . 0.0 112.166 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 153' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -67.92 166.82 20.31 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.819 2.048 . . . . 0.0 110.528 166.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 154' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.4 -28.36 53.44 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.653 2.235 . . . . 0.0 113.356 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 155' ' ' THR . . . . . . . . . . . . . 68.8 p -80.48 2.3 25.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.366 1.866 . . . . 0.0 114.523 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 156' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -60.37 -27.62 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -161.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.21 85.64 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.865 -1.147 . . . . 0.0 112.025 172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 158' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -72.19 -38.06 69.14 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.751 -1.119 . . . . 0.0 111.728 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 159' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.53 -55.53 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.008 0.822 . . . . 0.0 110.202 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 160' ' ' LEU . . . . . . . . . . . . . 26.7 tp -63.26 -49.24 74.9 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.985 -0.447 . . . . 0.0 112.176 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 161' ' ' ILE . . . . . . . . . . . . . 51.4 mt -64.7 -47.92 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.478 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -37.17 62.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.739 1.154 . . . . 0.0 112.333 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 163' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -61.38 -34.09 74.76 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.048 -1.032 . . . . 0.0 111.571 167.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 164' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.42 58.07 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.568 -1.333 . . . . 0.0 114.553 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -71.64 -50.48 30.3 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.136 1.334 . . . . 0.0 110.025 162.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.25 25.28 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -112.88 -24.97 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -160.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.53 126.9 31.8 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.155 1.343 . . . . 0.0 111.795 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 169' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.87 161.21 26.82 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -60.33 136.06 57.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 171' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.6 62.6 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.074 -1.403 . . . . 0.0 116.045 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -76.84 166.35 54.01 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.622 1.582 . . . . 0.0 115.026 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 173' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -107.79 156.94 18.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.985 1.314 . . . . 0.0 113.9 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.69 150.11 20.02 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.694 1.14 . . . . 0.0 112.114 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mtm -136.32 139.17 42.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.516 1.526 . . . . 0.0 109.935 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 176' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.45 131.77 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.263 0.625 . . . . 0.0 112.572 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 177' ' ' ALA . . . . . . . . . . . . . . . -92.82 89.89 6.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.86 1.264 . . . . 0.0 110.991 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 178' ' ' VAL . . . . . . . . . . . . . 23.2 t -72.51 102.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.374 1.469 . . . . 0.0 111.888 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 179' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -84.54 75.3 10.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.902 2.081 . . . . 0.0 109.424 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -41.94 -48.83 4.57 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.827 1.251 . . . . 0.0 113.898 -169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -18.96 64.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 182' ' ' SER . . . . . . . . . . . . . 50.2 m -99.16 -11.82 21.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.954 1.252 . . . . 0.0 113.363 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -88.87 -46.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.134 0.879 . . . . 0.0 110.474 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -157.07 114.1 3.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.431 0.692 . . . . 0.0 110.544 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 185' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.65 -1.08 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -6.21 57.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.323 1.449 . . . . 0.0 113.391 -171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 187' ' ' LYS . . . . . 0.439 ' HE2' HG22 ' E' ' 192' ' ' VAL . 18.6 pttt -143.37 158.32 43.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.293 1.437 . . . . 0.0 113.63 -173.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -55.39 134.43 70.03 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.872 1.269 . . . . 0.0 110.469 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 189' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.9 -33.88 53.48 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.523 2.815 . . . . 0.0 115.807 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 190' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.47 -25.95 66.41 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.684 -1.26 . . . . 0.0 113.806 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 191' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -73.19 -38.44 66.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.664 1.12 . . . . 0.0 111.744 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 192' ' ' VAL . . . . . 0.439 HG22 ' HE2' ' E' ' 187' ' ' LYS . 12.6 t -65.12 -49.33 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.279 1.031 . . . . 0.0 109.871 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 193' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.19 -33.33 72.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.282 1.033 . . . . 0.0 112.575 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 194' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -72.57 -35.6 67.99 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.165 0.893 . . . . 0.0 113.278 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 195' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.2 -39.88 71.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.582 1.083 . . . . 0.0 112.571 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 196' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.1 -41.62 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.655 0.661 . . . . 0.0 110.415 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 197' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.15 -42.7 96.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.794 -1.192 . . . . 0.0 112.812 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.31 -22.73 47.73 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -78.85 -46.51 18.47 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.486 1.039 . . . . 0.0 110.912 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.67 -35.66 81.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.148 -0.97 . . . . 0.0 111.915 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 201' ' ' SER . . . . . . . . . . . . . 77.6 p -78.46 11.15 2.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 202' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.48 12.24 31.65 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.653 1.181 . . . . 0.0 113.15 162.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 203' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -143.78 -45.28 0.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 204' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -98.48 170.99 8.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.072 1.749 . . . . 0.0 111.689 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 205' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.52 134.65 41.18 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.43 -0.794 . . . . 0.0 109.76 153.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 206' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.51 131.04 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 207' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.41 -29.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -157.6 146.57 19.65 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.499 1.045 . . . . 0.0 113.041 174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 209' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -134.5 132.07 38.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.593 1.957 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 210' ' ' LEU . . . . . . . . . . . . . 65.6 tp -137.94 123.31 19.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.245 1.418 . . . . 0.0 111.636 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 211' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -79.77 139.33 37.31 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 161.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 212' ' ' LEU . . . . . . . . . . . . . 73.0 mt -79.41 -3.48 46.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.88 148.04 92.75 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 121.057 -1.027 . . . . 0.0 111.892 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 214' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.68 27.64 17.35 Favored 'Cis proline' 0 CA--C 1.546 1.12 0 CA-C-N 119.928 1.01 . . . . 0.0 114.191 2.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 215' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -92.15 -52.42 4.71 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.472 -0.767 . . . . 0.0 109.824 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 216' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -129.68 -173.5 3.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.966 1.306 . . . . 0.0 111.235 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 217' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.7 145.98 50.39 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.861 -1.149 . . . . 0.0 113.566 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 218' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 55.6 0.75 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 128.445 2.698 . . . . 0.0 117.669 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 219' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.26 143.04 32.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.157 1.783 . . . . 0.0 109.886 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.5 156.63 42.96 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.353 -0.842 . . . . 0.0 112.847 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.69 126.9 55.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.078 1.351 . . . . 0.0 109.601 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 222' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -112.78 140.37 47.62 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.769 1.228 . . . . 0.0 109.388 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.28 137.97 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 122.214 1.006 . . . . 0.0 111.322 171.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 17.1 m -142.19 167.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 111.896 -162.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -136.58 135.66 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.597 1.159 . . . . 0.0 111.75 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 226' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.03 133.61 54.16 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.852 1.661 . . . . 0.0 108.451 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 227' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 122.838 2.359 . . . . 0.0 113.896 178.412 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 2' ' ' ILE . . . . . . . . . . . . . 71.1 mt -119.27 146.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.584 1.084 . . . . 0.0 110.795 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 3' ' ' SER . . . . . . . . . . . . . 9.0 t -151.8 166.21 32.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.941 1.697 . . . . 0.0 110.151 165.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -137.92 157.45 46.37 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 112.504 -167.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -139.91 -178.64 5.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 112.06 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' VAL . . . . . . . . . . . . . 69.9 t -54.76 -18.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.095 1.758 . . . . 0.0 115.511 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -108.01 -16.72 14.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.102 1.361 . . . . 0.0 114.095 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.97 38.16 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.29 131.6 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.095 2.158 . . . . 0.0 108.744 -166.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -135.99 139.55 43.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 112.352 -166.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.07 134.87 55.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.187 0.995 . . . . 0.0 112.149 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -134.9 148.36 50.06 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 113.834 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.65 13.36 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.567 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.22 6.93 5.76 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.34 0.16 14.72 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.884 1.674 . . . . 0.0 112.377 165.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.74 63.52 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.115 1.816 . . . . 0.0 115.47 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -71.01 139.84 50.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.996 1.398 . . . . 0.0 110.709 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 18' ' ' LEU . . . . . . . . . . . . . 19.7 tp -68.46 149.16 49.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.479 0.582 . . . . 0.0 111.055 170.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.72 -55.27 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 109.706 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.86 158.66 38.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.3 1.44 . . . . 0.0 110.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -139.85 143.1 36.6 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.784 2.033 . . . . 0.0 111.266 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -131.4 154.69 48.37 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.736 1.615 . . . . 0.0 110.789 171.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 23' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.49 150.23 38.24 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.164 1.386 . . . . 0.0 112.143 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -73.58 144.89 45.84 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 25' ' ' THR . . . . . . . . . . . . . 69.5 p -127.59 0.69 6.19 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -113.72 170.05 8.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.545 1.938 . . . . 0.0 109.261 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -56.19 112.44 4.38 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.394 1.478 . . . . 0.0 109.546 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.51 -19.7 14.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.83 2.353 . . . . 0.0 114.362 -154.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 29' ' ' GLU . . . . . . . . . . . . . 10.7 pm0 -57.03 -36.44 70.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.636 1.107 . . . . 0.0 112.509 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -65.78 -49.22 69.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.419 1.088 . . . . 0.0 111.539 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.98 -38.84 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.346 1.459 . . . . 0.0 110.208 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 mt -64.39 -49.31 72.09 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.793 1.237 . . . . 0.0 112.015 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 33' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.66 -35.8 80.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.939 1.7 . . . . 0.0 112.972 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -57.24 -58.27 8.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.72 0.808 . . . . 0.0 111.189 168.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.03 -33.5 75.89 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -66.94 -34.36 77.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.028 1.331 . . . . 0.0 111.787 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -94.53 12.67 26.59 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.777 1.631 . . . . 0.0 113.846 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.35 85.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -89.87 143.14 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.583 1.191 . . . . 0.0 111.496 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 tt -91.88 136.24 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.872 0.844 . . . . 0.0 112.333 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -114.8 160.31 19.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.932 1.693 . . . . 0.0 110.411 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 42' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -63.38 -36.17 82.82 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.133 -0.979 . . . . 0.0 113.357 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 43' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.42 -28.62 68.76 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.89 -39.5 50.73 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.121 -0.987 . . . . 0.0 111.503 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.64 -38.33 84.44 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.646 1.179 . . . . 0.0 111.909 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -74.67 -36.76 62.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 47' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.88 -46.74 83.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.831 0.852 . . . . 0.0 111.713 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.06 -29.76 67.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.618 -0.676 . . . . 0.0 112.43 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 49' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -65.14 -46.68 79.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.042 -0.504 . . . . 0.0 111.302 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 5.3 t -60.39 -37.94 82.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.392 0.677 . . . . 0.0 111.87 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.35 -42.53 87.94 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.121 -0.987 . . . . 0.0 113.096 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 52' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.076 1.307 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.62 -34.6 78.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.343 1.457 . . . . 0.0 112.222 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -86.04 -0.94 56.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.376 1.87 . . . . 0.0 114.063 171.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.39 34.83 11.41 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 117.265 1.666 . . . . 0.0 117.265 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 56' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.11 141.33 36.85 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.425 1.612 . . . . 0.0 112.699 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -135.89 -15.56 1.77 Allowed 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 -171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -81.54 50.21 1.44 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 119.411 -2.055 . . . . 0.0 115.331 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 59' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -63.71 87.3 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 p -101.41 127.59 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.566 1.146 . . . . 0.0 112.185 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 61' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.12 170.16 8.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.866 2.067 . . . . 0.0 112.107 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 62' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.58 -42.06 15.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 63' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.06 134.93 20.08 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-N 119.395 0.998 . . . . 0.0 112.017 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 64' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.75 -42.89 62.8 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.093 2.529 . . . . 0.0 114.368 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.81 -18.84 60.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.581 -0.699 . . . . 0.0 112.598 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 66' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.94 -41.64 67.58 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.518 -0.739 . . . . 0.0 110.757 171.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -60.1 -33.58 72.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.157 0.583 . . . . 0.0 111.353 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 68' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' F' ' 72' ' ' GLU . 0.4 OUTLIER -68.77 -47.35 66.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.901 1.68 . . . . 0.0 112.158 177.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -64.46 -34.98 79.47 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.975 0.807 . . . . 0.0 112.02 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.75 93.33 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.308 0.958 . . . . 0.0 113.082 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.91 -21.75 59.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 72' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' F' ' 68' ' ' ARG . 23.9 tt0 -70.7 -34.99 72.54 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.804 0.841 . . . . 0.0 113.01 165.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 73' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.72 0.13 13.89 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.761 1.224 . . . . 0.0 112.684 168.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.78 -17.61 52.36 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.874 2.178 . . . . 0.0 115.221 173.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.18 130.92 35.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.98 1.39 . . . . 0.0 112.052 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p -71.26 88.6 0.85 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.05 -1.031 . . . . 0.0 112.634 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.75 42.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 78' ' ' THR . . . . . . . . . . . . . 45.0 p -126.14 176.99 6.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.316 1.846 . . . . 0.0 111.913 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -130.86 131.21 44.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 0.0 112.331 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -155.95 123.59 5.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.911 1.684 . . . . 0.0 109.307 163.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 81' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.07 -49.66 9.79 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.167 -0.958 . . . . 0.0 113.324 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 82' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.38 22.92 0.32 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 123.226 2.617 . . . . 0.0 115.763 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -69.8 162.16 28.42 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.333 1.053 . . . . 0.0 113.832 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 84' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.05 -28.35 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.098 0.959 . . . . 0.0 113.182 -168.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.48 72.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.21 0.914 . . . . 0.0 112.397 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.01 -34.99 90.04 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 112.014 -0.435 . . . . 0.0 112.014 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -65.65 -48.28 72.7 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.778 . . . . 0.0 112.541 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 88' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -59.88 -51.58 69.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.787 0.835 . . . . 0.0 111.164 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.29 -53.32 59.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.81 1.644 . . . . 0.0 111.614 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 90' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 -75.48 -17.12 60.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -86.45 -28.17 23.65 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 92' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -125.46 62.97 42.58 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.244 0.929 . . . . 0.0 111.576 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 93' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.68 -31.14 86.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.947 2.432 . . . . 0.0 113.51 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.49 -26.12 67.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.71 1.204 . . . . 0.0 113.451 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.06 -27.07 64.34 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 119.817 1.189 . . . . 0.0 113.201 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 96' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -119.45 -19.18 8.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -163.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 97' ' ' LEU . . . . . . . . . . . . . 13.3 tp -134.67 -2.48 2.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.171 1.389 . . . . 0.0 114.178 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 -169.72 46.12 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.407 1.004 . . . . 0.0 114.591 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.48 -48.38 70.05 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 121.741 -0.858 . . . . 0.0 112.159 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.51 35.96 0.52 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.95 1.3 . . . . 0.0 113.1 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 101' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -54.45 -41.11 69.07 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -69.22 -27.75 65.75 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 103' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.69 -34.21 69.46 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.945 -1.097 . . . . 0.0 112.113 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.3 -43.06 64.76 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.673 -0.642 . . . . 0.0 111.027 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -55.8 -43.8 77.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.304 169.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.63 -50.75 70.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.637 0.775 . . . . 0.0 112.092 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 107' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -54.62 -42.89 71.72 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.796 1.238 . . . . 0.0 112.348 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 108' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.82 -31.68 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.373 0.669 . . . . 0.0 112.132 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.88 -44.2 96.18 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 119.182 0.901 . . . . 0.0 112.935 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.92 -32.42 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.304 1.052 . . . . 0.0 112.76 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.12 -43.97 69.88 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.477 -0.764 . . . . 0.0 111.72 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.55 -43.83 97.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.657 1.183 . . . . 0.0 111.353 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -59.58 -34.7 73.04 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.939 0.896 . . . . 0.0 112.647 171.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -73.11 -33.54 65.63 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.196 0.907 . . . . 0.0 113.275 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 115' ' ' MET . . . . . . . . . . . . . 22.9 ptm -78.9 -24.32 44.2 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.873 1.215 . . . . 0.0 113.659 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -76.03 10.41 1.92 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 117' ' ' ILE . . . . . . . . . . . . . 90.1 mt -67.68 95.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.81 1.186 . . . . 0.0 109.55 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -75.06 152.0 38.65 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -156.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -127.68 172.98 10.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.176 1.791 . . . . 0.0 110.135 152.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.89 129.39 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.58 1.552 . . . . 0.0 114.162 -149.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 121' ' ' SER . . . . . . . . . . . . . 60.1 p -145.1 147.98 33.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.037 0.935 . . . . 0.0 113.386 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.75 -1.85 68.22 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.767 1.467 . . . . 0.0 116.767 -169.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.47 6.8 8.95 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.956 1.378 . . . . 0.0 114.109 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -68.04 -22.8 64.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.218 -0.926 . . . . 0.0 113.24 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 -39.9 86.63 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.419 1.008 . . . . 0.0 112.48 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 126' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -63.9 -33.59 76.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.686 0.795 . . . . 0.0 111.065 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 127' ' ' MET . . . . . . . . . . . . . 27.3 mtt -73.72 -38.38 64.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.73 1.212 . . . . 0.0 111.946 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.21 -48.14 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 110.449 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 129' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.61 -43.93 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.433 0.56 . . . . 0.0 111.143 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.66 -36.93 81.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.596 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.68 78.79 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.661 1.119 . . . . 0.0 112.739 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.97 -50.76 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.621 1.169 . . . . 0.0 111.366 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 133' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -69.12 -26.77 65.07 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.514 1.052 . . . . 0.0 111.645 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.0 75.61 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.655 -1.278 . . . . 0.0 112.677 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -44.24 90.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.167 0.894 . . . . 0.0 109.587 171.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 136' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.47 -43.29 88.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.961 1.304 . . . . 0.0 112.341 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 137' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.99 -46.3 68.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.175 1.39 . . . . 0.0 112.504 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 138' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.92 -39.84 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.331 -1.48 . . . . 0.0 111.764 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.24 -32.8 70.31 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.771 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -74.66 -40.83 61.2 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 117.462 -1.256 . . . . 0.0 113.597 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 141' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.61 -37.18 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 121.038 1.745 . . . . 0.0 111.133 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.13 -48.51 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.522 0.729 . . . . 0.0 109.973 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 143' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -58.03 -39.79 79.24 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.616 1.098 . . . . 0.0 112.865 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.82 -47.66 71.33 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.035 -1.041 . . . . 0.0 112.492 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 145' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.73 -34.85 72.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.363 0.665 . . . . 0.0 111.977 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 146' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.63 -35.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.44 -0.787 . . . . 0.0 111.435 171.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.8 -40.6 92.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.021 1.282 . . . . 0.0 112.255 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -46.06 91.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.754 0.822 . . . . 0.0 111.092 171.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.4 -41.19 88.87 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.798 1.239 . . . . 0.0 112.309 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 150' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -64.71 -48.54 74.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.279 1.032 . . . . 0.0 111.907 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 151' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.44 -35.02 79.65 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.297 0.499 . . . . 0.0 112.025 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 152' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -74.74 -46.49 37.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 153' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -68.82 -20.51 64.31 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.623 -1.298 . . . . 0.0 112.625 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 70.2 m -65.02 -9.56 22.83 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 155' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.92 -8.71 59.11 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.097 0.959 . . . . 0.0 113.185 167.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 156' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -121.6 -30.34 4.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.47 1.508 . . . . 0.0 113.104 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.09 70.54 6.34 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 125.416 1.486 . . . . 0.0 110.953 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 158' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.27 -25.92 81.36 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.862 3.041 . . . . 0.0 114.508 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -66.85 -20.18 65.88 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.001 -1.062 . . . . 0.0 113.014 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.67 -35.42 72.82 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.283 -0.886 . . . . 0.0 112.76 -171.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 161' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.61 -31.13 70.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.585 -0.697 . . . . 0.0 111.937 171.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 162' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -82.15 4.47 23.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.177 1.391 . . . . 0.0 112.799 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 163' ' ' LEU . . . . . . . . . . . . . 37.8 tp -128.43 -31.34 2.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.188 1.395 . . . . 0.0 114.283 -172.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 164' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.31 87.2 39.82 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.672 1.189 . . . . 0.0 112.097 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 165' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -74.21 -16.04 22.56 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.145 2.564 . . . . 0.0 115.343 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 166' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -82.98 136.94 34.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.445 1.098 . . . . 0.0 111.06 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 167' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -83.13 -45.92 0.84 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 116.867 -1.54 . . . . 0.0 114.717 -168.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 168' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -59.79 -43.12 40.09 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.55 2.167 . . . . 0.0 113.631 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 169' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.6 -39.18 73.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.885 1.274 . . . . 0.0 112.717 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 170' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.06 -22.29 64.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.86 0.864 . . . . 0.0 113.007 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 171' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.07 -41.48 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.28 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.117 0.967 . . . . 0.0 112.602 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 173' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -56.46 -43.09 79.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.59 -34.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.722 0.809 . . . . 0.0 111.983 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -59.94 -41.24 91.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.544 1.137 . . . . 0.0 111.641 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 176' ' ' THR . . . . . . . . . . . . . 6.6 m -87.48 -50.05 6.8 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 177' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.28 -59.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.967 0.907 . . . . 0.0 111.65 -172.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 178' ' ' GLY . . . . . . . . . . . . . . . 68.28 -34.67 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.81 1.671 . . . . 0.0 116.802 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 179' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -80.91 114.68 19.95 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.824 1.812 . . . . 0.0 111.16 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -52.72 -33.24 46.96 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 181' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.42 -5.17 59.23 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 182' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -98.56 12.85 33.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 112.706 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 183' ' ' ILE . . . . . . . . . . . . . 73.6 mt -84.07 141.72 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.076 1.35 . . . . 0.0 110.943 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 184' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -150.95 165.4 33.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.546 2.738 . . . . 0.0 109.339 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 185' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -51.96 -44.18 63.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.832 1.196 . . . . 0.0 113.408 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 186' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -60.36 -42.9 96.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.693 1.197 . . . . 0.0 112.13 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 187' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.81 -7.99 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 188' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.25 -26.83 17.98 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.94 -1.1 . . . . 0.0 112.564 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 189' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -66.49 -50.76 62.19 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.618 1.167 . . . . 0.0 110.752 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.16 -31.94 73.38 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.291 -0.881 . . . . 0.0 113.272 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 191' ' ' LEU . . . . . . . . . . . . . 40.1 tp -64.78 -6.95 9.17 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.547 1.539 . . . . 0.0 113.283 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.66 33.58 27.31 Favored Glycine 0 CA--C 1.527 0.829 0 O-C-N 120.905 -1.122 . . . . 0.0 113.307 172.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.96 178.64 6.77 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 122.194 0.997 . . . . 0.0 110.583 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 194' ' ' SER . . . . . . . . . . . . . 44.0 p -116.18 152.41 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.602 1.961 . . . . 0.0 109.129 168.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 195' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.51 -40.88 62.91 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.505 1.048 . . . . 0.0 113.455 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 196' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.4 -13.47 58.72 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 114.221 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 197' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -99.93 -29.2 12.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.959 2.104 . . . . 0.0 111.984 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 198' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.72 -28.0 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.873 1.269 . . . . 0.0 113.035 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 199' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.96 -32.92 74.49 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.042 0.837 . . . . 0.0 112.444 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 200' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.38 164.51 26.32 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.379 -1.451 . . . . 0.0 108.707 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 201' ' ' ILE . . . . . . . . . . . . . 15.4 mt 67.66 -62.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 120.919 -1.113 . . . . 0.0 110.717 -151.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 202' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.63 -39.67 94.94 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.715 1.143 . . . . 0.0 113.281 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 203' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -54.65 -25.53 27.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.532 1.533 . . . . 0.0 113.099 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 204' ' ' ALA . . . . . . . . . . . . . . . -109.9 9.91 24.45 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.179 1.791 . . . . 0.0 113.481 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -47.57 -49.68 25.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.819 1.648 . . . . 0.0 114.484 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 206' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.56 -35.6 12.18 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.957 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 207' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -100.82 20.94 14.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -162.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 208' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.67 142.14 35.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.433 0.693 . . . . 0.0 110.584 162.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 209' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -78.13 8.22 5.15 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 210' ' ' GLY . . . . . . . . . . . . . . . -85.03 163.39 37.89 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.196 0.903 . . . . 0.0 114.668 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.33 -131.39 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.699 1.599 . . . . 0.0 113.73 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 212' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -137.54 108.24 6.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.108 1.363 . . . . 0.0 110.435 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 213' ' ' MET . . . . . . . . . . . . . 60.5 ttm -77.12 124.53 27.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.738 1.215 . . . . 0.0 108.969 162.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 214' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -65.09 156.98 29.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.941 0.896 . . . . 0.0 112.526 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 215' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -56.51 -21.67 27.63 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.653 1.181 . . . . 0.0 112.114 166.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 216' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.75 -14.07 25.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.448 1.499 . . . . 0.0 114.391 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 217' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.35 -42.05 14.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.534 1.061 . . . . 0.0 110.487 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 218' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.33 -23.38 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.61 -0.681 . . . . 0.0 111.717 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 219' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.37 -46.64 87.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.79 -33.73 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.468 1.031 . . . . 0.0 111.136 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 221' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.56 -36.52 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.93 0.892 . . . . 0.0 111.337 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 222' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -70.24 -46.08 65.17 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.707 1.203 . . . . 0.0 111.946 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 223' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -60.51 -33.01 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.629 1.104 . . . . 0.0 112.682 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 224' ' ' LEU . . . . . . . . . . . . . 9.9 tt -66.62 -46.48 75.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.712 0.805 . . . . 0.0 111.915 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.17 82.46 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 226' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -62.77 -37.32 86.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.11 1.364 . . . . 0.0 111.497 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 227' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.82 -33.36 75.45 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.394 -0.816 . . . . 0.0 112.248 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 228' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.21 -31.34 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.275 -0.891 . . . . 0.0 111.202 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 229' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.77 -43.71 98.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.029 1.74 . . . . 0.0 111.316 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 230' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -63.45 -33.34 75.34 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.55 -1.344 . . . . 0.0 111.779 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 231' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.51 -34.18 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 171.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 232' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -63.85 -36.02 82.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.588 1.54 . . . . 0.0 111.292 168.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 233' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -67.85 -39.83 83.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.645 172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 234' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.48 -44.86 95.49 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 121.104 1.775 . . . . 0.0 112.408 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 235' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -56.07 -42.19 76.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.37 0.668 . . . . 0.0 110.455 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 236' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -71.55 -36.44 70.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.557 0.743 . . . . 0.0 112.881 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 237' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -57.75 -41.35 81.75 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.549 1.14 . . . . 0.0 110.871 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 238' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.84 -41.36 64.9 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.351 1.06 . . . . 0.0 112.635 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.64 -21.44 63.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.668 1.587 . . . . 0.0 113.535 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 240' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.63 -40.76 33.39 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.327 1.451 . . . . 0.0 111.595 163.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 241' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -76.0 -28.39 57.78 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 242' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.5 -39.35 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.506 1.048 . . . . 0.0 111.941 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 243' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -38.38 51.99 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.791 -0.568 . . . . 0.0 111.214 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 244' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -59.36 -22.8 61.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.008 1.723 . . . . 0.0 114.33 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 245' ' ' ALA . . . . . . . . . . . . . . . -97.39 -11.29 24.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.056 1.342 . . . . 0.0 113.448 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 246' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.83 -31.19 15.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.51 1.124 . . . . 0.0 112.182 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 247' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.61 12.8 0.43 Allowed 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -167.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 248' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -70.12 -2.84 14.14 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 120.393 -1.442 . . . . 0.0 113.201 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 249' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.5 79.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 152.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.94 118.68 48.06 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -160.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 251' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.98 164.77 32.45 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.0 3.133 . . . . 0.0 113.045 166.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 252' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -64.23 -40.31 95.77 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.33 -0.856 . . . . 0.0 111.498 174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 253' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.91 -37.75 80.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 254' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -63.8 -60.28 3.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.659 0.784 . . . . 0.0 110.063 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 255' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.83 65.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -165.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 256' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.7 -27.59 66.95 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 257' ' ' VAL . . . . . . . . . . . . . 15.6 m -140.88 -46.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.0 150.23 5.18 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.68 1.127 . . . . 0.0 114.024 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 259' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.98 79.79 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 260' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.42 -27.96 68.92 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.849 -1.157 . . . . 0.0 112.529 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 261' ' ' LEU . . . . . . . . . . . . . 18.8 tp -75.12 -45.55 40.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.263 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 262' ' ' ALA . . . . . . . . . . . . . . . -59.36 -45.67 90.76 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.303 0.956 . . . . 0.0 112.573 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 263' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.44 84.17 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.579 0.752 . . . . 0.0 111.939 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 264' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -70.65 -35.36 72.84 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.133 -0.979 . . . . 0.0 113.527 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 265' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.92 -46.25 85.29 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.769 1.168 . . . . 0.0 111.249 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 266' ' ' ILE . . . . . . . . . . . . . 88.6 mt -71.32 -39.97 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 122.968 0.507 . . . . 0.0 110.951 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 267' ' ' SER . . . . . . . . . . . . . 22.7 t -58.05 -40.07 80.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.463 1.105 . . . . 0.0 113.026 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.42 -28.74 41.73 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.36 -33.46 61.06 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.388 0.995 . . . . 0.0 112.966 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.29 -4.73 77.53 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.743 1.639 . . . . 0.0 114.262 -172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.47 160.2 20.53 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.468 1.033 . . . . 0.0 112.86 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 272' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.09 -31.39 70.98 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.089 -0.654 . . . . 0.0 111.975 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 273' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -58.99 -48.83 80.18 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.0 0.92 . . . . 0.0 111.039 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 274' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -61.19 -46.45 90.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.335 1.054 . . . . 0.0 111.227 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -64.86 -38.29 90.49 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.697 -0.627 . . . . 0.0 112.397 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.49 -6.39 43.43 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.662 1.185 . . . . 0.0 113.715 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 277' ' ' MET . . . . . . . . . . . . . 53.1 mtt -103.95 -27.53 12.11 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 112.958 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 278' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.82 144.77 97.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 119.468 1.031 . . . . 0.0 112.773 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 279' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.61 165.1 16.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.202 3.268 . . . . 0.0 113.354 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 280' ' ' SER . . . . . . . . . . . . . 84.4 p -55.38 -45.79 76.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 111.691 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 281' ' ' SER . . . . . . . . . . . . . 4.9 m -74.67 22.09 0.1 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.505 1.522 . . . . 0.0 114.888 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 282' ' ' THR . . . . . . . . . . . . . 53.9 m -128.28 -42.79 1.49 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.846 1.659 . . . . 0.0 109.905 159.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 283' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.25 -28.51 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.062 0.945 . . . . 0.0 111.561 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 284' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.19 -39.18 43.25 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.0 112.567 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.63 6.19 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.699 1.6 . . . . 0.0 113.45 -170.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 286' ' ' LEU . . . . . . . . . . . . . 57.1 tp -57.26 124.21 18.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.947 0.899 . . . . 0.0 110.99 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 287' ' ' GLY . . . . . . . . . . . . . . . 95.66 -16.59 60.92 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.471 -1.183 . . . . 0.0 115.273 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 288' ' ' ALA . . . . . . . . . . . . . . . -75.18 36.58 0.12 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.968 1.884 . . . . 0.0 113.585 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 289' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -66.14 -37.48 85.79 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.002 -1.686 . . . . 0.0 112.988 -165.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 290' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -68.76 -10.47 56.74 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.659 -1.276 . . . . 0.0 113.562 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 291' ' ' ALA . . . . . . . . . . . . . . . -92.23 -41.87 10.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.73 1.15 . . . . 0.0 111.553 167.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 292' ' ' LEU . . . . . . . . . . . . . 59.9 tp -55.41 -45.86 76.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.606 0.762 . . . . 0.0 111.517 172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 293' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -52.64 -58.8 5.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.586 1.555 . . . . 0.0 112.542 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 294' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -66.05 -31.81 72.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 295' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -71.71 -45.52 61.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.331 0.652 . . . . 0.0 112.616 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 296' ' ' LEU . . . . . 0.405 HD12 " H1'" ' W' ' 1' ' ' ' U' . 2.4 tm? -58.94 -40.4 84.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.499 1.119 . . . . 0.0 111.308 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 297' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -70.76 -7.25 43.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.348 2.259 . . . . 0.0 114.879 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 298' ' ' THR . . . . . . . . . . . . . 77.4 p -140.95 -24.81 0.75 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 61.26 23.9 62.74 Favored Glycine 0 CA--C 1.54 1.626 0 O-C-N 120.637 -1.289 . . . . 0.0 113.893 -166.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.17 -135.41 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.079 1.352 . . . . 0.0 112.585 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 301' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.81 124.65 90.99 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 120.514 -1.366 . . . . 0.0 110.707 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 302' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.9 157.62 34.82 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.466 2.777 . . . . 0.0 113.727 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.03 136.85 58.76 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.407 2.738 . . . . 0.0 112.506 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 304' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -95.78 -45.74 6.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.907 0.883 . . . . 0.0 113.239 -166.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 305' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.13 142.12 20.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.413 2.285 . . . . 0.0 111.697 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 306' ' ' GLY . . . . . . . . . . . . . . . -92.9 -144.7 15.15 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.57 1.081 . . . . 0.0 112.385 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 307' ' ' VAL . . . . . . . . . . . . . 9.8 p -47.45 -25.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.095 2.158 . . . . 0.0 114.818 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 308' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.07 -9.84 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.574 1.55 . . . . 0.0 114.613 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 309' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -58.24 -44.09 88.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.501 1.046 . . . . 0.0 113.316 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 310' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -74.94 31.06 0.09 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.901 1.28 . . . . 0.0 114.374 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 311' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -119.1 139.81 27.94 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.685 1.994 . . . . 0.0 110.511 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -53.12 -33.07 62.19 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.345 2.697 . . . . 0.0 116.735 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.79 63.22 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.448 1.022 . . . . 0.0 113.62 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 314' ' ' ILE . . . . . . . . . . . . . 33.5 mt -111.97 -53.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.749 1.219 . . . . 0.0 111.124 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 315' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -76.02 -2.09 28.94 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.66 1.573 . . . . 0.0 115.24 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 316' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.55 58.19 1.71 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.471 1.508 . . . . 0.0 112.805 158.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 317' ' ' SER . . . . . . . . . . . . . 27.9 m -136.87 146.59 55.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 125.936 1.694 . . . . 0.0 109.983 159.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -52.11 143.57 40.95 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.459 2.772 . . . . 0.0 113.672 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 319' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -56.58 -32.91 65.68 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 320' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -50.91 -26.21 5.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.068 1.747 . . . . 0.0 114.659 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 321' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -119.12 0.22 11.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.255 1.422 . . . . 0.0 114.183 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 322' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -67.27 -12.25 59.62 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 323' ' ' GLY . . . . . . . . . . . . . . . -92.83 -48.8 2.84 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.399 1.0 . . . . 0.0 111.967 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 324' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -58.1 -36.66 73.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.636 1.574 . . . . 0.0 113.617 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 325' ' ' ILE . . . . . . . . . . . . . 95.5 mt -73.1 -36.45 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.07 -1.019 . . . . 0.0 110.997 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.03 82.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 327' ' ' ARG . . . . . . . . . . . . . 34.4 mtt85 -65.6 -53.79 36.87 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.38 0.991 . . . . 0.0 111.593 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.18 -34.21 70.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 329' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.49 -40.03 96.0 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.88 -1.137 . . . . 0.0 111.167 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.64 72.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 331' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.89 79.61 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 119.398 0.999 . . . . 0.0 113.613 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 332' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -70.23 -28.02 64.92 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.012 -1.287 . . . . 0.0 112.33 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 333' ' ' LEU . . . . . . . . . . . . . 70.7 mt -68.67 -38.52 80.44 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.027 0.83 . . . . 0.0 113.081 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 334' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.64 87.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.858 0.863 . . . . 0.0 111.733 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 335' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.32 -47.42 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.358 1.063 . . . . 0.0 110.357 170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 336' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.29 77.77 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.711 1.141 . . . . 0.0 113.043 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.13 84.28 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 338' ' ' ARG . . . . . 0.458 HH21 ' CD2' ' G' ' 63' ' ' HIS . 67.1 mtt85 -71.93 -37.23 70.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 111.97 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -61.37 -47.54 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.704 0.801 . . . . 0.0 110.374 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 340' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -68.0 -27.63 66.73 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 341' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.31 -38.14 14.4 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 342' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -108.62 -33.65 6.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 343' ' ' SER . . . . . . . . . . . . . 1.9 t -105.56 -48.93 3.54 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.865 0.757 . . . . 0.0 112.886 -162.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 344' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.65 52.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.258 1.409 . . . . 0.0 116.241 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 345' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.02 151.01 35.76 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.113 1.456 . . . . 0.0 111.271 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 346' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -101.83 117.69 35.37 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.416 -0.802 . . . . 0.0 110.837 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 347' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.44 16.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.233 1.413 . . . . 0.0 113.297 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 348' ' ' ALA . . . . . . . . . . . . . . . -52.74 -39.01 61.73 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 349' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -69.09 -26.8 65.11 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.44 -0.787 . . . . 0.0 113.056 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 350' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -79.65 -39.35 31.65 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.24 -0.913 . . . . 0.0 111.226 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 351' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.21 -34.39 73.58 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.565 0.621 . . . . 0.0 111.661 169.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 352' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.16 -44.87 71.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.773 1.229 . . . . 0.0 112.251 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 353' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -57.64 -38.51 75.14 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.322 0.964 . . . . 0.0 111.741 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 354' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.6 -42.96 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.292 1.437 . . . . 0.0 112.589 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 355' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.61 -42.56 91.45 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.962 -1.087 . . . . 0.0 111.698 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 356' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.79 -24.23 67.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.341 -0.849 . . . . 0.0 112.373 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 357' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.74 80.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 121.07 1.759 . . . . 0.0 112.722 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 358' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -71.47 -37.54 71.34 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.897 0.771 . . . . 0.0 111.858 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 359' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.59 -42.69 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.033 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 360' ' ' ARG . . . . . . . . . . . . . 24.9 mtp-105 -54.01 -44.76 71.19 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.63 1.105 . . . . 0.0 112.019 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 361' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.38 -45.69 90.75 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.813 0.279 . . . . 0.0 111.353 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 362' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.86 -14.19 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.565 1.146 . . . . 0.0 112.82 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 363' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -95.91 -8.36 34.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 168.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 364' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.08 -34.64 8.35 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.204 1.365 . . . . 0.0 112.374 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 365' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -69.28 -30.53 68.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 113.31 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 366' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.624 1.57 . . . . 0.0 113.85 -172.905 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 1' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 2' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.17 141.3 56.79 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.725 2.283 . . . . 0.0 111.465 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -96.36 -16.24 21.39 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 4' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -78.21 -7.82 57.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.093 1.357 . . . . 0.0 114.462 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 m -81.23 70.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.537 1.535 . . . . 0.0 111.283 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 6' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -73.26 2.02 8.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 7' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -144.1 142.67 30.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.075 0.852 . . . . 0.0 111.689 164.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.45 140.06 37.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.074 0.95 . . . . 0.0 109.659 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.81 146.72 36.14 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 10' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.89 -179.73 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.331 2.687 . . . . 0.0 111.494 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.01 27.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 12' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -138.67 178.37 7.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.072 2.549 . . . . 0.0 110.09 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt 61.81 -41.04 0.14 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.383 2.273 . . . . 0.0 117.131 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.56 69.18 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 121.319 1.872 . . . . 0.0 113.247 -173.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.91 -30.96 71.24 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.211 -0.931 . . . . 0.0 110.992 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -70.84 -30.54 66.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.434 1.094 . . . . 0.0 112.755 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.87 -35.95 67.28 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.195 -0.941 . . . . 0.0 111.906 171.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.19 -46.21 81.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.233 0.613 . . . . 0.0 110.534 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 19' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.03 -39.51 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.056 1.342 . . . . 0.0 112.2 171.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.4 68.52 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 21' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.69 -48.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.039 0.836 . . . . 0.0 110.43 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -55.72 -38.62 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.342 0.973 . . . . 0.0 113.453 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 pt -88.25 -14.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.96 -29.24 25.25 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.281 -0.887 . . . . 0.0 112.468 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -35.56 -59.66 0.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.308 2.643 . . . . 0.0 114.13 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -101.47 6.4 42.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.029 1.332 . . . . 0.0 114.517 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -121.73 -11.51 8.6 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.04 -162.67 9.21 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.748 1.166 . . . . 0.0 115.402 -169.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -118.57 122.4 42.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.65 1.58 . . . . 0.0 109.671 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.76 150.34 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.496 1.919 . . . . 0.0 109.252 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -127.07 130.7 50.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.36 1.464 . . . . 0.0 108.975 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.31 143.4 50.49 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.48 1.112 . . . . 0.0 112.037 -166.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.56 153.21 22.85 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 124.456 1.098 . . . . 0.0 111.615 -163.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -73.01 -24.6 60.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.847 -1.384 . . . . 0.0 113.88 -169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 35' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -79.55 -41.2 27.76 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 111.978 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.87 -32.81 71.37 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.187 -0.946 . . . . 0.0 112.401 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -58.32 -45.93 87.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.215 0.916 . . . . 0.0 110.43 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 38' ' ' THR . . . . . . . . . . . . . 92.6 m -63.58 -42.35 98.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.938 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.68 -44.68 90.3 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.556 1.071 . . . . 0.0 112.287 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.09 -31.32 69.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 41' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.19 -47.91 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.004 0.921 . . . . 0.0 110.572 170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -59.86 -43.65 94.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.007 0.923 . . . . 0.0 112.369 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -80.31 6.24 12.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.802 1.241 . . . . 0.0 113.011 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.38 29.67 60.69 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.775 -1.203 . . . . 0.0 114.152 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 45' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -88.59 -31.04 18.81 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.146 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.26 57.84 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.585 0.754 . . . . 0.0 112.711 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 47' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -108.89 -22.05 12.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.317 1.847 . . . . 0.0 111.933 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 tp -149.73 142.29 24.45 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.277 2.231 . . . . 0.0 108.126 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.63 141.63 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.389 1.076 . . . . 0.0 111.216 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.72 133.4 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.995 1.718 . . . . 0.0 109.069 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 mt -125.54 142.17 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.981 1.313 . . . . 0.0 109.689 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.6 150.64 30.97 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 53' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.15 -7.54 59.62 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.57 23.29 12.47 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.44 1.496 . . . . 0.0 114.004 -171.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 t -80.06 128.03 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.423 1.089 . . . . 0.0 110.289 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -146.34 118.64 4.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.482 1.513 . . . . 0.0 107.532 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.99 151.91 86.65 Favored 'Cis proline' 0 CA--C 1.538 0.705 0 CA-C-N 120.956 1.377 . . . . 0.0 113.037 0.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 58' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.32 -24.57 62.15 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.147 -0.971 . . . . 0.0 112.428 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -71.07 16.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.071 1.748 . . . . 0.0 114.955 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.13 -34.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.131 -0.981 . . . . 0.0 111.559 161.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 61' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.43 -14.45 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.231 1.412 . . . . 0.0 114.441 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.91 -20.34 5.88 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 63' ' ' HIS . . . . . 0.458 ' CD2' HH21 ' F' ' 338' ' ' ARG . 27.1 p-80 -83.29 -19.83 35.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 114.369 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 64' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.99 -44.75 85.88 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.763 -1.589 . . . . 0.0 114.022 -170.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 65' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.74 -54.82 3.27 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 CA-C-N 122.333 1.869 . . . . 0.0 114.621 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.41 -29.71 37.46 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.077 1.777 . . . . 0.0 113.376 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 67' ' ' LEU . . . . . . . . . . . . . 61.5 tp -71.7 -32.78 68.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.603 0.761 . . . . 0.0 113.017 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 68' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.89 -29.34 19.7 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 69' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -64.27 -46.54 83.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.638 0.775 . . . . 0.0 111.48 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.73 -4.48 6.53 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.181 -0.949 . . . . 0.0 113.06 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -121.24 11.38 10.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.473 1.909 . . . . 0.0 114.487 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 72' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 53.11 54.58 10.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.952 1.301 . . . . 0.0 113.115 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.87 135.78 22.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.39 1.476 . . . . 0.0 110.327 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -67.21 136.97 42.33 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.158 2.572 . . . . 0.0 112.732 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 75' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -132.56 148.92 52.38 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.38 1.072 . . . . 0.0 113.569 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 tt -151.49 166.94 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.203 1.401 . . . . 0.0 111.575 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -118.25 149.96 40.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 111.596 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.94 156.53 72.53 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 124.994 1.318 . . . . 0.0 112.073 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -67.61 -31.4 33.3 Favored 'Trans proline' 0 C--N 1.35 0.626 0 N-CA-C 117.257 1.984 . . . . 0.0 117.257 -160.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 80' ' ' SER . . . . . . . . . . . . . 74.7 m -154.02 142.61 20.8 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -68.05 -29.85 68.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.074 2.149 . . . . 0.0 114.829 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 82' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -72.41 -44.2 62.8 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.71 0.687 . . . . 0.0 111.33 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 83' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -64.3 -42.67 96.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.682 1.193 . . . . 0.0 111.864 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -61.55 -43.32 99.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.217 0.607 . . . . 0.0 112.316 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.89 -45.16 96.74 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.835 -0.541 . . . . 0.0 112.846 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.97 93.09 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.42 90.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.187 0.595 . . . . 0.0 111.676 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.23 15.11 0.47 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.152 1.381 . . . . 0.0 114.68 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.84 -3.11 87.61 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.194 1.378 . . . . 0.0 116.295 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 pt -104.81 152.55 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.326 1.563 . . . . 0.0 111.774 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.6 -16.75 35.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -82.19 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.368 1.067 . . . . 0.0 111.001 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.74 169.97 8.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.007 1.723 . . . . 0.0 111.153 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.16 124.35 19.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.569 0.748 . . . . 0.0 109.664 165.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.06 71.46 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 96' ' ' SER . . . . . . . . . . . . . 67.2 p -149.11 161.71 41.42 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.423 1.089 . . . . 0.0 113.274 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 88.4 t -141.13 145.35 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.882 1.673 . . . . 0.0 109.976 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.71 141.03 52.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 111.935 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 99' ' ' ILE . . . . . . . . . . . . . 24.7 mt -102.91 121.46 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.223 1.009 . . . . 0.0 108.524 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.01 -43.07 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.91 1.284 . . . . 0.0 110.851 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 101' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -131.25 109.79 15.13 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 163.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -67.66 -3.48 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 N-CA-C 116.633 1.743 . . . . 0.0 116.633 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.58 -114.55 6.06 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.867 1.212 . . . . 0.0 112.026 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.88 -26.46 66.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.497 1.519 . . . . 0.0 113.351 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.77 4.14 23.16 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 106' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -54.36 -43.58 71.45 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.625 1.557 . . . . 0.0 114.348 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.16 -28.05 59.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.719 1.208 . . . . 0.0 113.506 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 108' ' ' LEU . . . . . . . . . . . . . 47.3 tp -77.12 -38.23 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 111.542 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 109' ' ' VAL . . . . . . . . . . . . . 44.7 t -61.59 -36.58 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.437 -0.79 . . . . 0.0 110.885 170.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 110' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -70.75 -33.45 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 111' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -62.81 -49.01 76.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.551 1.069 . . . . 0.0 110.89 170.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 112' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.38 -51.3 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 110.243 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.57 -45.55 91.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.603 0.638 . . . . 0.0 112.178 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 114' ' ' MET . . . . . . . . . . . . . 34.6 mmt -70.91 -34.98 72.08 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.72 -36.38 37.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.348 0.976 . . . . 0.0 112.91 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 116' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.95 -42.94 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.351 0.978 . . . . 0.0 110.478 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.75 54.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.588 1.155 . . . . 0.0 113.843 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -87.36 -12.81 45.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 pp -101.29 -11.98 19.03 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.549 1.522 . . . . 0.0 114.089 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 120' ' ' MET . . . . . . . . . . . . . 91.3 mtp -75.64 40.4 0.18 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.92 1.288 . . . . 0.0 112.489 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 121' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.949 2.099 . . . . 0.0 110.892 -171.551 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.73 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 m -150.76 155.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 127.28 2.232 . . . . 0.0 109.676 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -138.8 164.97 28.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.714 1.206 . . . . 0.0 111.182 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 t -136.45 137.66 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.974 0.91 . . . . 0.0 111.779 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -138.72 161.4 37.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.92 2.088 . . . . 0.0 111.548 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -74.75 153.58 38.75 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.771 -1.205 . . . . 0.0 111.644 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 7' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -94.26 -171.46 2.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.415 1.086 . . . . 0.0 111.333 170.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 8' ' ' LYS . . . . . 0.446 ' HE3' ' CZ ' ' H' ' 9' ' ' PHE . 54.9 pttt -79.56 -17.72 53.34 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 173.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 9' ' ' PHE . . . . . 0.446 ' CZ ' ' HE3' ' H' ' 8' ' ' LYS . 21.6 m-85 -103.68 144.62 29.03 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.435 1.094 . . . . 0.0 112.343 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -62.99 131.86 34.47 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.958 2.439 . . . . 0.0 111.894 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -6.99 29.11 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 115.574 0.99 . . . . 0.0 115.574 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 t -91.2 141.05 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.932 1.366 . . . . 0.0 110.037 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -127.97 166.43 18.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.633 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.13 136.98 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.58 1.952 . . . . 0.0 108.022 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.76 146.76 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.374 1.07 . . . . 0.0 110.249 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 16' ' ' ILE . . . . . . . . . . . . . 10.3 mm -106.41 127.42 61.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.699 1.6 . . . . 0.0 108.051 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.65 175.71 6.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 113.305 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 18' ' ' ASP . . . . . . . . . . . . 0.304 0.4 OUTLIER -72.2 -3.46 23.58 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -167.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -91.29 -28.27 17.88 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.664 1.186 . . . . 0.0 113.549 163.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.51 -0.18 21.91 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 127.024 2.25 . . . . 0.0 115.728 -168.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 21' ' ' SER . . . . . . . . . . . . . 85.2 p -74.98 147.35 40.9 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.108 1.954 . . . . 0.0 113.891 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 22' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.36 137.41 32.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.982 1.313 . . . . 0.0 111.473 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -143.66 148.34 35.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.518 1.527 . . . . 0.0 110.865 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.25 148.07 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.04 14.47 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.667 1.587 . . . . 0.0 113.62 -169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 26' ' ' THR . . . . . . . . . . . . . 24.6 p -138.71 160.8 38.77 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.639 1.576 . . . . 0.0 112.269 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -79.26 123.77 27.75 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.98 1.312 . . . . 0.0 110.425 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 28' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -65.11 122.95 18.25 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.906 0.776 . . . . 0.0 112.26 -174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.27 -27.23 68.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.286 1.434 . . . . 0.0 113.252 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.39 89.73 11.96 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 125.088 1.355 . . . . 0.0 111.714 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 31' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.71 133.14 56.11 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.668 2.912 . . . . 0.0 115.164 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.55 -29.36 12.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.123 1.821 . . . . 0.0 113.575 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -66.39 140.27 58.05 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.179 -1.189 . . . . 0.0 111.345 175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -104.09 140.36 37.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.176 1.39 . . . . 0.0 107.509 158.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.28 -30.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -159.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 36' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -143.31 27.4 1.57 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 171.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.27 37.08 48.98 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.931 0.777 . . . . 0.0 113.152 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -104.28 172.41 6.81 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -166.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -77.35 123.65 26.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.922 1.289 . . . . 0.0 110.907 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 40' ' ' VAL . . . . . . . . . . . . . 22.9 t -137.43 137.62 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.205 1.402 . . . . 0.0 110.136 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 41' ' ' ILE . . . . . . . . . . . . . 46.2 pt -138.0 158.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.225 1.81 . . . . 0.0 112.061 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -105.83 147.96 28.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.819 1.248 . . . . 0.0 111.3 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 43' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -133.49 -146.41 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.233 1.813 . . . . 0.0 109.956 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.95 93.9 0.12 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.519 -1.363 . . . . 0.0 111.533 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.3 -15.62 1.93 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.812 1.672 . . . . 0.0 116.206 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -126.33 165.48 18.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.11 1.364 . . . . 0.0 112.826 -164.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.81 138.37 52.75 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.658 1.183 . . . . 0.0 111.651 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 48' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -132.66 140.39 48.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.027 1.731 . . . . 0.0 111.282 -170.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -131.16 138.55 49.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.301 1.44 . . . . 0.0 112.946 -168.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 50' ' ' ILE . . . . . . . . . . . . . 8.8 tp -69.61 142.29 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.309 1.044 . . . . 0.0 112.339 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 51' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -100.79 97.85 8.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.044 0.938 . . . . 0.0 109.305 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -77.87 118.53 72.73 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 121.227 -0.921 . . . . 0.0 110.778 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 53' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.23 -22.35 34.64 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 113.96 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 54' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -79.48 -34.24 41.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.294 0.952 . . . . 0.0 112.758 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 55' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -102.0 -29.27 11.89 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -170.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -118.83 63.55 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 108.906 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 57' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -46.04 -34.28 3.99 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 127.89 2.476 . . . . 0.0 116.658 -148.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tt -48.81 -33.74 11.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.631 1.573 . . . . 0.0 112.289 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.49 -33.77 72.9 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.819 -1.176 . . . . 0.0 114.294 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.2 -36.77 85.22 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.939 1.37 . . . . 0.0 112.099 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.51 -38.19 80.71 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.638 -0.664 . . . . 0.0 112.087 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 62' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.61 -40.9 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.588 0.755 . . . . 0.0 111.023 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 63' ' ' VAL . . . . . . . . . . . . . 90.8 t -74.31 -41.88 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 118.586 0.63 . . . . 0.0 112.155 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 64' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -78.92 -24.69 43.91 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.55 9.55 0.03 OUTLIER Glycine 0 N--CA 1.477 1.369 0 N-CA-C 119.554 2.582 . . . . 0.0 119.554 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.62 120.76 12.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.904 1.852 . . . . 0.0 111.535 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -103.38 -40.09 6.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.747 1.619 . . . . 0.0 111.179 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -83.31 85.93 7.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.525 1.13 . . . . 0.0 111.461 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -109.32 91.43 9.78 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.319 1.448 . . . . 0.0 110.516 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.0 -16.1 10.13 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.673 2.249 . . . . 0.0 115.445 -163.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 71' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.15 150.95 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.296 0.953 . . . . 0.0 113.318 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -143.65 160.09 51.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.786 2.034 . . . . 0.0 109.602 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -54.65 146.43 54.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.063 1.842 . . . . 0.0 111.673 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 6.02 85.3 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 75' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -94.53 169.28 10.31 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.01 1.405 . . . . 0.0 113.431 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 76' ' ' SER . . . . . . . . . . . . . 89.6 p -111.65 130.32 55.81 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 111.932 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -140.0 140.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.765 0.826 . . . . 0.0 112.962 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 78' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.66 127.81 49.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.734 1.614 . . . . 0.0 109.15 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.75 118.33 32.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.849 1.26 . . . . 0.0 109.995 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 mt -103.22 122.92 45.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.862 1.265 . . . . 0.0 108.922 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.89 5.31 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.738 0.685 . . . . 0.0 112.61 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 82' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.66 -18.31 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.592 -0.946 . . . . 0.0 113.551 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 83' ' ' ALA . . . . . . . . . . . . . . . 47.25 -135.26 0.97 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.998 1.319 . . . . 0.0 111.945 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 84' ' ' SER . . . . . . . . . . . . . 18.3 m -89.08 22.54 2.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.055 -1.028 . . . . 0.0 112.666 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.27 75.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.98 1.276 . . . . 0.0 116.13 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 86' ' ' THR . . . . . . . . . . . . . 34.5 p -50.42 -59.06 4.38 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.336 1.568 . . . . 0.0 112.989 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 87' ' ' THR . . . . . . . . . . . . . 18.6 m -77.83 -48.09 17.32 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.457 -0.777 . . . . 0.0 111.692 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.2 64.14 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -168.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 89' ' ' SER . . . . . . . . . . . . . 61.0 p -54.94 -33.09 61.92 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.93 -1.107 . . . . 0.0 112.592 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 90' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -74.06 -33.08 63.55 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 m -73.89 -32.94 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 120.149 1.34 . . . . 0.0 111.654 171.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.92 -36.88 80.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.226 1.01 . . . . 0.0 112.539 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.39 -37.3 84.94 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 94' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.03 -39.06 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.22 1.408 . . . . 0.0 112.546 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -77.58 -22.77 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.72 1.208 . . . . 0.0 112.592 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.39 -164.79 54.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.413 1.006 . . . . 0.0 114.521 172.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 97' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -89.21 -28.24 20.1 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -174.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 98' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.18 -22.21 58.21 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.352 0.661 . . . . 0.0 112.218 171.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 165.33 33.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.579 1.085 . . . . 0.0 113.428 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 100' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -130.05 128.4 41.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.559 1.144 . . . . 0.0 111.627 -168.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 118.76 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.696 1.198 . . . . 0.0 110.427 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 102' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.6 124.79 42.02 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.561 0.744 . . . . 0.0 109.487 168.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.18 108.99 1.71 Allowed Glycine 0 N--CA 1.468 0.812 0 CA-C-N 118.88 0.764 . . . . 0.0 113.302 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.06 132.75 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.744 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -145.89 143.87 29.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.081 1.353 . . . . 0.0 109.981 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 106' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -90.23 -34.18 15.88 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 112.211 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 107' ' ' SER . . . . . . . . . . . . . 3.5 m -79.88 100.44 0.61 Allowed Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.152 1.781 . . . . 0.0 111.383 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 108' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -64.51 -44.01 12.3 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.397 1.535 . . . . 0.0 114.359 -157.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 109' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -62.93 -24.86 68.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.607 1.163 . . . . 0.0 113.191 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -77.04 -44.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.654 1.116 . . . . 0.0 110.463 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 111' ' ' LEU . . . . . . . . . . . . . 34.3 tp -67.46 -31.54 71.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.061 0.944 . . . . 0.0 111.816 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 112' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -57.67 -34.29 69.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.83 1.252 . . . . 0.0 113.12 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 113' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -79.38 -9.47 59.6 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -92.8 -28.09 16.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.774 1.23 . . . . 0.0 112.142 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 115' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.53 -47.01 99.01 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.348 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 116' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.36 -33.34 58.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.469 2.112 . . . . 0.0 113.713 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 117' ' ' ILE . . . . . . . . . . . . . 31.5 mt -69.32 -37.81 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.071 -1.018 . . . . 0.0 111.317 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.26 -0.9 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.204 1.002 . . . . 0.0 113.618 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -68.65 -17.59 64.13 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.884 0.873 . . . . 0.0 111.273 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -108.47 -46.4 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.407 1.883 . . . . 0.0 112.896 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 121' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 -77.24 62.22 2.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.628 1.571 . . . . 0.0 112.784 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 122' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -73.36 9.98 1.15 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 123' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -87.68 -8.38 56.2 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 163.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 124' ' ' ILE . . . . . . . . . . . . . 23.2 mt -103.57 135.03 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.38 123.34 39.89 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.913 0.885 . . . . 0.0 109.696 166.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 126' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.86 123.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.499 2.799 . . . . 0.0 111.238 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -125.37 117.3 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.153 1.381 . . . . 0.0 109.856 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 119.02 22.46 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.766 -0.584 . . . . 0.0 110.595 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.77 157.43 18.59 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.927 0.775 . . . . 0.0 114.483 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 130' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -77.57 123.62 26.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.552 0.741 . . . . 0.0 109.276 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.03 -16.91 62.71 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.03 -7.92 55.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.354 1.862 . . . . 0.0 112.712 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -124.36 55.53 10.18 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.982 2.113 . . . . 0.0 111.2 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 134' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.31 -23.56 72.05 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.23 2.62 . . . . 0.0 114.487 -167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -54.81 -32.83 60.83 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.917 -1.115 . . . . 0.0 112.4 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.35 3.72 4.45 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 137' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -132.42 18.04 4.4 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 163.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 138' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -53.61 -30.03 40.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.9 -2.32 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.114 1.366 . . . . 0.0 114.459 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 140' ' ' LEU . . . . . . . . . . . . . 71.6 mt -106.55 -2.89 21.4 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 141' ' ' VAL . . . . . . . . . . . . . 13.2 m -142.22 158.0 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.618 1.167 . . . . 0.0 111.526 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 142' ' ' THR . . . . . . . . . . . . . 71.6 p -85.95 -177.82 6.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.633 1.173 . . . . 0.0 111.99 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -64.96 157.96 26.75 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.048 -1.033 . . . . 0.0 109.6 154.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 144' ' ' VAL . . . . . . . . . . . . . 24.8 m -134.44 158.97 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.357 1.463 . . . . 0.0 113.198 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 145' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.32 -34.72 59.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.981 1.312 . . . . 0.0 112.635 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 146' ' ' VAL . . . . . . . . . . . . . 57.0 t -140.51 146.39 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.041 1.337 . . . . 0.0 111.486 -171.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 147' ' ' ILE . . . . . . . . . . . . . 57.3 mt -116.02 137.68 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.764 1.225 . . . . 0.0 109.681 164.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 148' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -118.93 142.49 47.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.675 1.19 . . . . 0.0 110.486 164.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -131.01 130.33 43.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.195 0.998 . . . . 0.0 113.114 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 150' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.51 9.88 2.69 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 128.442 2.697 . . . . 0.0 111.056 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 151' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.75 -26.89 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.57 -1.331 . . . . 0.0 112.363 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 152' ' ' ALA . . . . . . . . . . . . . . . 54.49 48.47 20.43 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.176 1.391 . . . . 0.0 114.117 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 153' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -96.44 161.83 25.53 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.501 1.521 . . . . 0.0 113.557 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 154' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -58.07 -23.27 60.01 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.503 2.802 . . . . 0.0 116.423 -171.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 155' ' ' THR . . . . . . . . . . . . . 27.2 p -119.42 22.41 11.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.856 1.662 . . . . 0.0 112.788 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 156' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -56.58 -25.49 52.68 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.11 77.52 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.477 -1.39 . . . . 0.0 112.978 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 158' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -71.39 -36.67 71.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.812 0.845 . . . . 0.0 111.951 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 159' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.54 -46.54 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 160' ' ' LEU . . . . . . . . . . . . . 49.4 tp -62.16 -44.68 96.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.204 0.602 . . . . 0.0 112.325 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 161' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.76 -50.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.809 0.844 . . . . 0.0 111.484 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 162' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -76.93 -30.99 56.33 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.402 -0.811 . . . . 0.0 112.215 -172.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 163' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -66.13 -34.42 78.02 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.534 -1.354 . . . . 0.0 111.511 166.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.53 63.15 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.298 -1.501 . . . . 0.0 113.704 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 165' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.94 -55.6 21.36 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.506 1.048 . . . . 0.0 110.354 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.36 68.88 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 167' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.21 -30.52 2.65 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 -165.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 168' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.95 134.25 36.25 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.004 1.729 . . . . 0.0 112.49 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 169' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -72.83 160.44 32.16 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.166 0.986 . . . . 0.0 112.599 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -49.93 132.14 22.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.499 1.52 . . . . 0.0 111.3 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 171' ' ' GLY . . . . . . . . . . . . . . . 65.99 4.14 20.04 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.36 162.31 54.22 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-N 119.798 1.799 . . . . 0.0 113.581 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 173' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -105.71 153.71 21.47 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.49 145.19 16.19 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.948 1.261 . . . . 0.0 111.679 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 175' ' ' MET . . . . . . . . . . . . . 69.5 mtp -136.64 142.8 43.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.503 1.521 . . . . 0.0 109.51 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 176' ' ' ILE . . . . . . . . . . . . . 12.1 tt -151.42 127.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -169.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 177' ' ' ALA . . . . . . . . . . . . . . . -97.6 120.83 38.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 111.087 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 178' ' ' VAL . . . . . . . . . . . . . 40.8 t -113.53 121.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 111.478 -168.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 179' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -105.72 101.38 10.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.851 1.66 . . . . 0.0 109.796 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 180' ' ' SER . . . . . . . . . . . . . 25.0 t -51.93 -49.35 63.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.315 0.646 . . . . 0.0 112.551 -168.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 181' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -66.81 -3.47 6.89 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 182' ' ' SER . . . . . . . . . . . . . 10.0 t -80.39 -36.99 33.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.653 0.781 . . . . 0.0 111.322 165.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.38 -49.31 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.065 1.346 . . . . 0.0 110.325 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 184' ' ' ASP . . . . . 0.44 ' CG ' ' HE3' ' H' ' 187' ' ' LYS . 7.1 t70 -156.91 140.33 15.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.449 1.5 . . . . 0.0 111.793 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 185' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.31 2.37 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.73 1.612 . . . . 0.0 113.131 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 186' ' ' THR . . . . . . . . . . . . . 53.7 m -99.64 -33.69 10.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.511 1.524 . . . . 0.0 111.858 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 187' ' ' LYS . . . . . 0.44 ' HE3' ' CG ' ' H' ' 184' ' ' ASP . 16.1 ptpt -93.62 170.26 9.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.295 1.438 . . . . 0.0 114.181 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 188' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.6 123.48 81.36 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.343 1.457 . . . . 0.0 110.868 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 189' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.34 -32.34 51.1 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.848 3.032 . . . . 0.0 116.199 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 190' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -62.92 -23.12 67.22 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 113.227 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 191' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -73.8 -36.21 64.99 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.618 -1.301 . . . . 0.0 112.277 170.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.01 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.319 0.647 . . . . 0.0 109.88 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 193' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -65.67 -26.52 67.82 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.411 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 194' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -70.01 -32.99 71.44 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.131 1.332 . . . . 0.0 113.611 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.45 -36.71 74.08 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.927 -1.108 . . . . 0.0 111.237 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 196' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.72 -39.93 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 119.887 -1.758 . . . . 0.0 111.332 171.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 197' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -55.42 -43.32 75.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.068 1.347 . . . . 0.0 112.002 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 198' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.13 -19.4 47.37 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -87.61 -44.4 11.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.452 1.024 . . . . 0.0 111.694 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.68 -40.81 89.07 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.013 -1.054 . . . . 0.0 111.039 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 201' ' ' SER . . . . . . . . . . . . . 87.1 p -76.42 8.43 3.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 202' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -97.52 -6.65 33.16 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.759 -1.213 . . . . 0.0 112.29 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 203' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -142.33 -18.15 0.71 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 204' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.99 169.77 9.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.905 -1.122 . . . . 0.0 113.512 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 205' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -89.92 128.55 36.24 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 154.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 206' ' ' VAL . . . . . . . . . . . . . 27.3 t -100.07 133.31 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.246 -0.909 . . . . 0.0 109.901 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 207' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.42 -12.78 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -149.16 143.76 26.17 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.385 0.993 . . . . 0.0 111.366 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 138.14 27.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 109.391 164.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 210' ' ' LEU . . . . . . . . . . . . . 87.4 mt -139.6 175.25 9.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.021 1.329 . . . . 0.0 112.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 211' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -124.84 141.87 51.82 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.322 2.649 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 1.2 36.66 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 213' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.14 141.53 76.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 120.645 -1.284 . . . . 0.0 111.121 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 214' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.27 -0.07 66.1 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 120.362 1.165 . . . . 0.0 114.245 1.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 215' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -68.88 -34.84 76.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.265 0.939 . . . . 0.0 112.805 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 216' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -117.84 175.71 5.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.533 1.533 . . . . 0.0 112.149 171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 217' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -123.5 141.29 52.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.35 1.46 . . . . 0.0 110.199 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 218' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.46 35.52 26.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.127 1.771 . . . . 0.0 114.364 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -134.18 135.42 43.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -161.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.21 174.2 9.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.244 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 221' ' ' LEU . . . . . . . . . . . . . 7.9 tt -144.43 147.18 33.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.226 1.411 . . . . 0.0 110.415 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 222' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.89 158.98 35.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.039 1.336 . . . . 0.0 111.866 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 223' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.0 139.07 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.033 1.333 . . . . 0.0 110.219 167.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 224' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.86 164.85 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.125 1.77 . . . . 0.0 112.117 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 225' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -124.12 139.86 53.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.275 1.43 . . . . 0.0 110.83 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 226' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -72.5 144.71 86.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.006 1.323 . . . . 0.0 109.808 165.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 227' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo . . . . . 0 C--O 1.257 1.428 0 C-N-CA 123.566 2.844 . . . . 0.0 114.573 179.58 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 mp -78.13 145.83 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 119.137 0.88 . . . . 0.0 109.623 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 3' ' ' SER . . . . . . . . . . . . . 34.4 t -132.76 145.1 50.73 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.611 1.164 . . . . 0.0 111.383 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -114.93 114.01 24.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.665 1.586 . . . . 0.0 109.616 -161.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -145.53 165.94 27.14 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -166.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.91 -38.86 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.279 1.832 . . . . 0.0 114.4 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 7' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -87.37 52.44 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.892 1.224 . . . . 0.0 110.677 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.75 -179.29 52.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.518 1.532 . . . . 0.0 114.034 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -109.39 145.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.657 1.583 . . . . 0.0 111.245 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 10' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -127.66 147.85 50.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.612 1.165 . . . . 0.0 112.693 -161.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 130.86 45.74 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.769 1.228 . . . . 0.0 112.17 173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 12' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.57 154.8 46.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.695 1.998 . . . . 0.0 112.003 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.5 172.06 11.28 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.362 1.465 . . . . 0.0 114.335 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -56.02 -27.63 53.88 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 15' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -88.55 -5.1 58.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.683 1.193 . . . . 0.0 113.753 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.37 27.88 31.85 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.743 -1.223 . . . . 0.0 115.352 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -98.57 151.71 20.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.004 1.321 . . . . 0.0 109.792 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 18' ' ' LEU . . . . . . . . . . . . . 23.6 tp -72.52 144.01 48.14 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 111.119 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 19' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.48 -58.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.229 1.412 . . . . 0.0 109.56 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -157.2 158.04 35.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.303 1.441 . . . . 0.0 110.423 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -140.64 146.78 38.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.407 1.083 . . . . 0.0 110.994 164.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 22' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -128.83 145.43 51.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.948 1.299 . . . . 0.0 111.622 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 23' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -92.76 158.83 15.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 24' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -80.87 152.08 28.32 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 25' ' ' THR . . . . . . . . . . . . . 77.6 p -116.73 12.92 15.03 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -130.89 170.36 14.53 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.899 1.679 . . . . 0.0 108.729 156.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -51.14 114.52 4.97 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.462 1.505 . . . . 0.0 110.699 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.31 -31.02 65.23 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.575 2.85 . . . . 0.0 116.032 -168.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.26 -36.26 79.53 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.833 0.742 . . . . 0.0 112.721 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -77.03 -30.16 55.6 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.397 -0.814 . . . . 0.0 112.619 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.41 -39.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.78 -0.575 . . . . 0.0 110.758 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.1 -39.56 93.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.645 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 33' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.15 -36.92 83.3 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.905 1.229 . . . . 0.0 112.708 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 34' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -67.33 -53.35 30.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.024 0.93 . . . . 0.0 111.538 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.16 -33.84 76.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 36' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.05 -42.3 66.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.732 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -84.98 11.32 9.69 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.6 22.31 40.5 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 161.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 39' ' ' GLU . . . . . . . . . . . . 0.352 13.0 pt-20 -113.38 139.14 49.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.488 2.144 . . . . 0.0 113.865 165.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 40' ' ' ILE . . . . . . . . . . . . . 14.7 tt -85.34 154.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.974 1.31 . . . . 0.0 112.215 -165.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 41' ' ' THR . . . . . . . . . . . . . 72.9 p -131.21 157.77 42.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.165 0.986 . . . . 0.0 113.557 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -53.41 -34.92 59.63 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.43 1.892 . . . . 0.0 115.287 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.82 -28.12 58.16 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.89 -0.506 . . . . 0.0 111.946 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.15 -34.27 32.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.243 1.017 . . . . 0.0 111.245 173.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.59 -42.79 67.98 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.056 0.844 . . . . 0.0 110.774 165.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.68 -42.08 67.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.344 -0.847 . . . . 0.0 112.64 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.7 -39.4 94.21 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.244 -0.91 . . . . 0.0 112.425 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.8 -28.19 60.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.549 1.068 . . . . 0.0 112.677 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -66.64 -38.56 87.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.311 0.96 . . . . 0.0 112.084 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 50' ' ' SER . . . . . . . . . . . . . 23.5 t -60.71 -46.84 88.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.591 0.756 . . . . 0.0 110.788 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 51' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.95 -36.43 83.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.97 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 52' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -66.66 -45.03 80.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.198 1.399 . . . . 0.0 111.791 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -70.42 -24.61 62.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.579 1.151 . . . . 0.0 113.33 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.75 -24.43 64.45 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.495 1.118 . . . . 0.0 112.875 167.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.75 5.29 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 115.464 0.946 . . . . 0.0 115.464 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 56' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.6 155.07 20.53 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.696 1.198 . . . . 0.0 110.887 168.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -131.24 -25.67 2.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 58' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -80.91 64.44 5.68 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.33 1.452 . . . . 0.0 112.084 -168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 59' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -76.26 72.2 3.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.795 1.238 . . . . 0.0 113.53 -167.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 p -76.15 118.54 22.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 170.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 61' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.15 171.78 8.72 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.075 2.55 . . . . 0.0 111.517 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -79.45 -41.4 27.63 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.904 -0.497 . . . . 0.0 112.152 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 63' ' ' HIS . . . . . 0.414 ' CD2' ' HD2' ' I' ' 64' ' ' PRO . 49.1 t-80 -101.08 139.53 20.56 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -167.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 64' ' ' PRO . . . . . 0.414 ' HD2' ' CD2' ' I' ' 63' ' ' HIS . 56.0 Cg_endo -68.8 -38.84 9.47 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.773 2.316 . . . . 0.0 113.81 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -89.11 -29.44 19.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.379 0.99 . . . . 0.0 112.36 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.35 -43.62 88.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.086 0.555 . . . . 0.0 110.562 163.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 67' ' ' SER . . . . . . . . . . . . . 9.5 t -65.82 -34.13 77.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.622 0.769 . . . . 0.0 112.333 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -60.35 -55.46 33.3 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.2 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 69' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.83 -37.43 71.23 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.377 1.444 . . . . 0.0 111.306 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.99 69.73 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 71' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -79.74 -23.45 42.27 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.87 -34.34 75.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.557 1.543 . . . . 0.0 111.632 168.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 73' ' ' LEU . . . . . . . . . . . . . 47.9 tp -77.34 -30.15 53.81 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.659 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.46 2.69 1.98 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 169.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 75' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -81.53 160.23 23.94 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.941 1.371 . . . . 0.0 112.909 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 76' ' ' SER . . . . . . . . . . . . . 4.5 p -83.47 57.29 3.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.085 1.754 . . . . 0.0 112.204 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.48 141.26 30.76 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 78' ' ' THR . . . . . . . . . . . . . 41.8 p -133.62 -175.98 4.01 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.751 1.62 . . . . 0.0 111.236 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 79' ' ' THR . . . . . . . . . . . . . 40.7 m -139.46 126.38 20.93 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.091 -1.005 . . . . 0.0 112.794 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -149.73 108.28 3.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.974 1.31 . . . . 0.0 109.104 162.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 81' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -56.53 -43.5 99.35 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.362 1.065 . . . . 0.0 113.779 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.54 20.22 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.282 2.655 . . . . 0.0 114.971 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -62.4 158.02 18.62 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.085 1.311 . . . . 0.0 112.732 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 tp -60.61 -22.5 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -167.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.04 -55.1 20.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.835 0.743 . . . . 0.0 111.798 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.51 -38.15 90.42 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.367 0.508 . . . . 0.0 112.491 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 87' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.95 -26.3 68.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.041 0.937 . . . . 0.0 112.88 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -86.12 -56.88 3.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.957 1.253 . . . . 0.0 111.736 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.97 -45.48 90.44 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.928 1.291 . . . . 0.0 112.293 -171.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 90' ' ' ARG . . . . . . . . . . . . . 92.9 mtm-85 -82.35 -9.66 59.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 91' ' ' SER . . . . . . . . . . . . . 75.3 m -82.38 -44.24 16.37 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.153 1.342 . . . . 0.0 111.958 173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 92' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -141.28 89.45 9.52 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.42 -21.73 68.84 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.668 2.245 . . . . 0.0 114.266 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.66 -37.77 76.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.879 1.272 . . . . 0.0 112.368 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 95' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.44 -16.51 63.71 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.649 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 96' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -131.16 -39.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -166.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.38 -27.35 13.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.157 1.383 . . . . 0.0 113.753 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.01 159.84 31.52 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.272 1.415 . . . . 0.0 112.839 -166.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.22 -26.29 66.53 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 100' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -86.86 19.01 3.16 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 101' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -48.18 -32.15 6.66 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 102' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.85 -24.44 66.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.944 0.897 . . . . 0.0 113.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 103' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.31 -39.04 91.96 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 119.576 1.08 . . . . 0.0 111.0 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 104' ' ' GLU . . . . . 0.424 ' HA ' ' HE2' ' I' ' 107' ' ' LYS . 0.9 OUTLIER -77.47 -37.08 52.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.555 0.742 . . . . 0.0 112.183 -178.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 105' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.38 -50.44 72.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.405 0.682 . . . . 0.0 111.22 166.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.52 -53.5 56.73 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.951 0.901 . . . . 0.0 112.187 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 107' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' I' ' 104' ' ' GLU . 55.9 pttt -67.16 -26.57 66.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.77 -37.7 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.763 0.825 . . . . 0.0 111.632 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.42 -46.65 93.93 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.345 0.975 . . . . 0.0 113.114 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 110' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.78 -32.08 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.829 -0.806 . . . . 0.0 112.283 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.33 68.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.553 0.741 . . . . 0.0 112.001 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.83 -47.5 82.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.006 0.922 . . . . 0.0 111.078 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 113' ' ' THR . . . . . . . . . . . . . 64.5 m -65.66 -36.17 82.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 114' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -69.16 -22.42 63.93 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.102 -0.999 . . . . 0.0 112.727 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 115' ' ' MET . . . . . . . . . . . . . 54.8 ttp -95.5 -20.04 19.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.504 1.522 . . . . 0.0 114.851 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -72.27 37.14 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 117' ' ' ILE . . . . . . . . . . . . . 19.0 tt -137.72 124.46 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.182 1.393 . . . . 0.0 111.125 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 118' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -74.8 157.67 34.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.659 . . . . 0.0 112.468 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 119' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.04 128.7 44.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.606 1.562 . . . . 0.0 114.274 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 120' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -156.21 68.01 0.6 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.128 0.971 . . . . 0.0 111.639 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m -70.82 163.61 26.95 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.936 -1.102 . . . . 0.0 111.747 165.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.24 -30.71 13.27 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.809 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.69 58.7 1.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 111.467 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 124' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -66.98 -23.88 65.99 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -160.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.17 -39.92 95.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.593 1.542 . . . . 0.0 111.635 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 126' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -66.19 -40.68 90.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.825 1.25 . . . . 0.0 111.79 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 127' ' ' MET . . . . . . . . . . . . . 21.0 mtt -73.91 -4.5 35.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.098 1.359 . . . . 0.0 113.317 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 128' ' ' VAL . . . . . . . . . . . . . 71.8 t -105.89 -31.9 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.56 1.544 . . . . 0.0 111.722 168.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 129' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.57 -40.99 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.431 1.469 . . . . 0.0 110.958 169.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 130' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -63.59 -28.96 70.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.82 -29.36 50.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.036 0.834 . . . . 0.0 112.844 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.12 -41.38 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.463 -0.773 . . . . 0.0 110.527 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -65.89 -34.26 77.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.868 0.758 . . . . 0.0 112.218 167.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.48 75.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.924 1.238 . . . . 0.0 112.046 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.18 -39.08 78.92 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.982 0.81 . . . . 0.0 111.205 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.78 -44.7 80.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.701 0.8 . . . . 0.0 112.019 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.92 -29.62 65.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.261 1.424 . . . . 0.0 112.541 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 138' ' ' VAL . . . . . . . . . . . . . 10.9 t -71.47 -47.75 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 119.937 -1.727 . . . . 0.0 111.932 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 139' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -62.46 -33.91 75.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.484 1.038 . . . . 0.0 111.028 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 140' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -62.61 -40.01 95.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.588 1.155 . . . . 0.0 113.316 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.77 -34.31 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.73 1.15 . . . . 0.0 112.877 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 142' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.05 -46.73 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 110.216 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 143' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -70.43 -3.81 19.49 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.373 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.55 -56.29 2.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.638 1.575 . . . . 0.0 110.654 172.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 145' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.93 -34.4 77.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.164 -0.96 . . . . 0.0 112.881 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 146' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.76 -25.38 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.423 -0.798 . . . . 0.0 111.913 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.04 -43.88 86.28 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.101 1.319 . . . . 0.0 111.039 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -42.86 99.37 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.713 0.805 . . . . 0.0 111.537 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 149' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.26 -42.72 99.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.011 0.925 . . . . 0.0 112.321 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 150' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -61.52 -52.02 66.22 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.499 1.12 . . . . 0.0 111.382 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 151' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.04 -38.88 92.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.172 0.589 . . . . 0.0 112.58 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 152' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -72.71 -47.99 42.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.748 0.819 . . . . 0.0 111.906 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.2 -30.9 70.09 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.732 -1.23 . . . . 0.0 112.712 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 48.7 m -67.46 -8.85 36.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 155' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.55 -30.73 71.76 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.02 -1.05 . . . . 0.0 111.779 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 156' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -107.69 -33.76 7.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.025 1.73 . . . . 0.0 113.468 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 157' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -149.75 72.03 9.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.321 1.048 . . . . 0.0 111.773 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.18 -13.0 38.08 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.856 3.037 . . . . 0.0 114.593 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 159' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -71.52 6.26 1.94 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.221 1.408 . . . . 0.0 114.472 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 160' ' ' LEU . . . . . . . . . . . . . 18.4 tp -111.17 -26.35 9.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.405 1.882 . . . . 0.0 114.187 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.03 -50.05 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.492 1.117 . . . . 0.0 113.564 -165.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 162' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.71 -6.44 55.81 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.337 1.055 . . . . 0.0 113.594 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 163' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.91 -31.49 11.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.36 1.464 . . . . 0.0 112.47 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 164' ' ' LEU . . . . . . . . . . . . . 53.3 mt -115.92 68.36 3.23 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.973 1.709 . . . . 0.0 110.693 168.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 165' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.55 -27.79 18.36 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.562 2.174 . . . . 0.0 113.63 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 166' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -69.31 115.33 8.47 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.485 -1.385 . . . . 0.0 109.665 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 167' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -40.1 81.5 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -164.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 168' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.78 -35.77 87.3 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.065 1.843 . . . . 0.0 113.927 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 169' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -71.85 -35.15 69.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.71 -0.619 . . . . 0.0 111.491 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 170' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.64 -43.73 83.85 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.572 0.749 . . . . 0.0 111.524 172.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 171' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.92 -44.6 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.475 -0.766 . . . . 0.0 111.251 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.71 -37.73 87.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.813 0.733 . . . . 0.0 112.537 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 173' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -61.27 -49.47 76.95 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.582 -0.699 . . . . 0.0 111.557 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.16 -32.73 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 118.527 -0.749 . . . . 0.0 112.062 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 175' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -68.54 -57.74 5.32 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.61 1.095 . . . . 0.0 111.537 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 176' ' ' THR . . . . . . . . . . . . . 36.2 m -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -164.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 177' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.12 -50.69 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.043 -1.036 . . . . 0.0 110.784 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.3 -107.83 2.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.82 0.724 . . . . 0.0 114.111 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 179' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -67.24 134.18 51.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.584 -0.95 . . . . 0.0 112.11 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 180' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -59.02 -30.01 67.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 181' ' ' ASP . . . . . 0.403 ' HA ' ' HE2' ' I' ' 205' ' ' LYS . 3.3 m-20 -83.01 -0.83 50.68 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 182' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.7 -23.74 60.91 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 112.494 165.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 183' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.84 122.14 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.809 1.244 . . . . 0.0 111.034 -169.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 184' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -140.93 172.2 13.02 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.518 1.927 . . . . 0.0 110.301 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 185' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -67.46 -29.71 69.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 186' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -80.68 -45.96 16.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.126 0.97 . . . . 0.0 111.176 -172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 187' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.72 -22.36 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 188' ' ' LEU . . . . . . . . . . . . . 86.1 mt -75.82 -29.2 58.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.3 -0.875 . . . . 0.0 112.254 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 189' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 -78.54 -32.67 48.01 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.037 170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.78 -11.42 58.44 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 167.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 191' ' ' LEU . . . . . . . . . . . . . 47.8 tp -99.18 -7.36 26.68 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.676 1.99 . . . . 0.0 112.644 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.13 25.96 46.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.631 1.11 . . . . 0.0 115.863 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 193' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.27 150.46 25.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.45 1.625 . . . . 0.0 111.598 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 194' ' ' SER . . . . . . . . . . . . . 13.4 p -91.83 157.14 17.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.255 1.422 . . . . 0.0 112.703 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 195' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -52.27 -39.52 60.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.007 1.323 . . . . 0.0 113.721 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 196' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -57.71 -28.13 63.58 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.351 2.26 . . . . 0.0 114.516 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 197' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -93.17 -26.77 17.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.513 1.925 . . . . 0.0 111.181 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 198' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.43 -17.86 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.003 2.121 . . . . 0.0 113.026 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 199' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.53 -51.67 66.48 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.612 -1.305 . . . . 0.0 110.796 162.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 200' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -68.43 175.54 3.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.96 0.904 . . . . 0.0 109.677 161.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 201' ' ' ILE . . . . . . . . . . . . . 21.5 mt 64.59 -61.79 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.005 1.322 . . . . 0.0 112.292 -166.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 202' ' ' LEU . . . . . . . . . . . . . 46.9 mt -63.58 -34.73 78.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.705 1.139 . . . . 0.0 112.022 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -47.14 -37.7 10.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.436 1.094 . . . . 0.0 113.164 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.83 -16.09 30.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 113.737 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 205' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' I' ' 181' ' ' ASP . 25.9 tptp -56.09 -34.13 65.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.549 1.139 . . . . 0.0 112.752 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 206' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -92.36 -9.47 41.68 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.934 1.293 . . . . 0.0 114.274 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 207' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -148.91 10.41 0.81 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -167.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 208' ' ' THR . . . . . . . . . . . . . 4.4 t -47.33 153.05 0.54 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.884 1.22 . . . . 0.0 113.554 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 209' ' ' MET . . . . . . . . . . . . . 11.6 ptp -105.11 -0.48 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.49 1.516 . . . . 0.0 114.022 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.06 154.37 52.84 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-N 118.84 0.746 . . . . 0.0 114.136 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 211' ' ' ALA . . . . . . . . . . . . . . . -101.52 150.01 23.5 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.673 1.989 . . . . 0.0 111.984 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 212' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -70.55 131.42 43.95 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 213' ' ' MET . . . . . . . . . . . . . 64.7 mtt -95.36 134.7 37.87 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.913 1.685 . . . . 0.0 110.674 155.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 214' ' ' ASP . . . . . . . . . . . . 0.263 13.8 t0 -87.55 172.99 9.34 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 215' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -54.81 -33.14 61.21 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -164.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 216' ' ' THR . . . . . 0.422 ' CB ' HH12 ' L' ' 244' ' ' ARG 0.263 23.7 p -114.31 18.41 16.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 175.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 217' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -84.71 -49.16 8.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.3 0.64 . . . . 0.0 109.89 155.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 218' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.36 -25.49 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.576 . . . . 0.0 112.11 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.98 -47.7 84.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.173 -0.918 . . . . 0.0 112.439 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -29.96 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.62 1.555 . . . . 0.0 112.038 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.24 -34.96 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 0.0 110.676 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 222' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -70.09 -37.59 75.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 118.196 -0.906 . . . . 0.0 113.052 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 223' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -60.01 -45.21 93.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.411 1.005 . . . . 0.0 110.604 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 224' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.57 -43.18 93.68 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.817 -0.552 . . . . 0.0 111.902 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.9 -34.07 75.94 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 226' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.85 -35.48 74.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.149 1.38 . . . . 0.0 112.112 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 227' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.8 -35.16 60.16 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.118 -0.989 . . . . 0.0 112.756 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 228' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 -32.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.564 -1.335 . . . . 0.0 111.477 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 229' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.71 -42.79 68.4 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 230' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -68.17 -27.95 66.86 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.367 -0.833 . . . . 0.0 112.952 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 231' ' ' LEU . . . . . . . . . . . . . 98.9 mt -68.94 -30.42 68.86 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.886 1.221 . . . . 0.0 112.537 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 232' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -71.71 -34.89 69.99 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.012 -1.055 . . . . 0.0 112.393 168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 233' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.0 -39.04 92.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.862 0.755 . . . . 0.0 111.606 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 234' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.17 -37.02 83.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.637 1.175 . . . . 0.0 112.044 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 235' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -62.28 -40.9 97.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.528 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 236' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.46 -44.05 97.33 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.599 1.09 . . . . 0.0 111.995 171.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 237' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -56.54 -39.34 73.22 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.285 1.034 . . . . 0.0 111.854 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 238' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.1 -42.91 62.45 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 239' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.03 -43.63 95.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.505 1.048 . . . . 0.0 111.741 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 240' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -70.46 -28.44 65.01 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.069 1.348 . . . . 0.0 113.166 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 241' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -72.6 -46.96 51.65 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.854 0.862 . . . . 0.0 111.686 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 242' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.14 -41.19 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.784 0.834 . . . . 0.0 111.098 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 243' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.39 -15.56 62.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.356 1.063 . . . . 0.0 113.805 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -46.16 4.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.837 1.655 . . . . 0.0 113.127 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 245' ' ' ALA . . . . . . . . . . . . . . . -91.38 -23.75 19.97 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 246' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.96 -2.81 49.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.693 1.133 . . . . 0.0 113.955 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 247' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.74 -0.42 51.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 113.56 172.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 248' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -73.09 147.19 45.19 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.926 -1.109 . . . . 0.0 112.434 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 249' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.46 135.02 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.216 1.807 . . . . 0.0 109.732 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 250' ' ' ALA . . . . . . . . . . . . . . . -147.73 134.5 10.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.868 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 251' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -75.93 148.62 32.03 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.736 2.291 . . . . 0.0 113.58 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 252' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -82.33 -48.65 10.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.41 1.484 . . . . 0.0 112.314 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 253' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.77 -40.63 76.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.882 0.873 . . . . 0.0 111.497 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 254' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -56.06 -27.42 53.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.775 2.03 . . . . 0.0 113.635 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 255' ' ' ALA . . . . . . . . . . . . . . . -100.93 -35.24 9.47 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.9 1.28 . . . . 0.0 113.694 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 256' ' ' LEU . . . . . . . . . . . . . 67.5 tp -72.47 -43.53 63.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.225 0.921 . . . . 0.0 113.095 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 257' ' ' VAL . . . . . . . . . . . . . 18.0 m -117.71 -6.41 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.4 142.91 6.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.505 1.05 . . . . 0.0 112.532 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 259' ' ' ALA . . . . . . . . . . . . . . . -52.15 -48.92 64.65 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -166.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 260' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -67.14 -38.98 86.47 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.49 0.716 . . . . 0.0 112.776 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 261' ' ' LEU . . . . . . . . . . . . . 44.0 tp -72.25 -41.03 67.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.51 0.724 . . . . 0.0 111.589 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 262' ' ' ALA . . . . . . . . . . . . . . . -57.8 -50.64 72.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.447 0.699 . . . . 0.0 111.556 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.39 82.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.791 0.837 . . . . 0.0 112.276 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 264' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -66.92 -51.53 54.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 118.941 0.791 . . . . 0.0 111.776 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 265' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.32 -36.3 73.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.165 0.986 . . . . 0.0 113.022 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 266' ' ' ILE . . . . . . . . . . . . . 44.5 mt -57.8 -27.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.825 1.25 . . . . 0.0 113.039 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 267' ' ' SER . . . . . . . . . . . . . 11.9 t -96.77 -28.92 14.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 268' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.4 -23.5 66.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.802 0.728 . . . . 0.0 112.254 170.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.92 -2.99 56.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.935 1.294 . . . . 0.0 113.677 169.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.67 -36.42 2.65 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.768 -1.208 . . . . 0.0 114.107 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 271' ' ' GLY . . . . . . . . . . . . . . . -170.3 171.29 43.49 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 118.531 1.166 . . . . 0.0 114.942 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 272' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.64 -30.96 71.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.399 -1.059 . . . . 0.0 111.736 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -54.86 39.52 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.096 1.358 . . . . 0.0 110.491 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 274' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.42 -42.9 96.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.266 0.627 . . . . 0.0 112.475 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 275' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.43 -25.09 67.78 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 119.482 1.037 . . . . 0.0 112.948 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 276' ' ' ALA . . . . . . . . . . . . . . . -91.52 -4.54 55.34 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.929 1.692 . . . . 0.0 114.249 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 277' ' ' MET . . . . . . . . . . . . . 20.0 mmt -107.31 -51.04 2.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.046 1.339 . . . . 0.0 111.451 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 278' ' ' MET . . . . . . . . . . . . . 56.4 mtt -54.14 154.37 7.99 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.907 2.083 . . . . 0.0 114.286 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 279' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.58 154.12 27.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.776 2.984 . . . . 0.0 112.445 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 280' ' ' SER . . . . . . . . . . . . . 96.8 p -53.85 -38.31 64.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.776 0.831 . . . . 0.0 113.095 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 281' ' ' SER . . . . . . . . . . . . . 18.4 m -57.54 -29.55 64.47 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 282' ' ' THR . . . . . . . . . . . . . 87.4 m -90.2 -41.87 11.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.11 0.964 . . . . 0.0 110.429 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 283' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.06 -28.98 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.738 1.215 . . . . 0.0 111.622 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 284' ' ' GLN . . . . . 0.405 ' NE2' ' H62' ' A' ' 50' ' ' ' A' . 50.3 tt0 -59.86 -33.49 71.86 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.911 1.685 . . . . 0.0 113.602 172.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 285' ' ' VAL . . . . . . . . . . . . . 32.0 m -113.27 -0.98 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 286' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.45 125.15 10.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.662 1.185 . . . . 0.0 112.329 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 287' ' ' GLY . . . . . . . . . . . . . . . 63.06 32.21 83.37 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.68 -4.85 25.62 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 119.67 1.735 . . . . 0.0 114.314 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 289' ' ' GLU . . . . . . . . . . . . 0.25 43.4 mt-10 49.77 -139.81 0.82 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.225 1.81 . . . . 0.0 111.061 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 290' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -61.15 -10.57 6.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.85 74.09 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.216 -0.927 . . . . 0.0 112.386 170.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 292' ' ' LEU . . . . . . . . . . . . . 48.4 tp -73.03 -43.03 62.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.51 -0.744 . . . . 0.0 110.918 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 293' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -50.4 -53.0 32.57 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.359 1.063 . . . . 0.0 112.174 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 294' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -72.93 -21.86 60.82 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 295' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -67.76 -41.56 83.15 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.168 0.895 . . . . 0.0 112.386 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 296' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.13 -70.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.675 0.671 . . . . 0.0 110.881 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 297' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -38.28 88.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.683 1.593 . . . . 0.0 113.463 -167.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 298' ' ' THR . . . . . . . . . . . . . 3.7 m -105.56 -4.11 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.201 1.0 . . . . 0.0 113.165 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 299' ' ' GLY . . . . . . . . . . . . . . . 68.94 28.18 73.26 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.674 -1.266 . . . . 0.0 115.501 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 300' ' ' ALA . . . . . . . . . . . . . . . -68.95 178.3 2.26 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.11 1.364 . . . . 0.0 113.112 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 301' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -61.55 137.8 94.89 Favored Pre-proline 0 CA--C 1.55 0.965 0 O-C-N 120.85 -1.157 . . . . 0.0 110.285 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 302' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -54.11 143.82 60.98 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.803 2.335 . . . . 0.0 112.959 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 303' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.16 136.52 37.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.047 1.831 . . . . 0.0 111.453 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 304' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -67.69 -25.06 65.5 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.862 -1.149 . . . . 0.0 113.518 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 305' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.58 145.7 9.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.066 1.346 . . . . 0.0 111.336 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 306' ' ' GLY . . . . . . . . . . . . . . . -95.22 -136.8 8.72 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.126 1.346 . . . . 0.0 112.007 164.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 307' ' ' VAL . . . . . . . . . . . . . 54.8 t -54.99 -21.62 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.466 1.506 . . . . 0.0 113.546 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 308' ' ' ILE . . . . . . . . . . . . . 26.3 pt -59.39 -13.86 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.863 -1.148 . . . . 0.0 114.01 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 309' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -59.4 -31.37 69.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.773 1.17 . . . . 0.0 112.407 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 310' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.62 -0.91 7.56 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 311' ' ' TYR . . . . . 0.416 ' CD2' ' HD2' ' I' ' 312' ' ' PRO . 70.0 t80 -65.7 133.33 95.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 120.076 -1.64 . . . . 0.0 110.861 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 312' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' I' ' 311' ' ' TYR . 43.1 Cg_endo -67.91 -0.87 5.99 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.248 2.632 . . . . 0.0 116.824 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 313' ' ' ALA . . . . . . . . . . . . . . . -113.2 10.42 18.57 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.057 1.343 . . . . 0.0 113.778 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 314' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.2 -45.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 315' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -51.61 -46.26 63.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.743 1.217 . . . . 0.0 114.214 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -87.44 -10.3 52.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 317' ' ' SER . . . . . . . . . . . . . 15.8 m -88.96 152.44 48.43 Favored Pre-proline 0 N--CA 1.473 0.675 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -155.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 318' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.11 157.28 46.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.927 2.418 . . . . 0.0 113.155 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 319' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -60.32 -39.08 85.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 320' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -50.19 -32.32 16.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.387 1.875 . . . . 0.0 113.418 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 321' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.23 -26.16 9.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.409 1.884 . . . . 0.0 114.114 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 322' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -50.62 -42.58 56.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 120.557 1.526 . . . . 0.0 113.844 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 323' ' ' GLY . . . . . . . . . . . . . . . -70.92 -44.18 56.31 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.772 0.715 . . . . 0.0 113.877 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 324' ' ' LYS . . . . . 0.486 ' HE2' ' CE1' ' I' ' 366' ' ' TYR . 55.7 mttp -62.1 -44.27 97.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.861 1.265 . . . . 0.0 111.199 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 325' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.51 -41.05 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.998 0.919 . . . . 0.0 110.734 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.71 80.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.821 1.191 . . . . 0.0 113.518 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 327' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -67.78 -50.61 56.14 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.696 0.799 . . . . 0.0 111.865 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.36 83.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 112.786 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 329' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.17 -46.03 91.09 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.377 -0.827 . . . . 0.0 110.479 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.02 -37.09 85.8 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.383 0.992 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 331' ' ' GLY . . . . . . . . . . . . . . . -63.62 -54.43 31.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.699 0.666 . . . . 0.0 112.547 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 332' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -64.23 -31.86 73.22 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.046 -1.267 . . . . 0.0 113.188 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 333' ' ' LEU . . . . . . . . . . . . . 49.9 tp -65.66 -45.0 84.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.384 1.873 . . . . 0.0 111.94 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.13 85.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.255 0.622 . . . . 0.0 111.924 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 335' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.04 -51.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.417 1.087 . . . . 0.0 110.834 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 336' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.62 82.97 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.893 0.77 . . . . 0.0 112.944 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.83 97.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.879 0.472 . . . . 0.0 112.095 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 338' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -38.43 87.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.689 0.796 . . . . 0.0 112.534 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 339' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.16 -49.37 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.314 0.961 . . . . 0.0 111.676 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 340' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -60.92 -33.79 73.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.805 0.73 . . . . 0.0 112.784 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 341' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -91.22 -43.66 9.7 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 342' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.05 -25.3 18.0 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 343' ' ' SER . . . . . . . . . . . . . 22.8 t -119.72 -44.04 2.55 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 344' ' ' GLY . . . . . . . . . . . . . . . 66.43 30.31 76.36 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.24 -0.912 . . . . 0.0 113.416 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 345' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -110.02 170.61 7.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.567 1.947 . . . . 0.0 108.983 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 346' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -123.87 125.32 44.45 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.743 -1.223 . . . . 0.0 111.731 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 347' ' ' ILE . . . . . . . . . . . . . 40.1 pt -137.94 14.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.781 1.633 . . . . 0.0 112.616 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 348' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.63 70.06 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 119.797 -1.815 . . . . 0.0 114.885 -162.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 349' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -75.6 -21.64 57.61 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.348 -0.845 . . . . 0.0 112.669 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 350' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.04 -48.15 46.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.184 0.902 . . . . 0.0 110.095 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 351' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.56 -37.01 74.82 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.16 0.584 . . . . 0.0 111.988 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 352' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.58 -46.55 79.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.07 0.948 . . . . 0.0 112.441 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 353' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.18 -39.65 79.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.219 1.008 . . . . 0.0 112.253 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 354' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -68.52 -46.36 69.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.186 0.594 . . . . 0.0 112.566 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 355' ' ' LEU . . . . . . . . . . . . . 40.6 tp -64.56 -31.61 72.9 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.205 -0.934 . . . . 0.0 111.648 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 356' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.91 -36.45 75.38 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.899 1.28 . . . . 0.0 112.783 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 357' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.52 87.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.798 0.727 . . . . 0.0 111.309 168.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 358' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -61.73 -37.75 85.38 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.503 -0.748 . . . . 0.0 112.654 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 359' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.91 -41.18 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.829 1.195 . . . . 0.0 111.312 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 360' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -62.14 -42.1 98.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.96 0.8 . . . . 0.0 111.506 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 361' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.79 -37.39 87.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.416 0.687 . . . . 0.0 112.083 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 362' ' ' ILE . . . . . . . . . . . . . 46.1 mt -60.52 -40.42 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.066 -1.022 . . . . 0.0 111.058 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 363' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -43.15 88.61 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.753 1.161 . . . . 0.0 111.257 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.37 -19.02 64.61 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.516 1.126 . . . . 0.0 113.379 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 365' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -99.39 -24.56 14.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 366' ' ' TYR . . . . . 0.486 ' CE1' ' HE2' ' I' ' 324' ' ' LYS . 46.8 m-85 . . . . . 0 C--O 1.253 1.271 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -164.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 1' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 2' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.42 165.11 21.08 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.253 2.635 . . . . 0.0 113.988 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 3' ' ' SER . . . . . . . . . . . . . 87.8 p -69.96 -37.68 75.87 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.944 2.097 . . . . 0.0 113.902 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 4' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -72.59 -11.5 60.67 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -164.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.0 144.44 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.505 1.048 . . . . 0.0 112.361 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -116.41 -25.75 7.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.84 1.256 . . . . 0.0 113.764 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 7' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -139.13 151.17 46.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.309 1.843 . . . . 0.0 110.405 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.33 148.63 33.7 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 110.93 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.31 145.19 28.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.372 1.069 . . . . 0.0 111.722 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 10' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.61 -163.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.874 3.049 . . . . 0.0 111.316 160.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -65.31 -13.42 58.44 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.448 -1.408 . . . . 0.0 114.108 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.46 146.52 53.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.712 1.205 . . . . 0.0 111.545 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 13' ' ' LEU . . . . . . . . . . . . . 50.0 mt 59.82 -47.36 0.08 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.509 1.924 . . . . 0.0 114.531 -162.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.02 83.57 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.1 1.318 . . . . 0.0 113.256 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.61 -29.68 70.3 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.872 -1.143 . . . . 0.0 111.719 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.71 -33.51 62.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.917 0.887 . . . . 0.0 112.411 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.43 70.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.827 0.851 . . . . 0.0 112.368 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.93 -43.34 99.07 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.327 0.512 . . . . 0.0 110.448 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 19' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.32 -36.52 75.8 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.445 -0.784 . . . . 0.0 112.945 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.57 90.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.01 0.823 . . . . 0.0 112.518 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 21' ' ' VAL . . . . . . . . . . . . . 77.6 t -59.03 -41.65 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.015 0.825 . . . . 0.0 110.764 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.06 -7.15 15.71 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.5 -21.73 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.23 67.52 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.635 -1.29 . . . . 0.0 111.794 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 25' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -57.38 -34.76 69.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -125.64 4.51 7.51 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 25.6 p -115.75 -13.95 11.4 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.55 -139.91 4.1 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.859 1.695 . . . . 0.0 113.957 -171.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -134.16 127.58 32.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.334 1.454 . . . . 0.0 110.792 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 tt -143.13 153.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.722 1.209 . . . . 0.0 112.069 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 31' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -133.59 156.78 47.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.765 1.226 . . . . 0.0 111.445 164.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 144.69 41.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.209 1.803 . . . . 0.0 112.0 -169.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.22 154.58 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.397 0.998 . . . . 0.0 112.16 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 34' ' ' THR . . . . . . . . . . . . . 28.6 m -77.97 -28.12 49.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 35' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -76.44 -32.31 58.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 122.165 2.257 . . . . 0.0 112.744 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -72.18 -40.15 68.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.771 -1.206 . . . . 0.0 112.506 168.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -55.55 -45.53 77.26 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 168.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 38' ' ' THR . . . . . . . . . . . . . 85.5 m -67.82 -38.34 83.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.848 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 39' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -58.67 -49.9 75.83 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.457 1.481 . . . . 0.0 112.215 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.91 -16.61 62.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 41' ' ' VAL . . . . . 0.473 HG13 ' HE2' ' J' ' 71' ' ' LYS . 2.7 t -84.34 -52.92 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 117.275 -1.345 . . . . 0.0 110.956 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -61.46 -48.09 82.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.429 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 43' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -84.77 25.04 0.96 Allowed 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.051 -1.031 . . . . 0.0 113.318 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.63 -30.18 0.48 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.509 2.004 . . . . 0.0 118.052 168.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -56.55 -20.53 21.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.609 2.363 . . . . 0.0 116.629 -162.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.44 115.72 12.04 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.638 -1.289 . . . . 0.0 111.477 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -27.37 51.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.614 1.966 . . . . 0.0 112.758 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -148.93 139.39 22.51 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.22 1.808 . . . . 0.0 108.348 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -121.7 138.91 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 111.274 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.19 128.16 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.066 1.746 . . . . 0.0 108.199 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 51' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.01 156.0 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 111.778 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.06 158.47 20.43 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.735 -1.228 . . . . 0.0 114.164 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 53' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.15 -5.09 55.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.654 1.582 . . . . 0.0 114.351 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -128.66 22.4 5.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.34 1.456 . . . . 0.0 114.339 -169.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.46 138.06 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.801 0.84 . . . . 0.0 110.034 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -152.47 102.47 2.74 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.881 0.873 . . . . 0.0 110.807 -165.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -60.21 143.65 34.4 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.176 1.099 . . . . 0.0 112.875 -0.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.49 -21.91 65.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -66.6 -23.19 66.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.255 1.422 . . . . 0.0 114.654 -169.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.958 1.254 . . . . 0.0 113.581 -174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.1 -1.76 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.937 1.295 . . . . 0.0 114.164 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.92 -16.14 63.59 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -167.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 63' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -77.31 -25.82 51.6 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.951 1.7 . . . . 0.0 114.226 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.12 -42.31 80.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.104 -1.427 . . . . 0.0 113.458 -169.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -63.03 -55.23 0.83 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 CA-C-N 122.105 1.787 . . . . 0.0 115.144 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 66' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.81 -34.28 50.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 122.505 1.93 . . . . 0.0 112.991 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.86 -27.45 66.69 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.525 -0.734 . . . . 0.0 112.32 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 68' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.52 -17.63 55.94 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.09 -43.67 56.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.33 0.968 . . . . 0.0 111.695 162.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.6 -31.59 72.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.833 1.653 . . . . 0.0 113.287 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 71' ' ' LYS . . . . . 0.473 ' HE2' HG13 ' J' ' 41' ' ' VAL . 1.6 pttt -103.95 -7.85 20.07 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 115.485 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 63.47 68.78 0.59 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.737 1.615 . . . . 0.0 114.943 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 73' ' ' ILE . . . . . 0.444 ' HB ' ' HE3' ' J' ' 71' ' ' LYS . 20.4 mm -138.3 145.07 45.59 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.843 2.057 . . . . 0.0 110.678 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 74' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.55 146.48 39.21 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.499 2.799 . . . . 0.0 114.333 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 75' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.22 147.66 47.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.904 1.682 . . . . 0.0 112.057 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.4 159.3 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.344 1.057 . . . . 0.0 112.014 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.28 155.67 30.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.844 1.258 . . . . 0.0 113.871 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 m -139.03 152.02 69.21 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 126.403 1.881 . . . . 0.0 112.571 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.81 -12.92 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 N-CA-C 118.557 2.483 . . . . 0.0 118.557 -157.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -155.67 126.14 6.78 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.008 1.731 . . . . 0.0 113.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -61.77 -32.57 72.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.03 2.132 . . . . 0.0 114.834 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -69.08 -41.68 77.21 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.343 -0.848 . . . . 0.0 111.851 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.42 -33.03 70.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.655 0.782 . . . . 0.0 111.78 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.81 -41.18 92.21 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.551 -0.718 . . . . 0.0 112.072 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.47 95.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 118.412 0.551 . . . . 0.0 112.595 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.08 83.16 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.64 87.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.338 -0.851 . . . . 0.0 111.88 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.04 6.58 4.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.888 1.275 . . . . 0.0 114.189 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -15.47 30.07 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.599 1.571 . . . . 0.0 116.008 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 90' ' ' ILE . . . . . . . . . . . . . 43.0 pt -77.15 162.85 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.156 1.478 . . . . 0.0 112.027 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 91' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -97.54 -10.58 24.99 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 92' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.09 -155.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.742 1.617 . . . . 0.0 111.185 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.18 173.29 6.44 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.842 -1.161 . . . . 0.0 112.513 171.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.66 125.16 15.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.438 -0.789 . . . . 0.0 110.379 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -27.22 63.35 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 96' ' ' SER . . . . . . . . . . . . . 87.3 p -153.44 163.54 39.75 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 73.8 t -139.0 143.67 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.165 2.186 . . . . 0.0 109.931 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 130.52 52.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.082 1.353 . . . . 0.0 112.708 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.93 118.81 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.597 1.159 . . . . 0.0 109.322 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.01 -39.92 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 109.942 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 101' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -142.6 121.73 7.68 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.058 0.943 . . . . 0.0 109.562 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 102' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -64.39 -12.09 31.44 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.714 2.276 . . . . 0.0 116.057 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.48 -120.03 20.83 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 119.1 0.864 . . . . 0.0 111.206 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -72.05 -20.98 61.6 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.92 23.78 0.98 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -64.23 -51.01 65.74 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.452 -1.405 . . . . 0.0 113.608 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -33.2 66.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.006 0.821 . . . . 0.0 112.096 174.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 108' ' ' LEU . . . . . . . . . . . . . 17.1 tp -75.36 -44.94 42.36 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.772 1.229 . . . . 0.0 112.108 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 109' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.59 -34.2 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.577 0.751 . . . . 0.0 111.056 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.74 -36.43 78.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.739 0.7 . . . . 0.0 112.208 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 111' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -61.45 -47.54 85.25 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.475 1.034 . . . . 0.0 111.416 169.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 112' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.97 -48.65 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.228 0.611 . . . . 0.0 110.025 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.11 91.67 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.033 0.833 . . . . 0.0 112.219 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 114' ' ' MET . . . . . . . . . . . . . 60.4 ttm -64.61 -36.88 85.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.711 0.804 . . . . 0.0 112.846 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.56 -26.86 29.72 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.866 0.866 . . . . 0.0 113.127 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 116' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.58 -33.26 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.043 1.292 . . . . 0.0 111.129 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 117' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -69.4 -4.11 17.09 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.648 -1.283 . . . . 0.0 113.859 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 118' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -81.63 -17.16 49.09 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.178 -1.576 . . . . 0.0 113.353 163.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 119' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.53 -31.18 7.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.487 1.515 . . . . 0.0 113.378 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 120' ' ' MET . . . . . . . . . . . . . 40.6 mtm -76.62 48.46 0.56 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.914 1.686 . . . . 0.0 112.119 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 121' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 125.481 1.513 . . . . 0.0 113.609 -161.151 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.88 167.38 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.129 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 3' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -119.7 127.06 52.52 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.329 1.052 . . . . 0.0 110.697 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.01 136.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.221 1.008 . . . . 0.0 111.508 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.49 161.82 37.43 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.098 1.759 . . . . 0.0 112.547 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -80.21 152.62 29.04 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.258 1.023 . . . . 0.0 112.198 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -99.74 176.08 5.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.516 1.127 . . . . 0.0 112.595 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 8' ' ' LYS . . . . . 0.435 ' HE3' ' CZ ' ' K' ' 9' ' ' PHE . 48.1 pttt -66.05 -16.86 64.29 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 9' ' ' PHE . . . . . 0.435 ' CZ ' ' HE3' ' K' ' 8' ' ' LYS . 14.1 m-85 -112.3 137.72 21.63 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.218 1.407 . . . . 0.0 110.447 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.92 145.66 80.69 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.661 2.241 . . . . 0.0 111.508 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.2 -15.78 8.37 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.289 0.947 . . . . 0.0 114.867 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.34 140.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.807 1.303 . . . . 0.0 110.325 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -124.49 166.84 15.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.766 1.626 . . . . 0.0 111.431 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.45 145.23 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.264 1.826 . . . . 0.0 108.546 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.48 142.53 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.617 0.767 . . . . 0.0 110.389 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 164.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 17' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -85.03 163.6 18.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.525 0.73 . . . . 0.0 112.542 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.04 -25.55 68.17 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.829 -1.169 . . . . 0.0 113.078 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.97 -12.88 61.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.836 1.655 . . . . 0.0 115.086 171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.49 28.59 29.51 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.125 -0.984 . . . . 0.0 113.428 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -121.48 152.8 38.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.872 2.069 . . . . 0.0 111.738 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.91 129.3 34.93 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.818 0.847 . . . . 0.0 109.594 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 23' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.17 141.89 51.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.671 0.788 . . . . 0.0 111.662 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -89.12 144.15 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.824 0.85 . . . . 0.0 112.998 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.67 170.64 19.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.247 1.019 . . . . 0.0 113.134 -169.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 26' ' ' THR . . . . . . . . . . . . . 69.0 p -133.91 157.18 46.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.293 1.437 . . . . 0.0 110.899 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -80.14 122.08 26.36 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.429 -0.795 . . . . 0.0 108.957 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -62.29 126.39 27.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.573 0.749 . . . . 0.0 111.233 -166.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -46.25 -45.73 17.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.319 1.847 . . . . 0.0 112.781 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 30' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.98 141.45 39.54 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 125.375 1.47 . . . . 0.0 109.091 158.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 31' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.36 143.87 31.97 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 111.866 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.57 -10.34 74.27 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.01 1.29 . . . . 0.0 114.6 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -77.53 139.66 39.62 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.068 1.434 . . . . 0.0 112.242 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.84 148.84 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.951 1.7 . . . . 0.0 108.881 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.86 -33.24 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 117.84 -1.076 . . . . 0.0 113.649 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 36' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -142.57 38.39 1.51 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.626 1.203 . . . . 0.0 112.042 169.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.89 23.89 64.02 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.172 1.368 . . . . 0.0 114.27 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -81.95 167.09 19.28 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -156.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -67.73 92.62 0.34 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.944 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.71 145.81 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 111.219 167.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 41' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.76 114.79 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 108.654 -170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 42' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -78.81 139.07 38.44 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.246 1.018 . . . . 0.0 109.773 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -129.45 -175.34 3.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.441 1.496 . . . . 0.0 110.777 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.87 66.86 2.19 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.94 1.296 . . . . 0.0 113.625 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.38 10.86 43.48 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.866 1.222 . . . . 0.0 114.271 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -138.06 163.17 32.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.258 1.423 . . . . 0.0 110.434 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 47' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.63 140.21 45.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.996 -1.065 . . . . 0.0 110.51 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 48' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.83 156.8 40.75 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.031 1.732 . . . . 0.0 111.534 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -131.1 138.43 49.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.278 1.431 . . . . 0.0 111.097 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 tt -74.02 152.32 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.975 0.91 . . . . 0.0 111.661 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 51' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -119.33 87.92 2.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.797 1.639 . . . . 0.0 108.456 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 52' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -71.17 108.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -159.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 53' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.29 -12.41 33.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.874 1.716 . . . . 0.0 113.846 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -81.76 -6.89 59.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.819 1.19 . . . . 0.0 112.535 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 55' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -151.45 43.45 0.76 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.308 1.443 . . . . 0.0 111.283 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 56' ' ' SER . . . . . . . . . . . . . 67.7 m -159.94 110.81 1.93 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.371 -1.456 . . . . 0.0 111.711 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -60.05 -34.64 73.69 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.79 -45.29 86.9 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.767 0.712 . . . . 0.0 111.292 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.82 -44.87 88.15 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.266 0.46 . . . . 0.0 112.582 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.13 96.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.12 0.968 . . . . 0.0 112.168 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -38.98 92.9 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.036 -1.04 . . . . 0.0 112.418 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 62' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.71 -42.02 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.43 -0.794 . . . . 0.0 110.651 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -67.97 -35.76 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.076 0.853 . . . . 0.0 112.229 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -69.02 -3.7 14.07 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.312 1.045 . . . . 0.0 113.27 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.72 34.96 7.05 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.56 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -50.34 129.49 21.75 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.477 1.511 . . . . 0.0 111.082 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 67' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -93.88 -44.63 8.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.294 1.438 . . . . 0.0 113.59 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 68' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.7 98.2 8.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.181 1.793 . . . . 0.0 112.235 -171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 69' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -113.21 109.06 52.12 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 121.504 -0.748 . . . . 0.0 110.921 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 70' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -89.05 -11.95 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.245 2.63 . . . . 0.0 114.523 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 71' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.59 125.27 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.157 0.89 . . . . 0.0 109.083 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -145.48 161.46 41.09 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.94 1.696 . . . . 0.0 109.934 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 73' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.46 143.75 34.31 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.479 2.786 . . . . 0.0 114.734 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.7 -11.5 10.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 75' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -73.16 172.77 10.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.385 1.474 . . . . 0.0 113.74 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 76' ' ' SER . . . . . . . . . . . . . 90.1 p -113.7 133.2 55.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.957 1.303 . . . . 0.0 112.164 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.24 148.19 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.401 1.08 . . . . 0.0 112.492 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 tp -116.48 130.64 56.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.542 1.937 . . . . 0.0 109.498 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.47 133.35 56.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.805 1.242 . . . . 0.0 109.381 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -117.33 112.88 21.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.922 1.689 . . . . 0.0 108.884 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.51 68.37 1.52 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -167.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 tt -98.62 -30.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.63 1.172 . . . . 0.0 113.738 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 83' ' ' ALA . . . . . . . . . . . . . . . 43.8 -87.08 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.955 1.702 . . . . 0.0 114.367 -160.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -141.61 -58.83 0.48 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.35 1.86 . . . . 0.0 110.328 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.85 89.95 0.83 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.887 1.232 . . . . 0.0 116.173 148.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -53.12 -46.14 68.62 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.424 1.112 . . . . 0.0 110.598 153.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 87' ' ' THR . . . . . . . . . . . . . 3.9 t -85.71 -34.89 21.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.011 1.725 . . . . 0.0 112.598 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.2 -34.22 9.76 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -163.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 89' ' ' SER . . . . . . . . . . . . . 88.2 p -60.45 -25.49 66.04 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -165.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 90' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -60.44 -20.31 59.38 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.581 1.952 . . . . 0.0 114.016 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.85 -30.98 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.244 0.929 . . . . 0.0 111.99 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -65.63 -39.21 91.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.806 0.842 . . . . 0.0 112.127 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.13 -40.51 74.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.564 0.746 . . . . 0.0 111.845 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 94' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.12 -40.17 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.991 1.317 . . . . 0.0 111.628 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 95' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.88 -35.02 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 111.25 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 -173.84 38.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.134 1.349 . . . . 0.0 115.391 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 97' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -59.48 -21.03 59.52 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -97.94 -3.9 37.48 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.34 -172.75 18.4 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.87 1.224 . . . . 0.0 114.605 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 100' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -139.94 131.93 27.8 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.378 1.071 . . . . 0.0 112.343 -168.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.91 125.77 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.122 1.369 . . . . 0.0 109.79 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 102' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -99.29 124.09 44.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.639 0.776 . . . . 0.0 109.382 164.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.6 109.31 2.94 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.3 136.23 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.626 1.17 . . . . 0.0 109.493 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -139.42 138.81 36.82 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.849 0.86 . . . . 0.0 111.948 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 106' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -95.32 -32.83 12.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 111.683 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 107' ' ' SER . . . . . . . . . . . . . 5.5 m -65.48 115.26 20.41 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.069 1.748 . . . . 0.0 111.018 -173.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.86 2.96 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.692 2.928 . . . . 0.0 116.789 -156.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 109' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -120.26 -55.99 2.02 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 110' ' ' VAL . . . . . . . . . . . . . 26.4 m -56.31 -34.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -160.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 111' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.34 -19.78 56.77 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.238 -0.914 . . . . 0.0 112.969 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 112' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -62.0 -24.08 66.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.941 1.296 . . . . 0.0 113.319 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 113' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -86.39 -17.6 33.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.145 0.884 . . . . 0.0 113.153 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -76.75 -31.64 57.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.604 -1.31 . . . . 0.0 112.225 169.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 t -50.21 -44.63 81.39 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.915 1.686 . . . . 0.0 115.008 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 116' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.38 -39.81 4.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 CA-C-N 122.883 2.066 . . . . 0.0 113.072 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 117' ' ' ILE . . . . . . . . . . . . . 35.2 mt -60.91 -33.96 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.413 1.085 . . . . 0.0 111.09 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 118' ' ' VAL . . . . . . . . . . . . . 20.6 m -76.7 -1.34 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 119' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.26 -14.1 62.76 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 120.301 1.41 . . . . 0.0 112.261 165.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 120' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.22 -27.07 4.2 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 159.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -76.77 55.99 1.13 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 121.007 1.73 . . . . 0.0 112.944 171.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 122' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -71.16 9.71 0.69 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.954 2.102 . . . . 0.0 115.01 -173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 123' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -92.84 -10.53 36.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 113.067 164.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.85 144.85 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.489 1.516 . . . . 0.0 110.295 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 125' ' ' ILE . . . . . . . . . . . . . 45.5 mt -124.79 123.25 25.62 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.447 1.099 . . . . 0.0 108.976 163.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 126' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.44 130.66 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.788 2.992 . . . . 0.0 112.022 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.63 124.52 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.961 1.304 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.83 121.05 27.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.623 0.769 . . . . 0.0 111.719 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.29 155.13 12.08 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 126.419 1.961 . . . . 0.0 112.924 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 130' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.61 115.06 7.56 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.193 -1.18 . . . . 0.0 112.725 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.82 60.9 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 132' ' ' THR . . . . . . . . . . . . . 19.1 m -66.93 -26.27 66.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.349 1.46 . . . . 0.0 112.236 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 133' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.17 78.06 17.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.166 1.786 . . . . 0.0 108.46 -171.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 134' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.29 -16.7 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.188 3.259 . . . . 0.0 115.297 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -67.34 -22.64 65.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.646 1.978 . . . . 0.0 114.226 171.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 136' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -60.33 -28.43 68.14 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 121.011 1.732 . . . . 0.0 114.327 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -121.37 14.88 11.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.166 1.386 . . . . 0.0 113.915 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -51.46 -25.6 6.72 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.37 -12.85 51.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -121.55 13.45 10.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.262 1.425 . . . . 0.0 113.594 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 141' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.66 173.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.137 1.375 . . . . 0.0 112.307 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 142' ' ' THR . . . . . . . . . . . . . 68.3 p -139.41 -179.45 5.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.127 1.771 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 143' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -56.14 144.47 29.33 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 154.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.42 171.34 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.593 1.957 . . . . 0.0 111.64 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 145' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.65 -31.07 21.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 112.991 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.58 143.54 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.691 1.596 . . . . 0.0 111.266 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 147' ' ' ILE . . . . . . . . . . . . . 45.3 mt -123.43 139.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.079 1.352 . . . . 0.0 110.077 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 148' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -127.19 142.68 51.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.58 1.552 . . . . 0.0 111.678 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -134.99 134.01 40.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.832 1.653 . . . . 0.0 109.94 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 150' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -139.22 -1.98 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 151' ' ' VAL . . . . . . . . . . . . . 96.9 t -90.84 -23.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.243 -1.535 . . . . 0.0 111.876 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.74 48.32 5.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.539 1.536 . . . . 0.0 114.324 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -61.5 158.11 41.66 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.454 1.502 . . . . 0.0 111.84 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 154' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.62 -20.26 26.81 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.816 3.011 . . . . 0.0 115.604 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 155' ' ' THR . . . . . . . . . . . . . 59.1 p -95.63 1.73 53.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.064 1.746 . . . . 0.0 113.564 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -57.24 -31.27 65.37 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 -161.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.65 97.42 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.947 -1.096 . . . . 0.0 111.885 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 158' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.15 -38.55 72.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.794 -1.098 . . . . 0.0 111.756 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 159' ' ' ILE . . . . . . . . . . . . . 60.9 mt -50.48 -56.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 109.908 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 160' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 -45.69 65.68 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.424 1.011 . . . . 0.0 112.705 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 161' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.53 -48.63 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 119.241 0.928 . . . . 0.0 112.101 -170.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -32.13 35.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.907 1.23 . . . . 0.0 112.38 -173.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -57.14 -39.07 74.45 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.559 -1.338 . . . . 0.0 111.022 163.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.49 -6.74 48.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 165' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -81.74 -44.65 16.76 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.482 1.492 . . . . 0.0 111.888 166.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.41 -37.85 24.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 167' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.07 -4.56 11.02 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -163.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 168' ' ' LEU . . . . . . . . . . . . . 19.8 tp -105.17 131.25 52.89 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.447 1.93 . . . . 0.0 113.228 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 169' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -76.1 164.27 26.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.726 1.61 . . . . 0.0 113.714 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -64.81 132.23 48.93 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.325 1.05 . . . . 0.0 109.725 165.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.1 32.78 81.39 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.571 1.082 . . . . 0.0 113.7 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.51 167.23 21.07 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.496 1.522 . . . . 0.0 112.687 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 173' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.98 171.56 13.44 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.535 -0.979 . . . . 0.0 112.465 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.93 166.2 35.5 Favored Glycine 0 CA--C 1.527 0.828 0 O-C-N 121.225 -0.922 . . . . 0.0 113.718 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 175' ' ' MET . . . . . . . . . . . . . 98.5 mtp -142.21 146.98 35.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.64 1.576 . . . . 0.0 110.512 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 176' ' ' ILE . . . . . . . . . . . . . 18.6 tt -149.62 132.53 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.679 0.791 . . . . 0.0 111.746 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 177' ' ' ALA . . . . . . . . . . . . . . . -96.56 102.83 14.68 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.73 0.812 . . . . 0.0 110.914 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 178' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.84 129.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.867 1.667 . . . . 0.0 111.8 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 179' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -120.08 135.69 54.85 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.84 0.746 . . . . 0.0 111.544 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 180' ' ' SER . . . . . . . . . . . . . 94.4 p -66.66 -39.77 88.33 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 181' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -57.23 -28.33 62.82 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 182' ' ' SER . . . . . . . . . . . . . 11.6 m -73.72 -13.97 61.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.1 -40.2 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.005 1.322 . . . . 0.0 110.45 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 184' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -156.86 128.02 6.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.688 0.795 . . . . 0.0 111.514 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 185' ' ' VAL . . . . . . . . . . . . . 4.2 p -88.23 0.37 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 186' ' ' THR . . . . . . . . . . . . . 8.7 m -115.65 -40.86 3.31 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.467 -1.396 . . . . 0.0 113.927 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -84.0 162.75 20.3 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.866 0.757 . . . . 0.0 112.289 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 188' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -62.72 138.71 96.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 121.578 -0.702 . . . . 0.0 112.675 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 189' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.79 -44.98 43.85 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.846 2.364 . . . . 0.0 114.077 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 190' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -65.18 -25.38 67.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.273 -0.892 . . . . 0.0 113.251 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 191' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -75.88 -47.2 26.38 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.54 1.136 . . . . 0.0 110.835 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 192' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.87 -40.53 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.91 1.232 . . . . 0.0 110.829 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 193' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -61.74 -26.46 68.08 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.059 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 194' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -71.37 -41.44 69.68 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.978 1.717 . . . . 0.0 111.86 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 195' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.079 0.399 . . . . 0.0 110.586 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 196' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.2 -43.25 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 118.581 -0.724 . . . . 0.0 111.363 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 197' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.63 -38.48 72.16 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.631 1.56 . . . . 0.0 112.359 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.42 -23.32 40.42 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -81.53 -41.84 21.07 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.305 0.957 . . . . 0.0 111.33 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.4 -39.19 91.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.949 1.3 . . . . 0.0 111.119 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 201' ' ' SER . . . . . . . . . . . . . 80.0 p -75.53 -2.42 28.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -80.73 -3.67 51.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.83 -1.169 . . . . 0.0 112.753 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 203' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -139.11 -34.11 0.6 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 204' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -111.85 162.99 14.7 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.52 116.84 19.18 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 150.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 206' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.99 111.74 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 207' ' ' ILE . . . . . . . . . . . . . 36.6 pt -97.48 -22.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.598 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 208' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -153.95 151.78 29.81 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.844 1.202 . . . . 0.0 113.635 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 209' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -138.26 137.17 37.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.481 2.712 . . . . 0.0 108.862 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 210' ' ' LEU . . . . . . . . . . . . . 7.2 tt -143.01 136.17 28.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.896 1.678 . . . . 0.0 110.276 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 211' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -93.23 142.95 26.74 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.109 0.964 . . . . 0.0 109.829 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 212' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.11 -4.42 49.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 213' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -57.97 141.27 81.24 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 120.714 -1.241 . . . . 0.0 109.892 162.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 214' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -97.04 20.3 29.03 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.839 1.335 . . . . 0.0 114.225 11.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 215' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.08 -77.38 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.15 0.886 . . . . 0.0 109.824 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 216' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -117.01 134.6 54.54 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.637 -0.665 . . . . 0.0 111.371 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 217' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -97.39 142.1 29.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -164.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 218' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 60.2 17.85 7.32 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.411 1.884 . . . . 0.0 114.391 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.33 143.13 39.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.03 2.132 . . . . 0.0 109.326 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 220' ' ' ALA . . . . . . . . . . . . . . . -135.96 160.08 39.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.747 1.619 . . . . 0.0 110.873 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.75 129.35 51.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 222' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -113.31 147.55 37.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.434 1.494 . . . . 0.0 111.159 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 223' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.54 137.83 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.756 1.223 . . . . 0.0 110.01 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 224' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.92 156.44 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.866 1.267 . . . . 0.0 113.956 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 225' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -119.56 137.45 53.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.423 1.889 . . . . 0.0 110.819 167.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 226' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -92.7 128.15 45.2 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.706 1.602 . . . . 0.0 107.494 158.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 227' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.871 3.047 . . . . 0.0 114.501 -160.092 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 16.1 t80 . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 2' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.65 147.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.471 1.032 . . . . 0.0 111.243 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 3' ' ' SER . . . . . . . . . . . . . 13.2 t -150.57 159.62 44.37 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.972 2.109 . . . . 0.0 110.212 169.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -136.32 151.65 49.83 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.991 -1.068 . . . . 0.0 113.034 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -136.16 -179.06 5.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.581 1.153 . . . . 0.0 111.533 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -49.66 -23.48 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.777 2.031 . . . . 0.0 115.735 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 7' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -101.8 -20.79 14.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.27 -163.02 36.57 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 117.766 1.866 . . . . 0.0 117.766 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.36 134.32 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 127.839 2.456 . . . . 0.0 109.585 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.14 137.42 47.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 110.14 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.79 54.1 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.84 0.856 . . . . 0.0 112.549 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 12' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.17 151.25 48.59 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.477 1.511 . . . . 0.0 112.308 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -178.1 4.36 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.35 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.83 -20.6 65.92 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -88.79 -35.0 16.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.974 1.309 . . . . 0.0 112.392 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 19.12 4.3 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.172 1.844 . . . . 0.0 114.856 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 17' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -92.83 140.07 29.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.155 1.382 . . . . 0.0 111.23 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 18' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.87 131.98 43.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.244 1.018 . . . . 0.0 111.664 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 19' ' ' ILE . . . . . . . . . . . . . 81.4 mt -97.74 -50.43 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.55 1.94 . . . . 0.0 110.797 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -161.02 154.7 22.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.729 1.611 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 152.26 49.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.403 1.081 . . . . 0.0 112.548 164.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -140.39 145.05 36.58 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.018 1.327 . . . . 0.0 110.491 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 23' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -107.72 156.94 18.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.449 1.1 . . . . 0.0 112.126 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.06 138.67 57.33 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 25' ' ' THR . . . . . . . . . . . . . 77.8 p -90.42 -37.05 14.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.016 2.126 . . . . 0.0 112.852 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -87.58 -178.47 6.12 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.375 1.87 . . . . 0.0 111.236 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 27' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -65.67 123.0 83.46 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.124 -1.61 . . . . 0.0 108.374 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.85 -33.51 84.39 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.615 2.21 . . . . 0.0 114.753 -156.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -61.81 -29.2 70.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.621 1.1 . . . . 0.0 113.392 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -68.01 -35.76 78.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.268 1.027 . . . . 0.0 111.707 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 31' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.79 -39.76 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.832 0.853 . . . . 0.0 110.715 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.29 -43.21 98.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.146 -0.93 . . . . 0.0 112.03 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -58.84 -41.99 88.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.384 1.447 . . . . 0.0 112.117 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 34' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -62.49 -52.43 63.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.154 0.982 . . . . 0.0 111.625 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 35' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.59 -26.49 65.41 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 36' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.0 -28.8 63.63 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.342 0.973 . . . . 0.0 112.182 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 37' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -87.89 -11.55 47.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 167.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.81 13.37 69.75 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.8 1.667 . . . . 0.0 114.969 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.09 136.29 46.54 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.768 1.284 . . . . 0.0 110.177 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -95.17 137.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.493 0.717 . . . . 0.0 112.218 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -122.7 167.04 13.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.608 1.563 . . . . 0.0 112.594 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 42' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -40.85 -40.91 1.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.258 2.223 . . . . 0.0 113.928 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.22 -38.39 90.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.051 1.74 . . . . 0.0 112.089 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -88.29 -34.6 17.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.043 0.937 . . . . 0.0 111.685 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 45' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -55.86 -31.94 63.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.277 1.031 . . . . 0.0 112.596 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.45 -45.25 88.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.601 0.76 . . . . 0.0 111.81 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tt -73.52 -39.25 64.92 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.693 0.797 . . . . 0.0 112.096 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 48' ' ' LEU . . . . . . . . . . . . 0.301 1.1 pp -72.15 -24.42 61.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.842 1.201 . . . . 0.0 113.596 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 49' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.37 -41.12 57.19 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 111.551 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 50' ' ' SER . . . . . . . . . . . . . 28.7 t -53.61 -47.89 69.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 0.0 111.861 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.44 -23.26 46.69 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.628 -1.295 . . . . 0.0 113.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 52' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.36 -45.57 90.57 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.126 0.876 . . . . 0.0 110.651 164.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.23 -31.74 69.28 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.201 1.401 . . . . 0.0 112.996 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 54' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -74.98 1.2 13.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.611 1.565 . . . . 0.0 113.696 168.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.03 59.5 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 163.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 56' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.98 148.83 27.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.071 1.435 . . . . 0.0 113.314 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -121.77 -23.18 5.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.344 1.857 . . . . 0.0 114.043 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 58' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -84.43 44.73 1.06 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.991 1.316 . . . . 0.0 114.515 -163.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 59' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.61 78.4 0.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.037 1.735 . . . . 0.0 114.503 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.78 116.95 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.297 -0.877 . . . . 0.0 111.534 166.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.7 169.41 9.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.56 1.544 . . . . 0.0 111.409 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -95.79 3.04 54.1 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 63' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -136.5 128.32 17.06 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.597 1.09 . . . . 0.0 112.166 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.62 -37.96 53.99 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.945 2.43 . . . . 0.0 115.447 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.99 -34.07 61.92 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.526 -0.734 . . . . 0.0 111.293 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 66' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.66 -41.0 98.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.771 0.429 . . . . 0.0 111.192 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 67' ' ' SER . . . . . . . . . . . . . 26.1 m -62.14 -37.6 85.78 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.456 -0.777 . . . . 0.0 112.472 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 68' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -63.74 -53.59 48.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.114 0.87 . . . . 0.0 111.578 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -58.52 -34.03 70.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.169 0.895 . . . . 0.0 112.19 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.65 76.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 71' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -81.8 -16.4 51.05 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.808 -1.183 . . . . 0.0 114.024 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -70.29 -34.42 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.419 1.488 . . . . 0.0 111.752 161.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 73' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.81 10.26 2.35 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.693 1.597 . . . . 0.0 112.657 166.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.95 82.92 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.899 1.714 . . . . 0.0 116.576 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -70.68 154.39 41.9 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.546 1.673 . . . . 0.0 112.896 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 76' ' ' SER . . . . . . . . . . . . . 24.5 m -71.77 41.99 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.953 1.701 . . . . 0.0 113.81 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.65 142.91 31.34 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -163.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 78' ' ' THR . . . . . . . . . . . . . 67.9 p -136.07 178.79 6.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.825 2.05 . . . . 0.0 111.163 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -137.2 133.63 35.38 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -155.82 122.49 5.25 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.092 1.357 . . . . 0.0 110.128 158.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 81' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -64.08 -52.98 51.78 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.77 24.73 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.686 2.924 . . . . 0.0 114.792 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -72.15 151.52 42.93 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.654 -1.279 . . . . 0.0 111.601 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 84' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.02 -26.91 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.37 -51.06 69.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.752 0.706 . . . . 0.0 111.831 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.21 69.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.482 0.563 . . . . 0.0 112.663 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 87' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -64.6 -42.78 95.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.589 0.756 . . . . 0.0 111.795 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 88' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -69.9 -52.85 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.408 1.083 . . . . 0.0 112.293 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.39 -41.45 76.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.972 1.309 . . . . 0.0 112.255 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 mtm-85 -88.48 -6.69 57.47 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -95.81 -32.5 12.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.412 1.005 . . . . 0.0 113.51 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 92' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -116.66 53.26 1.13 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.745 1.218 . . . . 0.0 112.26 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 93' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -57.52 -30.99 90.3 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.312 2.008 . . . . 0.0 112.479 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 94' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.56 -21.9 65.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.743 1.617 . . . . 0.0 113.353 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 95' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -76.12 -26.56 56.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 0.0 111.915 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 96' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.41 -20.97 12.72 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -168.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 97' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.07 -0.27 1.68 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.823 1.649 . . . . 0.0 114.519 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -172.37 55.18 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.827 -1.171 . . . . 0.0 113.986 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -71.84 -28.5 63.6 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.876 -1.367 . . . . 0.0 113.318 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 100' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -81.28 16.41 1.62 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.501 1.52 . . . . 0.0 112.424 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 101' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -57.86 -34.58 69.89 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.827 -1.171 . . . . 0.0 113.461 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.62 -29.18 61.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -64.58 -40.86 96.29 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.174 -0.954 . . . . 0.0 111.172 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -67.56 -47.89 68.51 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -58.27 -45.1 88.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.157 0.983 . . . . 0.0 111.636 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 106' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -59.05 -52.61 65.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.374 0.67 . . . . 0.0 110.956 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 107' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -58.95 -45.8 89.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.351 1.46 . . . . 0.0 112.257 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.48 -34.63 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.646 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.09 -47.62 90.2 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.2 0.909 . . . . 0.0 112.627 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.23 -6.96 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.467 -1.02 . . . . 0.0 113.443 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.89 -49.35 6.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.324 1.05 . . . . 0.0 111.232 166.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 112' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.74 -41.28 95.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.577 1.151 . . . . 0.0 111.866 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 113' ' ' THR . . . . . . . . . . . . . 18.8 m -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.647 1.179 . . . . 0.0 113.392 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 114' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -87.18 -25.48 24.04 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.437 1.017 . . . . 0.0 113.055 168.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 115' ' ' MET . . . . . . . . . . . . . 54.5 ttp -81.48 -37.65 27.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.44 1.096 . . . . 0.0 113.588 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -63.12 122.88 17.19 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.923 0.783 . . . . 0.0 111.298 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.34 146.37 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.889 1.676 . . . . 0.0 107.455 167.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 118' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -114.79 153.2 30.8 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.81 161.04 19.91 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.624 2.769 . . . . 0.0 111.663 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 57.4 171.27 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.061 1.745 . . . . 0.0 114.299 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 121' ' ' SER . . . . . . . . . . . . . 39.1 t -155.9 137.32 14.01 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.038 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.41 -40.58 97.79 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -158.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.39 2.97 54.79 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -68.02 -29.42 68.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -159.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -28.11 68.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.049 1.295 . . . . 0.0 112.954 174.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -76.15 -33.82 59.39 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.137 -0.977 . . . . 0.0 111.086 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 127' ' ' MET . . . . . . . . . . . . . 73.1 mtm -69.07 -22.91 63.98 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.413 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 128' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.04 -47.99 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.123 1.329 . . . . 0.0 110.284 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 129' ' ' ILE . . . . . . . . . . . . . 25.9 mt -66.55 -47.45 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.786 0.835 . . . . 0.0 109.799 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 130' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -64.04 -35.17 79.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.809 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.23 73.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.394 0.997 . . . . 0.0 112.732 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 132' ' ' ILE . . . . . . . . . . . . . 16.9 mm -63.8 -47.83 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.749 0.82 . . . . 0.0 110.903 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 133' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.62 -37.63 88.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.207 0.458 . . . . 0.0 111.364 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.86 78.94 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.185 -0.947 . . . . 0.0 112.804 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.29 -43.05 82.72 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.766 0.712 . . . . 0.0 110.587 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 136' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.14 -36.32 72.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.847 0.749 . . . . 0.0 112.303 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -64.47 -44.4 91.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.258 1.023 . . . . 0.0 111.637 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.83 -40.22 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.205 -0.934 . . . . 0.0 111.236 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 139' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.32 -36.61 82.72 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.293 -0.879 . . . . 0.0 112.454 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 140' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -70.07 -42.79 72.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.775 1.23 . . . . 0.0 112.336 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 141' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.99 -32.06 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 119.639 1.109 . . . . 0.0 112.963 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 142' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.48 -47.47 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.091 0.86 . . . . 0.0 109.913 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 143' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -60.08 -38.4 82.77 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.887 0.767 . . . . 0.0 111.821 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 144' ' ' LEU . . . . . 0.414 HD23 ' C ' ' L' ' 144' ' ' LEU . 6.9 tt -65.98 -53.83 33.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.973 1.309 . . . . 0.0 112.683 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 145' ' ' LEU . . . . . . . . . . . . . 59.0 mt -68.15 -31.11 70.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.145 0.884 . . . . 0.0 112.302 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 146' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.73 -30.28 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.136 0.88 . . . . 0.0 111.831 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.85 99.88 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.415 1.461 . . . . 0.0 111.383 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.8 96.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.607 0.763 . . . . 0.0 111.989 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 tp -62.16 -41.39 98.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.355 1.062 . . . . 0.0 112.101 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 150' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -64.23 -49.26 72.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 111.431 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 151' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -66.26 -34.61 78.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.66 0.663 . . . . 0.0 112.522 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -75.18 -50.56 15.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.596 0.758 . . . . 0.0 112.069 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 153' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.66 -18.39 64.27 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.096 -1.003 . . . . 0.0 112.667 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 61.6 m -61.22 -16.48 45.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 168.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 155' ' ' LEU . . . . . . . . . . . . . 77.9 mt -74.94 -9.89 58.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.552 1.069 . . . . 0.0 113.05 170.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -123.93 -36.78 2.67 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.993 1.317 . . . . 0.0 113.284 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 157' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -158.02 70.86 4.08 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.385 1.074 . . . . 0.0 113.834 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 158' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.16 -20.13 33.36 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.343 3.362 . . . . 0.0 115.701 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -50.66 -27.21 6.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.99 1.316 . . . . 0.0 113.947 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 160' ' ' LEU . . . . . . . . . . . . . 12.5 tp -68.74 -24.55 64.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.35 1.06 . . . . 0.0 113.563 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 161' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.01 -31.9 64.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -166.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 162' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.11 -14.5 20.41 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.231 -0.918 . . . . 0.0 112.863 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 163' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.5 -45.49 30.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.435 -0.791 . . . . 0.0 111.734 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 164' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.52 89.0 6.81 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.023 1.329 . . . . 0.0 112.04 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 165' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.54 -22.01 21.67 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.565 2.177 . . . . 0.0 112.96 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 166' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -76.59 97.24 4.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.63 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 167' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -40.09 -47.83 5.83 Favored Pre-proline 0 N--CA 1.477 0.917 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.82 -28.73 76.04 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 122.696 1.998 . . . . 0.0 114.883 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 169' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -71.6 -35.65 70.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.236 1.38 . . . . 0.0 111.634 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 170' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -64.37 -40.74 96.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.675 -0.641 . . . . 0.0 111.367 172.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 171' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.33 -48.11 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.485 -0.759 . . . . 0.0 111.335 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.0 78.96 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -58.38 -53.76 54.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.415 0.686 . . . . 0.0 110.868 170.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.97 -30.25 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.13 -0.981 . . . . 0.0 112.559 -176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 175' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -63.24 -49.15 75.25 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.11 0.868 . . . . 0.0 112.034 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 176' ' ' THR . . . . . . . . . . . . . 8.4 m -85.72 -37.4 19.42 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -167.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 177' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.73 -44.41 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.742 1.217 . . . . 0.0 111.324 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.71 -88.44 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 O-C-N 121.413 -0.804 . . . . 0.0 112.451 -171.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 179' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -85.51 123.43 30.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.417 1.487 . . . . 0.0 111.736 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -16.83 60.37 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.02 -5.8 58.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 182' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -104.13 18.66 21.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.978 1.311 . . . . 0.0 114.533 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 183' ' ' ILE . . . . . . . . . . . . . 23.2 pt -65.26 151.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.919 1.288 . . . . 0.0 113.677 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 184' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -151.81 -169.12 3.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.481 2.312 . . . . 0.0 109.431 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 185' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.4 -39.01 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.834 -1.166 . . . . 0.0 113.786 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.87 -46.25 81.95 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.354 1.061 . . . . 0.0 111.347 -172.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 187' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.88 -11.22 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 188' ' ' LEU . . . . . . . . . . . . . 40.4 mt -101.6 -49.86 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.255 1.422 . . . . 0.0 110.307 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 189' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -66.8 -43.33 84.13 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.623 1.569 . . . . 0.0 111.865 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -33.64 74.96 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.674 -0.641 . . . . 0.0 111.687 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 191' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.83 -6.9 35.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.023 1.329 . . . . 0.0 112.822 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.18 27.36 60.1 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.672 -1.267 . . . . 0.0 113.644 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.83 143.0 53.0 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.863 1.332 . . . . 0.0 108.004 158.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 194' ' ' SER . . . . . . . . . . . . . 67.6 p -78.02 163.11 26.22 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.655 -0.653 . . . . 0.0 111.197 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 195' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.11 -29.72 63.77 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.873 0.844 . . . . 0.0 110.797 170.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 196' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -67.06 -12.83 61.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.751 1.621 . . . . 0.0 113.561 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 197' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -100.94 -28.91 12.5 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.604 1.962 . . . . 0.0 112.432 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 198' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.01 -23.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.852 1.261 . . . . 0.0 111.787 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 199' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -71.85 21.43 0.05 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.196 -1.565 . . . . 0.0 113.894 164.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 200' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -147.9 -175.85 5.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 131.171 3.789 . . . . 0.0 106.657 167.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 201' ' ' ILE . . . . . . . . . . . . . 88.8 mt 66.75 -66.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.4 -1.437 . . . . 0.0 112.216 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 202' ' ' LEU . . . . . . . . . . . . . 69.8 mt -61.1 -42.93 99.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.262 1.025 . . . . 0.0 112.598 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 203' ' ' GLU . . . . . 0.425 ' O ' ' HE3' ' L' ' 207' ' ' LYS . 0.4 OUTLIER -63.45 -11.91 27.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 174.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 204' ' ' ALA . . . . . . . . . . . . . . . -96.58 3.47 52.58 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.036 -1.04 . . . . 0.0 113.544 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -39.62 -45.73 1.69 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.967 2.107 . . . . 0.0 114.717 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 206' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -116.87 -23.01 8.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.883 1.273 . . . . 0.0 114.205 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 207' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' L' ' 203' ' ' GLU . 17.0 pttp -111.85 16.43 20.41 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.151 1.781 . . . . 0.0 114.642 -173.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 208' ' ' THR . . . . . . . . . . . . . 2.3 t -49.47 143.38 6.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.94 0.896 . . . . 0.0 110.251 158.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 209' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -71.44 -7.95 50.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 210' ' ' GLY . . . . . . . . . . . . . . . -76.19 172.81 54.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.934 1.254 . . . . 0.0 115.058 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 211' ' ' ALA . . . . . . . . . . . . . . . -96.65 -125.71 0.13 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.071 1.348 . . . . 0.0 112.177 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 212' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -147.91 107.35 3.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.185 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 213' ' ' MET . . . . . . . . . . . . . 59.2 mtp -81.06 146.55 30.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.359 0.6 . . . . 0.0 109.462 153.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 214' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 151.69 34.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 215' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -51.66 -33.05 31.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.559 1.944 . . . . 0.0 112.885 168.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 216' ' ' THR . . . . . . . . . . . . . 26.0 m -82.14 -33.83 29.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.54 1.536 . . . . 0.0 113.407 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 217' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.7 -35.1 27.05 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.689 0.795 . . . . 0.0 111.843 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -68.74 -11.54 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 113.189 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 219' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -50.69 -42.41 56.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.22 1.408 . . . . 0.0 112.118 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 220' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.32 -27.91 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.536 -0.727 . . . . 0.0 112.024 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 221' ' ' VAL . . . . . . . . . . . . . 3.3 t -83.71 -33.53 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.238 1.015 . . . . 0.0 110.934 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 222' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.78 -46.4 90.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.887 1.275 . . . . 0.0 111.148 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 223' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.57 -43.69 89.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 112.021 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 224' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.54 -41.66 66.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.789 0.835 . . . . 0.0 112.033 171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.48 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 226' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.58 -34.66 76.19 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.585 1.084 . . . . 0.0 112.765 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -45.15 92.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.728 0.811 . . . . 0.0 111.281 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 228' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.01 -32.32 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.838 -1.164 . . . . 0.0 111.928 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 229' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.33 -31.83 73.09 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.53 -1.356 . . . . 0.0 112.382 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -28.95 69.99 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.76 -1.212 . . . . 0.0 112.493 169.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 231' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.48 -28.88 63.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.144 -0.973 . . . . 0.0 113.238 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 232' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.73 -35.38 79.98 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.536 1.516 . . . . 0.0 111.446 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 233' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.9 -42.22 99.7 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.269 169.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 234' ' ' LEU . . . . . . . . . . . . . 62.4 tp -59.19 -45.26 91.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.076 1.307 . . . . 0.0 112.519 172.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 235' ' ' ARG . . . . . . . . . . . . . 49.7 ttt-85 -57.89 -40.43 80.26 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.364 -0.835 . . . . 0.0 111.111 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -41.1 69.11 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.528 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 237' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -58.43 -37.25 75.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.299 1.44 . . . . 0.0 111.795 172.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 238' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.46 -40.02 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.379 0.672 . . . . 0.0 112.576 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 239' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.32 -36.33 83.76 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.604 1.093 . . . . 0.0 112.248 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 240' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.29 -25.06 66.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.925 0.89 . . . . 0.0 112.651 171.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 241' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -94.48 -30.29 14.5 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 242' ' ' ILE . . . . . . . . . . . . . 41.9 mt -57.39 -42.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.9 1.227 . . . . 0.0 110.543 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -50.75 72.66 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.47 0.308 . . . . 0.0 110.857 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 244' ' ' ARG . . . . . 0.422 HH12 ' CB ' ' I' ' 216' ' ' THR . 65.0 ttt180 -58.31 -32.12 68.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 114.281 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.679 -0.638 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 246' ' ' MET . . . . . . . . . . . . . 23.6 mmt -80.84 -34.17 34.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.88 0.872 . . . . 0.0 113.135 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 247' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -92.52 16.68 11.42 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 248' ' ' ASP . . . . . . . . . . . . 0.273 6.8 t0 -74.64 31.42 0.09 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.97 -156.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.406 1.482 . . . . 0.0 109.112 145.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 250' ' ' ALA . . . . . . . . . . . . . . . -116.19 78.73 8.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 120.854 -1.154 . . . . 0.0 113.084 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 251' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -64.35 149.36 90.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.22 2.613 . . . . 0.0 111.594 161.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 252' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -67.72 -41.26 83.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.879 0.872 . . . . 0.0 111.579 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 253' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.31 -46.51 89.63 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.467 0.707 . . . . 0.0 111.92 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 254' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -62.25 -37.72 86.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.852 1.261 . . . . 0.0 112.313 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.3 58.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 256' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.21 -53.22 10.26 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 112.205 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 257' ' ' VAL . . . . . . . . . . . . . 17.8 m -114.23 -2.57 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.79 143.68 6.34 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 122.113 0.84 . . . . 0.0 112.986 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 259' ' ' ALA . . . . . . . . . . . . . . . -54.69 -44.09 73.08 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -167.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 260' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.25 -33.0 72.8 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.997 -1.064 . . . . 0.0 112.767 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 261' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.56 -33.86 25.34 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.865 -0.522 . . . . 0.0 111.713 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.39 -48.88 79.85 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.401 0.546 . . . . 0.0 111.67 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 263' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.57 84.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.504 1.121 . . . . 0.0 112.215 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 264' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -62.92 -45.94 90.11 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.227 -0.921 . . . . 0.0 112.743 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 265' ' ' LEU . . . . . . . . . . . . . 66.7 mt -59.3 -44.99 92.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.366 0.985 . . . . 0.0 111.596 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 266' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.87 -43.14 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.725 0.81 . . . . 0.0 110.767 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 267' ' ' SER . . . . . . . . . . . . . 35.2 t -65.69 -34.15 77.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.688 1.195 . . . . 0.0 113.825 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 268' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.01 -30.14 26.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.299 0.64 . . . . 0.0 112.073 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.73 61.85 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 168.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.71 -10.38 66.49 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.897 1.713 . . . . 0.0 114.593 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.05 172.87 38.36 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.995 1.283 . . . . 0.0 112.798 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 272' ' ' LEU . . . . . . . . . . . . . 54.3 tp -77.88 -33.14 52.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.483 -1.01 . . . . 0.0 113.1 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 273' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -62.47 -44.78 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.916 0.78 . . . . 0.0 109.45 171.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 274' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -64.49 -45.19 88.38 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.077 2.151 . . . . 0.0 110.351 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 275' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.37 -46.23 84.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.393 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.43 -24.22 67.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 277' ' ' MET . . . . . . . . . . . . . 27.3 mmm -82.85 -3.17 56.48 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.719 1.608 . . . . 0.0 113.957 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 278' ' ' MET . . . . . . . . . . . . . 65.5 mtt -91.06 155.33 44.9 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 279' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -82.38 159.93 17.29 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.584 2.856 . . . . 0.0 112.076 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -45.42 -48.02 13.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.575 1.55 . . . . 0.0 111.651 166.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 281' ' ' SER . . . . . . . . . . . . . 1.4 m -61.96 -5.46 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 282' ' ' THR . . . . . . . . . . . . . 62.6 m -113.72 -41.96 3.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.126 1.37 . . . . 0.0 111.206 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 283' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.83 -32.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.462 1.105 . . . . 0.0 111.667 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 284' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -56.44 -32.84 65.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.531 1.532 . . . . 0.0 113.927 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 285' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.74 6.81 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.089 1.356 . . . . 0.0 114.41 -165.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 286' ' ' LEU . . . . . . . . . . . . . 32.8 mt -52.41 125.83 17.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.547 0.739 . . . . 0.0 111.499 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 287' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.73 90.0 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.459 -1.189 . . . . 0.0 115.839 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 288' ' ' ALA . . . . . . . . . . . . . . . -75.59 27.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.106 1.453 . . . . 0.0 112.937 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 289' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -42.96 80.84 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.692 -1.255 . . . . 0.0 113.065 -159.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 290' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -63.68 -21.93 66.64 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.84 -39.9 12.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.354 1.061 . . . . 0.0 112.151 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 292' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.51 -33.01 74.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.428 0.691 . . . . 0.0 112.447 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 293' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.83 -49.95 68.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.385 0.674 . . . . 0.0 111.971 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 294' ' ' ARG . . . . . 0.413 ' HD3' " H4'" ' B' ' 18' ' ' ' A' . 21.9 ptt-85 -68.84 -24.82 64.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 295' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -62.39 -50.0 73.26 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.469 0.708 . . . . 0.0 110.382 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.82 -27.38 57.89 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 297' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -78.85 -40.75 31.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.888 1.275 . . . . 0.0 112.581 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 298' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.77 2.99 2.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -156.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 299' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.82 65.34 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 121.131 -0.981 . . . . 0.0 114.184 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.27 150.03 48.93 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 301' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -45.7 128.55 6.65 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.418 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 302' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.56 152.83 31.81 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.545 2.83 . . . . 0.0 115.414 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 303' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.68 127.89 18.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.677 2.252 . . . . 0.0 112.253 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 304' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.55 -25.51 35.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.095 1.758 . . . . 0.0 113.028 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 305' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -164.72 162.48 21.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 111.468 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 306' ' ' GLY . . . . . . . . . . . . . . . -121.0 -136.49 5.09 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.271 1.415 . . . . 0.0 111.371 165.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 307' ' ' VAL . . . . . . . . . . . . . 28.6 m -51.1 -24.34 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 308' ' ' ILE . . . . . . . . . . . . . 47.0 pt -61.03 -11.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.601 1.56 . . . . 0.0 114.936 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 309' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.0 -23.31 53.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.519 1.508 . . . . 0.0 112.815 168.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 310' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.34 -13.11 60.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 311' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -77.92 126.35 84.08 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 120.046 1.293 . . . . 0.0 110.469 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 312' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.04 -30.64 71.0 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.745 2.296 . . . . 0.0 116.042 -164.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 313' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.66 72.04 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 314' ' ' ILE . . . . . . . . . . . . . 46.0 mt -82.13 -28.88 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 315' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -88.81 26.67 1.47 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.203 1.401 . . . . 0.0 114.044 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 316' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -143.64 48.14 1.44 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.799 1.639 . . . . 0.0 111.978 163.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 317' ' ' SER . . . . . . . . . . . . . 62.4 m -150.98 132.22 7.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.001 1.32 . . . . 0.0 112.825 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 318' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.62 152.93 31.71 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.453 3.435 . . . . 0.0 115.133 169.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 319' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -56.93 -39.66 74.91 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 320' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -43.91 -53.06 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.147 1.379 . . . . 0.0 112.152 168.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 321' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -91.15 -11.09 39.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 322' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -56.01 -49.95 72.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.594 1.543 . . . . 0.0 111.968 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 323' ' ' GLY . . . . . . . . . . . . . . . -68.87 -34.9 78.23 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.387 0.539 . . . . 0.0 113.768 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -68.29 -42.69 79.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.137 0.968 . . . . 0.0 111.506 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 325' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.63 -33.49 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.758 0.823 . . . . 0.0 110.869 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 326' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.02 99.22 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.2 0.909 . . . . 0.0 112.463 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 327' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -58.78 -48.56 80.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.867 0.867 . . . . 0.0 111.945 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 328' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.19 91.37 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 329' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.97 -44.56 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 111.224 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.59 84.22 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 331' ' ' GLY . . . . . . . . . . . . . . . -62.18 -38.09 95.6 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.697 0.665 . . . . 0.0 113.358 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 -36.63 44.35 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.953 0.877 . . . . 0.0 112.865 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 333' ' ' LEU . . . . . . . . . . . . . 36.4 mt -60.72 -37.86 83.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.198 0.908 . . . . 0.0 112.392 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.951 0.9 . . . . 0.0 113.075 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 335' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.18 -52.04 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.377 0.671 . . . . 0.0 109.71 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 336' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.29 77.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.12 72.76 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 338' ' ' ARG . . . . . . . . . . . . . 54.5 mtm-85 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.155 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 339' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.91 -48.82 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.202 0.91 . . . . 0.0 110.118 165.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 340' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.39 -28.93 70.03 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 341' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -98.43 -39.46 8.76 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 342' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -100.05 -32.08 11.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 343' ' ' SER . . . . . . . . . . . . . 97.1 p -117.41 -28.77 6.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 344' ' ' GLY . . . . . . . . . . . . . . . 70.1 23.42 77.19 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 119.839 1.199 . . . . 0.0 115.138 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 345' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -107.22 -177.88 3.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.425 1.89 . . . . 0.0 110.74 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 346' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -129.5 133.05 47.06 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.484 -1.385 . . . . 0.0 112.889 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 347' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.76 4.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.505 1.522 . . . . 0.0 113.758 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 348' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.46 65.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -158.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 349' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -67.77 -41.22 83.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.193 1.36 . . . . 0.0 111.709 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 350' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.78 -35.53 80.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 111.99 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 351' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.79 -43.24 99.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.459 1.027 . . . . 0.0 111.78 171.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 352' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -62.17 -37.44 85.28 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.059 0.944 . . . . 0.0 111.156 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 353' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -70.69 -40.94 72.61 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.126 1.37 . . . . 0.0 113.182 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 354' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -65.91 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.851 0.751 . . . . 0.0 110.917 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 355' ' ' LEU . . . . . . . . . . . . . 56.5 tp -63.35 -43.77 96.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.67 -0.644 . . . . 0.0 112.048 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 356' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.04 -37.36 84.65 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.973 0.806 . . . . 0.0 112.127 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 357' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.14 85.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.868 0.758 . . . . 0.0 112.561 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 358' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -66.75 -34.5 77.98 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.131 -0.981 . . . . 0.0 111.758 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 359' ' ' ILE . . . . . . . . . . . . . 65.8 mt -66.04 -46.03 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.392 -0.818 . . . . 0.0 111.048 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 360' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -62.19 -29.12 70.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 0.0 113.378 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 361' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.34 -47.53 19.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.805 1.642 . . . . 0.0 111.609 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 362' ' ' ILE . . . . . . . . . . . . . 88.5 mt -60.54 -37.32 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.901 -1.124 . . . . 0.0 111.024 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 363' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -64.88 -13.66 57.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.404 1.481 . . . . 0.0 114.988 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 364' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -99.65 -32.0 11.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.319 0.963 . . . . 0.0 112.027 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 365' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -70.38 -40.27 74.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 366' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 116.928 -1.511 . . . . 0.0 114.526 -167.653 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' M' M ' 1' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' M' M ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.06 160.63 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.978 2.452 . . . . 0.0 112.875 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 3' ' ' SER . . . . . . . . . . . . . 85.2 p -74.74 -8.66 57.09 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.571 1.949 . . . . 0.0 115.456 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -92.23 -17.15 25.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 m -84.08 91.59 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.51 1.05 . . . . 0.0 109.828 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -76.04 -38.88 56.65 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 7' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.4 147.88 38.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.325 1.05 . . . . 0.0 111.154 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.76 119.18 21.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.17 139.05 42.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.626 0.77 . . . . 0.0 111.74 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.3 178.92 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.347 2.698 . . . . 0.0 114.13 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -74.46 -29.99 61.69 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.318 -0.864 . . . . 0.0 112.722 163.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.35 176.1 7.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.304 0.642 . . . . 0.0 111.368 161.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 13' ' ' LEU . . . . . . . . . . . . . 51.2 mt 63.96 -55.06 0.23 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.5 1.92 . . . . 0.0 114.734 -168.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.63 80.91 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.138 1.336 . . . . 0.0 113.216 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -60.61 -32.56 71.69 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.44 -0.788 . . . . 0.0 111.654 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -76.7 -31.46 57.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.921 1.289 . . . . 0.0 112.271 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.1 90.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.467 0.707 . . . . 0.0 111.355 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.58 -46.06 91.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.906 0.883 . . . . 0.0 110.522 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -64.17 -25.86 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.96 67.71 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.817 -1.177 . . . . 0.0 112.26 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 21' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.25 -37.29 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.006 0.922 . . . . 0.0 111.082 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 22' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.24 -10.68 11.49 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 23' ' ' ILE . . . . . . . . . . . . . 94.4 mt -120.98 -46.0 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.108 1.322 . . . . 0.0 112.762 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.35 69.63 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.885 -1.134 . . . . 0.0 113.069 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 25' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -45.0 -51.45 9.86 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 128.545 2.738 . . . . 0.0 114.803 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -113.33 -14.63 12.79 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 27' ' ' THR . . . . . . . . . . . . . 34.1 p -95.08 -8.01 37.84 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.56 -123.32 0.99 Allowed Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.046 1.308 . . . . 0.0 113.2 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 29' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -143.26 125.08 15.08 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.598 1.559 . . . . 0.0 111.498 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 30' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.06 155.63 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.044 1.738 . . . . 0.0 111.985 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -130.26 142.08 50.58 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.732 1.213 . . . . 0.0 110.127 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 145.35 37.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.966 1.306 . . . . 0.0 112.147 -166.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.77 151.48 14.09 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 123.909 0.755 . . . . 0.0 111.439 -164.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 34' ' ' THR . . . . . . . . . . . . . 4.3 m -70.39 -31.94 69.37 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.972 -1.311 . . . . 0.0 113.851 -170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 35' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -73.12 -36.64 66.77 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.031 1.287 . . . . 0.0 112.175 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 36' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.6 -33.67 58.41 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.663 -1.273 . . . . 0.0 113.706 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 37' ' ' THR . . . . . . . . . . . . . 81.9 m -53.47 -46.55 69.99 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.877 0.762 . . . . 0.0 109.777 167.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 38' ' ' THR . . . . . . . . . . . . . 69.5 m -63.93 -48.14 77.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.626 1.17 . . . . 0.0 111.466 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -58.27 -38.92 77.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.75 1.159 . . . . 0.0 113.193 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.81 -34.09 71.39 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.51 -41.48 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 110.508 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.97 -33.97 76.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.081 -1.012 . . . . 0.0 113.616 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -75.71 0.41 17.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.548 1.139 . . . . 0.0 113.366 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.04 10.28 61.56 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.558 1.075 . . . . 0.0 115.163 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 45' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -96.0 -20.05 19.0 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.9 139.9 56.49 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.749 0.704 . . . . 0.0 112.122 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -106.88 -21.02 13.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.372 1.469 . . . . 0.0 113.506 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 48' ' ' LEU . . . . . . . . . . . . . 46.7 tp -159.1 143.25 15.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.094 2.558 . . . . 0.0 108.628 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.54 139.25 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.255 1.022 . . . . 0.0 112.425 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.33 132.34 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.781 2.032 . . . . 0.0 109.161 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.54 142.78 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.994 1.318 . . . . 0.0 110.77 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.63 145.8 36.52 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.581 -1.324 . . . . 0.0 113.431 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 53' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.31 -2.41 45.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -122.84 24.62 8.98 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -166.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.59 135.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.109 1.364 . . . . 0.0 112.472 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.04 122.23 5.79 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.701 1.6 . . . . 0.0 111.186 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -64.66 140.16 40.77 Favored 'Cis proline' 0 C--N 1.351 0.679 0 CA-C-N 120.984 1.387 . . . . 0.0 113.235 -1.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.33 -24.29 67.23 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -67.53 -20.7 65.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.599 1.16 . . . . 0.0 114.102 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -37.03 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 120.212 1.369 . . . . 0.0 111.312 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 m -94.2 -14.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.94 -23.83 34.34 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -24.03 66.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.52 -43.7 85.07 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 116.83 -1.557 . . . . 0.0 112.972 -166.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 65' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.08 -55.62 2.15 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.15 1.9 . . . . 0.0 114.411 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 66' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.21 -32.86 51.15 Favored 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 122.561 1.951 . . . . 0.0 113.13 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -69.98 -31.12 68.66 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 113.494 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -84.79 -31.26 24.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.807 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 69' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.92 -39.06 90.19 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.684 1.129 . . . . 0.0 113.126 172.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.17 -24.4 67.38 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.804 0.729 . . . . 0.0 112.382 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 71' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -109.56 10.22 25.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.554 1.942 . . . . 0.0 114.482 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 57.81 32.75 22.35 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.35 1.46 . . . . 0.0 114.862 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm -98.22 131.53 26.15 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.993 1.317 . . . . 0.0 110.115 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.2 144.37 46.3 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.956 2.437 . . . . 0.0 112.943 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -129.95 139.28 51.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.761 1.625 . . . . 0.0 112.724 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 tp -143.16 151.82 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.566 1.146 . . . . 0.0 111.633 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.32 148.91 34.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.368 1.067 . . . . 0.0 112.078 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.29 152.89 75.96 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.898 1.279 . . . . 0.0 113.161 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -62.0 -27.54 79.63 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 119.296 2.768 . . . . 0.0 119.296 -162.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 80' ' ' SER . . . . . . . . . . . . . 44.4 m -158.49 136.88 10.89 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 121.852 2.115 . . . . 0.0 115.417 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 81' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -59.97 -32.75 71.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.022 1.729 . . . . 0.0 115.509 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -75.46 -39.17 59.04 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.298 -0.876 . . . . 0.0 111.786 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -67.57 -36.37 80.79 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.304 0.642 . . . . 0.0 111.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.16 -40.48 90.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.492 0.717 . . . . 0.0 112.371 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.52 97.71 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.359 0.527 . . . . 0.0 112.661 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.94 95.94 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.989 -0.712 . . . . 0.0 112.537 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.13 99.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.349 -0.845 . . . . 0.0 112.069 174.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -8.66 34.82 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.82 3.31 77.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.469 1.509 . . . . 0.0 115.447 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -88.53 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.23 1.515 . . . . 0.0 111.609 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -92.61 -29.52 16.1 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -84.31 -152.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.499 1.519 . . . . 0.0 111.77 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.9 171.16 8.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.698 1.599 . . . . 0.0 112.349 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.95 125.58 20.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.44 0.696 . . . . 0.0 110.211 164.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.73 69.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.46 0.704 . . . . 0.0 112.258 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 96' ' ' SER . . . . . . . . . . . . . 90.0 p -153.49 162.38 41.32 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -141.88 145.1 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.805 2.042 . . . . 0.0 109.843 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.63 140.65 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.383 1.473 . . . . 0.0 112.223 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 99' ' ' ILE . . . . . . . . . . . . . 19.6 mm -97.18 124.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.619 1.168 . . . . 0.0 109.502 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.01 -52.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.16 0.891 . . . . 0.0 110.415 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -118.91 112.6 36.42 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 108.165 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -61.94 -13.99 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.054 2.503 . . . . 0.0 116.167 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.7 -124.69 36.92 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 118.927 0.785 . . . . 0.0 112.165 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -9.03 57.93 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.91 18.08 9.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.004 1.322 . . . . 0.0 114.16 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 106' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -52.61 -49.48 64.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.439 1.472 . . . . 0.0 114.171 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.61 -42.25 74.64 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.385 0.993 . . . . 0.0 111.964 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 108' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.92 -36.23 78.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.997 1.319 . . . . 0.0 113.05 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -72.17 -30.38 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 110' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -73.22 -41.55 63.63 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.889 1.222 . . . . 0.0 112.175 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.62 -35.38 80.34 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.364 0.984 . . . . 0.0 112.867 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 112' ' ' ILE . . . . . . . . . . . . . 19.4 tt -74.65 -42.56 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.3 0.955 . . . . 0.0 111.993 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.61 91.7 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.883 1.22 . . . . 0.0 112.177 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 114' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.27 -47.79 78.2 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.819 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.84 -22.27 61.56 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.24 -38.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.776 1.231 . . . . 0.0 111.373 168.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 117' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -65.56 -29.49 70.11 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.149 -0.969 . . . . 0.0 113.303 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -55.46 -31.79 62.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.842 0.857 . . . . 0.0 112.976 165.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 119' ' ' LEU . . . . . . . . . . . . . 28.4 tp -93.12 -29.58 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.992 1.317 . . . . 0.0 113.47 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 120' ' ' MET . . . . . . . . . . . . . 49.2 mtp -60.91 -15.72 34.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.476 1.511 . . . . 0.0 114.443 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 126.438 1.895 . . . . 0.0 114.521 -168.151 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 m -147.65 149.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.648 1.179 . . . . 0.0 110.303 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 3' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -138.49 143.86 39.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.521 1.129 . . . . 0.0 110.728 169.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.58 131.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.643 1.177 . . . . 0.0 110.242 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 5' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.01 157.69 40.99 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.277 2.631 . . . . 0.0 109.897 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.15 153.25 40.81 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.368 -1.457 . . . . 0.0 112.512 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -107.43 176.95 4.99 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.431 1.092 . . . . 0.0 110.599 160.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -88.05 2.67 51.33 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 9' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -113.52 146.85 36.26 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.566 1.546 . . . . 0.0 110.796 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 10' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.29 142.4 85.86 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.416 2.077 . . . . 0.0 111.134 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.39 -7.73 4.59 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.81 139.55 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.407 1.483 . . . . 0.0 110.934 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -136.29 156.7 48.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.909 1.683 . . . . 0.0 110.642 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 140.95 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.274 1.83 . . . . 0.0 107.702 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.63 152.02 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.115 0.871 . . . . 0.0 112.693 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 16' ' ' ILE . . . . . . . . . . . . . 34.6 mm -113.43 142.04 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.785 1.634 . . . . 0.0 108.668 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -136.22 -176.89 4.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.695 1.998 . . . . 0.0 109.427 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 18' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -75.89 6.08 5.58 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -172.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -27.36 40.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.658 -1.276 . . . . 0.0 111.767 158.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.36 -12.8 68.19 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.863 1.697 . . . . 0.0 116.094 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -81.42 147.45 29.77 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.205 2.002 . . . . 0.0 112.967 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 22' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -69.83 115.91 9.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.515 1.126 . . . . 0.0 110.47 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -101.75 170.49 8.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.83 1.652 . . . . 0.0 110.505 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 pt -118.73 150.79 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.239 1.016 . . . . 0.0 113.096 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.77 171.8 18.32 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.783 1.633 . . . . 0.0 112.645 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 26' ' ' THR . . . . . . . . . . . . . 19.9 p -129.36 156.73 43.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.651 1.58 . . . . 0.0 111.126 168.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -76.08 129.86 37.45 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.356 -0.84 . . . . 0.0 109.898 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -71.94 121.69 19.53 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.819 0.736 . . . . 0.0 112.035 -169.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.14 -37.83 23.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.392 1.877 . . . . 0.0 114.103 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.46 143.08 28.56 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.898 1.279 . . . . 0.0 109.372 152.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.78 157.19 55.83 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.892 3.061 . . . . 0.0 114.022 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.73 -21.98 43.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.163 1.839 . . . . 0.0 114.746 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.68 141.68 31.31 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.151 1.475 . . . . 0.0 113.353 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 34' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -109.45 150.07 28.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.486 1.514 . . . . 0.0 108.683 153.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.27 -26.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.671 0.788 . . . . 0.0 112.976 -168.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -145.53 25.13 1.36 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.97 38.21 36.28 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.682 -1.261 . . . . 0.0 113.315 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -92.51 159.34 15.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.134 1.374 . . . . 0.0 114.586 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 39' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -70.53 137.84 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.004 1.322 . . . . 0.0 110.216 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.08 149.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.213 1.005 . . . . 0.0 111.638 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.74 115.25 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.621 1.569 . . . . 0.0 107.607 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 42' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -82.86 144.18 30.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 43' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -136.9 172.21 13.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.73 1.212 . . . . 0.0 110.543 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 44' ' ' GLU . . . . . . . . . . . . 0.251 6.4 pt-20 -67.29 90.17 0.22 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 123.055 1.407 . . . . 0.0 112.441 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.37 5.83 66.9 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 126.933 2.206 . . . . 0.0 115.621 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 46' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -145.17 169.91 17.26 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 119.887 1.844 . . . . 0.0 113.397 -166.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.36 136.96 33.7 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.468 -1.395 . . . . 0.0 111.451 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.15 143.51 50.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.007 1.723 . . . . 0.0 111.396 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.58 132.51 49.83 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.35 1.46 . . . . 0.0 111.818 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.11 144.93 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.042 0.937 . . . . 0.0 111.782 -168.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 51' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -111.74 73.16 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.914 1.685 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -65.25 126.9 92.29 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 121.317 -0.864 . . . . 0.0 111.616 -172.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 53' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.0 -36.64 9.81 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.54 2.16 . . . . 0.0 113.213 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -62.76 -15.09 51.91 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.532 1.133 . . . . 0.0 113.639 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 55' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -130.16 22.52 5.26 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.796 2.038 . . . . 0.0 112.448 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 56' ' ' SER . . . . . . . . . . . . . 2.3 m -161.93 103.96 1.17 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.566 1.146 . . . . 0.0 111.515 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 57' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -60.34 -30.04 69.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.06 1.344 . . . . 0.0 113.653 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -38.28 71.48 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.239 -0.913 . . . . 0.0 111.916 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -40.51 98.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.203 -0.935 . . . . 0.0 112.163 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.61 79.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 117.747 0.773 . . . . 0.0 112.495 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.59 76.1 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.245 -0.909 . . . . 0.0 113.327 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 62' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.27 -37.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.235 -0.916 . . . . 0.0 111.176 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 63' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.95 -36.14 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.277 -0.889 . . . . 0.0 111.16 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 64' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -77.03 8.48 3.81 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.1 26.11 53.61 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 166.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -47.27 126.18 9.04 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.438 1.495 . . . . 0.0 111.521 171.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -94.62 -45.8 7.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.097 0.959 . . . . 0.0 112.366 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 68' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -92.9 81.69 4.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 69' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.07 115.98 65.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.063 -1.023 . . . . 0.0 110.31 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 70' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -90.3 -15.91 1.83 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.351 2.034 . . . . 0.0 115.747 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -77.59 143.7 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.32 0.964 . . . . 0.0 110.695 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 72' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.19 154.79 72.48 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 126.048 1.739 . . . . 0.0 111.072 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -60.52 154.38 54.38 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.72 2.28 . . . . 0.0 111.898 166.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.41 -12.71 7.14 Favored Glycine 0 CA--C 1.539 1.569 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 75' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.83 -174.26 2.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.799 1.64 . . . . 0.0 111.346 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 76' ' ' SER . . . . . . . . . . . . . 95.9 p -131.19 146.04 52.18 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 114.092 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.77 137.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.832 0.853 . . . . 0.0 112.71 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 78' ' ' LEU . . . . . . . . . . . . . 49.4 tp -97.96 113.41 25.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.713 1.605 . . . . 0.0 109.216 170.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 79' ' ' TYR . . . . . 0.486 ' CE2' ' HA ' ' N' ' 82' ' ' ILE . 1.7 t80 -99.33 128.87 45.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.608 1.163 . . . . 0.0 109.845 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 80' ' ' LEU . . . . . . . . . . . . . 62.9 mt -115.03 118.74 34.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.315 1.446 . . . . 0.0 110.562 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.35 39.24 5.71 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.982 1.277 . . . . 0.0 114.313 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 82' ' ' ILE . . . . . 0.486 ' HA ' ' CE2' ' N' ' 79' ' ' TYR . 16.7 tt -64.67 -28.83 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -166.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 83' ' ' ALA . . . . . . . . . . . . . . . 40.47 -130.07 0.38 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.56 1.544 . . . . 0.0 112.742 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -73.78 7.54 2.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.306 1.443 . . . . 0.0 114.787 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.32 18.39 74.14 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.424 1.33 . . . . 0.0 116.424 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 86' ' ' THR . . . . . . . . . . . . . 13.4 m -47.3 -66.43 0.41 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.388 1.594 . . . . 0.0 113.298 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 87' ' ' THR . . . . . . . . . . . . . 25.2 p -80.73 -23.87 39.16 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.995 -1.065 . . . . 0.0 112.079 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.33 -31.35 71.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 89' ' ' SER . . . . . . . . . . . . . 82.7 p -57.01 -42.81 81.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 112.543 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 90' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -75.98 -34.34 59.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.386 0.674 . . . . 0.0 112.181 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 m -71.84 -27.29 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.583 -1.323 . . . . 0.0 112.699 170.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 92' ' ' SER . . . . . . . . . . . . . 12.6 t -66.45 -34.06 77.09 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.742 1.155 . . . . 0.0 112.882 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 93' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.04 -47.68 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 0.697 . . . . 0.0 111.593 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 94' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.76 -36.74 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.135 1.374 . . . . 0.0 112.882 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.67 -26.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.674 1.19 . . . . 0.0 112.496 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.75 -167.89 40.81 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.232 0.92 . . . . 0.0 114.893 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 97' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -84.8 -16.72 40.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -101.25 9.63 41.59 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.238 1.015 . . . . 0.0 113.192 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.07 173.07 14.53 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.236 1.874 . . . . 0.0 112.276 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 100' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -139.63 135.74 33.61 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -165.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 101' ' ' ILE . . . . . . . . . . . . . 20.0 mt -127.88 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.556 1.142 . . . . 0.0 111.438 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 102' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -102.01 136.9 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.894 0.878 . . . . 0.0 109.884 163.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.91 108.04 1.12 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.004 0.811 . . . . 0.0 111.857 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.41 136.37 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.329 1.051 . . . . 0.0 109.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 105' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -139.11 157.09 46.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 106' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -84.27 -35.87 23.06 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 107' ' ' SER . . . . . . . . . . . . . 13.4 t -120.96 136.98 26.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-N 119.658 1.117 . . . . 0.0 113.216 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 108' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.12 -32.93 63.11 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.237 2.625 . . . . 0.0 112.035 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -70.8 -29.49 65.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.642 0.656 . . . . 0.0 112.584 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -77.87 -39.05 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 110.497 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 111' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.67 -24.52 53.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.376 1.07 . . . . 0.0 113.761 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 112' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -48.74 -40.49 28.76 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.74 1.616 . . . . 0.0 112.47 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.06 -21.89 66.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 113.014 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 114' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.94 -22.83 22.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.416 1.487 . . . . 0.0 113.092 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 115' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.78 -44.68 99.86 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.422 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 116' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.09 -32.01 22.28 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.334 1.869 . . . . 0.0 112.641 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 117' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.51 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.919 -1.113 . . . . 0.0 110.577 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.28 -10.3 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -77.74 2.42 16.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.072 1.305 . . . . 0.0 111.98 167.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 120' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -123.36 -49.96 1.9 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.575 1.55 . . . . 0.0 111.859 162.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 121' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -81.81 65.91 7.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.127 1.371 . . . . 0.0 112.305 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -67.34 5.05 0.81 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 123' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -85.82 -3.53 58.93 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 119.631 1.105 . . . . 0.0 113.903 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mt -109.42 139.85 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 110.209 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 125' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.38 124.57 29.92 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.323 1.049 . . . . 0.0 110.023 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.29 127.02 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.117 3.212 . . . . 0.0 111.652 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 127' ' ' ILE . . . . . . . . . . . . . 71.9 mt -131.72 136.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.102 1.361 . . . . 0.0 110.305 -171.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 128' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.03 115.77 30.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.368 1.067 . . . . 0.0 112.531 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.4 167.71 34.23 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.968 0.794 . . . . 0.0 114.489 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -70.55 106.79 3.59 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.63 -0.923 . . . . 0.0 111.891 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.17 19.61 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 132' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.7 -7.94 59.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.319 1.448 . . . . 0.0 112.588 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 133' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -132.93 73.48 75.54 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.0 2.12 . . . . 0.0 108.661 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 134' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -57.78 -13.9 16.03 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.065 3.177 . . . . 0.0 115.315 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 135' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -54.74 -31.58 58.62 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.444 1.898 . . . . 0.0 113.575 167.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.02 -23.87 21.7 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.481 1.912 . . . . 0.0 115.085 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 137' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.47 15.96 6.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.691 1.196 . . . . 0.0 113.012 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 138' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -52.07 -31.78 31.85 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.95 -2.66 46.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 140' ' ' LEU . . . . . . . . . . . . . 68.9 mt -110.7 -1.52 16.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.996 1.718 . . . . 0.0 113.641 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 141' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.89 179.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.659 1.183 . . . . 0.0 112.469 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 142' ' ' THR . . . . . . . . . . . . . 66.1 p -133.38 -179.93 5.81 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.276 1.831 . . . . 0.0 110.5 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 143' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -57.7 150.05 20.5 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.23 -0.919 . . . . 0.0 110.485 155.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 144' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.23 164.72 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.169 1.788 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -85.74 -30.81 22.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.581 1.152 . . . . 0.0 113.04 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 t -139.73 150.58 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.974 1.31 . . . . 0.0 112.188 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 147' ' ' ILE . . . . . . . . . . . . . 95.1 mt -115.14 142.94 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.99 1.316 . . . . 0.0 110.628 163.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 148' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -128.78 149.34 50.76 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.485 1.514 . . . . 0.0 111.15 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.18 135.41 41.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.346 1.458 . . . . 0.0 111.643 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -145.12 31.31 1.12 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.823 1.249 . . . . 0.0 111.36 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 151' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.42 -28.42 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.113 -1.617 . . . . 0.0 113.803 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.36 24.35 6.51 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 153' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -87.54 160.21 48.23 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 0.0 112.723 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 154' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.93 -27.93 37.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.536 2.824 . . . . 0.0 113.965 173.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 155' ' ' THR . . . . . . . . . . . . . 23.3 p -88.9 2.25 54.06 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.454 1.502 . . . . 0.0 114.61 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 156' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -57.06 -36.38 70.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.209 1.822 . . . . 0.0 114.535 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.84 74.76 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.908 -1.12 . . . . 0.0 113.078 174.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 158' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -64.05 -40.43 96.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.492 1.117 . . . . 0.0 111.672 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 159' ' ' ILE . . . . . . . . . . . . . 67.4 mt -57.09 -50.56 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.24 1.416 . . . . 0.0 110.317 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 160' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.79 -44.76 96.42 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.853 0.751 . . . . 0.0 112.108 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 161' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.07 -50.3 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.134 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -31.38 69.17 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.603 1.547 . . . . 0.0 112.053 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 163' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.31 -1.494 . . . . 0.0 112.683 169.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 164' ' ' ALA . . . . . . . . . . . . . . . -84.47 -13.42 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.654 -1.279 . . . . 0.0 113.941 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 165' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -79.56 -36.82 37.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.379 1.472 . . . . 0.0 110.922 162.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.33 -55.51 4.85 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 167' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.5 -21.25 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -159.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 168' ' ' LEU . . . . . . . . . . . . . 23.7 tp -80.86 129.27 34.44 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.046 1.294 . . . . 0.0 112.485 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 169' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.18 154.01 42.04 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.845 0.858 . . . . 0.0 112.23 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 170' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.44 137.6 58.29 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.325 -0.86 . . . . 0.0 109.731 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 171' ' ' GLY . . . . . . . . . . . . . . . 72.9 4.0 61.27 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -166.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 172' ' ' GLY . . . . . . . . . . . . . . . -78.25 168.0 53.66 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.595 1.198 . . . . 0.0 112.476 167.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 173' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.84 166.74 15.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.398 1.079 . . . . 0.0 113.243 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 174' ' ' GLY . . . . . . . . . . . . . . . -146.16 153.79 25.54 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.123 -0.986 . . . . 0.0 113.208 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 175' ' ' MET . . . . . . . . . . . . . 23.9 mtt -132.97 144.12 49.91 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.816 1.646 . . . . 0.0 110.64 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 176' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.25 135.04 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.282 1.433 . . . . 0.0 110.617 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 177' ' ' ALA . . . . . . . . . . . . . . . -108.6 75.1 0.95 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.965 1.306 . . . . 0.0 110.616 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 178' ' ' VAL . . . . . . . . . . . . . 24.7 t -67.99 107.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.93 1.292 . . . . 0.0 111.188 -166.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -95.11 85.2 4.26 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.653 1.581 . . . . 0.0 108.916 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 180' ' ' SER . . . . . . . . . . . . . 5.3 t -48.98 -46.54 43.89 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -152.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -14.93 54.62 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 182' ' ' SER . . . . . . . . . . . . . 26.7 m -72.03 -25.12 61.69 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.357 0.98 . . . . 0.0 112.804 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 183' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.66 -44.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 110.637 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 184' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -158.62 152.09 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.838 1.255 . . . . 0.0 110.458 166.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 185' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.84 19.04 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.2 1.4 . . . . 0.0 112.208 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 186' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 -39.62 15.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.415 . . . . 0.0 112.15 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -111.89 177.99 4.46 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.687 1.595 . . . . 0.0 113.62 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 188' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.89 133.5 95.28 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.972 0.909 . . . . 0.0 111.591 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 189' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -57.98 -30.33 89.59 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.834 2.356 . . . . 0.0 115.926 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 190' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -61.01 -37.47 82.63 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.31 0.959 . . . . 0.0 112.35 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 191' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -78.7 -30.59 46.11 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.323 -0.86 . . . . 0.0 111.671 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 192' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.68 -44.68 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.783 0.719 . . . . 0.0 110.46 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -58.21 -38.91 77.7 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.028 0.831 . . . . 0.0 112.043 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 194' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.53 -32.93 74.59 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 195' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -76.42 -30.4 57.42 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.925 0.784 . . . . 0.0 112.917 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 196' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.45 -39.74 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.713 -1.242 . . . . 0.0 110.463 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 197' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.4 -34.43 78.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.286 1.034 . . . . 0.0 112.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -22.51 60.07 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.686 1.13 . . . . 0.0 113.948 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.2 -43.66 27.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.165 0.986 . . . . 0.0 110.372 170.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 200' ' ' LEU . . . . . . . . . . . . . 21.8 tp -68.44 -46.15 70.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.121 . . . . 0.0 112.241 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 201' ' ' SER . . . . . . . . . . . . . 88.5 p -76.34 -6.96 53.89 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 202' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -68.92 -23.92 64.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.044 0.937 . . . . 0.0 111.622 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 203' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -120.93 -29.79 4.53 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 204' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -117.21 157.15 26.48 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 205' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -78.68 108.17 11.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 156.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 206' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.97 128.27 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.952 0.901 . . . . 0.0 109.355 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 207' ' ' ILE . . . . . . . . . . . . . 39.9 pt -116.81 -26.81 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 208' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -157.52 142.66 16.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.095 -1.003 . . . . 0.0 112.205 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.56 134.07 42.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.49 2.316 . . . . 0.0 109.074 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 210' ' ' LEU . . . . . . . . . . . . . 34.1 tp -142.3 138.5 31.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.146 0.979 . . . . 0.0 112.872 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 211' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -75.44 144.53 42.09 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.283 1.833 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 mp -104.38 5.43 34.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.78 1.232 . . . . 0.0 113.88 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 213' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.91 144.6 46.75 Favored Pre-proline 0 CA--C 1.55 0.959 0 O-C-N 120.511 -1.368 . . . . 0.0 111.112 162.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 214' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.79 -2.84 60.39 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 120.108 1.074 . . . . 0.0 114.4 0.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 215' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -71.91 -33.96 68.71 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.33 1.052 . . . . 0.0 113.092 -171.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 216' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -124.12 176.29 6.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.889 1.676 . . . . 0.0 112.733 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -126.93 132.11 50.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.564 1.546 . . . . 0.0 111.163 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 218' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 48.82 44.48 21.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.574 1.549 . . . . 0.0 113.181 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 219' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -133.59 131.69 39.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.244 1.417 . . . . 0.0 110.644 -167.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 220' ' ' ALA . . . . . . . . . . . . . . . -142.7 135.43 28.0 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 221' ' ' LEU . . . . . . . . . . . . . 62.4 tp -86.51 128.93 35.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.932 0.893 . . . . 0.0 109.72 170.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 222' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -113.32 147.12 38.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.214 1.006 . . . . 0.0 109.779 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 223' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.82 140.17 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.484 1.114 . . . . 0.0 111.369 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 224' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.2 162.98 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 113.632 -164.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 225' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -128.89 144.6 51.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.182 2.193 . . . . 0.0 111.538 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 226' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.3 117.88 69.18 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 117.055 -1.45 . . . . 0.0 111.158 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 227' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.185 3.257 . . . . 0.0 115.564 -179.726 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' W' W ' 1' ' ' ' U' . . . . . 0.405 " H1'" HD12 ' F' ' 296' ' ' LEU . . . . . . . . 0 O4'--C4' 1.427 -2.163 1 O4'-C1'-N19 113.543 5.343 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' W' W ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.043 1 O4'-C1'-N19 113.192 4.992 . 0.387 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' W' W ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.954 1 O4'-C1'-N19 112.55 4.35 . 0.168 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' W' W ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.975 1 O4'-C1'-N19 115.416 7.216 . 0.371 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' W' W ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.29 1 O4'-C1'-N19 113.076 4.876 . 0.097 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' W' W ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.339 1 O4'-C1'-N19 112.962 4.762 . 0.166 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' W' W ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 0 O5'-C5'-C4' 114.811 3.293 . 0.525 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' W' W ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 1 O4'-C1'-N19 113.361 5.161 . 0.439 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' W' W ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.404 0 O4'-C1'-N19 111.943 3.743 . 0.604 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' W' W ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 0 C5'-C4'-C3' 111.249 -2.834 . 0.651 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' W' W ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 0 O4'-C1'-N19 110.418 2.218 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.3 1 O4'-C1'-N19 113.161 4.961 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.733 1 O4'-C1'-N19 113.19 4.99 . 0.188 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.26 1 C5'-C4'-O4' 115.504 4.503 . 0.286 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.407 -2.034 1 O4'-C1'-N19 112.966 4.766 . 0.572 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.433 -1.691 2 C4'-C3'-C2' 98.325 -4.375 . 0.441 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 1 O4'-C1'-N19 113.825 5.625 . 0.631 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.546 2.751 0 O4'-C1'-N19 111.507 3.307 . 0.256 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.201 1 O4'-C1'-N19 112.903 4.703 . 0.659 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.053 1 O4'-C1'-N19 113.815 5.615 . 0.647 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.006 1 O4'-C1'-N19 114.289 6.089 . 0.485 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.276 1 O4'-C1'-N19 112.781 4.581 . 0.414 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.178 0 O4'-C1'-N19 111.463 3.263 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' Y' Y ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.157 3 O4'-C1'-N19 113.457 5.257 . 0.234 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.455 1 O4'-C1'-N19 113.702 5.502 . 0.154 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.881 1 O4'-C1'-N19 112.864 4.664 . 0.625 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.37 1 O4'-C1'-N19 113.327 5.127 . 0.545 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.411 -1.827 1 O4'-C1'-N19 115.449 7.249 . 0.367 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.268 1 O4'-C1'-N19 113.679 5.479 . 0.404 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 O4'-C1'-N19 113.657 5.457 . 0.698 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Y' Y ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.088 0 O4'-C1'-N19 112.032 3.832 . 0.542 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' Y' Y ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.311 0 C4'-C3'-C2' 98.879 -3.821 . 0.592 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' Y' Y ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.221 1 O4'-C1'-N19 112.871 4.671 . 0.637 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.293 0 O4'-C1'-N19 111.585 3.385 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' Z' Z ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.292 2 O4'-C1'-N19 114.286 6.086 . 0.234 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.423 1 O4'-C1'-N19 113.695 5.495 . 0.015 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.111 1 O4'-C1'-N19 113.095 4.895 . 0.06 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.436 1.829 2 O4'-C1'-N19 112.775 4.575 . 0.609 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.432 -1.766 1 O4'-C1'-N19 113.498 5.298 . 0.567 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.231 1 C3'-C2'-C1' 105.302 4.225 . 0.01 1L . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 1 O4'-C1'-N19 113.972 5.772 . 0.313 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.256 2 O4'-C1'-N19 115.032 6.832 . 0.608 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.499 0 O4'-C1'-N19 111.64 3.44 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' Z' Z ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.443 1 O4'-C1'-N19 114.202 6.002 . 0.694 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 C5'-C4'-O4' 112.981 2.701 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.429 -2.022 1 O4'-C1'-N19 113.121 4.921 . 0.219 1L . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.423 ' C8 ' " H2'" ' A' ' 2' ' ' ' C' . . . . . . . . 0 C5'--C4' 1.537 2.049 1 O4'-C1'-N19 113.144 4.944 . 0.334 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.024 1 O4'-C1'-N19 112.325 4.125 . 0.731 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 113.093 4.893 . 0.658 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.576 1 O4'-C1'-N19 112.999 4.799 . 0.688 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.58 -2.228 0 C4'-C3'-C2' 99.15 -3.55 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.325 1 O4'-C1'-N19 113.538 5.338 . 0.297 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.337 1 O4'-C1'-N19 114.713 6.513 . 0.588 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 P-O3'-C3' 124.745 4.204 . 0.619 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.565 0 O3'-P-O5' 97.761 -3.284 . 0.117 4g . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.381 0 C5'-C4'-O4' 114.17 3.55 . 0.628 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.581 -2.133 1 O4'-C1'-N19 112.241 4.041 . 0.218 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 O4'-C1'-N19 111.229 3.029 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.226 2 C1'-O4'-C4' 105.099 -5.001 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.705 2 P-O3'-C3' 126.746 5.872 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 1 O4'-C1'-N19 112.594 4.394 . 0.386 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 C4'-C3'-C2' 98.837 -3.863 . 0.445 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.047 2 O4'-C1'-N19 112.943 4.743 . 0.498 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.354 0 O4'-C1'-N19 111.25 3.05 . 0.523 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 O4'-C1'-N19 111.83 3.63 . 0.64 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 O4'-C1'-N19 111.758 3.558 . 0.562 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.034 2 C4'-C3'-C2' 97.938 -4.762 . 0.401 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 O4'-C1'-N19 111.865 3.665 . 0.263 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.109 1 O4'-C1'-N19 114.549 6.349 . 0.502 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.209 0 C5'-C4'-C3' 110.546 -3.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 113.111 4.911 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.822 0 O4'-C1'-N19 111.419 3.219 . 0.509 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.216 0 C3'-C2'-C1' 104.11 2.899 OUTLIER-DELTA 0.106 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.767 0 O4'-C1'-N19 111.115 2.915 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 C5'-C4'-C3' 110.106 -3.596 . 0.171 0i . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 1 O4'-C1'-N19 113.014 4.814 . 0.806 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.098 0 O4'-C1'-N19 112.144 3.944 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.55 3.111 1 O4'-C1'-N19 112.688 4.488 . 0.538 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.625 3.15 0 O4'-C1'-N19 111.234 3.034 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.995 0 C3'-C2'-C1' 105.094 3.993 . 0.471 1g . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ' A' . . . . . 0.451 " H2'" ' C8 ' ' A' ' 38' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.429 -2.007 1 O4'-C1'-N19 112.265 4.065 . 0.238 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ' A' . . . . . 0.451 ' C8 ' " H2'" ' A' ' 37' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.538 2.122 1 O4'-C1'-N19 113.958 5.758 . 0.37 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.231 1 O4'-C1'-N19 112.308 4.108 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.146 0 O4'-C1'-N19 111.33 3.13 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 O4'-C1'-N19 113.325 5.125 . 0.594 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.669 0 O4'-C1'-N19 111.618 3.418 . 0.541 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.969 0 C5'-C4'-O4' 113.5 3.071 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.159 1 O4'-C1'-N19 114.151 5.951 . 0.536 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.339 0 O4'-C1'-N19 111.789 3.589 . 0.715 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.249 0 C5'-C4'-C3' 111.069 -2.954 . 0.514 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.568 -3.232 0 C4'-C3'-C2' 99.819 -2.881 . 0.136 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 1 O4'-C1'-N19 113.455 5.255 . 0.808 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.022 0 N19-C1'-C2' 108.912 -2.805 . 0.584 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ' A' . . . . . 0.405 ' H62' ' NE2' ' I' ' 284' ' ' GLN . . . . . . . . 0 O4'--C4' 1.43 -1.884 1 O4'-C1'-N19 115.506 7.306 . 0.669 1c . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.996 0 O4'-C1'-N19 110.77 2.57 . 0.062 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 1 C3'-C2'-C1' 105.108 4.008 . 0.108 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.221 1 O4'-C1'-N19 114.026 5.826 . 0.022 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 O4'-C1'-N19 111.938 3.738 . 0.392 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ' U' . . . . . 0.409 " H2'" ' C8 ' ' A' ' 56' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 O4'-C1'-N19 112.075 3.875 . 0.773 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ' G' . . . . . 0.409 ' C8 ' " H2'" ' A' ' 55' ' ' ' U' . . . . . . . . 0 C5'--C4' 1.538 2.168 0 O4'-C1'-N19 111.273 3.073 . 0.604 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.143 1 O4'-C1'-N19 112.725 4.525 . 0.353 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.025 1 O4'-C1'-N19 112.658 4.458 . 0.695 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.216 1 O4'-C1'-N19 114.604 6.404 . 0.595 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.171 0 C4'-C3'-C2' 99.17 -3.53 . 0.301 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 110.447 2.247 . 0.795 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.289 0 O4'-C1'-N19 111.972 3.772 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.461 2 O4'-C1'-N19 115.6 7.4 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.05 0 C4'-C3'-C2' 100.299 -2.401 . 0.238 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.902 0 C5'-C4'-C3' 110.281 -3.479 . 0.563 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.793 0 O4'-C1'-N19 111.984 3.784 . 0.225 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.422 0 O5'-C5'-C4' 114.423 3.016 . 0.409 0i . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.382 1 O4'-C1'-N19 112.812 4.612 . 0.731 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.178 1 O4'-C1'-N19 112.511 4.311 . 0.676 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.204 1 O4'-C1'-N19 112.406 4.206 OUTLIER-EPSILON 0.489 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 1 P-O3'-C3' 126.52 5.684 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.013 0 N19-C1'-C2' 109.556 -2.403 . 0.189 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 0 C3'-C2'-C1' 103.903 2.669 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.885 2 C4'-C3'-C2' 96.579 -6.121 . 0.199 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.426 1 O4'-C1'-N19 113.959 5.759 . 0.235 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.884 0 O4'-C1'-N19 111.647 3.447 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 C4'-C3'-C2' 99.145 -3.555 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.087 0 O4'-C1'-N19 112.09 3.89 . 0.698 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.29 0 C4'-C3'-C2' 99.664 -3.036 . 0.701 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.062 1 O4'-C1'-N19 114.561 6.361 . 0.431 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.441 0 O4'-C1'-N19 111.796 3.596 . 0.604 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 P-O3'-C3' 123.325 3.021 . 0.396 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.57 -3.067 0 C4'-C3'-C2' 99.949 -2.751 . 0.074 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.532 0 O4'-C1'-N19 111.568 3.368 . 0.674 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.115 1 O4'-C1'-N19 113.086 4.886 . 0.487 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O5'-C5'-C4' 115.608 3.863 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.554 2.696 3 O4'-C1'-N19 113.773 5.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.566 0 O4'-C1'-N19 111.299 3.099 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.41 -1.881 2 O4'-C1'-N19 113.96 5.76 . 0.027 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ' A' . . . . . 0.413 " H4'" ' HD3' ' L' ' 294' ' ' ARG . . . . . . . . 0 C5'--C4' 1.539 2.252 1 C5'-C4'-O4' 116.001 4.858 . 0.188 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.95 1 O4'-C1'-N19 112.816 4.616 . 0.537 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.984 1 O4'-C1'-N19 112.318 4.118 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 O4'-C1'-N19 111.683 3.483 . 0.582 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.427 0 O4'-C1'-N19 111.023 2.823 . 0.267 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.388 1 O4'-C1'-N19 112.892 4.692 . 0.335 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.293 1 O4'-C1'-N19 112.253 4.053 . 0.622 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.228 1 C3'-C2'-C1' 105.47 4.411 . 0.373 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 1 C3'-C2'-C1' 105.297 4.219 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.94 2 O4'-C1'-N19 112.934 4.734 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 112.377 4.177 . 0.615 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.035 0 O4'-C1'-N19 111.951 3.751 . 0.401 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 O4'-C1'-N19 113.254 5.054 . 0.231 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 1 C5'-C4'-C3' 109.381 -4.079 . 0.527 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 1 O4'-C1'-N19 112.528 4.328 . 0.639 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.173 0 O4'-C1'-N19 112.061 3.861 . 0.866 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.451 0 O4'-C1'-N19 111.323 3.123 . 0.714 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.729 0 C3'-C2'-C1' 104.592 3.436 . 0.427 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.222 1 C3'-C2'-C1' 106.159 5.176 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ' A' . . . . . 0.493 " H2'" ' C8 ' ' B' ' 38' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 O4'-C1'-N19 112.064 3.864 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ' A' . . . . . 0.493 ' C8 ' " H2'" ' B' ' 37' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.543 2.54 1 O4'-C1'-N19 113.164 4.964 . 0.0 OUTLIER '7D dist 1a' 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 O4'-C1'-N19 111.085 2.885 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.931 2.731 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.201 0 C4'-C3'-C2' 99.132 -3.568 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.96 0 C4'-C3'-C2' 98.94 -3.76 . 0.538 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.081 0 C4'-C3'-C2' 99.027 -3.673 . 0.596 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 1 O4'-C1'-N19 114.494 6.294 . 0.464 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.282 0 O4'-C1'-N19 111.527 3.327 . 0.689 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 P-O3'-C3' 123.679 3.316 . 0.428 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.477 0 O4'-C1'-N19 110.557 2.357 . 0.257 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.884 1 O4'-C1'-N19 112.588 4.388 . 0.397 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.134 2 O4'-C1'-N19 113.975 5.775 OUTLIER-EPSILON 0.444 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 3 P-O3'-C3' 126.25 5.458 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.344 0 C5'-C4'-O4' 113.779 3.271 . 0.029 7d . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.155 1 O4'-C1'-N19 112.734 4.534 . 0.566 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.074 1 O4'-C1'-N19 113.31 5.11 . 0.593 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.198 1 O4'-C1'-N19 113.679 5.479 . 0.314 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.192 1 O4'-C1'-N19 114.118 5.918 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.117 1 C4'-C3'-C2' 97.677 -5.023 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.118 0 O4'-C1'-N19 112.098 3.898 . 0.691 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.454 1 O4'-C1'-N19 112.946 4.746 . 0.491 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 112.026 3.826 . 0.613 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C4'-C3'-C2' 99.278 -3.422 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.05 0 C4'-C3'-C2' 99.098 -3.602 . 0.618 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 1 C4'-C3'-C2' 98.674 -4.026 . 0.345 1e . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ' C' . . . . . 0.443 " H4'" ' OP2' ' B' ' 63' ' ' ' C' . . . . . . . . 0 P--O5' 1.623 2.982 5 O4'-C1'-N19 117.483 9.283 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.129 0 O4'-C1'-N19 111.918 3.718 . 0.01 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.583 -2.022 1 C5'-C4'-C3' 108.857 -4.429 . 0.415 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 C3'-C2'-C1' 105.039 3.933 . 0.087 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 1 C5'-C4'-O4' 115.26 4.328 . 0.158 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.821 0 O4'-C1'-N19 111.577 3.377 . 0.893 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.876 1 O4'-C1'-N19 113.939 5.739 . 0.898 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.412 -1.725 1 O4'-C1'-N19 112.676 4.476 OUTLIER-EPSILON 0.504 1a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 1 P-O3'-C3' 126.92 6.017 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 C4'-C3'-C2' 100.974 -1.726 . 0.544 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' PHE . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.76 147.15 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.084 0.856 . . . . 0.0 109.946 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 47.6 t -150.26 159.66 44.28 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.634 1.974 . . . . 0.0 110.647 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -135.37 145.46 47.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.584 1.554 . . . . 0.0 110.79 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 179.3 6.71 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.502 0.721 . . . . 0.0 111.995 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -38.35 -33.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -114.2 -8.88 12.93 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.44 -168.12 40.03 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 117.031 1.572 . . . . 0.0 117.031 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -135.01 130.52 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 127.036 2.134 . . . . 0.0 107.92 -165.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 133.95 34.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.614 0.766 . . . . 0.0 112.027 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.59 122.92 49.09 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.164 0.986 . . . . 0.0 111.468 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -122.87 144.19 49.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.385 1.474 . . . . 0.0 110.846 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.28 173.16 11.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.14 -4.25 37.6 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -92.04 -47.07 7.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.938 1.245 . . . . 0.0 111.518 163.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.03 27.58 0.17 Allowed Glycine 0 CA--C 1.534 1.254 0 N-CA-C 117.836 1.894 . . . . 0.0 117.836 163.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -109.53 151.4 26.81 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.536 1.668 . . . . 0.0 112.691 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.03 132.2 45.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 mt -98.18 -54.81 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.617 1.567 . . . . 0.0 109.731 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -152.09 153.58 34.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.996 1.318 . . . . 0.0 111.423 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -133.96 143.86 48.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.259 1.423 . . . . 0.0 112.198 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -124.63 160.4 28.56 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.935 2.094 . . . . 0.0 111.003 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -118.18 155.27 30.78 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.524 1.93 . . . . 0.0 108.368 168.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -71.65 138.2 48.47 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' THR . . . . . . . . . . . . . 46.6 p -90.37 9.9 27.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.341 1.457 . . . . 0.0 113.66 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -142.11 167.74 21.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.342 1.457 . . . . 0.0 110.803 165.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.37 130.19 80.6 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.9 1.28 . . . . 0.0 109.994 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.76 -41.22 47.98 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.257 2.638 . . . . 0.0 114.092 -155.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -59.22 -36.91 76.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.299 0.954 . . . . 0.0 112.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -70.53 -31.73 68.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.648 1.179 . . . . 0.0 112.396 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.18 -40.66 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.434 1.494 . . . . 0.0 111.592 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 mt -68.27 -35.14 77.42 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.211 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.35 -43.74 79.41 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 121.041 1.746 . . . . 0.0 112.434 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.13 -49.85 76.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.622 0.769 . . . . 0.0 111.111 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.72 -28.2 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.541 HD21 ' H ' ' E' ' 139' ' ' ALA . 47.3 mt -76.93 -44.42 31.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.702 1.601 . . . . 0.0 112.057 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.37 -16.03 58.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.187 0.995 . . . . 0.0 113.436 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.81 16.85 4.82 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 167.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -117.61 155.53 29.7 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 120.629 2.215 . . . . 0.0 113.234 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 9.1 tp -82.81 143.99 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.26 . . . . 0.0 112.352 -170.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 62.1 p -129.32 155.42 45.65 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.772 1.229 . . . . 0.0 110.847 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -55.09 -33.15 62.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -72.46 -39.73 67.54 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.47 1.032 . . . . 0.0 112.466 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 tp -70.65 -37.39 73.73 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.446 171.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.58 -44.17 93.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.038 0.935 . . . . 0.0 111.542 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 -35.57 77.9 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.794 -1.191 . . . . 0.0 112.424 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' LEU . . . . . . . . . . . . . 66.8 tp -63.83 -51.59 63.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.753 0.706 . . . . 0.0 111.713 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.48 -26.6 66.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.48 1.036 . . . . 0.0 112.702 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -74.94 -30.8 61.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.707 168.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t -61.59 -42.73 99.28 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.527 1.512 . . . . 0.0 111.746 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.68 -36.78 84.98 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.659 -1.276 . . . . 0.0 111.945 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -67.05 -33.17 74.93 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.257 1.023 . . . . 0.0 113.218 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -71.16 -38.33 72.18 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.55 -1.344 . . . . 0.0 110.94 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.65 0.66 14.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.13 1.372 . . . . 0.0 114.546 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.01 24.21 35.65 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -91.33 125.82 36.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.369 1.585 . . . . 0.0 109.883 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.71 -20.54 13.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -174.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.25 140.35 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.831 1.253 . . . . 0.0 111.788 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -130.41 141.99 50.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 111.916 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -131.6 118.12 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.114 1.366 . . . . 0.0 109.437 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -115.31 178.8 4.16 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.951 1.7 . . . . 0.0 111.695 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -91.68 -41.95 10.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -96.58 133.17 25.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.519 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.05 -30.81 83.34 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.906 2.404 . . . . 0.0 113.636 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -93.41 -33.66 13.75 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.458 -0.776 . . . . 0.0 112.523 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.83 -37.13 75.74 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.924 -0.485 . . . . 0.0 110.354 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -66.23 -37.62 85.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.223 0.609 . . . . 0.0 112.493 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -65.03 -46.34 81.72 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.234 1.414 . . . . 0.0 111.328 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.14 -36.52 84.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.711 0.804 . . . . 0.0 112.467 172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.87 92.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.341 0.973 . . . . 0.0 113.212 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -72.14 -33.23 67.61 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 119.76 1.163 . . . . 0.0 113.382 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.24 -23.78 65.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.555 -0.716 . . . . 0.0 112.72 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -78.52 -6.49 55.6 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.527 1.531 . . . . 0.0 113.722 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.37 25.43 7.01 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -118.0 147.41 43.22 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 119.043 1.421 . . . . 0.0 112.647 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . . . . . . . . . 61.2 m -71.7 76.95 0.84 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.223 1.011 . . . . 0.0 111.8 166.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.02 141.35 37.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.55 -1.344 . . . . 0.0 113.226 -172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' THR . . . . . . . . . . . . . 44.6 p -142.31 175.49 9.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.244 1.818 . . . . 0.0 111.762 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -122.18 130.03 52.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.165 1.386 . . . . 0.0 111.691 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.56 98.27 1.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.697 1.199 . . . . 0.0 108.013 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.24 -37.73 18.06 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.747 -1.22 . . . . 0.0 113.658 -171.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -70.31 14.77 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.823 3.015 . . . . 0.0 116.508 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -72.25 152.81 41.93 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.733 -1.229 . . . . 0.0 113.317 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 70.7 mt -54.82 -36.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.644 1.178 . . . . 0.0 113.78 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.35 81.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.36 0.982 . . . . 0.0 111.977 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.58 -35.97 27.51 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.29 0.471 . . . . 0.0 113.348 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.89 -40.77 98.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.074 0.549 . . . . 0.0 111.385 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -68.61 -53.59 21.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.968 0.907 . . . . 0.0 111.83 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.4 -41.02 75.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.793 0.837 . . . . 0.0 112.435 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -84.66 -18.66 34.67 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.261 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 50.6 m -85.55 -38.51 18.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.323 1.42 . . . . 0.0 113.373 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.05 55.25 17.85 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.038 0.935 . . . . 0.0 111.139 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -58.22 -28.24 83.5 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.07 2.514 . . . . 0.0 113.306 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -63.71 -18.88 64.46 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.67 -23.7 56.25 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.866 1.266 . . . . 0.0 112.423 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -114.98 -37.23 4.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.476 1.11 . . . . 0.0 113.106 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.44 -4.69 13.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.519 1.528 . . . . 0.0 112.927 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.2 174.04 46.85 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.72 1.145 . . . . 0.0 114.445 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -69.99 2.46 3.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -101.05 1.21 39.24 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.996 1.719 . . . . 0.0 113.728 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -45.84 -36.57 5.36 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -165.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.07 -24.93 67.89 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.602 0.761 . . . . 0.0 112.818 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.34 -32.89 72.27 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.32 -0.863 . . . . 0.0 112.822 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -79.36 -39.1 33.43 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.434 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -53.34 -48.05 68.82 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.735 0.814 . . . . 0.0 111.5 168.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.58 -50.82 71.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.928 1.291 . . . . 0.0 112.36 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -61.05 -29.52 69.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.306 1.042 . . . . 0.0 113.157 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.47 -32.33 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.432 0.693 . . . . 0.0 112.466 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.75 89.29 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.625 1.102 . . . . 0.0 112.785 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.82 -33.31 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 122.061 -0.67 . . . . 0.0 112.346 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.62 -38.66 73.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.59 0.756 . . . . 0.0 112.686 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.84 -42.45 97.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.628 0.771 . . . . 0.0 111.182 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' THR . . . . . . . . . . . . . 26.4 m -63.43 -29.89 71.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.278 0.631 . . . . 0.0 112.368 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -75.11 -14.54 60.58 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.921 -1.112 . . . . 0.0 113.85 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' MET . . . . . . . . . . . . . 16.4 ttt -104.52 -26.8 12.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.594 1.958 . . . . 0.0 114.169 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -76.5 32.57 0.13 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 tt -143.38 143.36 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.523 1.929 . . . . 0.0 108.654 170.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -75.22 153.18 38.21 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -133.79 109.66 9.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 109.296 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -146.47 103.86 3.72 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.903 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' SER . . . . . . . . . . . . . 13.8 t -95.22 159.36 15.05 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.075 -1.016 . . . . 0.0 112.467 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.95 -10.04 56.68 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.513 -1.16 . . . . 0.0 114.552 164.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.88 31.65 0.94 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.23 1.015 . . . . 0.0 112.721 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.16 -42.56 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -165.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.45 -33.86 69.74 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.017 0.826 . . . . 0.0 112.428 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -67.29 -36.41 81.49 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.118 -0.988 . . . . 0.0 111.53 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' MET . . . . . . . . . . . . . 22.5 mmt -65.64 -42.11 91.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.83 0.852 . . . . 0.0 111.145 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.53 -40.09 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.825 0.85 . . . . 0.0 111.898 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -60.96 -46.06 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.84 1.2 . . . . 0.0 110.67 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -65.55 -32.81 74.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.253 0.933 . . . . 0.0 112.474 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.08 -34.57 77.93 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.141 0.882 . . . . 0.0 113.073 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -70.05 -42.88 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.567 1.147 . . . . 0.0 111.687 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.44 -38.18 90.11 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.201 0.455 . . . . 0.0 110.637 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.83 75.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.509 0.723 . . . . 0.0 112.177 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -69.88 -40.67 75.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.549 1.068 . . . . 0.0 111.676 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.21 -39.96 74.85 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.611 -0.681 . . . . 0.0 112.324 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' C' ' 140' ' ' LYS . 89.5 m-20 -66.59 -38.16 86.43 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.816 0.734 . . . . 0.0 112.55 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.7 -48.14 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.966 1.306 . . . . 0.0 111.122 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.9 -38.42 85.66 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.27 0.941 . . . . 0.0 111.244 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' C' ' 137' ' ' ASP . 35.7 ttpt -66.67 -37.63 85.17 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.238 1.415 . . . . 0.0 113.784 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.24 -29.21 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.088 1.313 . . . . 0.0 113.143 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.37 -49.18 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.958 0.799 . . . . 0.0 109.218 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -55.55 -40.54 72.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.173 0.897 . . . . 0.0 112.501 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.24 -54.06 39.42 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.363 0.665 . . . . 0.0 112.135 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.08 -30.09 68.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.784 -0.573 . . . . 0.0 112.253 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.26 -35.85 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.845 0.858 . . . . 0.0 111.839 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.78 93.26 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.699 1.136 . . . . 0.0 111.989 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -43.48 81.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.46 0.704 . . . . 0.0 111.735 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.299 1.04 . . . . 0.0 112.393 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -59.07 -51.08 71.6 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.871 0.868 . . . . 0.0 111.41 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.54 -44.15 83.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -70.93 -46.04 63.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.982 0.513 . . . . 0.0 111.812 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.12 -24.89 65.06 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.654 -1.279 . . . . 0.0 112.284 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 71.1 m -63.59 -16.91 62.16 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.82 -32.78 74.63 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.056 1.298 . . . . 0.0 111.457 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -106.78 -21.04 13.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.84 1.256 . . . . 0.0 114.039 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.58 72.33 7.44 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-N 119.867 1.212 . . . . 0.0 112.084 172.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.12 -20.51 67.42 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.184 3.256 . . . . 0.0 115.342 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -70.79 -16.88 62.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.442 1.097 . . . . 0.0 113.25 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.95 -28.5 62.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.842 1.257 . . . . 0.0 113.348 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.63 -48.45 74.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.931 0.892 . . . . 0.0 113.072 -167.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.62 -24.1 61.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.281 1.032 . . . . 0.0 112.266 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.79 -29.92 23.42 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.88 1.272 . . . . 0.0 113.665 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.8 mt -117.42 85.17 19.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.282 1.433 . . . . 0.0 110.399 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.1 -32.81 10.34 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.781 2.32 . . . . 0.0 113.527 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -71.94 112.59 8.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.973 1.309 . . . . 0.0 111.199 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -58.01 -51.22 83.33 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -168.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.43 -28.15 71.08 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 122.701 2.0 . . . . 0.0 113.161 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -71.05 -32.57 69.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.914 -1.116 . . . . 0.0 111.751 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -69.16 -42.1 76.38 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.067 0.947 . . . . 0.0 111.616 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.59 -55.21 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.147 0.979 . . . . 0.0 110.988 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.7 80.61 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.44 -54.5 44.99 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.588 -0.695 . . . . 0.0 111.041 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.14 -36.65 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.794 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.23 -49.45 69.42 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.334 1.454 . . . . 0.0 112.071 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' THR . . . . . . . . . . . . . 34.4 m -90.42 -29.82 17.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.37 -49.87 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 111.889 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.28 -101.52 0.24 Allowed Glycine 0 CA--C 1.535 1.306 0 CA-C-N 118.928 0.785 . . . . 0.0 111.69 -168.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.55 139.06 45.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.428 -1.043 . . . . 0.0 113.548 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -60.76 -13.52 15.61 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.35 -4.46 57.08 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.715 1.598 . . . . 0.0 113.685 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.75 3.98 17.74 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.515 -0.741 . . . . 0.0 112.993 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -77.23 120.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 120.837 -1.164 . . . . 0.0 109.43 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -140.97 151.4 44.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.437 1.495 . . . . 0.0 109.795 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -49.35 -38.64 28.85 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.082 1.353 . . . . 0.0 112.579 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -62.57 -53.72 50.44 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.99 0.916 . . . . 0.0 112.671 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.03 -30.16 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.528 -0.733 . . . . 0.0 112.938 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.44 -34.81 70.6 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.585 -0.697 . . . . 0.0 111.763 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.35 -28.17 47.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.221 1.009 . . . . 0.0 112.957 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.33 -46.96 75.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.259 0.936 . . . . 0.0 111.398 165.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.61 -5.29 3.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.963 1.305 . . . . 0.0 112.826 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.32 70.65 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.646 -1.085 . . . . 0.0 115.129 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.02 157.41 28.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.794 1.297 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' SER . . . . . . . . . . . . . 85.8 p -80.25 153.63 28.38 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.708 -0.62 . . . . 0.0 112.158 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -54.03 -31.55 51.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -62.71 -52.83 61.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.48 1.112 . . . . 0.0 111.912 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -64.23 -31.17 72.26 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.817 -0.552 . . . . 0.0 111.273 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.59 -17.82 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 127.033 2.133 . . . . 0.0 112.702 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -71.65 -26.87 62.73 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.853 -1.154 . . . . 0.0 111.774 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.19 -167.69 1.62 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.279 1.431 . . . . 0.0 109.081 159.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' ILE . . . . . . . . . . . . . 43.6 mt 64.22 -64.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.879 1.672 . . . . 0.0 111.995 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.51 -42.43 98.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 111.74 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -58.19 -37.48 74.85 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.661 -0.65 . . . . 0.0 112.037 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.53 -36.55 52.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 112.578 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -56.88 -34.47 67.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.616 1.166 . . . . 0.0 112.604 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.94 -11.77 60.02 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 4.41 3.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' THR . . . . . . . . . . . . . 8.1 t -49.68 143.13 7.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -94.67 3.17 55.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.927 1.691 . . . . 0.0 113.553 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' GLY . . . . . . . . . . . . . . . -64.86 160.56 41.6 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.951 0.786 . . . . 0.0 114.193 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.71 -165.63 0.65 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.775 1.23 . . . . 0.0 112.024 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -117.31 113.82 22.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.671 1.188 . . . . 0.0 112.024 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 86.9 mtp -93.12 135.18 34.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.53 1.132 . . . . 0.0 109.581 159.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -69.98 168.4 15.47 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.285 -0.885 . . . . 0.0 111.779 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -55.91 -36.67 67.94 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.548 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' THR . . . . . . . . . . . . . 3.0 m -71.01 -26.28 63.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.858 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.41 -50.11 6.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.629 1.172 . . . . 0.0 111.642 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.73 -22.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.295 -0.878 . . . . 0.0 112.833 -168.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.98 -27.63 68.96 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.549 -0.719 . . . . 0.0 111.964 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.42 -40.35 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 120.376 1.443 . . . . 0.0 110.803 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.33 -30.51 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.404 0.682 . . . . 0.0 111.266 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -66.51 -41.84 88.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.983 0.913 . . . . 0.0 112.264 170.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.02 -39.34 90.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.366 1.066 . . . . 0.0 111.373 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.14 -44.15 83.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.62 0.645 . . . . 0.0 111.561 170.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.01 -37.6 84.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.14 -42.63 93.67 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.42 -0.8 . . . . 0.0 112.352 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -24.98 64.01 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 62.6 mt -73.4 -33.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 120.53 -1.356 . . . . 0.0 111.112 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.33 -28.97 63.4 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.846 -1.159 . . . . 0.0 111.98 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -57.89 -50.74 72.32 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.825 -1.172 . . . . 0.0 110.797 162.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.15 -38.59 80.09 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -29.59 68.9 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.041 -1.037 . . . . 0.0 113.154 174.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.12 -41.81 63.61 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.81 0.732 . . . . 0.0 111.301 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.86 -40.45 76.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.059 0.845 . . . . 0.0 111.928 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -53.31 -46.27 69.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.938 0.895 . . . . 0.0 111.679 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.16 -39.47 86.5 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.502 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -61.67 -33.13 73.43 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 119.915 1.234 . . . . 0.0 112.686 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' LEU . . . . . . . . . . . . . 83.4 mt -66.94 -46.49 74.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 0.0 111.991 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.14 -41.35 98.19 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.212 0.605 . . . . 0.0 112.108 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.61 -31.1 61.9 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.598 1.159 . . . . 0.0 113.14 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.42 -48.79 79.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.108 0.867 . . . . 0.0 110.923 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.55 -37.76 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 122.974 0.509 . . . . 0.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.61 -25.33 68.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.154 0.982 . . . . 0.0 113.508 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -87.15 -48.73 7.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.645 1.178 . . . . 0.0 112.524 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.66 -29.35 67.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.246 1.018 . . . . 0.0 113.303 -170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' MET . . . . . . . . . . . . . 96.3 mmm -72.18 7.99 1.49 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.3 -24.39 16.78 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.764 1.62 . . . . 0.0 112.857 167.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -88.83 79.41 7.4 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.906 -1.746 . . . . 0.0 111.929 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.09 136.91 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.481 1.512 . . . . 0.0 112.013 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' ALA . . . . . . . . . . . . . . . -156.68 158.66 31.45 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.241 1.416 . . . . 0.0 113.341 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.61 154.41 11.92 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.663 3.575 . . . . 0.0 113.227 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -79.94 -43.85 21.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.76 1.624 . . . . 0.0 113.719 -170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.33 -31.57 70.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.102 -0.999 . . . . 0.0 112.472 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.54 -29.77 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.292 1.037 . . . . 0.0 112.702 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ALA . . . . . . . . . . . . . . . -92.74 -38.03 12.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.181 0.992 . . . . 0.0 113.292 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.32 -36.84 66.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.59 -30.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.69 166.81 42.58 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 119.121 0.873 . . . . 0.0 114.811 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' ALA . . . . . . . . . . . . . . . -54.71 -41.9 70.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -163.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.29 -34.48 57.47 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.056 1.342 . . . . 0.0 112.562 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 23.6 tp -101.43 -40.55 7.02 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.059 0.944 . . . . 0.0 112.282 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.16 70.81 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.089 0.858 . . . . 0.0 112.763 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' ALA . . . . . . . . . . . . . . . -69.91 -25.86 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.518 -0.739 . . . . 0.0 112.522 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -47.23 66.51 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.23 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.8 -40.14 96.41 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.841 0.746 . . . . 0.0 111.546 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.97 -46.89 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.365 0.666 . . . . 0.0 110.887 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' SER . . . . . . . . . . . . . 13.1 t -69.82 -32.3 70.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.93 -24.81 37.91 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.338 0.972 . . . . 0.0 112.524 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.13 -1.6 49.33 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 164.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.28 -29.41 1.67 Allowed Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.111 1.339 . . . . 0.0 114.845 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.44 173.37 43.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.294 1.547 . . . . 0.0 113.91 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.96 -30.34 61.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.326 -1.102 . . . . 0.0 113.152 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -57.62 -49.46 76.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.3 0.955 . . . . 0.0 109.63 167.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -67.49 -42.1 83.44 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.457 1.103 . . . . 0.0 110.548 -173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.3 -40.94 87.77 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.28 0.632 . . . . 0.0 112.302 171.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.29 -29.69 68.52 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.42 -0.8 . . . . 0.0 112.736 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' MET . . . . . . . . . . . . . 13.4 mmt -80.55 -1.64 42.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.702 1.201 . . . . 0.0 113.95 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' MET . . . . . . . . . . . . . 52.2 mtt -94.12 150.36 38.3 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.171 1.35 . . . . 0.0 113.89 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.2 155.42 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.694 2.929 . . . . 0.0 111.992 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' SER . . . . . . . . . . . . . 67.0 p -50.19 -46.38 54.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.683 1.193 . . . . 0.0 112.986 170.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' SER . . . . . . . . . . . . . 7.9 p -73.7 16.23 0.22 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.188 1.795 . . . . 0.0 114.668 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' THR . . . . . . . . . . . . . 97.4 m -124.68 -36.27 2.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.929 -1.732 . . . . 0.0 110.58 158.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.65 -30.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.851 1.26 . . . . 0.0 112.232 171.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.99 -33.27 64.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.581 . . . . 0.0 113.128 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.97 2.5 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.473 1.509 . . . . 0.0 113.933 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' LEU . . . . . . . . . . . . . 40.2 mt -53.7 129.19 32.31 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.471 -0.768 . . . . 0.0 109.954 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 66.76 26.33 73.05 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.291 -0.727 . . . . 0.0 114.29 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.1 -16.86 57.62 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.96 1.38 . . . . 0.0 112.138 159.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 52.06 -119.88 1.55 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.713 2.005 . . . . 0.0 111.875 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -45.42 -27.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' ALA . . . . . . . . . . . . . . . -77.74 -37.53 49.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.162 0.892 . . . . 0.0 113.135 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' LEU . . . . . . . . . . . . . 49.2 tp -73.13 -47.05 47.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.469 0.577 . . . . 0.0 110.138 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -47.84 -52.78 17.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.983 1.313 . . . . 0.0 113.053 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -83.52 -20.01 34.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -61.5 -34.77 76.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.961 0.8 . . . . 0.0 111.45 165.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 -75.88 0.17 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.701 0.8 . . . . 0.0 111.345 167.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 297' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -55.88 -42.55 76.11 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -163.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 298' ' ' THR . . . . . . . . . . . . . 75.8 p -108.81 6.68 25.74 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 299' ' ' GLY . . . . . . . . . . . . . . . 64.73 28.96 74.02 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.363 -0.836 . . . . 0.0 114.0 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 300' ' ' ALA . . . . . . . . . . . . . . . -71.46 -173.13 0.86 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.668 1.187 . . . . 0.0 114.024 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 301' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.45 126.2 46.31 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.518 1.527 . . . . 0.0 111.32 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 302' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -59.43 132.1 44.32 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.14 1.893 . . . . 0.0 112.228 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 303' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.28 123.49 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.468 2.112 . . . . 0.0 111.617 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.25 -32.64 68.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.047 0.939 . . . . 0.0 112.662 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 305' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.45 149.62 15.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.286 1.834 . . . . 0.0 110.647 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 306' ' ' GLY . . . . . . . . . . . . . . . -100.18 -136.38 9.32 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.701 1.619 . . . . 0.0 112.386 169.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 307' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.1 -14.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.813 1.245 . . . . 0.0 114.353 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 308' ' ' ILE . . . . . . . . . . . . . 39.0 pt -61.03 -12.27 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.092 1.357 . . . . 0.0 114.144 167.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 309' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -53.78 -37.78 63.82 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 310' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.49 19.16 1.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 311' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' C' ' 312' ' ' PRO . 85.2 t80 -62.2 146.1 92.91 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.799 -1.188 . . . . 0.0 111.571 170.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 312' ' ' PRO . . . . . 0.418 ' HD2' ' CD2' ' C' ' 311' ' ' TYR . 20.0 Cg_exo -48.41 1.94 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 1 C-N-CA 127.123 5.215 . . . . 0.0 120.303 176.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 313' ' ' ALA . . . . . . . . . . . . . . . -145.8 22.74 1.42 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.111 1.364 . . . . 0.0 114.421 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 314' ' ' ILE . . . . . . . . . . . . . 68.1 mt -117.94 -70.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.791 -1.193 . . . . 0.0 112.022 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 315' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -64.86 6.51 0.23 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 316' ' ' ARG . . . . . 0.411 ' CZ ' ' HA ' ' C' ' 312' ' ' PRO . 16.8 ptp180 -135.8 18.86 3.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.756 1.622 . . . . 0.0 114.437 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.4 m -142.3 163.41 39.7 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.127 0.971 . . . . 0.0 112.998 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 318' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -59.69 150.11 78.7 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.47 3.447 . . . . 0.0 114.188 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -55.52 -37.93 68.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 320' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -49.32 -37.44 24.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.191 1.796 . . . . 0.0 113.036 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 321' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.45 -33.06 14.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.155 0.982 . . . . 0.0 111.316 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 322' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -54.72 -39.96 68.75 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 323' ' ' GLY . . . . . . . . . . . . . . . -77.13 -37.65 31.91 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 118.575 0.625 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 324' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -73.43 -43.5 60.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.607 1.163 . . . . 0.0 111.464 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 325' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.35 -34.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.961 0.904 . . . . 0.0 111.636 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.18 -46.83 87.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 327' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -77.96 -35.76 49.87 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 328' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.17 95.78 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.878 0.763 . . . . 0.0 112.259 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 329' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.64 -43.99 89.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.54 1.136 . . . . 0.0 111.496 172.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.78 73.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 331' ' ' GLY . . . . . . . . . . . . . . . -57.44 -59.94 9.92 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.642 1.115 . . . . 0.0 111.645 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 332' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -61.1 -33.08 72.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.583 -0.951 . . . . 0.0 113.379 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 333' ' ' LEU . . . . . . . . . . . . . 36.8 mt -66.98 -38.6 86.36 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.123 0.969 . . . . 0.0 113.356 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 334' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.43 75.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.962 0.801 . . . . 0.0 111.9 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.44 -53.64 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.863 -0.523 . . . . 0.0 110.025 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 336' ' ' ALA . . . . . . . . . . . . . . . -58.9 -41.57 87.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 337' ' ' ALA . . . . . . . . . . . . . . . -65.68 -37.31 86.11 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.674 -0.641 . . . . 0.0 112.49 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 338' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -68.96 -38.59 79.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.397 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 339' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.3 -53.07 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.223 0.609 . . . . 0.0 110.996 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 340' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -67.39 -26.83 66.64 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 341' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -86.8 -50.62 6.61 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 342' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.55 -23.98 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 343' ' ' SER . . . . . . . . . . . . . 67.1 m -133.33 -35.7 1.02 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 344' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.18 74.28 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.183 0.897 . . . . 0.0 114.75 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 345' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -88.38 145.04 26.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.877 1.271 . . . . 0.0 110.675 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 346' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -95.0 124.14 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.003 -1.06 . . . . 0.0 113.158 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 347' ' ' ILE . . . . . . . . . . . . . 45.4 pt -137.18 6.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.025 1.73 . . . . 0.0 113.09 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 348' ' ' ALA . . . . . . . . . . . . . . . -63.71 -18.59 64.17 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -160.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 349' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.45 -28.56 66.22 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.353 1.433 . . . . 0.0 111.959 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 350' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.55 -40.69 49.06 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.553 -0.717 . . . . 0.0 110.963 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 351' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.64 -33.98 73.6 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.867 -0.521 . . . . 0.0 111.827 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 352' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.3 -51.05 57.37 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.34 1.056 . . . . 0.0 111.348 169.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 353' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -56.15 -42.14 76.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.68 1.127 . . . . 0.0 112.604 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 354' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.26 -34.93 79.24 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.079 0.854 . . . . 0.0 112.506 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 355' ' ' LEU . . . . . . . . . . . . . 25.1 tp -83.09 -21.44 33.71 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.95 0.9 . . . . 0.0 113.26 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -50.27 67.04 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.32 -1.487 . . . . 0.0 109.979 158.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 357' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.43 79.91 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.323 1.049 . . . . 0.0 113.183 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 358' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -64.91 -31.85 73.29 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.16 0.891 . . . . 0.0 112.316 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 359' ' ' ILE . . . . . . . . . . . . . 87.3 mt -79.95 -29.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.742 1.155 . . . . 0.0 111.73 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 360' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -64.6 -38.22 90.25 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.702 1.137 . . . . 0.0 111.938 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 361' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -43.26 93.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.144 0.978 . . . . 0.0 111.544 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 362' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.25 -27.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.834 0.854 . . . . 0.0 111.195 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 363' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.13 -46.25 21.15 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.009 -1.057 . . . . 0.0 112.848 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 364' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.93 -26.56 66.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.203 0.911 . . . . 0.0 112.147 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 365' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -77.81 -43.15 31.45 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 366' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.955 1.302 . . . . 0.0 112.752 -168.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 117.484 -1.246 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 156.07 45.26 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.318 2.012 . . . . 0.0 113.047 -172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' SER . . . . . . . . . . . . . 80.9 p -72.45 -13.96 61.57 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -88.45 -17.33 30.64 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.8 60.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 122.353 1.073 . . . . 0.0 111.228 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -70.82 -10.97 60.64 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -165.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -124.7 145.29 49.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.549 1.068 . . . . 0.0 112.583 170.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.98 119.4 17.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.492 0.717 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.07 126.98 55.35 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.443 0.697 . . . . 0.0 111.487 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.21 177.38 7.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.158 3.239 . . . . 0.0 112.857 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -69.88 20.18 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.38 164.51 29.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.11 2.164 . . . . 0.0 110.24 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' LEU . . . . . . . . . . . . . 43.1 mt 64.85 -35.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.27 74.2 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.891 1.678 . . . . 0.0 111.885 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.39 -26.69 68.86 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.331 -0.856 . . . . 0.0 112.502 174.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 tttp -76.11 -31.09 58.5 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.42 1.088 . . . . 0.0 111.688 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -39.7 69.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.014 0.925 . . . . 0.0 111.696 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -49.57 77.32 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 171.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.11 -39.35 82.0 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.379 1.072 . . . . 0.0 112.619 174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.04 87.82 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.296 -0.878 . . . . 0.0 112.086 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.66 -50.44 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.567 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -53.9 -41.08 67.23 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 pt -95.09 -19.92 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -30.92 67.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.752 1.16 . . . . 0.0 111.627 167.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -42.2 -39.86 2.19 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.14 2.576 . . . . 0.0 115.835 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.86 1.61 12.71 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 7.2 p -131.85 -17.06 2.85 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.71 -144.06 9.82 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.375 1.464 . . . . 0.0 111.768 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -140.31 128.74 22.68 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.848 1.659 . . . . 0.0 107.103 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 tt -150.2 144.9 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.041 0.936 . . . . 0.0 110.857 -158.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -125.53 154.53 42.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.067 1.347 . . . . 0.0 111.191 170.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.9 34.69 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.76 1.624 . . . . 0.0 111.153 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.74 152.76 19.98 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 123.924 0.765 . . . . 0.0 111.568 -164.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' THR . . . . . . . . . . . . . 13.3 m -78.83 -30.25 45.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.455 -1.259 . . . . 0.0 114.044 -166.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -75.0 -41.15 60.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 121.974 2.17 . . . . 0.0 111.627 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -65.01 -38.57 91.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.675 -1.266 . . . . 0.0 112.568 169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' THR . . . . . . . . . . . . . 51.2 m -53.87 -53.17 56.25 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.951 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 40.2 m -54.11 -49.45 69.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.569 1.148 . . . . 0.0 111.795 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -69.17 -41.14 77.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.541 1.064 . . . . 0.0 113.038 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.92 -8.46 56.56 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.524 1.056 . . . . 0.0 113.815 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . 0.441 HG13 ' HE2' ' D' ' 71' ' ' LYS . 5.6 t -88.25 -34.82 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.573 1.549 . . . . 0.0 109.753 172.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -72.28 -53.2 13.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 120.291 1.405 . . . . 0.0 112.214 167.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -100.11 140.42 34.36 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.979 1.312 . . . . 0.0 113.141 -158.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.67 -159.47 34.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.971 0.762 . . . . 0.0 112.943 -174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -108.2 85.37 2.1 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.08 -1.247 . . . . 0.0 111.664 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.85 151.31 18.2 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.572 -0.705 . . . . 0.0 111.368 161.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -108.73 -38.67 5.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.201 1.0 . . . . 0.0 112.547 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 tp -154.13 151.04 28.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.19 2.196 . . . . 0.0 109.92 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -129.0 143.12 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.617 1.167 . . . . 0.0 111.183 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.43 138.08 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.527 1.931 . . . . 0.0 109.083 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -125.41 154.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.627 1.571 . . . . 0.0 109.888 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.81 155.94 27.64 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.284 -1.51 . . . . 0.0 112.655 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.5 -8.01 56.92 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.35 21.58 13.97 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.682 1.193 . . . . 0.0 113.88 -175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.63 127.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.594 -0.691 . . . . 0.0 110.532 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -150.95 113.15 3.12 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.838 0.855 . . . . 0.0 109.133 -167.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.59 142.83 29.71 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.491 1.211 . . . . 0.0 113.622 0.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.58 -25.58 65.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.652 0.739 . . . . 0.0 112.176 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -54.99 -33.37 62.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.922 2.489 . . . . 0.0 113.461 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -35.54 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 O-C-N 121.488 -0.758 . . . . 0.0 111.358 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -102.2 -9.99 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.19 1.396 . . . . 0.0 113.942 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.46 -18.09 25.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -73.72 -25.79 60.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.422 1.089 . . . . 0.0 113.892 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.67 -40.17 29.89 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.881 -171.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.79 -55.87 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.038 1.825 . . . . 0.0 114.283 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.55 -34.05 65.68 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.776 2.027 . . . . 0.0 112.309 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 22.9 tp -63.23 -29.91 71.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.457 -0.777 . . . . 0.0 112.37 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.17 -25.58 47.27 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.5 -1.375 . . . . 0.0 113.476 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.95 -27.51 57.59 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.433 1.093 . . . . 0.0 113.707 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.62 -25.89 60.53 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.448 1.099 . . . . 0.0 112.317 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' LYS . . . . . 0.441 ' HE2' HG13 ' D' ' 41' ' ' VAL . 13.9 pttp -127.52 17.26 6.99 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -168.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 63.8 25.71 14.17 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 167.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 20.6 mm -104.07 140.56 21.18 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.927 1.291 . . . . 0.0 111.488 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.42 152.03 26.37 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.557 2.838 . . . . 0.0 112.764 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -133.36 157.02 46.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.492 1.117 . . . . 0.0 112.121 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -151.8 166.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.585 1.554 . . . . 0.0 109.898 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.34 158.48 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.17 154.62 80.17 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 126.392 1.877 . . . . 0.0 111.966 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -68.34 -6.45 17.53 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 N-CA-C 119.113 2.697 . . . . 0.0 119.113 -157.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 10.5 t -162.37 134.89 5.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.724 1.602 . . . . 0.0 114.098 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -62.15 -31.52 72.01 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 113.391 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -75.62 -36.97 60.11 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.62 0.768 . . . . 0.0 111.442 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -70.68 -36.32 73.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.514 0.726 . . . . 0.0 112.052 170.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -68.03 -37.67 81.63 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 112.212 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.17 -45.97 95.46 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 121.862 -0.524 . . . . 0.0 112.567 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.49 77.96 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.439 -1.036 . . . . 0.0 113.089 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.0 90.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.676 0.79 . . . . 0.0 111.976 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.59 -21.76 65.4 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.03 30.86 8.02 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.988 1.28 . . . . 0.0 114.521 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' ILE . . . . . . . . . . . . . 35.6 pt -120.2 142.09 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.298 1.439 . . . . 0.0 109.676 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLU . . . . . . . . . . . . 0.344 5.5 pt-20 -84.39 1.2 46.35 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.09 -149.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 126.149 1.78 . . . . 0.0 111.238 166.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.58 171.33 7.55 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.058 1.743 . . . . 0.0 111.9 172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.77 17.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.857 . . . . 0.0 110.239 165.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.92 -31.79 63.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -151.83 163.44 39.19 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -141.67 139.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.814 2.046 . . . . 0.0 110.098 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.0 137.09 54.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.058 1.343 . . . . 0.0 113.173 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -102.24 119.5 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.092 1.357 . . . . 0.0 110.241 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.26 -44.16 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.28 1.432 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -126.83 134.85 26.52 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.889 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -74.02 -21.0 18.74 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.561 1.507 . . . . 0.0 114.932 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.75 -117.6 12.12 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.69 -27.12 68.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.72 1.208 . . . . 0.0 113.47 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.22 7.46 5.12 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 23.6 ttm105 -64.84 -39.81 94.17 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.138 -1.601 . . . . 0.0 113.935 -168.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.09 -30.14 66.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.202 1.001 . . . . 0.0 111.741 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.67 -44.6 70.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.183 -0.948 . . . . 0.0 110.729 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.47 -39.96 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.033 0.933 . . . . 0.0 110.988 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -64.18 -44.03 93.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.667 0.667 . . . . 0.0 112.152 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.79 -42.78 94.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.448 -0.783 . . . . 0.0 112.425 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.22 -48.38 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 110.652 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.79 96.51 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.671 0.669 . . . . 0.0 112.082 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' MET . . . . . . . . . . . . . 19.8 mmt -60.13 -46.68 88.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.186 0.594 . . . . 0.0 112.29 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.01 -35.88 59.38 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.69 -38.59 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.25 -32.87 71.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -91.59 -10.08 41.84 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -77.18 -46.98 21.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.669 1.188 . . . . 0.0 111.145 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' MET . . . . . . . . . . . . . 91.4 mtp -78.21 6.02 9.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.654 1.582 . . . . 0.0 115.227 -171.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' LYS . . . . . . . . . . . . . 76.0 tttt . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.55 1.54 . . . . 0.0 114.935 -152.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -60.45 149.07 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.592 0.633 . . . . 0.0 112.085 164.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -138.96 132.83 30.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.959 1.304 . . . . 0.0 110.053 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.14 132.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.869 1.268 . . . . 0.0 108.312 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -138.05 156.59 47.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.642 1.177 . . . . 0.0 110.407 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.66 145.7 36.51 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.552 -1.342 . . . . 0.0 110.4 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.93 173.7 9.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 110.861 170.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -74.46 17.05 0.21 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -136.51 132.52 18.78 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.316 1.846 . . . . 0.0 110.097 -176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.17 132.02 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.391 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -12.16 34.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.671 1.129 . . . . 0.0 115.786 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.8 138.08 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.217 1.508 . . . . 0.0 110.65 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -120.06 166.93 12.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.753 1.221 . . . . 0.0 112.166 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.59 145.42 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.365 1.866 . . . . 0.0 108.618 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.21 143.36 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.211 0.605 . . . . 0.0 110.336 164.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.99 151.34 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.072 1.349 . . . . 0.0 108.526 163.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.74 -154.52 0.55 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -163.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -70.09 -17.64 63.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.995 2.118 . . . . 0.0 115.037 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.36 -22.68 18.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.726 1.603 . . . . 0.0 112.426 159.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.65 -7.93 77.43 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.104 1.335 . . . . 0.0 115.387 170.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -69.38 151.17 46.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.312 1.556 . . . . 0.0 111.904 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -69.64 134.53 48.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.813 0.845 . . . . 0.0 111.496 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -123.74 141.88 51.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.312 1.445 . . . . 0.0 109.919 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 pt -77.34 140.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.784 0.833 . . . . 0.0 112.004 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.64 166.42 28.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.846 0.858 . . . . 0.0 113.19 -172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' THR . . . . . . . . . . . . . 44.6 p -137.72 148.48 45.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.349 1.459 . . . . 0.0 111.78 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -82.4 116.16 21.75 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.895 0.878 . . . . 0.0 109.634 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.06 123.87 19.67 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.886 0.851 . . . . 0.0 112.758 -165.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.9 -33.16 73.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.204 1.402 . . . . 0.0 111.642 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.92 85.38 40.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.077 1.751 . . . . 0.0 110.324 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.13 135.31 69.8 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.608 2.872 . . . . 0.0 114.106 -174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -33.39 6.54 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.887 1.708 . . . . 0.0 114.848 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 144.39 33.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.118 1.459 . . . . 0.0 113.807 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' E' ' 47' ' ' GLU . 0.4 OUTLIER -103.89 161.6 13.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.975 1.71 . . . . 0.0 110.082 174.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -124.23 -50.93 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.815 1.246 . . . . 0.0 111.447 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -128.51 6.24 5.7 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.73 30.33 18.55 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.892 -1.13 . . . . 0.0 113.451 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -53.3 158.14 1.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.533 1.933 . . . . 0.0 115.75 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -76.61 137.5 39.53 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 162.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' VAL . . . . . . . . . . . . . 84.3 t -137.02 155.05 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.86 1.264 . . . . 0.0 110.927 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 58.2 mt -136.4 119.5 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.262 1.825 . . . . 0.0 108.717 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -78.58 142.11 37.55 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.418 -0.801 . . . . 0.0 109.43 162.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -139.77 179.18 6.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.237 1.015 . . . . 0.0 112.042 -169.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -57.34 90.19 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.504 1.922 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.07 9.39 85.42 Favored Glycine 0 CA--C 1.545 1.95 0 C-N-CA 125.397 1.475 . . . . 0.0 115.427 -177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -142.73 171.5 13.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.511 1.656 . . . . 0.0 113.081 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' E' ' 34' ' ' ARG . 27.3 tt0 -139.45 138.24 36.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.132 1.373 . . . . 0.0 110.1 168.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -124.68 137.27 54.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.422 1.489 . . . . 0.0 111.166 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -125.04 142.53 51.43 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.362 1.465 . . . . 0.0 111.553 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.66 145.47 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.078 1.351 . . . . 0.0 110.157 -172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -105.05 114.44 28.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.431 1.093 . . . . 0.0 108.544 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -76.36 122.29 86.46 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.171 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.36 -27.1 47.77 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.563 2.175 . . . . 0.0 113.647 -169.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -71.2 -1.96 14.34 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -100.14 -23.06 14.95 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.46 1.104 . . . . 0.0 113.481 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.56 129.39 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.977 0.911 . . . . 0.0 111.051 174.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -50.29 -34.81 24.75 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.308 1.843 . . . . 0.0 114.434 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.67 -32.56 74.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.813 0.733 . . . . 0.0 111.922 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.71 -48.61 65.72 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 118.298 0.499 . . . . 0.0 111.97 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.902 -0.763 . . . . 0.0 112.997 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.68 94.34 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 112.923 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' ILE . . . . . . . . . . . . . 90.5 mt -68.2 -34.98 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.299 1.039 . . . . 0.0 111.106 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.47 -41.17 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.057 0.943 . . . . 0.0 111.702 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -65.32 -48.23 73.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.0 0.92 . . . . 0.0 111.645 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.03 11.62 0.04 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.62 118.86 3.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.183 1.992 . . . . 0.0 111.027 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -106.9 -37.32 6.39 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.434 1.093 . . . . 0.0 112.775 -167.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -86.91 57.48 4.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.575 1.15 . . . . 0.0 112.878 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -84.08 120.2 74.41 Favored Pre-proline 0 CA--C 1.55 0.962 0 O-C-N 121.237 -0.915 . . . . 0.0 112.045 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -97.55 -17.55 0.23 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 115.194 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.3 114.17 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.478 1.036 . . . . 0.0 109.1 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -143.22 158.35 58.39 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.292 1.437 . . . . 0.0 111.078 -166.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -46.1 125.25 8.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.496 3.464 . . . . 0.0 114.817 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.47 87.07 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.11 1.604 . . . . 0.0 117.11 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -75.98 163.85 26.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.344 2.072 . . . . 0.0 113.071 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -105.54 132.74 51.32 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.558 1.143 . . . . 0.0 111.789 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.79 145.09 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.474 1.11 . . . . 0.0 111.927 -173.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' LEU . . . . . . . . . . . . . 10.6 tt -119.5 129.95 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.773 1.229 . . . . 0.0 109.167 169.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.4 136.14 53.83 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.701 1.601 . . . . 0.0 109.062 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.19 131.79 55.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.491 1.116 . . . . 0.0 109.968 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.1 59.34 1.11 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 124.873 1.225 . . . . 0.0 112.523 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 tt -103.99 -28.45 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 127.292 2.237 . . . . 0.0 112.936 -169.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 83' ' ' ALA . . . . . . . . . . . . . . . 40.2 -124.11 0.43 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.908 1.283 . . . . 0.0 112.568 -167.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -79.72 -3.94 49.68 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.65 33.49 10.06 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 119.214 2.446 . . . . 0.0 119.214 159.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -46.78 88.93 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.732 2.266 . . . . 0.0 111.946 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -48.36 -52.82 19.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.253 1.821 . . . . 0.0 112.126 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.01 -32.16 72.61 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.113 1.365 . . . . 0.0 112.618 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 89' ' ' SER . . . . . . . . . . . . . 14.3 p -61.92 -39.49 92.21 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 90' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.69 -36.26 37.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.584 -0.697 . . . . 0.0 112.249 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.99 -28.38 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 120.189 1.358 . . . . 0.0 112.791 170.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' SER . . . . . . . . . . . . . 12.8 t -58.83 -41.98 88.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.5 1.12 . . . . 0.0 112.007 168.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.06 -45.11 82.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.661 0.785 . . . . 0.0 112.859 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.68 -38.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.352 1.461 . . . . 0.0 112.118 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 74.0 t -81.74 -36.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.946 0.898 . . . . 0.0 111.719 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.47 -170.46 45.5 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.673 1.13 . . . . 0.0 114.738 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -67.75 -18.04 64.75 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -76.01 -23.31 55.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.975 1.31 . . . . 0.0 113.851 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.74 -165.73 27.17 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.303 0.954 . . . . 0.0 114.117 -172.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -146.73 126.42 13.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.274 1.429 . . . . 0.0 109.777 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mt -125.71 123.7 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.099 0.96 . . . . 0.0 110.077 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 102' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.7 138.39 40.41 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.201 1.0 . . . . 0.0 109.891 164.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.46 115.72 2.22 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.886 1.232 . . . . 0.0 111.356 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.46 133.54 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.554 1.542 . . . . 0.0 109.276 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -132.83 144.28 50.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.072 0.949 . . . . 0.0 112.689 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 106' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -98.98 -33.58 10.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.483 1.513 . . . . 0.0 112.877 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 107' ' ' SER . . . . . . . . . . . . . 45.5 t -71.53 114.76 30.93 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 119.469 1.031 . . . . 0.0 110.553 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.6 -38.92 2.18 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.518 1.479 . . . . 0.0 113.899 -159.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -82.98 -31.05 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.95 -25.82 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.273 0.942 . . . . 0.0 112.835 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.86 -27.58 66.81 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.217 -0.927 . . . . 0.0 112.956 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -54.67 -36.96 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.759 1.224 . . . . 0.0 112.494 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -69.63 -22.81 63.45 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.296 1.038 . . . . 0.0 112.82 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 tp -77.16 -21.15 54.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.002 1.721 . . . . 0.0 112.945 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.05 -43.87 99.44 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.338 1.455 . . . . 0.0 114.6 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -29.38 5.2 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 122.509 1.932 . . . . 0.0 113.158 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' ILE . . . . . . . . . . . . . 58.5 mt -66.21 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.65 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -73.61 -7.13 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -71.42 -22.65 61.82 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.704 1.593 . . . . 0.0 112.197 167.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -92.88 -47.92 6.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.775 0.716 . . . . 0.0 111.947 164.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -83.02 57.29 3.84 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.866 1.266 . . . . 0.0 112.662 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' ARG . . . . . . . . . . . . . 31.3 mtp85 -69.55 10.16 0.39 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.96 -6.09 51.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 165.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.99 139.79 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.814 2.045 . . . . 0.0 110.284 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' ILE . . . . . . . . . . . . . 59.3 mt -119.66 115.92 33.49 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.084 1.353 . . . . 0.0 109.262 165.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -85.04 135.11 5.38 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.872 3.048 . . . . 0.0 111.351 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' ILE . . . . . . . . . . . . . 59.1 mt -134.98 124.93 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.13 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.77 121.71 33.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.86 0.864 . . . . 0.0 110.927 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.72 21.91 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.665 1.126 . . . . 0.0 114.471 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.23 115.58 5.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.306 1.05 . . . . 0.0 111.972 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.12 -23.66 48.63 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.119 1.368 . . . . 0.0 113.623 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' THR . . . . . . . . . . . . . 1.1 m -78.43 -12.1 59.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.036 1.735 . . . . 0.0 113.277 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -128.76 77.63 77.32 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.944 1.698 . . . . 0.0 110.789 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.16 -31.81 47.11 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.034 3.156 . . . . 0.0 115.013 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -60.13 -23.12 63.63 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.869 1.268 . . . . 0.0 112.552 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -74.66 -6.9 51.28 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.28 1.832 . . . . 0.0 114.685 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.66 7.11 3.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.841 1.656 . . . . 0.0 113.816 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -45.7 -26.3 0.61 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 118.253 2.686 . . . . 0.0 118.253 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.541 ' H ' HD21 ' C' ' 36' ' ' LEU . . . -86.47 -19.07 30.11 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.926 1.29 . . . . 0.0 114.224 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 73.7 mt -116.44 17.36 15.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.3 1.44 . . . . 0.0 113.439 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.91 164.06 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.541 1.536 . . . . 0.0 111.47 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' THR . . . . . . . . . . . . . 72.0 p -135.01 176.34 8.75 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.332 1.453 . . . . 0.0 111.686 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.31 141.92 58.58 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.35 -0.844 . . . . 0.0 111.181 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -129.08 160.01 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.282 1.433 . . . . 0.0 113.162 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.46 -30.64 42.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.514 1.526 . . . . 0.0 113.042 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.89 142.81 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.44 1.496 . . . . 0.0 110.352 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 147' ' ' ILE . . . . . . . . . . . . . 83.2 mt -117.41 142.32 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.102 0.961 . . . . 0.0 110.217 161.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -128.56 136.34 50.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.055 1.342 . . . . 0.0 110.477 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -126.36 120.75 30.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.998 1.319 . . . . 0.0 110.532 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -149.19 31.13 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.549 1.54 . . . . 0.0 112.411 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 t -70.15 -45.14 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 123.438 1.59 . . . . 0.0 106.95 157.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . 0.256 . . 50.78 48.5 22.73 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.934 2.094 . . . . 0.0 112.166 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 153' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -67.92 166.82 20.31 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.819 2.048 . . . . 0.0 110.528 166.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 154' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.4 -28.36 53.44 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.653 2.235 . . . . 0.0 113.356 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 155' ' ' THR . . . . . . . . . . . . . 68.8 p -80.48 2.3 25.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.366 1.866 . . . . 0.0 114.523 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 156' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -60.37 -27.62 67.55 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -161.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.21 85.64 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.865 -1.147 . . . . 0.0 112.025 172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 158' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -72.19 -38.06 69.14 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.751 -1.119 . . . . 0.0 111.728 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 159' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.53 -55.53 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.008 0.822 . . . . 0.0 110.202 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 160' ' ' LEU . . . . . . . . . . . . . 26.7 tp -63.26 -49.24 74.9 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.985 -0.447 . . . . 0.0 112.176 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 161' ' ' ILE . . . . . . . . . . . . . 51.4 mt -64.7 -47.92 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.478 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -37.17 62.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.739 1.154 . . . . 0.0 112.333 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 163' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -61.38 -34.09 74.76 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.048 -1.032 . . . . 0.0 111.571 167.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 164' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.42 58.07 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.568 -1.333 . . . . 0.0 114.553 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -71.64 -50.48 30.3 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.136 1.334 . . . . 0.0 110.025 162.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.25 25.28 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -112.88 -24.97 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -160.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.53 126.9 31.8 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.155 1.343 . . . . 0.0 111.795 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 169' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.87 161.21 26.82 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 170' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -60.33 136.06 57.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 171' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.6 62.6 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.074 -1.403 . . . . 0.0 116.045 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -76.84 166.35 54.01 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.622 1.582 . . . . 0.0 115.026 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 173' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -107.79 156.94 18.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.985 1.314 . . . . 0.0 113.9 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.69 150.11 20.02 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.694 1.14 . . . . 0.0 112.114 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mtm -136.32 139.17 42.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.516 1.526 . . . . 0.0 109.935 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 176' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.45 131.77 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.263 0.625 . . . . 0.0 112.572 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 177' ' ' ALA . . . . . . . . . . . . . . . -92.82 89.89 6.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.86 1.264 . . . . 0.0 110.991 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 178' ' ' VAL . . . . . . . . . . . . . 23.2 t -72.51 102.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.374 1.469 . . . . 0.0 111.888 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 179' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -84.54 75.3 10.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.902 2.081 . . . . 0.0 109.424 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -41.94 -48.83 4.57 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.827 1.251 . . . . 0.0 113.898 -169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -18.96 64.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 182' ' ' SER . . . . . . . . . . . . . 50.2 m -99.16 -11.82 21.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.954 1.252 . . . . 0.0 113.363 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -88.87 -46.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.134 0.879 . . . . 0.0 110.474 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -157.07 114.1 3.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.431 0.692 . . . . 0.0 110.544 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 185' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.65 -1.08 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -6.21 57.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.323 1.449 . . . . 0.0 113.391 -171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 187' ' ' LYS . . . . . 0.439 ' HE2' HG22 ' E' ' 192' ' ' VAL . 18.6 pttt -143.37 158.32 43.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.293 1.437 . . . . 0.0 113.63 -173.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -55.39 134.43 70.03 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.872 1.269 . . . . 0.0 110.469 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 189' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.9 -33.88 53.48 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.523 2.815 . . . . 0.0 115.807 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 190' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.47 -25.95 66.41 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.684 -1.26 . . . . 0.0 113.806 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 191' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -73.19 -38.44 66.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.664 1.12 . . . . 0.0 111.744 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 192' ' ' VAL . . . . . 0.439 HG22 ' HE2' ' E' ' 187' ' ' LYS . 12.6 t -65.12 -49.33 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.279 1.031 . . . . 0.0 109.871 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 193' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.19 -33.33 72.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.282 1.033 . . . . 0.0 112.575 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 194' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -72.57 -35.6 67.99 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.165 0.893 . . . . 0.0 113.278 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 195' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.2 -39.88 71.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.582 1.083 . . . . 0.0 112.571 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 196' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.1 -41.62 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.655 0.661 . . . . 0.0 110.415 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 197' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.15 -42.7 96.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.794 -1.192 . . . . 0.0 112.812 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.31 -22.73 47.73 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -78.85 -46.51 18.47 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.486 1.039 . . . . 0.0 110.912 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.67 -35.66 81.29 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.148 -0.97 . . . . 0.0 111.915 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 201' ' ' SER . . . . . . . . . . . . . 77.6 p -78.46 11.15 2.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 202' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.48 12.24 31.65 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.653 1.181 . . . . 0.0 113.15 162.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 203' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -143.78 -45.28 0.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 204' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -98.48 170.99 8.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.072 1.749 . . . . 0.0 111.689 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 205' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.52 134.65 41.18 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.43 -0.794 . . . . 0.0 109.76 153.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 206' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.51 131.04 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 207' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.41 -29.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -157.6 146.57 19.65 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.499 1.045 . . . . 0.0 113.041 174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 209' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -134.5 132.07 38.78 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.593 1.957 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 210' ' ' LEU . . . . . . . . . . . . . 65.6 tp -137.94 123.31 19.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.245 1.418 . . . . 0.0 111.636 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 211' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -79.77 139.33 37.31 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 161.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 212' ' ' LEU . . . . . . . . . . . . . 73.0 mt -79.41 -3.48 46.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.88 148.04 92.75 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 121.057 -1.027 . . . . 0.0 111.892 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 214' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.68 27.64 17.35 Favored 'Cis proline' 0 CA--C 1.546 1.12 0 CA-C-N 119.928 1.01 . . . . 0.0 114.191 2.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 215' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -92.15 -52.42 4.71 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.472 -0.767 . . . . 0.0 109.824 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 216' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -129.68 -173.5 3.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.966 1.306 . . . . 0.0 111.235 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 217' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.7 145.98 50.39 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.861 -1.149 . . . . 0.0 113.566 -168.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 218' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 55.6 0.75 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 128.445 2.698 . . . . 0.0 117.669 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 219' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.26 143.04 32.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.157 1.783 . . . . 0.0 109.886 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.5 156.63 42.96 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.353 -0.842 . . . . 0.0 112.847 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.69 126.9 55.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.078 1.351 . . . . 0.0 109.601 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 222' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -112.78 140.37 47.62 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.769 1.228 . . . . 0.0 109.388 171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.28 137.97 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 122.214 1.006 . . . . 0.0 111.322 171.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 17.1 m -142.19 167.74 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 111.896 -162.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -136.58 135.66 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.597 1.159 . . . . 0.0 111.75 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 226' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.03 133.61 54.16 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.852 1.661 . . . . 0.0 108.451 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 227' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 122.838 2.359 . . . . 0.0 113.896 178.412 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' ILE . . . . . . . . . . . . . 71.1 mt -119.27 146.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.584 1.084 . . . . 0.0 110.795 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' SER . . . . . . . . . . . . . 9.0 t -151.8 166.21 32.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.941 1.697 . . . . 0.0 110.151 165.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -137.92 157.45 46.37 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 112.504 -167.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -139.91 -178.64 5.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 112.06 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' VAL . . . . . . . . . . . . . 69.9 t -54.76 -18.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.095 1.758 . . . . 0.0 115.511 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -108.01 -16.72 14.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.102 1.361 . . . . 0.0 114.095 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.97 38.16 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.29 131.6 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.095 2.158 . . . . 0.0 108.744 -166.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -135.99 139.55 43.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 112.352 -166.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.07 134.87 55.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.187 0.995 . . . . 0.0 112.149 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -134.9 148.36 50.06 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 113.834 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.65 13.36 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.567 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -77.22 6.93 5.76 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.34 0.16 14.72 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.884 1.674 . . . . 0.0 112.377 165.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.74 63.52 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.115 1.816 . . . . 0.0 115.47 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -71.01 139.84 50.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.996 1.398 . . . . 0.0 110.709 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' LEU . . . . . . . . . . . . . 19.7 tp -68.46 149.16 49.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.479 0.582 . . . . 0.0 111.055 170.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.72 -55.27 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.361 1.464 . . . . 0.0 109.706 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.86 158.66 38.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.3 1.44 . . . . 0.0 110.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -139.85 143.1 36.6 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.784 2.033 . . . . 0.0 111.266 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -131.4 154.69 48.37 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.736 1.615 . . . . 0.0 110.789 171.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.49 150.23 38.24 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.164 1.386 . . . . 0.0 112.143 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -73.58 144.89 45.84 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' THR . . . . . . . . . . . . . 69.5 p -127.59 0.69 6.19 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -113.72 170.05 8.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.545 1.938 . . . . 0.0 109.261 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -56.19 112.44 4.38 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.394 1.478 . . . . 0.0 109.546 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.51 -19.7 14.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.83 2.353 . . . . 0.0 114.362 -154.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' GLU . . . . . . . . . . . . . 10.7 pm0 -57.03 -36.44 70.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.636 1.107 . . . . 0.0 112.509 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -65.78 -49.22 69.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.419 1.088 . . . . 0.0 111.539 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.98 -38.84 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.346 1.459 . . . . 0.0 110.208 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 mt -64.39 -49.31 72.09 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.793 1.237 . . . . 0.0 112.015 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.66 -35.8 80.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 120.939 1.7 . . . . 0.0 112.972 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -57.24 -58.27 8.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.72 0.808 . . . . 0.0 111.189 168.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.03 -33.5 75.89 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 81.1 mt -66.94 -34.36 77.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.028 1.331 . . . . 0.0 111.787 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -94.53 12.67 26.59 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.777 1.631 . . . . 0.0 113.846 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.35 85.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -89.87 143.14 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.583 1.191 . . . . 0.0 111.496 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 tt -91.88 136.24 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.872 0.844 . . . . 0.0 112.333 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -114.8 160.31 19.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.932 1.693 . . . . 0.0 110.411 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -63.38 -36.17 82.82 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.133 -0.979 . . . . 0.0 113.357 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.42 -28.62 68.76 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.89 -39.5 50.73 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.121 -0.987 . . . . 0.0 111.503 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.64 -38.33 84.44 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.646 1.179 . . . . 0.0 111.909 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -74.67 -36.76 62.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.88 -46.74 83.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.831 0.852 . . . . 0.0 111.713 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.06 -29.76 67.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.618 -0.676 . . . . 0.0 112.43 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -65.14 -46.68 79.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.042 -0.504 . . . . 0.0 111.302 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 5.3 t -60.39 -37.94 82.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.392 0.677 . . . . 0.0 111.87 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.35 -42.53 87.94 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.121 -0.987 . . . . 0.0 113.096 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.076 1.307 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.62 -34.6 78.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.343 1.457 . . . . 0.0 112.222 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -86.04 -0.94 56.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.376 1.87 . . . . 0.0 114.063 171.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.39 34.83 11.41 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 117.265 1.666 . . . . 0.0 117.265 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.11 141.33 36.85 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.425 1.612 . . . . 0.0 112.699 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -135.89 -15.56 1.77 Allowed 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 -171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -81.54 50.21 1.44 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 119.411 -2.055 . . . . 0.0 115.331 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -63.71 87.3 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 p -101.41 127.59 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.566 1.146 . . . . 0.0 112.185 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -112.12 170.16 8.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.866 2.067 . . . . 0.0 112.107 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.58 -42.06 15.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.06 134.93 20.08 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-N 119.395 0.998 . . . . 0.0 112.017 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 64' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.75 -42.89 62.8 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.093 2.529 . . . . 0.0 114.368 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.81 -18.84 60.4 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.581 -0.699 . . . . 0.0 112.598 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 66' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.94 -41.64 67.58 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.518 -0.739 . . . . 0.0 110.757 171.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -60.1 -33.58 72.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.157 0.583 . . . . 0.0 111.353 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 68' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' F' ' 72' ' ' GLU . 0.4 OUTLIER -68.77 -47.35 66.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.901 1.68 . . . . 0.0 112.158 177.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -64.46 -34.98 79.47 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.975 0.807 . . . . 0.0 112.02 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -43.75 93.33 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.308 0.958 . . . . 0.0 113.082 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 71' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.91 -21.75 59.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 72' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' F' ' 68' ' ' ARG . 23.9 tt0 -70.7 -34.99 72.54 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.804 0.841 . . . . 0.0 113.01 165.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 73' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.72 0.13 13.89 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.761 1.224 . . . . 0.0 112.684 168.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.78 -17.61 52.36 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.874 2.178 . . . . 0.0 115.221 173.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.18 130.92 35.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.98 1.39 . . . . 0.0 112.052 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p -71.26 88.6 0.85 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.05 -1.031 . . . . 0.0 112.634 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.75 42.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 78' ' ' THR . . . . . . . . . . . . . 45.0 p -126.14 176.99 6.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.316 1.846 . . . . 0.0 111.913 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -130.86 131.21 44.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.163 0.985 . . . . 0.0 112.331 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -155.95 123.59 5.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.911 1.684 . . . . 0.0 109.307 163.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 81' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.07 -49.66 9.79 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 121.167 -0.958 . . . . 0.0 113.324 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 82' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.38 22.92 0.32 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 123.226 2.617 . . . . 0.0 115.763 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -69.8 162.16 28.42 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.333 1.053 . . . . 0.0 113.832 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 84' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.05 -28.35 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.098 0.959 . . . . 0.0 113.182 -168.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.48 72.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.21 0.914 . . . . 0.0 112.397 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.01 -34.99 90.04 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 112.014 -0.435 . . . . 0.0 112.014 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -65.65 -48.28 72.7 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.778 . . . . 0.0 112.541 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 88' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -59.88 -51.58 69.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.787 0.835 . . . . 0.0 111.164 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.29 -53.32 59.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.81 1.644 . . . . 0.0 111.614 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 90' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 -75.48 -17.12 60.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -86.45 -28.17 23.65 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 92' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -125.46 62.97 42.58 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.244 0.929 . . . . 0.0 111.576 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 93' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.68 -31.14 86.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.947 2.432 . . . . 0.0 113.51 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.49 -26.12 67.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.71 1.204 . . . . 0.0 113.451 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.06 -27.07 64.34 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 119.817 1.189 . . . . 0.0 113.201 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 96' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -119.45 -19.18 8.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -163.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 97' ' ' LEU . . . . . . . . . . . . . 13.3 tp -134.67 -2.48 2.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.171 1.389 . . . . 0.0 114.178 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 -169.72 46.12 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.407 1.004 . . . . 0.0 114.591 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.48 -48.38 70.05 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 121.741 -0.858 . . . . 0.0 112.159 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.51 35.96 0.52 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.95 1.3 . . . . 0.0 113.1 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 101' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -54.45 -41.11 69.07 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -165.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -69.22 -27.75 65.75 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 103' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.69 -34.21 69.46 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.945 -1.097 . . . . 0.0 112.113 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.3 -43.06 64.76 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.673 -0.642 . . . . 0.0 111.027 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -55.8 -43.8 77.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.304 169.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -62.63 -50.75 70.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.637 0.775 . . . . 0.0 112.092 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 107' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -54.62 -42.89 71.72 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.796 1.238 . . . . 0.0 112.348 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.82 -31.68 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.373 0.669 . . . . 0.0 112.132 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.88 -44.2 96.18 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 119.182 0.901 . . . . 0.0 112.935 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.92 -32.42 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.304 1.052 . . . . 0.0 112.76 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.12 -43.97 69.88 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.477 -0.764 . . . . 0.0 111.72 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.55 -43.83 97.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.657 1.183 . . . . 0.0 111.353 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' THR . . . . . . . . . . . . . 3.5 m -59.58 -34.7 73.04 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.939 0.896 . . . . 0.0 112.647 171.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -73.11 -33.54 65.63 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.196 0.907 . . . . 0.0 113.275 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' MET . . . . . . . . . . . . . 22.9 ptm -78.9 -24.32 44.2 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.873 1.215 . . . . 0.0 113.659 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -76.03 10.41 1.92 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' ILE . . . . . . . . . . . . . 90.1 mt -67.68 95.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.81 1.186 . . . . 0.0 109.55 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -75.06 152.0 38.65 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -156.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -127.68 172.98 10.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.176 1.791 . . . . 0.0 110.135 152.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.89 129.39 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.58 1.552 . . . . 0.0 114.162 -149.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' SER . . . . . . . . . . . . . 60.1 p -145.1 147.98 33.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.037 0.935 . . . . 0.0 113.386 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' GLY . . . . . . . . . . . . . . . -75.75 -1.85 68.22 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.767 1.467 . . . . 0.0 116.767 -169.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.47 6.8 8.95 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.956 1.378 . . . . 0.0 114.109 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -68.04 -22.8 64.94 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.218 -0.926 . . . . 0.0 113.24 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 -39.9 86.63 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.419 1.008 . . . . 0.0 112.48 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -63.9 -33.59 76.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.686 0.795 . . . . 0.0 111.065 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' MET . . . . . . . . . . . . . 27.3 mtt -73.72 -38.38 64.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.73 1.212 . . . . 0.0 111.946 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.21 -48.14 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 110.449 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.61 -43.93 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.433 0.56 . . . . 0.0 111.143 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.66 -36.93 81.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.596 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.68 78.79 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.661 1.119 . . . . 0.0 112.739 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.97 -50.76 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.621 1.169 . . . . 0.0 111.366 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -69.12 -26.77 65.07 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.514 1.052 . . . . 0.0 111.645 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.0 75.61 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.655 -1.278 . . . . 0.0 112.677 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -44.24 90.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.167 0.894 . . . . 0.0 109.587 171.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.47 -43.29 88.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.961 1.304 . . . . 0.0 112.341 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.99 -46.3 68.4 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.175 1.39 . . . . 0.0 112.504 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.92 -39.84 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.331 -1.48 . . . . 0.0 111.764 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.24 -32.8 70.31 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.771 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -74.66 -40.83 61.2 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 117.462 -1.256 . . . . 0.0 113.597 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.61 -37.18 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 121.038 1.745 . . . . 0.0 111.133 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.13 -48.51 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.522 0.729 . . . . 0.0 109.973 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -58.03 -39.79 79.24 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.616 1.098 . . . . 0.0 112.865 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.82 -47.66 71.33 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.035 -1.041 . . . . 0.0 112.492 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 145' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.73 -34.85 72.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.363 0.665 . . . . 0.0 111.977 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 146' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.63 -35.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.44 -0.787 . . . . 0.0 111.435 171.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.8 -40.6 92.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.021 1.282 . . . . 0.0 112.255 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -46.06 91.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.754 0.822 . . . . 0.0 111.092 171.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 149' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.4 -41.19 88.87 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.798 1.239 . . . . 0.0 112.309 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 150' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -64.71 -48.54 74.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.279 1.032 . . . . 0.0 111.907 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 151' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.44 -35.02 79.65 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.297 0.499 . . . . 0.0 112.025 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 152' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -74.74 -46.49 37.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 153' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -68.82 -20.51 64.31 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.623 -1.298 . . . . 0.0 112.625 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 70.2 m -65.02 -9.56 22.83 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 155' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.92 -8.71 59.11 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.097 0.959 . . . . 0.0 113.185 167.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 156' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -121.6 -30.34 4.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.47 1.508 . . . . 0.0 113.104 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.09 70.54 6.34 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 125.416 1.486 . . . . 0.0 110.953 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 158' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.27 -25.92 81.36 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.862 3.041 . . . . 0.0 114.508 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -66.85 -20.18 65.88 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.001 -1.062 . . . . 0.0 113.014 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.67 -35.42 72.82 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.283 -0.886 . . . . 0.0 112.76 -171.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 161' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.61 -31.13 70.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.585 -0.697 . . . . 0.0 111.937 171.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 162' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -82.15 4.47 23.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.177 1.391 . . . . 0.0 112.799 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 163' ' ' LEU . . . . . . . . . . . . . 37.8 tp -128.43 -31.34 2.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.188 1.395 . . . . 0.0 114.283 -172.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 164' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.31 87.2 39.82 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.672 1.189 . . . . 0.0 112.097 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 165' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -74.21 -16.04 22.56 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.145 2.564 . . . . 0.0 115.343 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 166' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -82.98 136.94 34.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.445 1.098 . . . . 0.0 111.06 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 167' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -83.13 -45.92 0.84 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 116.867 -1.54 . . . . 0.0 114.717 -168.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 168' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -59.79 -43.12 40.09 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.55 2.167 . . . . 0.0 113.631 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 169' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -56.6 -39.18 73.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.885 1.274 . . . . 0.0 112.717 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 170' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.06 -22.29 64.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.86 0.864 . . . . 0.0 113.007 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 171' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.07 -41.48 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 110.925 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.28 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.117 0.967 . . . . 0.0 112.602 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 173' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -56.46 -43.09 79.22 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.59 -34.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.722 0.809 . . . . 0.0 111.983 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 175' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -59.94 -41.24 91.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.544 1.137 . . . . 0.0 111.641 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 176' ' ' THR . . . . . . . . . . . . . 6.6 m -87.48 -50.05 6.8 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 177' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.28 -59.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.967 0.907 . . . . 0.0 111.65 -172.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 178' ' ' GLY . . . . . . . . . . . . . . . 68.28 -34.67 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.81 1.671 . . . . 0.0 116.802 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 179' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -80.91 114.68 19.95 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.824 1.812 . . . . 0.0 111.16 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -52.72 -33.24 46.96 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 181' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.42 -5.17 59.23 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 182' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -98.56 12.85 33.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 112.706 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 183' ' ' ILE . . . . . . . . . . . . . 73.6 mt -84.07 141.72 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.076 1.35 . . . . 0.0 110.943 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 184' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -150.95 165.4 33.8 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.546 2.738 . . . . 0.0 109.339 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 185' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -51.96 -44.18 63.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.832 1.196 . . . . 0.0 113.408 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 186' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -60.36 -42.9 96.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.693 1.197 . . . . 0.0 112.13 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 187' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.81 -7.99 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 188' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.25 -26.83 17.98 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.94 -1.1 . . . . 0.0 112.564 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 189' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -66.49 -50.76 62.19 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.618 1.167 . . . . 0.0 110.752 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 190' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.16 -31.94 73.38 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.291 -0.881 . . . . 0.0 113.272 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 191' ' ' LEU . . . . . . . . . . . . . 40.1 tp -64.78 -6.95 9.17 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.547 1.539 . . . . 0.0 113.283 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.66 33.58 27.31 Favored Glycine 0 CA--C 1.527 0.829 0 O-C-N 120.905 -1.122 . . . . 0.0 113.307 172.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -76.96 178.64 6.77 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 122.194 0.997 . . . . 0.0 110.583 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 194' ' ' SER . . . . . . . . . . . . . 44.0 p -116.18 152.41 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.602 1.961 . . . . 0.0 109.129 168.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 195' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.51 -40.88 62.91 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.505 1.048 . . . . 0.0 113.455 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 196' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.4 -13.47 58.72 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.877 1.271 . . . . 0.0 114.221 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 197' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -99.93 -29.2 12.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.959 2.104 . . . . 0.0 111.984 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 198' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.72 -28.0 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.873 1.269 . . . . 0.0 113.035 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 199' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.96 -32.92 74.49 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.042 0.837 . . . . 0.0 112.444 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 200' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.38 164.51 26.32 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.379 -1.451 . . . . 0.0 108.707 166.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 201' ' ' ILE . . . . . . . . . . . . . 15.4 mt 67.66 -62.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 120.919 -1.113 . . . . 0.0 110.717 -151.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 202' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.63 -39.67 94.94 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.715 1.143 . . . . 0.0 113.281 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 203' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -54.65 -25.53 27.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.532 1.533 . . . . 0.0 113.099 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 204' ' ' ALA . . . . . . . . . . . . . . . -109.9 9.91 24.45 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.179 1.791 . . . . 0.0 113.481 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -47.57 -49.68 25.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.819 1.648 . . . . 0.0 114.484 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 206' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.56 -35.6 12.18 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.957 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 207' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -100.82 20.94 14.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -162.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 208' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.67 142.14 35.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.433 0.693 . . . . 0.0 110.584 162.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 209' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -78.13 8.22 5.15 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 210' ' ' GLY . . . . . . . . . . . . . . . -85.03 163.39 37.89 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.196 0.903 . . . . 0.0 114.668 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 211' ' ' ALA . . . . . . . . . . . . . . . -77.33 -131.39 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.699 1.599 . . . . 0.0 113.73 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 212' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -137.54 108.24 6.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.108 1.363 . . . . 0.0 110.435 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 213' ' ' MET . . . . . . . . . . . . . 60.5 ttm -77.12 124.53 27.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.738 1.215 . . . . 0.0 108.969 162.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 214' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -65.09 156.98 29.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.941 0.896 . . . . 0.0 112.526 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 215' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -56.51 -21.67 27.63 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.653 1.181 . . . . 0.0 112.114 166.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 216' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.75 -14.07 25.1 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.448 1.499 . . . . 0.0 114.391 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 217' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.35 -42.05 14.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.534 1.061 . . . . 0.0 110.487 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 218' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.33 -23.38 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.61 -0.681 . . . . 0.0 111.717 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 219' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.37 -46.64 87.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.79 -33.73 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.468 1.031 . . . . 0.0 111.136 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 221' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.56 -36.52 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.93 0.892 . . . . 0.0 111.337 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 222' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -70.24 -46.08 65.17 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.707 1.203 . . . . 0.0 111.946 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 223' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -60.51 -33.01 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.629 1.104 . . . . 0.0 112.682 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 224' ' ' LEU . . . . . . . . . . . . . 9.9 tt -66.62 -46.48 75.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.712 0.805 . . . . 0.0 111.915 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.17 82.46 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 226' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -62.77 -37.32 86.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.11 1.364 . . . . 0.0 111.497 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 227' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.82 -33.36 75.45 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.394 -0.816 . . . . 0.0 112.248 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 228' ' ' ILE . . . . . . . . . . . . . 65.7 mt -69.21 -31.34 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.275 -0.891 . . . . 0.0 111.202 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 229' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.77 -43.71 98.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.029 1.74 . . . . 0.0 111.316 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 230' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -63.45 -33.34 75.34 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.55 -1.344 . . . . 0.0 111.779 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 231' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.51 -34.18 65.15 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 171.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 232' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -63.85 -36.02 82.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.588 1.54 . . . . 0.0 111.292 168.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 233' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -67.85 -39.83 83.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.645 172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 234' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.48 -44.86 95.49 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 121.104 1.775 . . . . 0.0 112.408 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 235' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 -56.07 -42.19 76.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.37 0.668 . . . . 0.0 110.455 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 236' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -71.55 -36.44 70.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.557 0.743 . . . . 0.0 112.881 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 237' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -57.75 -41.35 81.75 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.549 1.14 . . . . 0.0 110.871 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 238' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.84 -41.36 64.9 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.351 1.06 . . . . 0.0 112.635 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 239' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.64 -21.44 63.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.668 1.587 . . . . 0.0 113.535 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 240' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.63 -40.76 33.39 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.327 1.451 . . . . 0.0 111.595 163.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 241' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -76.0 -28.39 57.78 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 242' ' ' ILE . . . . . . . . . . . . . 23.6 mt -55.5 -39.35 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.506 1.048 . . . . 0.0 111.941 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 243' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -38.38 51.99 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.791 -0.568 . . . . 0.0 111.214 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 244' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -59.36 -22.8 61.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.008 1.723 . . . . 0.0 114.33 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 245' ' ' ALA . . . . . . . . . . . . . . . -97.39 -11.29 24.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.056 1.342 . . . . 0.0 113.448 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 246' ' ' MET . . . . . . . . . . . . . 26.2 ttt -92.83 -31.19 15.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.51 1.124 . . . . 0.0 112.182 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 247' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.61 12.8 0.43 Allowed 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -167.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 248' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -70.12 -2.84 14.14 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 120.393 -1.442 . . . . 0.0 113.201 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 249' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.5 79.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 152.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.94 118.68 48.06 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -160.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 251' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.98 164.77 32.45 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.0 3.133 . . . . 0.0 113.045 166.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 252' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -64.23 -40.31 95.77 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.33 -0.856 . . . . 0.0 111.498 174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 253' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.91 -37.75 80.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 254' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -63.8 -60.28 3.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.659 0.784 . . . . 0.0 110.063 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 255' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.83 65.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -165.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 256' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.7 -27.59 66.95 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 257' ' ' VAL . . . . . . . . . . . . . 15.6 m -140.88 -46.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.0 150.23 5.18 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.68 1.127 . . . . 0.0 114.024 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 259' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.98 79.79 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 260' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -61.42 -27.96 68.92 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.849 -1.157 . . . . 0.0 112.529 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 261' ' ' LEU . . . . . . . . . . . . . 18.8 tp -75.12 -45.55 40.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.263 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 262' ' ' ALA . . . . . . . . . . . . . . . -59.36 -45.67 90.76 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.303 0.956 . . . . 0.0 112.573 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 263' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.44 84.17 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.579 0.752 . . . . 0.0 111.939 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 264' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -70.65 -35.36 72.84 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.133 -0.979 . . . . 0.0 113.527 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 265' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.92 -46.25 85.29 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.769 1.168 . . . . 0.0 111.249 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 266' ' ' ILE . . . . . . . . . . . . . 88.6 mt -71.32 -39.97 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 122.968 0.507 . . . . 0.0 110.951 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 267' ' ' SER . . . . . . . . . . . . . 22.7 t -58.05 -40.07 80.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.463 1.105 . . . . 0.0 113.026 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.42 -28.74 41.73 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.36 -33.46 61.06 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.388 0.995 . . . . 0.0 112.966 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.29 -4.73 77.53 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.743 1.639 . . . . 0.0 114.262 -172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.47 160.2 20.53 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.468 1.033 . . . . 0.0 112.86 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 272' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.09 -31.39 70.98 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.089 -0.654 . . . . 0.0 111.975 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 273' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -58.99 -48.83 80.18 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.0 0.92 . . . . 0.0 111.039 172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 274' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -61.19 -46.45 90.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.335 1.054 . . . . 0.0 111.227 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -64.86 -38.29 90.49 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.697 -0.627 . . . . 0.0 112.397 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.49 -6.39 43.43 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.662 1.185 . . . . 0.0 113.715 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 277' ' ' MET . . . . . . . . . . . . . 53.1 mtt -103.95 -27.53 12.11 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.676 1.19 . . . . 0.0 112.958 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 278' ' ' MET . . . . . . . . . . . . . 63.6 mtt -63.82 144.77 97.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 119.468 1.031 . . . . 0.0 112.773 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 279' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.61 165.1 16.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.202 3.268 . . . . 0.0 113.354 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 280' ' ' SER . . . . . . . . . . . . . 84.4 p -55.38 -45.79 76.55 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 111.691 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 281' ' ' SER . . . . . . . . . . . . . 4.9 m -74.67 22.09 0.1 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.505 1.522 . . . . 0.0 114.888 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 282' ' ' THR . . . . . . . . . . . . . 53.9 m -128.28 -42.79 1.49 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.846 1.659 . . . . 0.0 109.905 159.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 283' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.25 -28.51 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.062 0.945 . . . . 0.0 111.561 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 284' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.19 -39.18 43.25 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.0 112.567 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.63 6.19 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.699 1.6 . . . . 0.0 113.45 -170.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 286' ' ' LEU . . . . . . . . . . . . . 57.1 tp -57.26 124.21 18.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.947 0.899 . . . . 0.0 110.99 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 287' ' ' GLY . . . . . . . . . . . . . . . 95.66 -16.59 60.92 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.471 -1.183 . . . . 0.0 115.273 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 288' ' ' ALA . . . . . . . . . . . . . . . -75.18 36.58 0.12 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.968 1.884 . . . . 0.0 113.585 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 289' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -66.14 -37.48 85.79 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.002 -1.686 . . . . 0.0 112.988 -165.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 290' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -68.76 -10.47 56.74 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.659 -1.276 . . . . 0.0 113.562 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 291' ' ' ALA . . . . . . . . . . . . . . . -92.23 -41.87 10.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.73 1.15 . . . . 0.0 111.553 167.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 292' ' ' LEU . . . . . . . . . . . . . 59.9 tp -55.41 -45.86 76.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.606 0.762 . . . . 0.0 111.517 172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 293' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -52.64 -58.8 5.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.586 1.555 . . . . 0.0 112.542 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 294' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -66.05 -31.81 72.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 295' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -71.71 -45.52 61.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.331 0.652 . . . . 0.0 112.616 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 296' ' ' LEU . . . . . 0.405 HD12 " H1'" ' W' ' 1' ' ' ' U' . 2.4 tm? -58.94 -40.4 84.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.499 1.119 . . . . 0.0 111.308 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 297' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -70.76 -7.25 43.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.348 2.259 . . . . 0.0 114.879 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 298' ' ' THR . . . . . . . . . . . . . 77.4 p -140.95 -24.81 0.75 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 61.26 23.9 62.74 Favored Glycine 0 CA--C 1.54 1.626 0 O-C-N 120.637 -1.289 . . . . 0.0 113.893 -166.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.17 -135.41 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.079 1.352 . . . . 0.0 112.585 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 301' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -72.81 124.65 90.99 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 120.514 -1.366 . . . . 0.0 110.707 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 302' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.9 157.62 34.82 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.466 2.777 . . . . 0.0 113.727 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.03 136.85 58.76 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.407 2.738 . . . . 0.0 112.506 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 304' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -95.78 -45.74 6.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.907 0.883 . . . . 0.0 113.239 -166.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 305' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.13 142.12 20.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.413 2.285 . . . . 0.0 111.697 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 306' ' ' GLY . . . . . . . . . . . . . . . -92.9 -144.7 15.15 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.57 1.081 . . . . 0.0 112.385 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 307' ' ' VAL . . . . . . . . . . . . . 9.8 p -47.45 -25.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.095 2.158 . . . . 0.0 114.818 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 308' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.07 -9.84 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.574 1.55 . . . . 0.0 114.613 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 309' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -58.24 -44.09 88.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.501 1.046 . . . . 0.0 113.316 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 310' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -74.94 31.06 0.09 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.901 1.28 . . . . 0.0 114.374 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 311' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -119.1 139.81 27.94 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.685 1.994 . . . . 0.0 110.511 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -53.12 -33.07 62.19 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.345 2.697 . . . . 0.0 116.735 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.59 -17.79 63.22 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.448 1.022 . . . . 0.0 113.62 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 314' ' ' ILE . . . . . . . . . . . . . 33.5 mt -111.97 -53.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.749 1.219 . . . . 0.0 111.124 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 315' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -76.02 -2.09 28.94 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.66 1.573 . . . . 0.0 115.24 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 316' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.55 58.19 1.71 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.471 1.508 . . . . 0.0 112.805 158.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 317' ' ' SER . . . . . . . . . . . . . 27.9 m -136.87 146.59 55.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 125.936 1.694 . . . . 0.0 109.983 159.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -52.11 143.57 40.95 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.459 2.772 . . . . 0.0 113.672 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 319' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -56.58 -32.91 65.68 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 320' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -50.91 -26.21 5.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.068 1.747 . . . . 0.0 114.659 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 321' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -119.12 0.22 11.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.255 1.422 . . . . 0.0 114.183 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 322' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -67.27 -12.25 59.62 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 323' ' ' GLY . . . . . . . . . . . . . . . -92.83 -48.8 2.84 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.399 1.0 . . . . 0.0 111.967 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 324' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -58.1 -36.66 73.2 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.636 1.574 . . . . 0.0 113.617 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 325' ' ' ILE . . . . . . . . . . . . . 95.5 mt -73.1 -36.45 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.07 -1.019 . . . . 0.0 110.997 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.03 82.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -170.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 327' ' ' ARG . . . . . . . . . . . . . 34.4 mtt85 -65.6 -53.79 36.87 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.38 0.991 . . . . 0.0 111.593 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.18 -34.21 70.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 329' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.49 -40.03 96.0 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.88 -1.137 . . . . 0.0 111.167 173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.64 72.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 331' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.89 79.61 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 119.398 0.999 . . . . 0.0 113.613 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 332' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -70.23 -28.02 64.92 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.012 -1.287 . . . . 0.0 112.33 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 333' ' ' LEU . . . . . . . . . . . . . 70.7 mt -68.67 -38.52 80.44 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.027 0.83 . . . . 0.0 113.081 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 334' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.64 87.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.858 0.863 . . . . 0.0 111.733 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 335' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.32 -47.42 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.358 1.063 . . . . 0.0 110.357 170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 336' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.29 77.77 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.711 1.141 . . . . 0.0 113.043 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.13 84.28 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 338' ' ' ARG . . . . . 0.458 HH21 ' CD2' ' G' ' 63' ' ' HIS . 67.1 mtt85 -71.93 -37.23 70.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.112 0.965 . . . . 0.0 111.97 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -61.37 -47.54 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.704 0.801 . . . . 0.0 110.374 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 340' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -68.0 -27.63 66.73 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 341' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.31 -38.14 14.4 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 342' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -108.62 -33.65 6.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 343' ' ' SER . . . . . . . . . . . . . 1.9 t -105.56 -48.93 3.54 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.865 0.757 . . . . 0.0 112.886 -162.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 344' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.65 52.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.258 1.409 . . . . 0.0 116.241 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 345' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.02 151.01 35.76 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.113 1.456 . . . . 0.0 111.271 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 346' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -101.83 117.69 35.37 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.416 -0.802 . . . . 0.0 110.837 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 347' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.44 16.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.233 1.413 . . . . 0.0 113.297 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 348' ' ' ALA . . . . . . . . . . . . . . . -52.74 -39.01 61.73 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 349' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -69.09 -26.8 65.11 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.44 -0.787 . . . . 0.0 113.056 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 350' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -79.65 -39.35 31.65 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.24 -0.913 . . . . 0.0 111.226 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 351' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.21 -34.39 73.58 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.565 0.621 . . . . 0.0 111.661 169.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 352' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.16 -44.87 71.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.773 1.229 . . . . 0.0 112.251 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 353' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -57.64 -38.51 75.14 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.322 0.964 . . . . 0.0 111.741 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 354' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.6 -42.96 50.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.292 1.437 . . . . 0.0 112.589 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 355' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.61 -42.56 91.45 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.962 -1.087 . . . . 0.0 111.698 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 356' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.79 -24.23 67.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.341 -0.849 . . . . 0.0 112.373 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 357' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.74 80.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 121.07 1.759 . . . . 0.0 112.722 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 358' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -71.47 -37.54 71.34 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.897 0.771 . . . . 0.0 111.858 173.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 359' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.59 -42.69 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.033 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 360' ' ' ARG . . . . . . . . . . . . . 24.9 mtp-105 -54.01 -44.76 71.19 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.63 1.105 . . . . 0.0 112.019 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 361' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.38 -45.69 90.75 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.813 0.279 . . . . 0.0 111.353 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 362' ' ' ILE . . . . . . . . . . . . . 91.9 mt -66.86 -14.19 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.565 1.146 . . . . 0.0 112.82 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 363' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -95.91 -8.36 34.16 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 168.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 364' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.08 -34.64 8.35 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 120.204 1.365 . . . . 0.0 112.374 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 365' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -69.28 -30.53 68.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 113.31 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 366' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.624 1.57 . . . . 0.0 113.85 -172.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.17 141.3 56.79 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.725 2.283 . . . . 0.0 111.465 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -96.36 -16.24 21.39 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -78.21 -7.82 57.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.093 1.357 . . . . 0.0 114.462 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 m -81.23 70.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.537 1.535 . . . . 0.0 111.283 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -73.26 2.02 8.25 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -144.1 142.67 30.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.075 0.852 . . . . 0.0 111.689 164.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.45 140.06 37.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.074 0.95 . . . . 0.0 109.659 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.81 146.72 36.14 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -68.89 -179.73 2.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.331 2.687 . . . . 0.0 111.494 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.01 27.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -138.67 178.37 7.2 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.072 2.549 . . . . 0.0 110.09 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt 61.81 -41.04 0.14 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.383 2.273 . . . . 0.0 117.131 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.56 69.18 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 121.319 1.872 . . . . 0.0 113.247 -173.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.91 -30.96 71.24 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.211 -0.931 . . . . 0.0 110.992 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -70.84 -30.54 66.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.434 1.094 . . . . 0.0 112.755 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.87 -35.95 67.28 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.195 -0.941 . . . . 0.0 111.906 171.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.19 -46.21 81.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.233 0.613 . . . . 0.0 110.534 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.03 -39.51 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.056 1.342 . . . . 0.0 112.2 171.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.4 68.52 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.69 -48.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.039 0.836 . . . . 0.0 110.43 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -55.72 -38.62 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.342 0.973 . . . . 0.0 113.453 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 pt -88.25 -14.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.96 -29.24 25.25 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.281 -0.887 . . . . 0.0 112.468 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -35.56 -59.66 0.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.308 2.643 . . . . 0.0 114.13 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -101.47 6.4 42.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.029 1.332 . . . . 0.0 114.517 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -121.73 -11.51 8.6 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.04 -162.67 9.21 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.748 1.166 . . . . 0.0 115.402 -169.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -118.57 122.4 42.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.65 1.58 . . . . 0.0 109.671 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -129.76 150.34 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.496 1.919 . . . . 0.0 109.252 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -127.07 130.7 50.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.36 1.464 . . . . 0.0 108.975 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.31 143.4 50.49 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.48 1.112 . . . . 0.0 112.037 -166.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.56 153.21 22.85 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 124.456 1.098 . . . . 0.0 111.615 -163.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -73.01 -24.6 60.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.847 -1.384 . . . . 0.0 113.88 -169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 35' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -79.55 -41.2 27.76 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 111.978 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.87 -32.81 71.37 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.187 -0.946 . . . . 0.0 112.401 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -58.32 -45.93 87.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.215 0.916 . . . . 0.0 110.43 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 38' ' ' THR . . . . . . . . . . . . . 92.6 m -63.58 -42.35 98.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.938 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -58.68 -44.68 90.3 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.556 1.071 . . . . 0.0 112.287 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.09 -31.32 69.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 41' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.19 -47.91 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.004 0.921 . . . . 0.0 110.572 170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -59.86 -43.65 94.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.007 0.923 . . . . 0.0 112.369 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -80.31 6.24 12.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.802 1.241 . . . . 0.0 113.011 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.38 29.67 60.69 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.775 -1.203 . . . . 0.0 114.152 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 45' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -88.59 -31.04 18.81 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.146 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.26 57.84 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.585 0.754 . . . . 0.0 112.711 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 47' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -108.89 -22.05 12.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.317 1.847 . . . . 0.0 111.933 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 tp -149.73 142.29 24.45 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.277 2.231 . . . . 0.0 108.126 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.63 141.63 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.389 1.076 . . . . 0.0 111.216 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.72 133.4 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.995 1.718 . . . . 0.0 109.069 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 mt -125.54 142.17 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.981 1.313 . . . . 0.0 109.689 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.6 150.64 30.97 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 53' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.15 -7.54 59.62 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.57 23.29 12.47 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.44 1.496 . . . . 0.0 114.004 -171.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 t -80.06 128.03 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.423 1.089 . . . . 0.0 110.289 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -146.34 118.64 4.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.482 1.513 . . . . 0.0 107.532 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.99 151.91 86.65 Favored 'Cis proline' 0 CA--C 1.538 0.705 0 CA-C-N 120.956 1.377 . . . . 0.0 113.037 0.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 58' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.32 -24.57 62.15 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.147 -0.971 . . . . 0.0 112.428 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -71.07 16.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.071 1.748 . . . . 0.0 114.955 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.13 -34.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 121.131 -0.981 . . . . 0.0 111.559 161.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 61' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.43 -14.45 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.231 1.412 . . . . 0.0 114.441 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.91 -20.34 5.88 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 63' ' ' HIS . . . . . 0.458 ' CD2' HH21 ' F' ' 338' ' ' ARG . 27.1 p-80 -83.29 -19.83 35.55 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 114.369 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 64' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.99 -44.75 85.88 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.763 -1.589 . . . . 0.0 114.022 -170.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 65' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.74 -54.82 3.27 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 CA-C-N 122.333 1.869 . . . . 0.0 114.621 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.41 -29.71 37.46 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 122.077 1.777 . . . . 0.0 113.376 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 67' ' ' LEU . . . . . . . . . . . . . 61.5 tp -71.7 -32.78 68.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.603 0.761 . . . . 0.0 113.017 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 68' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.89 -29.34 19.7 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 69' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -64.27 -46.54 83.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.638 0.775 . . . . 0.0 111.48 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.73 -4.48 6.53 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 121.181 -0.949 . . . . 0.0 113.06 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -121.24 11.38 10.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.473 1.909 . . . . 0.0 114.487 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 72' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 53.11 54.58 10.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.952 1.301 . . . . 0.0 113.115 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mm -114.87 135.78 22.46 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 125.39 1.476 . . . . 0.0 110.327 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -67.21 136.97 42.33 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.158 2.572 . . . . 0.0 112.732 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 75' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -132.56 148.92 52.38 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.38 1.072 . . . . 0.0 113.569 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 tt -151.49 166.94 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.203 1.401 . . . . 0.0 111.575 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -118.25 149.96 40.25 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 111.596 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.94 156.53 72.53 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 124.994 1.318 . . . . 0.0 112.073 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -67.61 -31.4 33.3 Favored 'Trans proline' 0 C--N 1.35 0.626 0 N-CA-C 117.257 1.984 . . . . 0.0 117.257 -160.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 80' ' ' SER . . . . . . . . . . . . . 74.7 m -154.02 142.61 20.8 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -68.05 -29.85 68.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.074 2.149 . . . . 0.0 114.829 -173.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 82' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -72.41 -44.2 62.8 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.71 0.687 . . . . 0.0 111.33 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 83' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -64.3 -42.67 96.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.682 1.193 . . . . 0.0 111.864 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -61.55 -43.32 99.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.217 0.607 . . . . 0.0 112.316 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.89 -45.16 96.74 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.835 -0.541 . . . . 0.0 112.846 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.97 93.09 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.42 90.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.187 0.595 . . . . 0.0 111.676 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.23 15.11 0.47 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.152 1.381 . . . . 0.0 114.68 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.84 -3.11 87.61 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.194 1.378 . . . . 0.0 116.295 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 pt -104.81 152.55 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.326 1.563 . . . . 0.0 111.774 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.6 -16.75 35.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -82.19 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.368 1.067 . . . . 0.0 111.001 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.74 169.97 8.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.007 1.723 . . . . 0.0 111.153 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.16 124.35 19.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.569 0.748 . . . . 0.0 109.664 165.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.06 71.46 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 96' ' ' SER . . . . . . . . . . . . . 67.2 p -149.11 161.71 41.42 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.423 1.089 . . . . 0.0 113.274 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 88.4 t -141.13 145.35 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.882 1.673 . . . . 0.0 109.976 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.71 141.03 52.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 111.935 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 99' ' ' ILE . . . . . . . . . . . . . 24.7 mt -102.91 121.46 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.223 1.009 . . . . 0.0 108.524 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.01 -43.07 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.91 1.284 . . . . 0.0 110.851 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 101' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -131.25 109.79 15.13 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 163.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -67.66 -3.48 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 N-CA-C 116.633 1.743 . . . . 0.0 116.633 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.58 -114.55 6.06 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.867 1.212 . . . . 0.0 112.026 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.88 -26.46 66.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.497 1.519 . . . . 0.0 113.351 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.77 4.14 23.16 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 106' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -54.36 -43.58 71.45 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.625 1.557 . . . . 0.0 114.348 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.16 -28.05 59.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.719 1.208 . . . . 0.0 113.506 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 108' ' ' LEU . . . . . . . . . . . . . 47.3 tp -77.12 -38.23 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 111.542 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 109' ' ' VAL . . . . . . . . . . . . . 44.7 t -61.59 -36.58 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.437 -0.79 . . . . 0.0 110.885 170.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 110' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -70.75 -33.45 70.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 111' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -62.81 -49.01 76.61 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.551 1.069 . . . . 0.0 110.89 170.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 112' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.38 -51.3 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.173 0.989 . . . . 0.0 110.243 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.57 -45.55 91.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.603 0.638 . . . . 0.0 112.178 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 114' ' ' MET . . . . . . . . . . . . . 34.6 mmt -70.91 -34.98 72.08 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.72 -36.38 37.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.348 0.976 . . . . 0.0 112.91 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 116' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.95 -42.94 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.351 0.978 . . . . 0.0 110.478 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.75 54.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.588 1.155 . . . . 0.0 113.843 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -87.36 -12.81 45.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 pp -101.29 -11.98 19.03 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.549 1.522 . . . . 0.0 114.089 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 120' ' ' MET . . . . . . . . . . . . . 91.3 mtp -75.64 40.4 0.18 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.92 1.288 . . . . 0.0 112.489 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 121' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.949 2.099 . . . . 0.0 110.892 -171.551 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.73 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 m -150.76 155.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 127.28 2.232 . . . . 0.0 109.676 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -138.8 164.97 28.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.714 1.206 . . . . 0.0 111.182 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 t -136.45 137.66 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.974 0.91 . . . . 0.0 111.779 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -138.72 161.4 37.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.92 2.088 . . . . 0.0 111.548 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -74.75 153.58 38.75 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.771 -1.205 . . . . 0.0 111.644 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -94.26 -171.46 2.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.415 1.086 . . . . 0.0 111.333 170.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' LYS . . . . . 0.446 ' HE3' ' CZ ' ' H' ' 9' ' ' PHE . 54.9 pttt -79.56 -17.72 53.34 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 173.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' PHE . . . . . 0.446 ' CZ ' ' HE3' ' H' ' 8' ' ' LYS . 21.6 m-85 -103.68 144.62 29.03 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.435 1.094 . . . . 0.0 112.343 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -62.99 131.86 34.47 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.958 2.439 . . . . 0.0 111.894 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.69 -6.99 29.11 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 115.574 0.99 . . . . 0.0 115.574 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 t -91.2 141.05 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.932 1.366 . . . . 0.0 110.037 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -127.97 166.43 18.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.633 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.13 136.98 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.58 1.952 . . . . 0.0 108.022 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.76 146.76 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.374 1.07 . . . . 0.0 110.249 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' ILE . . . . . . . . . . . . . 10.3 mm -106.41 127.42 61.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.699 1.6 . . . . 0.0 108.051 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.65 175.71 6.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 113.305 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' ASP . . . . . . . . . . . . 0.304 0.4 OUTLIER -72.2 -3.46 23.58 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -167.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -91.29 -28.27 17.88 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.664 1.186 . . . . 0.0 113.549 163.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.51 -0.18 21.91 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 127.024 2.25 . . . . 0.0 115.728 -168.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' SER . . . . . . . . . . . . . 85.2 p -74.98 147.35 40.9 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.108 1.954 . . . . 0.0 113.891 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.36 137.41 32.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.982 1.313 . . . . 0.0 111.473 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -143.66 148.34 35.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.518 1.527 . . . . 0.0 110.865 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' ILE . . . . . . . . . . . . . 20.0 pt -84.25 148.07 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.04 14.47 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.667 1.587 . . . . 0.0 113.62 -169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' THR . . . . . . . . . . . . . 24.6 p -138.71 160.8 38.77 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.639 1.576 . . . . 0.0 112.269 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -79.26 123.77 27.75 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.98 1.312 . . . . 0.0 110.425 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -65.11 122.95 18.25 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.906 0.776 . . . . 0.0 112.26 -174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.27 -27.23 68.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.286 1.434 . . . . 0.0 113.252 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.39 89.73 11.96 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 125.088 1.355 . . . . 0.0 111.714 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 31' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.71 133.14 56.11 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.668 2.912 . . . . 0.0 115.164 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.55 -29.36 12.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.123 1.821 . . . . 0.0 113.575 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -66.39 140.27 58.05 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.179 -1.189 . . . . 0.0 111.345 175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -104.09 140.36 37.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.176 1.39 . . . . 0.0 107.509 158.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.28 -30.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -159.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 36' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -143.31 27.4 1.57 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 171.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.27 37.08 48.98 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.931 0.777 . . . . 0.0 113.152 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -104.28 172.41 6.81 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -166.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -77.35 123.65 26.8 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.922 1.289 . . . . 0.0 110.907 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 40' ' ' VAL . . . . . . . . . . . . . 22.9 t -137.43 137.62 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.205 1.402 . . . . 0.0 110.136 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 41' ' ' ILE . . . . . . . . . . . . . 46.2 pt -138.0 158.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.225 1.81 . . . . 0.0 112.061 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -105.83 147.96 28.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.819 1.248 . . . . 0.0 111.3 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 43' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -133.49 -146.41 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.233 1.813 . . . . 0.0 109.956 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.95 93.9 0.12 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.519 -1.363 . . . . 0.0 111.533 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.3 -15.62 1.93 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.812 1.672 . . . . 0.0 116.206 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -126.33 165.48 18.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.11 1.364 . . . . 0.0 112.826 -164.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.81 138.37 52.75 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.658 1.183 . . . . 0.0 111.651 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 48' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -132.66 140.39 48.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.027 1.731 . . . . 0.0 111.282 -170.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -131.16 138.55 49.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.301 1.44 . . . . 0.0 112.946 -168.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 50' ' ' ILE . . . . . . . . . . . . . 8.8 tp -69.61 142.29 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.309 1.044 . . . . 0.0 112.339 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 51' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -100.79 97.85 8.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.044 0.938 . . . . 0.0 109.305 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -77.87 118.53 72.73 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 121.227 -0.921 . . . . 0.0 110.778 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 53' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.23 -22.35 34.64 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.762 2.308 . . . . 0.0 113.96 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 54' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -79.48 -34.24 41.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.294 0.952 . . . . 0.0 112.758 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 55' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -102.0 -29.27 11.89 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -170.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -118.83 63.55 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 108.906 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 57' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -46.04 -34.28 3.99 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 127.89 2.476 . . . . 0.0 116.658 -148.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 tt -48.81 -33.74 11.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.631 1.573 . . . . 0.0 112.289 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.49 -33.77 72.9 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.819 -1.176 . . . . 0.0 114.294 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.2 -36.77 85.22 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.939 1.37 . . . . 0.0 112.099 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.51 -38.19 80.71 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.638 -0.664 . . . . 0.0 112.087 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 62' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.61 -40.9 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.588 0.755 . . . . 0.0 111.023 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 63' ' ' VAL . . . . . . . . . . . . . 90.8 t -74.31 -41.88 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 118.586 0.63 . . . . 0.0 112.155 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 64' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -78.92 -24.69 43.91 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.55 9.55 0.03 OUTLIER Glycine 0 N--CA 1.477 1.369 0 N-CA-C 119.554 2.582 . . . . 0.0 119.554 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.62 120.76 12.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.904 1.852 . . . . 0.0 111.535 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 67' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -103.38 -40.09 6.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.747 1.619 . . . . 0.0 111.179 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -83.31 85.93 7.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.525 1.13 . . . . 0.0 111.461 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -109.32 91.43 9.78 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.319 1.448 . . . . 0.0 110.516 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.0 -16.1 10.13 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.673 2.249 . . . . 0.0 115.445 -163.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 71' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.15 150.95 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.296 0.953 . . . . 0.0 113.318 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -143.65 160.09 51.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.786 2.034 . . . . 0.0 109.602 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -54.65 146.43 54.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.063 1.842 . . . . 0.0 111.673 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 6.02 85.3 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 75' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -94.53 169.28 10.31 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.01 1.405 . . . . 0.0 113.431 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 76' ' ' SER . . . . . . . . . . . . . 89.6 p -111.65 130.32 55.81 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.086 1.354 . . . . 0.0 111.932 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -140.0 140.83 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.765 0.826 . . . . 0.0 112.962 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 78' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.66 127.81 49.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.734 1.614 . . . . 0.0 109.15 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -116.75 118.33 32.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.849 1.26 . . . . 0.0 109.995 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 mt -103.22 122.92 45.74 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.862 1.265 . . . . 0.0 108.922 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.89 5.31 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.738 0.685 . . . . 0.0 112.61 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 82' ' ' ILE . . . . . . . . . . . . . 15.2 tt -67.66 -18.31 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.592 -0.946 . . . . 0.0 113.551 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 83' ' ' ALA . . . . . . . . . . . . . . . 47.25 -135.26 0.97 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.998 1.319 . . . . 0.0 111.945 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 84' ' ' SER . . . . . . . . . . . . . 18.3 m -89.08 22.54 2.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.055 -1.028 . . . . 0.0 112.666 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.27 75.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.98 1.276 . . . . 0.0 116.13 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 86' ' ' THR . . . . . . . . . . . . . 34.5 p -50.42 -59.06 4.38 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.336 1.568 . . . . 0.0 112.989 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 87' ' ' THR . . . . . . . . . . . . . 18.6 m -77.83 -48.09 17.32 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.457 -0.777 . . . . 0.0 111.692 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.2 64.14 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -168.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 89' ' ' SER . . . . . . . . . . . . . 61.0 p -54.94 -33.09 61.92 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.93 -1.107 . . . . 0.0 112.592 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 90' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -74.06 -33.08 63.55 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 m -73.89 -32.94 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 120.149 1.34 . . . . 0.0 111.654 171.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.92 -36.88 80.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.226 1.01 . . . . 0.0 112.539 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.39 -37.3 84.94 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 94' ' ' ILE . . . . . . . . . . . . . 80.8 mt -83.03 -39.06 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.22 1.408 . . . . 0.0 112.546 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -77.58 -22.77 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.72 1.208 . . . . 0.0 112.592 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.39 -164.79 54.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.413 1.006 . . . . 0.0 114.521 172.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 97' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -89.21 -28.24 20.1 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -174.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 98' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.18 -22.21 58.21 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.352 0.661 . . . . 0.0 112.218 171.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 165.33 33.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.579 1.085 . . . . 0.0 113.428 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 100' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -130.05 128.4 41.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.559 1.144 . . . . 0.0 111.627 -168.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 118.76 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.696 1.198 . . . . 0.0 110.427 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 102' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.6 124.79 42.02 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.561 0.744 . . . . 0.0 109.487 168.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.18 108.99 1.71 Allowed Glycine 0 N--CA 1.468 0.812 0 CA-C-N 118.88 0.764 . . . . 0.0 113.302 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.06 132.75 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.744 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -145.89 143.87 29.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.081 1.353 . . . . 0.0 109.981 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 106' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -90.23 -34.18 15.88 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 112.211 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 107' ' ' SER . . . . . . . . . . . . . 3.5 m -79.88 100.44 0.61 Allowed Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.152 1.781 . . . . 0.0 111.383 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 108' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -64.51 -44.01 12.3 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.397 1.535 . . . . 0.0 114.359 -157.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 109' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -62.93 -24.86 68.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.607 1.163 . . . . 0.0 113.191 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -77.04 -44.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.654 1.116 . . . . 0.0 110.463 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 111' ' ' LEU . . . . . . . . . . . . . 34.3 tp -67.46 -31.54 71.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.061 0.944 . . . . 0.0 111.816 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 112' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -57.67 -34.29 69.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.83 1.252 . . . . 0.0 113.12 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 113' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -79.38 -9.47 59.6 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -92.8 -28.09 16.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.774 1.23 . . . . 0.0 112.142 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 115' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.53 -47.01 99.01 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.348 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 116' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.36 -33.34 58.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.469 2.112 . . . . 0.0 113.713 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 117' ' ' ILE . . . . . . . . . . . . . 31.5 mt -69.32 -37.81 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.071 -1.018 . . . . 0.0 111.317 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.26 -0.9 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.204 1.002 . . . . 0.0 113.618 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -68.65 -17.59 64.13 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.884 0.873 . . . . 0.0 111.273 160.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -108.47 -46.4 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.407 1.883 . . . . 0.0 112.896 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 121' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 -77.24 62.22 2.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.628 1.571 . . . . 0.0 112.784 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 122' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -73.36 9.98 1.15 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 123' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -87.68 -8.38 56.2 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 163.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 124' ' ' ILE . . . . . . . . . . . . . 23.2 mt -103.57 135.03 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.38 123.34 39.89 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.913 0.885 . . . . 0.0 109.696 166.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 126' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.86 123.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.499 2.799 . . . . 0.0 111.238 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -125.37 117.3 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.153 1.381 . . . . 0.0 109.856 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 119.02 22.46 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.766 -0.584 . . . . 0.0 110.595 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.77 157.43 18.59 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.927 0.775 . . . . 0.0 114.483 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 130' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -77.57 123.62 26.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.552 0.741 . . . . 0.0 109.276 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.03 -16.91 62.71 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.03 -7.92 55.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.354 1.862 . . . . 0.0 112.712 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -124.36 55.53 10.18 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.982 2.113 . . . . 0.0 111.2 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 134' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.31 -23.56 72.05 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.23 2.62 . . . . 0.0 114.487 -167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -54.81 -32.83 60.83 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.917 -1.115 . . . . 0.0 112.4 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.35 3.72 4.45 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 137' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -132.42 18.04 4.4 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 163.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 138' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -53.61 -30.03 40.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.9 -2.32 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.114 1.366 . . . . 0.0 114.459 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 140' ' ' LEU . . . . . . . . . . . . . 71.6 mt -106.55 -2.89 21.4 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 141' ' ' VAL . . . . . . . . . . . . . 13.2 m -142.22 158.0 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.618 1.167 . . . . 0.0 111.526 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 142' ' ' THR . . . . . . . . . . . . . 71.6 p -85.95 -177.82 6.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.633 1.173 . . . . 0.0 111.99 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -64.96 157.96 26.75 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.048 -1.033 . . . . 0.0 109.6 154.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 144' ' ' VAL . . . . . . . . . . . . . 24.8 m -134.44 158.97 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.357 1.463 . . . . 0.0 113.198 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 145' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.32 -34.72 59.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.981 1.312 . . . . 0.0 112.635 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 146' ' ' VAL . . . . . . . . . . . . . 57.0 t -140.51 146.39 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.041 1.337 . . . . 0.0 111.486 -171.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 147' ' ' ILE . . . . . . . . . . . . . 57.3 mt -116.02 137.68 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.764 1.225 . . . . 0.0 109.681 164.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 148' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -118.93 142.49 47.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.675 1.19 . . . . 0.0 110.486 164.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -131.01 130.33 43.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.195 0.998 . . . . 0.0 113.114 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 150' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.51 9.88 2.69 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 128.442 2.697 . . . . 0.0 111.056 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.75 -26.89 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.57 -1.331 . . . . 0.0 112.363 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 152' ' ' ALA . . . . . . . . . . . . . . . 54.49 48.47 20.43 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.176 1.391 . . . . 0.0 114.117 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 153' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -96.44 161.83 25.53 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.501 1.521 . . . . 0.0 113.557 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 154' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -58.07 -23.27 60.01 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.503 2.802 . . . . 0.0 116.423 -171.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 155' ' ' THR . . . . . . . . . . . . . 27.2 p -119.42 22.41 11.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.856 1.662 . . . . 0.0 112.788 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 156' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -56.58 -25.49 52.68 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.11 77.52 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.477 -1.39 . . . . 0.0 112.978 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 158' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -71.39 -36.67 71.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.812 0.845 . . . . 0.0 111.951 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 159' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.54 -46.54 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 160' ' ' LEU . . . . . . . . . . . . . 49.4 tp -62.16 -44.68 96.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.204 0.602 . . . . 0.0 112.325 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 161' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.76 -50.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.809 0.844 . . . . 0.0 111.484 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 162' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -76.93 -30.99 56.33 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.402 -0.811 . . . . 0.0 112.215 -172.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 163' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -66.13 -34.42 78.02 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.534 -1.354 . . . . 0.0 111.511 166.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.53 63.15 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.298 -1.501 . . . . 0.0 113.704 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 165' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.94 -55.6 21.36 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.506 1.048 . . . . 0.0 110.354 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.36 68.88 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 167' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.21 -30.52 2.65 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 -165.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 168' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.95 134.25 36.25 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.004 1.729 . . . . 0.0 112.49 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 169' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -72.83 160.44 32.16 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.166 0.986 . . . . 0.0 112.599 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 170' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -49.93 132.14 22.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.499 1.52 . . . . 0.0 111.3 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 171' ' ' GLY . . . . . . . . . . . . . . . 65.99 4.14 20.04 Favored Glycine 0 CA--C 1.542 1.748 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.36 162.31 54.22 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-N 119.798 1.799 . . . . 0.0 113.581 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 173' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -105.71 153.71 21.47 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.49 145.19 16.19 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.948 1.261 . . . . 0.0 111.679 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 175' ' ' MET . . . . . . . . . . . . . 69.5 mtp -136.64 142.8 43.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.503 1.521 . . . . 0.0 109.51 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 176' ' ' ILE . . . . . . . . . . . . . 12.1 tt -151.42 127.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -169.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 177' ' ' ALA . . . . . . . . . . . . . . . -97.6 120.83 38.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 111.087 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 178' ' ' VAL . . . . . . . . . . . . . 40.8 t -113.53 121.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 111.478 -168.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 179' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -105.72 101.38 10.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.851 1.66 . . . . 0.0 109.796 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 180' ' ' SER . . . . . . . . . . . . . 25.0 t -51.93 -49.35 63.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.315 0.646 . . . . 0.0 112.551 -168.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 181' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -66.81 -3.47 6.89 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 182' ' ' SER . . . . . . . . . . . . . 10.0 t -80.39 -36.99 33.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.653 0.781 . . . . 0.0 111.322 165.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -87.38 -49.31 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.065 1.346 . . . . 0.0 110.325 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 184' ' ' ASP . . . . . 0.44 ' CG ' ' HE3' ' H' ' 187' ' ' LYS . 7.1 t70 -156.91 140.33 15.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.449 1.5 . . . . 0.0 111.793 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 185' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.31 2.37 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.73 1.612 . . . . 0.0 113.131 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 186' ' ' THR . . . . . . . . . . . . . 53.7 m -99.64 -33.69 10.51 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.511 1.524 . . . . 0.0 111.858 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 187' ' ' LYS . . . . . 0.44 ' HE3' ' CG ' ' H' ' 184' ' ' ASP . 16.1 ptpt -93.62 170.26 9.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.295 1.438 . . . . 0.0 114.181 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 188' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.6 123.48 81.36 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.343 1.457 . . . . 0.0 110.868 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 189' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.34 -32.34 51.1 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.848 3.032 . . . . 0.0 116.199 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 190' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -62.92 -23.12 67.22 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.684 -1.26 . . . . 0.0 113.227 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 191' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -73.8 -36.21 64.99 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.618 -1.301 . . . . 0.0 112.277 170.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.01 -46.47 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.319 0.647 . . . . 0.0 109.88 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 193' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -65.67 -26.52 67.82 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.411 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 194' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -70.01 -32.99 71.44 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.131 1.332 . . . . 0.0 113.611 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.45 -36.71 74.08 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.927 -1.108 . . . . 0.0 111.237 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 196' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.72 -39.93 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 119.887 -1.758 . . . . 0.0 111.332 171.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 197' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -55.42 -43.32 75.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.068 1.347 . . . . 0.0 112.002 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 198' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.13 -19.4 47.37 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -87.61 -44.4 11.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.452 1.024 . . . . 0.0 111.694 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.68 -40.81 89.07 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.013 -1.054 . . . . 0.0 111.039 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 201' ' ' SER . . . . . . . . . . . . . 87.1 p -76.42 8.43 3.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 202' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -97.52 -6.65 33.16 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.759 -1.213 . . . . 0.0 112.29 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 203' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -142.33 -18.15 0.71 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 204' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -118.99 169.77 9.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.905 -1.122 . . . . 0.0 113.512 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 205' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -89.92 128.55 36.24 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 154.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 206' ' ' VAL . . . . . . . . . . . . . 27.3 t -100.07 133.31 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.246 -0.909 . . . . 0.0 109.901 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 207' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.42 -12.78 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -149.16 143.76 26.17 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.385 0.993 . . . . 0.0 111.366 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 138.14 27.53 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.931 1.692 . . . . 0.0 109.391 164.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 210' ' ' LEU . . . . . . . . . . . . . 87.4 mt -139.6 175.25 9.73 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.021 1.329 . . . . 0.0 112.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 211' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -124.84 141.87 51.82 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.322 2.649 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 1.2 36.66 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 213' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.14 141.53 76.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 120.645 -1.284 . . . . 0.0 111.121 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 214' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.27 -0.07 66.1 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 120.362 1.165 . . . . 0.0 114.245 1.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 215' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -68.88 -34.84 76.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.265 0.939 . . . . 0.0 112.805 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 216' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -117.84 175.71 5.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.533 1.533 . . . . 0.0 112.149 171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 217' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -123.5 141.29 52.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.35 1.46 . . . . 0.0 110.199 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 218' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.46 35.52 26.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.127 1.771 . . . . 0.0 114.364 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -134.18 135.42 43.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -161.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.21 174.2 9.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.244 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 221' ' ' LEU . . . . . . . . . . . . . 7.9 tt -144.43 147.18 33.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.226 1.411 . . . . 0.0 110.415 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 222' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.89 158.98 35.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.039 1.336 . . . . 0.0 111.866 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 223' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.0 139.07 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.033 1.333 . . . . 0.0 110.219 167.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 224' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.86 164.85 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.125 1.77 . . . . 0.0 112.117 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 225' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -124.12 139.86 53.53 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.275 1.43 . . . . 0.0 110.83 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 226' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -72.5 144.71 86.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.006 1.323 . . . . 0.0 109.808 165.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 227' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo . . . . . 0 C--O 1.257 1.428 0 C-N-CA 123.566 2.844 . . . . 0.0 114.573 179.58 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 mp -78.13 145.83 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 119.137 0.88 . . . . 0.0 109.623 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 3' ' ' SER . . . . . . . . . . . . . 34.4 t -132.76 145.1 50.73 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.611 1.164 . . . . 0.0 111.383 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -114.93 114.01 24.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.665 1.586 . . . . 0.0 109.616 -161.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -145.53 165.94 27.14 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -166.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.91 -38.86 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.279 1.832 . . . . 0.0 114.4 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -87.37 52.44 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.892 1.224 . . . . 0.0 110.677 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.75 -179.29 52.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.518 1.532 . . . . 0.0 114.034 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 pp -109.39 145.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.657 1.583 . . . . 0.0 111.245 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -127.66 147.85 50.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.612 1.165 . . . . 0.0 112.693 -161.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 130.86 45.74 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.769 1.228 . . . . 0.0 112.17 173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.57 154.8 46.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.695 1.998 . . . . 0.0 112.003 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.5 172.06 11.28 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.362 1.465 . . . . 0.0 114.335 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -56.02 -27.63 53.88 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -88.55 -5.1 58.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.683 1.193 . . . . 0.0 113.753 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.37 27.88 31.85 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.743 -1.223 . . . . 0.0 115.352 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -98.57 151.71 20.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.004 1.321 . . . . 0.0 109.792 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' LEU . . . . . . . . . . . . . 23.6 tp -72.52 144.01 48.14 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 111.119 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.48 -58.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.229 1.412 . . . . 0.0 109.56 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -157.2 158.04 35.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.303 1.441 . . . . 0.0 110.423 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -140.64 146.78 38.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.407 1.083 . . . . 0.0 110.994 164.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 22' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -128.83 145.43 51.2 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.948 1.299 . . . . 0.0 111.622 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 23' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -92.76 158.83 15.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 24' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -80.87 152.08 28.32 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 25' ' ' THR . . . . . . . . . . . . . 77.6 p -116.73 12.92 15.03 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -130.89 170.36 14.53 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.899 1.679 . . . . 0.0 108.729 156.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -51.14 114.52 4.97 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.462 1.505 . . . . 0.0 110.699 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.31 -31.02 65.23 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.575 2.85 . . . . 0.0 116.032 -168.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.26 -36.26 79.53 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.833 0.742 . . . . 0.0 112.721 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 30' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -77.03 -30.16 55.6 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.397 -0.814 . . . . 0.0 112.619 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.41 -39.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.78 -0.575 . . . . 0.0 110.758 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.1 -39.56 93.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.645 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 33' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.15 -36.92 83.3 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.905 1.229 . . . . 0.0 112.708 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 34' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -67.33 -53.35 30.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.024 0.93 . . . . 0.0 111.538 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.16 -33.84 76.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 36' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.05 -42.3 66.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.732 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -84.98 11.32 9.69 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.6 22.31 40.5 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 161.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 39' ' ' GLU . . . . . . . . . . . . 0.352 13.0 pt-20 -113.38 139.14 49.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.488 2.144 . . . . 0.0 113.865 165.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 40' ' ' ILE . . . . . . . . . . . . . 14.7 tt -85.34 154.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.974 1.31 . . . . 0.0 112.215 -165.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 41' ' ' THR . . . . . . . . . . . . . 72.9 p -131.21 157.77 42.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.165 0.986 . . . . 0.0 113.557 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -53.41 -34.92 59.63 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.43 1.892 . . . . 0.0 115.287 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.82 -28.12 58.16 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.89 -0.506 . . . . 0.0 111.946 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.15 -34.27 32.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.243 1.017 . . . . 0.0 111.245 173.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.59 -42.79 67.98 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.056 0.844 . . . . 0.0 110.774 165.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.68 -42.08 67.88 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.344 -0.847 . . . . 0.0 112.64 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.7 -39.4 94.21 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.244 -0.91 . . . . 0.0 112.425 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.8 -28.19 60.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.549 1.068 . . . . 0.0 112.677 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -66.64 -38.56 87.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.311 0.96 . . . . 0.0 112.084 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 50' ' ' SER . . . . . . . . . . . . . 23.5 t -60.71 -46.84 88.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.591 0.756 . . . . 0.0 110.788 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 51' ' ' LEU . . . . . . . . . . . . . 18.0 tp -63.95 -36.43 83.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.97 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 52' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -66.66 -45.03 80.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.198 1.399 . . . . 0.0 111.791 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -70.42 -24.61 62.94 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.579 1.151 . . . . 0.0 113.33 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.75 -24.43 64.45 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.495 1.118 . . . . 0.0 112.875 167.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.75 5.29 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 115.464 0.946 . . . . 0.0 115.464 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 56' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.6 155.07 20.53 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.696 1.198 . . . . 0.0 110.887 168.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -131.24 -25.67 2.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 58' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -80.91 64.44 5.68 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.33 1.452 . . . . 0.0 112.084 -168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 59' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -76.26 72.2 3.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.795 1.238 . . . . 0.0 113.53 -167.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 p -76.15 118.54 22.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 170.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 61' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.15 171.78 8.72 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.075 2.55 . . . . 0.0 111.517 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -79.45 -41.4 27.63 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.904 -0.497 . . . . 0.0 112.152 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 63' ' ' HIS . . . . . 0.414 ' CD2' ' HD2' ' I' ' 64' ' ' PRO . 49.1 t-80 -101.08 139.53 20.56 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -167.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 64' ' ' PRO . . . . . 0.414 ' HD2' ' CD2' ' I' ' 63' ' ' HIS . 56.0 Cg_endo -68.8 -38.84 9.47 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.773 2.316 . . . . 0.0 113.81 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -89.11 -29.44 19.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.379 0.99 . . . . 0.0 112.36 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.35 -43.62 88.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.086 0.555 . . . . 0.0 110.562 163.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 67' ' ' SER . . . . . . . . . . . . . 9.5 t -65.82 -34.13 77.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.622 0.769 . . . . 0.0 112.333 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -60.35 -55.46 33.3 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.2 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 69' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.83 -37.43 71.23 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.377 1.444 . . . . 0.0 111.306 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.99 69.73 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 71' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -79.74 -23.45 42.27 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.87 -34.34 75.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.557 1.543 . . . . 0.0 111.632 168.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 73' ' ' LEU . . . . . . . . . . . . . 47.9 tp -77.34 -30.15 53.81 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.659 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.46 2.69 1.98 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 169.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 75' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -81.53 160.23 23.94 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.941 1.371 . . . . 0.0 112.909 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 76' ' ' SER . . . . . . . . . . . . . 4.5 p -83.47 57.29 3.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.085 1.754 . . . . 0.0 112.204 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.48 141.26 30.76 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 78' ' ' THR . . . . . . . . . . . . . 41.8 p -133.62 -175.98 4.01 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.751 1.62 . . . . 0.0 111.236 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 79' ' ' THR . . . . . . . . . . . . . 40.7 m -139.46 126.38 20.93 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.091 -1.005 . . . . 0.0 112.794 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -149.73 108.28 3.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.974 1.31 . . . . 0.0 109.104 162.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 81' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -56.53 -43.5 99.35 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.362 1.065 . . . . 0.0 113.779 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.54 20.22 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.282 2.655 . . . . 0.0 114.971 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -62.4 158.02 18.62 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.085 1.311 . . . . 0.0 112.732 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 tp -60.61 -22.5 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -167.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.04 -55.1 20.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.835 0.743 . . . . 0.0 111.798 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.51 -38.15 90.42 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.367 0.508 . . . . 0.0 112.491 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 87' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.95 -26.3 68.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.041 0.937 . . . . 0.0 112.88 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -86.12 -56.88 3.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.957 1.253 . . . . 0.0 111.736 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.97 -45.48 90.44 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.928 1.291 . . . . 0.0 112.293 -171.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 90' ' ' ARG . . . . . . . . . . . . . 92.9 mtm-85 -82.35 -9.66 59.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 91' ' ' SER . . . . . . . . . . . . . 75.3 m -82.38 -44.24 16.37 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.153 1.342 . . . . 0.0 111.958 173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 92' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -141.28 89.45 9.52 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.42 -21.73 68.84 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.668 2.245 . . . . 0.0 114.266 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.66 -37.77 76.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.879 1.272 . . . . 0.0 112.368 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 95' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.44 -16.51 63.71 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.649 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 96' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -131.16 -39.3 1.19 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -166.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.38 -27.35 13.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.157 1.383 . . . . 0.0 113.753 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.01 159.84 31.52 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.272 1.415 . . . . 0.0 112.839 -166.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.22 -26.29 66.53 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 100' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -86.86 19.01 3.16 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 101' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -48.18 -32.15 6.66 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 102' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.85 -24.44 66.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.944 0.897 . . . . 0.0 113.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 103' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.31 -39.04 91.96 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 119.576 1.08 . . . . 0.0 111.0 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 104' ' ' GLU . . . . . 0.424 ' HA ' ' HE2' ' I' ' 107' ' ' LYS . 0.9 OUTLIER -77.47 -37.08 52.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.555 0.742 . . . . 0.0 112.183 -178.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 105' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.38 -50.44 72.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.405 0.682 . . . . 0.0 111.22 166.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.52 -53.5 56.73 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.951 0.901 . . . . 0.0 112.187 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 107' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' I' ' 104' ' ' GLU . 55.9 pttt -67.16 -26.57 66.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.77 -37.7 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.763 0.825 . . . . 0.0 111.632 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.42 -46.65 93.93 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.345 0.975 . . . . 0.0 113.114 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 110' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.78 -32.08 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.829 -0.806 . . . . 0.0 112.283 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.33 68.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.553 0.741 . . . . 0.0 112.001 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.83 -47.5 82.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.006 0.922 . . . . 0.0 111.078 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 113' ' ' THR . . . . . . . . . . . . . 64.5 m -65.66 -36.17 82.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 114' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -69.16 -22.42 63.93 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.102 -0.999 . . . . 0.0 112.727 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 115' ' ' MET . . . . . . . . . . . . . 54.8 ttp -95.5 -20.04 19.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.504 1.522 . . . . 0.0 114.851 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -72.27 37.14 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 117' ' ' ILE . . . . . . . . . . . . . 19.0 tt -137.72 124.46 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.182 1.393 . . . . 0.0 111.125 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 118' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -74.8 157.67 34.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.849 1.659 . . . . 0.0 112.468 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 119' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.04 128.7 44.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.606 1.562 . . . . 0.0 114.274 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 120' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -156.21 68.01 0.6 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.128 0.971 . . . . 0.0 111.639 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 121' ' ' SER . . . . . . . . . . . . . 4.0 m -70.82 163.61 26.95 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.936 -1.102 . . . . 0.0 111.747 165.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.24 -30.71 13.27 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.809 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.69 58.7 1.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 111.467 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 124' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -66.98 -23.88 65.99 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -160.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.17 -39.92 95.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.593 1.542 . . . . 0.0 111.635 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 126' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -66.19 -40.68 90.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.825 1.25 . . . . 0.0 111.79 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 127' ' ' MET . . . . . . . . . . . . . 21.0 mtt -73.91 -4.5 35.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.098 1.359 . . . . 0.0 113.317 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 128' ' ' VAL . . . . . . . . . . . . . 71.8 t -105.89 -31.9 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.56 1.544 . . . . 0.0 111.722 168.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 129' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.57 -40.99 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.431 1.469 . . . . 0.0 110.958 169.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 130' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -63.59 -28.96 70.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.82 -29.36 50.59 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.036 0.834 . . . . 0.0 112.844 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 132' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.12 -41.38 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.463 -0.773 . . . . 0.0 110.527 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -65.89 -34.26 77.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.868 0.758 . . . . 0.0 112.218 167.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.48 75.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.924 1.238 . . . . 0.0 112.046 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.18 -39.08 78.92 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.982 0.81 . . . . 0.0 111.205 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.78 -44.7 80.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.701 0.8 . . . . 0.0 112.019 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.92 -29.62 65.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.261 1.424 . . . . 0.0 112.541 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 138' ' ' VAL . . . . . . . . . . . . . 10.9 t -71.47 -47.75 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 119.937 -1.727 . . . . 0.0 111.932 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 139' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -62.46 -33.91 75.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.484 1.038 . . . . 0.0 111.028 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 140' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -62.61 -40.01 95.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.588 1.155 . . . . 0.0 113.316 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.77 -34.31 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.73 1.15 . . . . 0.0 112.877 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 142' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.05 -46.73 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 110.216 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 143' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -70.43 -3.81 19.49 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.914 1.286 . . . . 0.0 113.373 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.55 -56.29 2.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.638 1.575 . . . . 0.0 110.654 172.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 145' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.93 -34.4 77.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.164 -0.96 . . . . 0.0 112.881 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 146' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.76 -25.38 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.423 -0.798 . . . . 0.0 111.913 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.04 -43.88 86.28 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.101 1.319 . . . . 0.0 111.039 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -42.86 99.37 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.713 0.805 . . . . 0.0 111.537 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 149' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.26 -42.72 99.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.011 0.925 . . . . 0.0 112.321 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 150' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -61.52 -52.02 66.22 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.499 1.12 . . . . 0.0 111.382 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 151' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.04 -38.88 92.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.172 0.589 . . . . 0.0 112.58 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 152' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -72.71 -47.99 42.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.748 0.819 . . . . 0.0 111.906 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.2 -30.9 70.09 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.732 -1.23 . . . . 0.0 112.712 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 48.7 m -67.46 -8.85 36.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 155' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.55 -30.73 71.76 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.02 -1.05 . . . . 0.0 111.779 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 156' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -107.69 -33.76 7.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.025 1.73 . . . . 0.0 113.468 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 157' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -149.75 72.03 9.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.321 1.048 . . . . 0.0 111.773 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.18 -13.0 38.08 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.856 3.037 . . . . 0.0 114.593 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 159' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -71.52 6.26 1.94 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.221 1.408 . . . . 0.0 114.472 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 160' ' ' LEU . . . . . . . . . . . . . 18.4 tp -111.17 -26.35 9.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.405 1.882 . . . . 0.0 114.187 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.03 -50.05 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.492 1.117 . . . . 0.0 113.564 -165.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 162' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.71 -6.44 55.81 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.337 1.055 . . . . 0.0 113.594 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 163' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.91 -31.49 11.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.36 1.464 . . . . 0.0 112.47 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 164' ' ' LEU . . . . . . . . . . . . . 53.3 mt -115.92 68.36 3.23 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.973 1.709 . . . . 0.0 110.693 168.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 165' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.55 -27.79 18.36 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.562 2.174 . . . . 0.0 113.63 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 166' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -69.31 115.33 8.47 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.485 -1.385 . . . . 0.0 109.665 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 167' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -40.1 81.5 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -164.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 168' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.78 -35.77 87.3 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.065 1.843 . . . . 0.0 113.927 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 169' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -71.85 -35.15 69.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.71 -0.619 . . . . 0.0 111.491 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 170' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.64 -43.73 83.85 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.572 0.749 . . . . 0.0 111.524 172.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 171' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.92 -44.6 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.475 -0.766 . . . . 0.0 111.251 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.71 -37.73 87.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.813 0.733 . . . . 0.0 112.537 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 173' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -61.27 -49.47 76.95 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.582 -0.699 . . . . 0.0 111.557 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.16 -32.73 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 118.527 -0.749 . . . . 0.0 112.062 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 175' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -68.54 -57.74 5.32 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.61 1.095 . . . . 0.0 111.537 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 176' ' ' THR . . . . . . . . . . . . . 36.2 m -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -164.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 177' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.12 -50.69 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.043 -1.036 . . . . 0.0 110.784 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.3 -107.83 2.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.82 0.724 . . . . 0.0 114.111 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 179' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -67.24 134.18 51.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.584 -0.95 . . . . 0.0 112.11 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 180' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -59.02 -30.01 67.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 181' ' ' ASP . . . . . 0.403 ' HA ' ' HE2' ' I' ' 205' ' ' LYS . 3.3 m-20 -83.01 -0.83 50.68 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 182' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.7 -23.74 60.91 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 112.494 165.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 183' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.84 122.14 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.809 1.244 . . . . 0.0 111.034 -169.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 184' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -140.93 172.2 13.02 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.518 1.927 . . . . 0.0 110.301 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 185' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -67.46 -29.71 69.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 186' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -80.68 -45.96 16.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.126 0.97 . . . . 0.0 111.176 -172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 187' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.72 -22.36 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 188' ' ' LEU . . . . . . . . . . . . . 86.1 mt -75.82 -29.2 58.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.3 -0.875 . . . . 0.0 112.254 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 189' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 -78.54 -32.67 48.01 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.037 170.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.78 -11.42 58.44 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 167.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 191' ' ' LEU . . . . . . . . . . . . . 47.8 tp -99.18 -7.36 26.68 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.676 1.99 . . . . 0.0 112.644 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.13 25.96 46.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.631 1.11 . . . . 0.0 115.863 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 193' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.27 150.46 25.42 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.45 1.625 . . . . 0.0 111.598 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 194' ' ' SER . . . . . . . . . . . . . 13.4 p -91.83 157.14 17.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.255 1.422 . . . . 0.0 112.703 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 195' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -52.27 -39.52 60.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.007 1.323 . . . . 0.0 113.721 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 196' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -57.71 -28.13 63.58 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.351 2.26 . . . . 0.0 114.516 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 197' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -93.17 -26.77 17.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.513 1.925 . . . . 0.0 111.181 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 198' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.43 -17.86 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.003 2.121 . . . . 0.0 113.026 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 199' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.53 -51.67 66.48 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.612 -1.305 . . . . 0.0 110.796 162.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 200' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -68.43 175.54 3.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.96 0.904 . . . . 0.0 109.677 161.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 201' ' ' ILE . . . . . . . . . . . . . 21.5 mt 64.59 -61.79 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.005 1.322 . . . . 0.0 112.292 -166.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 202' ' ' LEU . . . . . . . . . . . . . 46.9 mt -63.58 -34.73 78.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.705 1.139 . . . . 0.0 112.022 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -47.14 -37.7 10.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.436 1.094 . . . . 0.0 113.164 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 204' ' ' ALA . . . . . . . . . . . . . . . -89.83 -16.09 30.88 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 113.737 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 205' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' I' ' 181' ' ' ASP . 25.9 tptp -56.09 -34.13 65.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.549 1.139 . . . . 0.0 112.752 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 206' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -92.36 -9.47 41.68 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.934 1.293 . . . . 0.0 114.274 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 207' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -148.91 10.41 0.81 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -167.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 208' ' ' THR . . . . . . . . . . . . . 4.4 t -47.33 153.05 0.54 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.884 1.22 . . . . 0.0 113.554 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 209' ' ' MET . . . . . . . . . . . . . 11.6 ptp -105.11 -0.48 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.49 1.516 . . . . 0.0 114.022 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 210' ' ' GLY . . . . . . . . . . . . . . . -67.06 154.37 52.84 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-N 118.84 0.746 . . . . 0.0 114.136 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 211' ' ' ALA . . . . . . . . . . . . . . . -101.52 150.01 23.5 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.673 1.989 . . . . 0.0 111.984 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 212' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -70.55 131.42 43.95 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 213' ' ' MET . . . . . . . . . . . . . 64.7 mtt -95.36 134.7 37.87 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.913 1.685 . . . . 0.0 110.674 155.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 214' ' ' ASP . . . . . . . . . . . . 0.263 13.8 t0 -87.55 172.99 9.34 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 215' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -54.81 -33.14 61.21 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -164.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 216' ' ' THR . . . . . 0.422 ' CB ' HH12 ' L' ' 244' ' ' ARG 0.263 23.7 p -114.31 18.41 16.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 175.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 217' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -84.71 -49.16 8.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.3 0.64 . . . . 0.0 109.89 155.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 218' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.36 -25.49 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.576 . . . . 0.0 112.11 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.98 -47.7 84.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.173 -0.918 . . . . 0.0 112.439 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -29.96 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 120.62 1.555 . . . . 0.0 112.038 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.24 -34.96 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 0.0 110.676 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 222' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -70.09 -37.59 75.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 118.196 -0.906 . . . . 0.0 113.052 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 223' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -60.01 -45.21 93.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.411 1.005 . . . . 0.0 110.604 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 224' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.57 -43.18 93.68 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.817 -0.552 . . . . 0.0 111.902 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.9 -34.07 75.94 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 226' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.85 -35.48 74.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.149 1.38 . . . . 0.0 112.112 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 227' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.8 -35.16 60.16 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.118 -0.989 . . . . 0.0 112.756 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 228' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 -32.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.564 -1.335 . . . . 0.0 111.477 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 229' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.71 -42.79 68.4 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 230' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -68.17 -27.95 66.86 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.367 -0.833 . . . . 0.0 112.952 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 231' ' ' LEU . . . . . . . . . . . . . 98.9 mt -68.94 -30.42 68.86 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.886 1.221 . . . . 0.0 112.537 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 232' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -71.71 -34.89 69.99 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.012 -1.055 . . . . 0.0 112.393 168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 233' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.0 -39.04 92.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.862 0.755 . . . . 0.0 111.606 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 234' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.17 -37.02 83.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.637 1.175 . . . . 0.0 112.044 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 235' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -62.28 -40.9 97.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.528 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 236' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.46 -44.05 97.33 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.599 1.09 . . . . 0.0 111.995 171.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 237' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -56.54 -39.34 73.22 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.285 1.034 . . . . 0.0 111.854 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 238' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.1 -42.91 62.45 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 239' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.03 -43.63 95.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.505 1.048 . . . . 0.0 111.741 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 240' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -70.46 -28.44 65.01 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.069 1.348 . . . . 0.0 113.166 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 241' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -72.6 -46.96 51.65 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.854 0.862 . . . . 0.0 111.686 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 242' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.14 -41.19 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.784 0.834 . . . . 0.0 111.098 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 243' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.39 -15.56 62.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.356 1.063 . . . . 0.0 113.805 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -46.16 4.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.837 1.655 . . . . 0.0 113.127 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 245' ' ' ALA . . . . . . . . . . . . . . . -91.38 -23.75 19.97 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 246' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.96 -2.81 49.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.693 1.133 . . . . 0.0 113.955 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 247' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -95.74 -0.42 51.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.588 1.555 . . . . 0.0 113.56 172.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 248' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -73.09 147.19 45.19 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.926 -1.109 . . . . 0.0 112.434 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 249' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.46 135.02 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.216 1.807 . . . . 0.0 109.732 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 250' ' ' ALA . . . . . . . . . . . . . . . -147.73 134.5 10.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.868 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 251' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -75.93 148.62 32.03 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.736 2.291 . . . . 0.0 113.58 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 252' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -82.33 -48.65 10.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.41 1.484 . . . . 0.0 112.314 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 253' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.77 -40.63 76.19 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.882 0.873 . . . . 0.0 111.497 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 254' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -56.06 -27.42 53.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.775 2.03 . . . . 0.0 113.635 175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 255' ' ' ALA . . . . . . . . . . . . . . . -100.93 -35.24 9.47 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.9 1.28 . . . . 0.0 113.694 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 256' ' ' LEU . . . . . . . . . . . . . 67.5 tp -72.47 -43.53 63.56 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.225 0.921 . . . . 0.0 113.095 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 257' ' ' VAL . . . . . . . . . . . . . 18.0 m -117.71 -6.41 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.4 142.91 6.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.505 1.05 . . . . 0.0 112.532 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 259' ' ' ALA . . . . . . . . . . . . . . . -52.15 -48.92 64.65 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -166.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 260' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -67.14 -38.98 86.47 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.49 0.716 . . . . 0.0 112.776 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 261' ' ' LEU . . . . . . . . . . . . . 44.0 tp -72.25 -41.03 67.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.51 0.724 . . . . 0.0 111.589 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 262' ' ' ALA . . . . . . . . . . . . . . . -57.8 -50.64 72.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.447 0.699 . . . . 0.0 111.556 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.39 82.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.791 0.837 . . . . 0.0 112.276 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 264' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -66.92 -51.53 54.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 118.941 0.791 . . . . 0.0 111.776 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 265' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.32 -36.3 73.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.165 0.986 . . . . 0.0 113.022 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 266' ' ' ILE . . . . . . . . . . . . . 44.5 mt -57.8 -27.03 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.825 1.25 . . . . 0.0 113.039 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 267' ' ' SER . . . . . . . . . . . . . 11.9 t -96.77 -28.92 14.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 268' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.4 -23.5 66.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.802 0.728 . . . . 0.0 112.254 170.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.92 -2.99 56.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.935 1.294 . . . . 0.0 113.677 169.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.67 -36.42 2.65 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 120.768 -1.208 . . . . 0.0 114.107 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 271' ' ' GLY . . . . . . . . . . . . . . . -170.3 171.29 43.49 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 118.531 1.166 . . . . 0.0 114.942 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 272' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.64 -30.96 71.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.399 -1.059 . . . . 0.0 111.736 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -54.86 39.52 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.096 1.358 . . . . 0.0 110.491 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 274' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.42 -42.9 96.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.266 0.627 . . . . 0.0 112.475 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 275' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.43 -25.09 67.78 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 119.482 1.037 . . . . 0.0 112.948 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 276' ' ' ALA . . . . . . . . . . . . . . . -91.52 -4.54 55.34 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.929 1.692 . . . . 0.0 114.249 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 277' ' ' MET . . . . . . . . . . . . . 20.0 mmt -107.31 -51.04 2.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.046 1.339 . . . . 0.0 111.451 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 278' ' ' MET . . . . . . . . . . . . . 56.4 mtt -54.14 154.37 7.99 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.907 2.083 . . . . 0.0 114.286 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 279' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.58 154.12 27.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.776 2.984 . . . . 0.0 112.445 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 280' ' ' SER . . . . . . . . . . . . . 96.8 p -53.85 -38.31 64.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.776 0.831 . . . . 0.0 113.095 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 281' ' ' SER . . . . . . . . . . . . . 18.4 m -57.54 -29.55 64.47 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 282' ' ' THR . . . . . . . . . . . . . 87.4 m -90.2 -41.87 11.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.11 0.964 . . . . 0.0 110.429 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 283' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.06 -28.98 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.738 1.215 . . . . 0.0 111.622 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 284' ' ' GLN . . . . . 0.405 ' NE2' ' H62' ' A' ' 50' ' ' ' A' . 50.3 tt0 -59.86 -33.49 71.86 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.911 1.685 . . . . 0.0 113.602 172.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 285' ' ' VAL . . . . . . . . . . . . . 32.0 m -113.27 -0.98 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 286' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.45 125.15 10.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.662 1.185 . . . . 0.0 112.329 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 287' ' ' GLY . . . . . . . . . . . . . . . 63.06 32.21 83.37 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 288' ' ' ALA . . . . . . . . . . . . . . . -70.68 -4.85 25.62 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 119.67 1.735 . . . . 0.0 114.314 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 289' ' ' GLU . . . . . . . . . . . . 0.25 43.4 mt-10 49.77 -139.81 0.82 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.225 1.81 . . . . 0.0 111.061 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 290' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -61.15 -10.57 6.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 291' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.85 74.09 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.216 -0.927 . . . . 0.0 112.386 170.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 292' ' ' LEU . . . . . . . . . . . . . 48.4 tp -73.03 -43.03 62.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.51 -0.744 . . . . 0.0 110.918 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 293' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -50.4 -53.0 32.57 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.359 1.063 . . . . 0.0 112.174 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 294' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -72.93 -21.86 60.82 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 295' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -67.76 -41.56 83.15 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.168 0.895 . . . . 0.0 112.386 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 296' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.13 -70.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.675 0.671 . . . . 0.0 110.881 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 297' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -38.28 88.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.683 1.593 . . . . 0.0 113.463 -167.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 298' ' ' THR . . . . . . . . . . . . . 3.7 m -105.56 -4.11 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.201 1.0 . . . . 0.0 113.165 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 299' ' ' GLY . . . . . . . . . . . . . . . 68.94 28.18 73.26 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.674 -1.266 . . . . 0.0 115.501 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 300' ' ' ALA . . . . . . . . . . . . . . . -68.95 178.3 2.26 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.11 1.364 . . . . 0.0 113.112 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 301' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -61.55 137.8 94.89 Favored Pre-proline 0 CA--C 1.55 0.965 0 O-C-N 120.85 -1.157 . . . . 0.0 110.285 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 302' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -54.11 143.82 60.98 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.803 2.335 . . . . 0.0 112.959 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 303' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.16 136.52 37.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.047 1.831 . . . . 0.0 111.453 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 304' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -67.69 -25.06 65.5 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.862 -1.149 . . . . 0.0 113.518 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 305' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.58 145.7 9.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.066 1.346 . . . . 0.0 111.336 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 306' ' ' GLY . . . . . . . . . . . . . . . -95.22 -136.8 8.72 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.126 1.346 . . . . 0.0 112.007 164.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 307' ' ' VAL . . . . . . . . . . . . . 54.8 t -54.99 -21.62 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.466 1.506 . . . . 0.0 113.546 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 308' ' ' ILE . . . . . . . . . . . . . 26.3 pt -59.39 -13.86 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.863 -1.148 . . . . 0.0 114.01 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 309' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -59.4 -31.37 69.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.773 1.17 . . . . 0.0 112.407 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 310' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.62 -0.91 7.56 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 311' ' ' TYR . . . . . 0.416 ' CD2' ' HD2' ' I' ' 312' ' ' PRO . 70.0 t80 -65.7 133.33 95.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 120.076 -1.64 . . . . 0.0 110.861 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 312' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' I' ' 311' ' ' TYR . 43.1 Cg_endo -67.91 -0.87 5.99 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.248 2.632 . . . . 0.0 116.824 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 313' ' ' ALA . . . . . . . . . . . . . . . -113.2 10.42 18.57 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.057 1.343 . . . . 0.0 113.778 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 314' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.2 -45.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.419 1.488 . . . . 0.0 110.085 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 315' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -51.61 -46.26 63.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.743 1.217 . . . . 0.0 114.214 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -87.44 -10.3 52.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 317' ' ' SER . . . . . . . . . . . . . 15.8 m -88.96 152.44 48.43 Favored Pre-proline 0 N--CA 1.473 0.675 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -155.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 318' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.11 157.28 46.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.927 2.418 . . . . 0.0 113.155 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 319' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -60.32 -39.08 85.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 320' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -50.19 -32.32 16.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.387 1.875 . . . . 0.0 113.418 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 321' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.23 -26.16 9.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.409 1.884 . . . . 0.0 114.114 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 322' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -50.62 -42.58 56.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 120.557 1.526 . . . . 0.0 113.844 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 323' ' ' GLY . . . . . . . . . . . . . . . -70.92 -44.18 56.31 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.772 0.715 . . . . 0.0 113.877 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 324' ' ' LYS . . . . . 0.486 ' HE2' ' CE1' ' I' ' 366' ' ' TYR . 55.7 mttp -62.1 -44.27 97.01 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.861 1.265 . . . . 0.0 111.199 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 325' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.51 -41.05 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.998 0.919 . . . . 0.0 110.734 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.71 80.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.821 1.191 . . . . 0.0 113.518 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 327' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -67.78 -50.61 56.14 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.696 0.799 . . . . 0.0 111.865 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.36 83.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 112.786 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 329' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.17 -46.03 91.09 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.377 -0.827 . . . . 0.0 110.479 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.02 -37.09 85.8 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.383 0.992 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 331' ' ' GLY . . . . . . . . . . . . . . . -63.62 -54.43 31.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.699 0.666 . . . . 0.0 112.547 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 332' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -64.23 -31.86 73.22 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.046 -1.267 . . . . 0.0 113.188 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 333' ' ' LEU . . . . . . . . . . . . . 49.9 tp -65.66 -45.0 84.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.384 1.873 . . . . 0.0 111.94 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.13 85.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.255 0.622 . . . . 0.0 111.924 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 335' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.04 -51.91 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.417 1.087 . . . . 0.0 110.834 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 336' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.62 82.97 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.893 0.77 . . . . 0.0 112.944 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 337' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.83 97.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.879 0.472 . . . . 0.0 112.095 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 338' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -38.43 87.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.689 0.796 . . . . 0.0 112.534 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 339' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.16 -49.37 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.314 0.961 . . . . 0.0 111.676 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 340' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -60.92 -33.79 73.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.805 0.73 . . . . 0.0 112.784 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 341' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -91.22 -43.66 9.7 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 342' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.05 -25.3 18.0 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 343' ' ' SER . . . . . . . . . . . . . 22.8 t -119.72 -44.04 2.55 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 344' ' ' GLY . . . . . . . . . . . . . . . 66.43 30.31 76.36 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.24 -0.912 . . . . 0.0 113.416 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 345' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -110.02 170.61 7.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.567 1.947 . . . . 0.0 108.983 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 346' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -123.87 125.32 44.45 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.743 -1.223 . . . . 0.0 111.731 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 347' ' ' ILE . . . . . . . . . . . . . 40.1 pt -137.94 14.66 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.781 1.633 . . . . 0.0 112.616 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 348' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.63 70.06 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 119.797 -1.815 . . . . 0.0 114.885 -162.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 349' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -75.6 -21.64 57.61 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.348 -0.845 . . . . 0.0 112.669 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 350' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.04 -48.15 46.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.184 0.902 . . . . 0.0 110.095 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 351' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.56 -37.01 74.82 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.16 0.584 . . . . 0.0 111.988 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 352' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.58 -46.55 79.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.07 0.948 . . . . 0.0 112.441 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 353' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.18 -39.65 79.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.219 1.008 . . . . 0.0 112.253 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 354' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -68.52 -46.36 69.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.186 0.594 . . . . 0.0 112.566 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 355' ' ' LEU . . . . . . . . . . . . . 40.6 tp -64.56 -31.61 72.9 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.205 -0.934 . . . . 0.0 111.648 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 356' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.91 -36.45 75.38 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.899 1.28 . . . . 0.0 112.783 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 357' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.52 87.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.798 0.727 . . . . 0.0 111.309 168.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 358' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -61.73 -37.75 85.38 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.503 -0.748 . . . . 0.0 112.654 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 359' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.91 -41.18 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.829 1.195 . . . . 0.0 111.312 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 360' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -62.14 -42.1 98.92 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.96 0.8 . . . . 0.0 111.506 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 361' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.79 -37.39 87.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.416 0.687 . . . . 0.0 112.083 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 362' ' ' ILE . . . . . . . . . . . . . 46.1 mt -60.52 -40.42 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.066 -1.022 . . . . 0.0 111.058 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 363' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -43.15 88.61 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.753 1.161 . . . . 0.0 111.257 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.37 -19.02 64.61 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.516 1.126 . . . . 0.0 113.379 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 365' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -99.39 -24.56 14.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 366' ' ' TYR . . . . . 0.486 ' CE1' ' HE2' ' I' ' 324' ' ' LYS . 46.8 m-85 . . . . . 0 C--O 1.253 1.271 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -164.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 1' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 2' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.42 165.11 21.08 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.253 2.635 . . . . 0.0 113.988 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 3' ' ' SER . . . . . . . . . . . . . 87.8 p -69.96 -37.68 75.87 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.944 2.097 . . . . 0.0 113.902 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 4' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -72.59 -11.5 60.67 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -164.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.0 144.44 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.505 1.048 . . . . 0.0 112.361 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -116.41 -25.75 7.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.84 1.256 . . . . 0.0 113.764 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -139.13 151.17 46.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.309 1.843 . . . . 0.0 110.405 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.33 148.63 33.7 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 110.93 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.31 145.19 28.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.372 1.069 . . . . 0.0 111.722 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.61 -163.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.874 3.049 . . . . 0.0 111.316 160.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -65.31 -13.42 58.44 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.448 -1.408 . . . . 0.0 114.108 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.46 146.52 53.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.712 1.205 . . . . 0.0 111.545 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' LEU . . . . . . . . . . . . . 50.0 mt 59.82 -47.36 0.08 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.509 1.924 . . . . 0.0 114.531 -162.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -48.02 83.57 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.1 1.318 . . . . 0.0 113.256 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.61 -29.68 70.3 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.872 -1.143 . . . . 0.0 111.719 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.71 -33.51 62.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.917 0.887 . . . . 0.0 112.411 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.43 70.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.827 0.851 . . . . 0.0 112.368 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.93 -43.34 99.07 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.327 0.512 . . . . 0.0 110.448 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.32 -36.52 75.8 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.445 -0.784 . . . . 0.0 112.945 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.57 90.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.01 0.823 . . . . 0.0 112.518 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' VAL . . . . . . . . . . . . . 77.6 t -59.03 -41.65 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.015 0.825 . . . . 0.0 110.764 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.06 -7.15 15.71 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.5 -21.73 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.23 67.52 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.635 -1.29 . . . . 0.0 111.794 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -57.38 -34.76 69.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -125.64 4.51 7.51 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 25.6 p -115.75 -13.95 11.4 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.55 -139.91 4.1 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.859 1.695 . . . . 0.0 113.957 -171.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -134.16 127.58 32.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.334 1.454 . . . . 0.0 110.792 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 tt -143.13 153.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.722 1.209 . . . . 0.0 112.069 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 31' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -133.59 156.78 47.22 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.765 1.226 . . . . 0.0 111.445 164.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 144.69 41.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.209 1.803 . . . . 0.0 112.0 -169.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.22 154.58 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.397 0.998 . . . . 0.0 112.16 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 34' ' ' THR . . . . . . . . . . . . . 28.6 m -77.97 -28.12 49.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 35' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -76.44 -32.31 58.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 122.165 2.257 . . . . 0.0 112.744 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -72.18 -40.15 68.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.771 -1.206 . . . . 0.0 112.506 168.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -55.55 -45.53 77.26 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 168.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 38' ' ' THR . . . . . . . . . . . . . 85.5 m -67.82 -38.34 83.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.212 1.005 . . . . 0.0 111.848 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 39' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -58.67 -49.9 75.83 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.457 1.481 . . . . 0.0 112.215 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.91 -16.61 62.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 41' ' ' VAL . . . . . 0.473 HG13 ' HE2' ' J' ' 71' ' ' LYS . 2.7 t -84.34 -52.92 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 117.275 -1.345 . . . . 0.0 110.956 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -61.46 -48.09 82.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.429 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 43' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -84.77 25.04 0.96 Allowed 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.051 -1.031 . . . . 0.0 113.318 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.63 -30.18 0.48 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.509 2.004 . . . . 0.0 118.052 168.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -56.55 -20.53 21.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.609 2.363 . . . . 0.0 116.629 -162.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.44 115.72 12.04 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.638 -1.289 . . . . 0.0 111.477 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -27.37 51.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.614 1.966 . . . . 0.0 112.758 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 48' ' ' LEU . . . . . . . . . . . . . 63.2 tp -148.93 139.39 22.51 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.22 1.808 . . . . 0.0 108.348 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -121.7 138.91 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 111.274 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.19 128.16 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.066 1.746 . . . . 0.0 108.199 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 51' ' ' ILE . . . . . . . . . . . . . 11.9 pt -125.01 156.0 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 111.778 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.06 158.47 20.43 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.735 -1.228 . . . . 0.0 114.164 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 53' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.15 -5.09 55.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.654 1.582 . . . . 0.0 114.351 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -128.66 22.4 5.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.34 1.456 . . . . 0.0 114.339 -169.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.46 138.06 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.801 0.84 . . . . 0.0 110.034 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -152.47 102.47 2.74 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.881 0.873 . . . . 0.0 110.807 -165.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -60.21 143.65 34.4 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.176 1.099 . . . . 0.0 112.875 -0.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.49 -21.91 65.49 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -66.6 -23.19 66.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.255 1.422 . . . . 0.0 114.654 -169.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.958 1.254 . . . . 0.0 113.581 -174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.1 -1.76 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.937 1.295 . . . . 0.0 114.164 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.92 -16.14 63.59 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -167.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 63' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -77.31 -25.82 51.6 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.951 1.7 . . . . 0.0 114.226 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.12 -42.31 80.68 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.104 -1.427 . . . . 0.0 113.458 -169.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -63.03 -55.23 0.83 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 CA-C-N 122.105 1.787 . . . . 0.0 115.144 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 66' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.81 -34.28 50.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 122.505 1.93 . . . . 0.0 112.991 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.86 -27.45 66.69 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.525 -0.734 . . . . 0.0 112.32 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 68' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.52 -17.63 55.94 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.09 -43.67 56.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.33 0.968 . . . . 0.0 111.695 162.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.6 -31.59 72.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.833 1.653 . . . . 0.0 113.287 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 71' ' ' LYS . . . . . 0.473 ' HE2' HG13 ' J' ' 41' ' ' VAL . 1.6 pttt -103.95 -7.85 20.07 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 115.485 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 63.47 68.78 0.59 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.737 1.615 . . . . 0.0 114.943 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 73' ' ' ILE . . . . . 0.444 ' HB ' ' HE3' ' J' ' 71' ' ' LYS . 20.4 mm -138.3 145.07 45.59 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.843 2.057 . . . . 0.0 110.678 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 74' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.55 146.48 39.21 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.499 2.799 . . . . 0.0 114.333 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 75' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.22 147.66 47.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.904 1.682 . . . . 0.0 112.057 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.4 159.3 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.344 1.057 . . . . 0.0 112.014 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.28 155.67 30.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.844 1.258 . . . . 0.0 113.871 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 m -139.03 152.02 69.21 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 126.403 1.881 . . . . 0.0 112.571 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.81 -12.92 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 N-CA-C 118.557 2.483 . . . . 0.0 118.557 -157.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -155.67 126.14 6.78 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 121.008 1.731 . . . . 0.0 113.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -61.77 -32.57 72.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.03 2.132 . . . . 0.0 114.834 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -69.08 -41.68 77.21 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.343 -0.848 . . . . 0.0 111.851 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.42 -33.03 70.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.655 0.782 . . . . 0.0 111.78 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.81 -41.18 92.21 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.551 -0.718 . . . . 0.0 112.072 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.47 95.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 118.412 0.551 . . . . 0.0 112.595 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.08 83.16 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.64 87.52 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.338 -0.851 . . . . 0.0 111.88 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.04 6.58 4.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.888 1.275 . . . . 0.0 114.189 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -15.47 30.07 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.599 1.571 . . . . 0.0 116.008 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 90' ' ' ILE . . . . . . . . . . . . . 43.0 pt -77.15 162.85 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.156 1.478 . . . . 0.0 112.027 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 91' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -97.54 -10.58 24.99 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 92' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.09 -155.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.742 1.617 . . . . 0.0 111.185 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.18 173.29 6.44 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.842 -1.161 . . . . 0.0 112.513 171.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.66 125.16 15.71 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.438 -0.789 . . . . 0.0 110.379 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -27.22 63.35 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 96' ' ' SER . . . . . . . . . . . . . 87.3 p -153.44 163.54 39.75 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 73.8 t -139.0 143.67 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.165 2.186 . . . . 0.0 109.931 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 130.52 52.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.082 1.353 . . . . 0.0 112.708 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.93 118.81 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.597 1.159 . . . . 0.0 109.322 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.01 -39.92 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.788 0.835 . . . . 0.0 109.942 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 101' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -142.6 121.73 7.68 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.058 0.943 . . . . 0.0 109.562 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 102' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -64.39 -12.09 31.44 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.714 2.276 . . . . 0.0 116.057 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.48 -120.03 20.83 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 119.1 0.864 . . . . 0.0 111.206 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -72.05 -20.98 61.6 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.92 23.78 0.98 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -64.23 -51.01 65.74 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.452 -1.405 . . . . 0.0 113.608 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -33.2 66.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.006 0.821 . . . . 0.0 112.096 174.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 108' ' ' LEU . . . . . . . . . . . . . 17.1 tp -75.36 -44.94 42.36 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.772 1.229 . . . . 0.0 112.108 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 109' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.59 -34.2 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.577 0.751 . . . . 0.0 111.056 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.74 -36.43 78.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.739 0.7 . . . . 0.0 112.208 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 111' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -61.45 -47.54 85.25 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.475 1.034 . . . . 0.0 111.416 169.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 112' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.97 -48.65 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.228 0.611 . . . . 0.0 110.025 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.11 91.67 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.033 0.833 . . . . 0.0 112.219 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 114' ' ' MET . . . . . . . . . . . . . 60.4 ttm -64.61 -36.88 85.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.711 0.804 . . . . 0.0 112.846 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.56 -26.86 29.72 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.866 0.866 . . . . 0.0 113.127 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 116' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.58 -33.26 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.043 1.292 . . . . 0.0 111.129 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 117' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -69.4 -4.11 17.09 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.648 -1.283 . . . . 0.0 113.859 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 118' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -81.63 -17.16 49.09 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.178 -1.576 . . . . 0.0 113.353 163.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 119' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.53 -31.18 7.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.487 1.515 . . . . 0.0 113.378 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 120' ' ' MET . . . . . . . . . . . . . 40.6 mtm -76.62 48.46 0.56 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.914 1.686 . . . . 0.0 112.119 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 121' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 125.481 1.513 . . . . 0.0 113.609 -161.151 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.88 167.38 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.129 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 3' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -119.7 127.06 52.52 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.329 1.052 . . . . 0.0 110.697 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.01 136.74 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.221 1.008 . . . . 0.0 111.508 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.49 161.82 37.43 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.098 1.759 . . . . 0.0 112.547 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -80.21 152.62 29.04 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.258 1.023 . . . . 0.0 112.198 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -99.74 176.08 5.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.516 1.127 . . . . 0.0 112.595 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' LYS . . . . . 0.435 ' HE3' ' CZ ' ' K' ' 9' ' ' PHE . 48.1 pttt -66.05 -16.86 64.29 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' PHE . . . . . 0.435 ' CZ ' ' HE3' ' K' ' 8' ' ' LYS . 14.1 m-85 -112.3 137.72 21.63 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.218 1.407 . . . . 0.0 110.447 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.92 145.66 80.69 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.661 2.241 . . . . 0.0 111.508 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.2 -15.78 8.37 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.289 0.947 . . . . 0.0 114.867 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.34 140.2 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.807 1.303 . . . . 0.0 110.325 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -124.49 166.84 15.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.766 1.626 . . . . 0.0 111.431 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.45 145.23 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.264 1.826 . . . . 0.0 108.546 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.48 142.53 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.617 0.767 . . . . 0.0 110.389 163.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 164.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -85.03 163.6 18.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.525 0.73 . . . . 0.0 112.542 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.04 -25.55 68.17 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.829 -1.169 . . . . 0.0 113.078 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.97 -12.88 61.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.836 1.655 . . . . 0.0 115.086 171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.49 28.59 29.51 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.125 -0.984 . . . . 0.0 113.428 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -121.48 152.8 38.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.872 2.069 . . . . 0.0 111.738 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.91 129.3 34.93 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.818 0.847 . . . . 0.0 109.594 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 23' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.17 141.89 51.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.671 0.788 . . . . 0.0 111.662 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -89.12 144.15 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.824 0.85 . . . . 0.0 112.998 -172.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.67 170.64 19.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.247 1.019 . . . . 0.0 113.134 -169.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 26' ' ' THR . . . . . . . . . . . . . 69.0 p -133.91 157.18 46.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.293 1.437 . . . . 0.0 110.899 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -80.14 122.08 26.36 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.429 -0.795 . . . . 0.0 108.957 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -62.29 126.39 27.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.573 0.749 . . . . 0.0 111.233 -166.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -46.25 -45.73 17.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.319 1.847 . . . . 0.0 112.781 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 30' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.98 141.45 39.54 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 125.375 1.47 . . . . 0.0 109.091 158.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 31' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.36 143.87 31.97 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.171 1.914 . . . . 0.0 111.866 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.57 -10.34 74.27 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.01 1.29 . . . . 0.0 114.6 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -77.53 139.66 39.62 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.068 1.434 . . . . 0.0 112.242 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.84 148.84 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.951 1.7 . . . . 0.0 108.881 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.86 -33.24 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 117.84 -1.076 . . . . 0.0 113.649 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 36' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -142.57 38.39 1.51 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.626 1.203 . . . . 0.0 112.042 169.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.89 23.89 64.02 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.172 1.368 . . . . 0.0 114.27 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -81.95 167.09 19.28 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -156.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -67.73 92.62 0.34 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.944 167.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.71 145.81 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 111.219 167.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 41' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.76 114.79 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 108.654 -170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 42' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -78.81 139.07 38.44 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.246 1.018 . . . . 0.0 109.773 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -129.45 -175.34 3.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.441 1.496 . . . . 0.0 110.777 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.87 66.86 2.19 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.94 1.296 . . . . 0.0 113.625 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.38 10.86 43.48 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.866 1.222 . . . . 0.0 114.271 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -138.06 163.17 32.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.258 1.423 . . . . 0.0 110.434 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 47' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.63 140.21 45.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.996 -1.065 . . . . 0.0 110.51 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 48' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.83 156.8 40.75 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.031 1.732 . . . . 0.0 111.534 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -131.1 138.43 49.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.278 1.431 . . . . 0.0 111.097 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 tt -74.02 152.32 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.975 0.91 . . . . 0.0 111.661 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 51' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -119.33 87.92 2.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.797 1.639 . . . . 0.0 108.456 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 52' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -71.17 108.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -159.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 53' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.29 -12.41 33.74 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.874 1.716 . . . . 0.0 113.846 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -81.76 -6.89 59.46 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.819 1.19 . . . . 0.0 112.535 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 55' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -151.45 43.45 0.76 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.308 1.443 . . . . 0.0 111.283 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 56' ' ' SER . . . . . . . . . . . . . 67.7 m -159.94 110.81 1.93 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.371 -1.456 . . . . 0.0 111.711 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -60.05 -34.64 73.69 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.79 -45.29 86.9 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.767 0.712 . . . . 0.0 111.292 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.82 -44.87 88.15 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.266 0.46 . . . . 0.0 112.582 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.13 96.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.12 0.968 . . . . 0.0 112.168 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -38.98 92.9 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.036 -1.04 . . . . 0.0 112.418 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 62' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.71 -42.02 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.43 -0.794 . . . . 0.0 110.651 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -67.97 -35.76 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.076 0.853 . . . . 0.0 112.229 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 64' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -69.02 -3.7 14.07 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.312 1.045 . . . . 0.0 113.27 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.72 34.96 7.05 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.56 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -50.34 129.49 21.75 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.477 1.511 . . . . 0.0 111.082 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 67' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -93.88 -44.63 8.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.294 1.438 . . . . 0.0 113.59 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 68' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -103.7 98.2 8.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.181 1.793 . . . . 0.0 112.235 -171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 69' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -113.21 109.06 52.12 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 121.504 -0.748 . . . . 0.0 110.921 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 70' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -89.05 -11.95 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.245 2.63 . . . . 0.0 114.523 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 71' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.59 125.27 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.157 0.89 . . . . 0.0 109.083 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -145.48 161.46 41.09 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.94 1.696 . . . . 0.0 109.934 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 73' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.46 143.75 34.31 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.479 2.786 . . . . 0.0 114.734 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.7 -11.5 10.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 75' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -73.16 172.77 10.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.385 1.474 . . . . 0.0 113.74 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 76' ' ' SER . . . . . . . . . . . . . 90.1 p -113.7 133.2 55.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.957 1.303 . . . . 0.0 112.164 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.24 148.19 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.401 1.08 . . . . 0.0 112.492 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 tp -116.48 130.64 56.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.542 1.937 . . . . 0.0 109.498 172.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.47 133.35 56.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.805 1.242 . . . . 0.0 109.381 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -117.33 112.88 21.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.922 1.689 . . . . 0.0 108.884 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.51 68.37 1.52 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -167.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 tt -98.62 -30.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.63 1.172 . . . . 0.0 113.738 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 83' ' ' ALA . . . . . . . . . . . . . . . 43.8 -87.08 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.955 1.702 . . . . 0.0 114.367 -160.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -141.61 -58.83 0.48 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.35 1.86 . . . . 0.0 110.328 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.85 89.95 0.83 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.887 1.232 . . . . 0.0 116.173 148.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 86' ' ' THR . . . . . . . . . . . . . 4.8 m -53.12 -46.14 68.62 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.424 1.112 . . . . 0.0 110.598 153.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 87' ' ' THR . . . . . . . . . . . . . 3.9 t -85.71 -34.89 21.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.011 1.725 . . . . 0.0 112.598 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.2 -34.22 9.76 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -163.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 89' ' ' SER . . . . . . . . . . . . . 88.2 p -60.45 -25.49 66.04 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -165.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 90' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -60.44 -20.31 59.38 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.581 1.952 . . . . 0.0 114.016 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 m -60.85 -30.98 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.244 0.929 . . . . 0.0 111.99 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -65.63 -39.21 91.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.806 0.842 . . . . 0.0 112.127 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 93' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.13 -40.51 74.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.564 0.746 . . . . 0.0 111.845 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 94' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.12 -40.17 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.991 1.317 . . . . 0.0 111.628 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 95' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.88 -35.02 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 111.25 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 -173.84 38.65 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.134 1.349 . . . . 0.0 115.391 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 97' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -59.48 -21.03 59.52 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -97.94 -3.9 37.48 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.34 -172.75 18.4 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.87 1.224 . . . . 0.0 114.605 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 100' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -139.94 131.93 27.8 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.378 1.071 . . . . 0.0 112.343 -168.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.91 125.77 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.122 1.369 . . . . 0.0 109.79 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 102' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -99.29 124.09 44.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.639 0.776 . . . . 0.0 109.382 164.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.6 109.31 2.94 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.3 136.23 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.626 1.17 . . . . 0.0 109.493 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -139.42 138.81 36.82 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.849 0.86 . . . . 0.0 111.948 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 106' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -95.32 -32.83 12.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 111.683 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 107' ' ' SER . . . . . . . . . . . . . 5.5 m -65.48 115.26 20.41 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.069 1.748 . . . . 0.0 111.018 -173.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 108' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.86 2.96 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.692 2.928 . . . . 0.0 116.789 -156.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 109' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -120.26 -55.99 2.02 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 110' ' ' VAL . . . . . . . . . . . . . 26.4 m -56.31 -34.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -160.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 111' ' ' LEU . . . . . . . . . . . . . 20.7 tp -60.34 -19.78 56.77 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.238 -0.914 . . . . 0.0 112.969 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 112' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -62.0 -24.08 66.82 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.941 1.296 . . . . 0.0 113.319 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 113' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -86.39 -17.6 33.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.145 0.884 . . . . 0.0 113.153 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -76.75 -31.64 57.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.604 -1.31 . . . . 0.0 112.225 169.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 t -50.21 -44.63 81.39 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.915 1.686 . . . . 0.0 115.008 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 116' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.38 -39.81 4.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 CA-C-N 122.883 2.066 . . . . 0.0 113.072 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 117' ' ' ILE . . . . . . . . . . . . . 35.2 mt -60.91 -33.96 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.413 1.085 . . . . 0.0 111.09 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 118' ' ' VAL . . . . . . . . . . . . . 20.6 m -76.7 -1.34 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 119' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.26 -14.1 62.76 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 120.301 1.41 . . . . 0.0 112.261 165.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 120' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.22 -27.07 4.2 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 159.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -76.77 55.99 1.13 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 121.007 1.73 . . . . 0.0 112.944 171.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 122' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -71.16 9.71 0.69 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.954 2.102 . . . . 0.0 115.01 -173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 123' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -92.84 -10.53 36.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 113.067 164.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.85 144.85 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.489 1.516 . . . . 0.0 110.295 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 125' ' ' ILE . . . . . . . . . . . . . 45.5 mt -124.79 123.25 25.62 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.447 1.099 . . . . 0.0 108.976 163.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 126' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.44 130.66 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.788 2.992 . . . . 0.0 112.022 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.63 124.52 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.961 1.304 . . . . 0.0 110.973 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.83 121.05 27.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.623 0.769 . . . . 0.0 111.719 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.29 155.13 12.08 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 126.419 1.961 . . . . 0.0 112.924 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 130' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.61 115.06 7.56 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.193 -1.18 . . . . 0.0 112.725 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.82 60.9 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 132' ' ' THR . . . . . . . . . . . . . 19.1 m -66.93 -26.27 66.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.349 1.46 . . . . 0.0 112.236 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 133' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.17 78.06 17.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.166 1.786 . . . . 0.0 108.46 -171.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 134' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.29 -16.7 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.188 3.259 . . . . 0.0 115.297 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -67.34 -22.64 65.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.646 1.978 . . . . 0.0 114.226 171.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 136' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -60.33 -28.43 68.14 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 121.011 1.732 . . . . 0.0 114.327 -173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 137' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -121.37 14.88 11.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.166 1.386 . . . . 0.0 113.915 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 138' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -51.46 -25.6 6.72 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.37 -12.85 51.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -121.55 13.45 10.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.262 1.425 . . . . 0.0 113.594 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 141' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.66 173.68 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.137 1.375 . . . . 0.0 112.307 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 142' ' ' THR . . . . . . . . . . . . . 68.3 p -139.41 -179.45 5.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.127 1.771 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 143' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -56.14 144.47 29.33 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 154.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.42 171.34 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.593 1.957 . . . . 0.0 111.64 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 145' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.65 -31.07 21.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 112.991 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.58 143.54 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.691 1.596 . . . . 0.0 111.266 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 147' ' ' ILE . . . . . . . . . . . . . 45.3 mt -123.43 139.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.079 1.352 . . . . 0.0 110.077 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 148' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -127.19 142.68 51.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.58 1.552 . . . . 0.0 111.678 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -134.99 134.01 40.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.832 1.653 . . . . 0.0 109.94 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 150' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -139.22 -1.98 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . . . . . . . . . 96.9 t -90.84 -23.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.243 -1.535 . . . . 0.0 111.876 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.74 48.32 5.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.539 1.536 . . . . 0.0 114.324 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -61.5 158.11 41.66 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.454 1.502 . . . . 0.0 111.84 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 154' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.62 -20.26 26.81 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.816 3.011 . . . . 0.0 115.604 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 155' ' ' THR . . . . . . . . . . . . . 59.1 p -95.63 1.73 53.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.064 1.746 . . . . 0.0 113.564 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -57.24 -31.27 65.37 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 -161.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.65 97.42 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.947 -1.096 . . . . 0.0 111.885 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 158' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.15 -38.55 72.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.794 -1.098 . . . . 0.0 111.756 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 159' ' ' ILE . . . . . . . . . . . . . 60.9 mt -50.48 -56.68 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 109.908 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 160' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 -45.69 65.68 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.424 1.011 . . . . 0.0 112.705 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 161' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.53 -48.63 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 119.241 0.928 . . . . 0.0 112.101 -170.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -32.13 35.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.907 1.23 . . . . 0.0 112.38 -173.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -57.14 -39.07 74.45 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.559 -1.338 . . . . 0.0 111.022 163.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.49 -6.74 48.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 165' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -81.74 -44.65 16.76 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.482 1.492 . . . . 0.0 111.888 166.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.41 -37.85 24.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 167' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.07 -4.56 11.02 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -163.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 168' ' ' LEU . . . . . . . . . . . . . 19.8 tp -105.17 131.25 52.89 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.447 1.93 . . . . 0.0 113.228 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 169' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -76.1 164.27 26.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.726 1.61 . . . . 0.0 113.714 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -64.81 132.23 48.93 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.325 1.05 . . . . 0.0 109.725 165.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.1 32.78 81.39 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.571 1.082 . . . . 0.0 113.7 -165.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.51 167.23 21.07 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.496 1.522 . . . . 0.0 112.687 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 173' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -131.98 171.56 13.44 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.535 -0.979 . . . . 0.0 112.465 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.93 166.2 35.5 Favored Glycine 0 CA--C 1.527 0.828 0 O-C-N 121.225 -0.922 . . . . 0.0 113.718 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 175' ' ' MET . . . . . . . . . . . . . 98.5 mtp -142.21 146.98 35.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.64 1.576 . . . . 0.0 110.512 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 176' ' ' ILE . . . . . . . . . . . . . 18.6 tt -149.62 132.53 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.679 0.791 . . . . 0.0 111.746 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 177' ' ' ALA . . . . . . . . . . . . . . . -96.56 102.83 14.68 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.73 0.812 . . . . 0.0 110.914 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 178' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.84 129.95 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.867 1.667 . . . . 0.0 111.8 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 179' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -120.08 135.69 54.85 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.84 0.746 . . . . 0.0 111.544 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 180' ' ' SER . . . . . . . . . . . . . 94.4 p -66.66 -39.77 88.33 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 181' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -57.23 -28.33 62.82 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 182' ' ' SER . . . . . . . . . . . . . 11.6 m -73.72 -13.97 61.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.1 -40.2 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.005 1.322 . . . . 0.0 110.45 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 184' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -156.86 128.02 6.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.688 0.795 . . . . 0.0 111.514 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 185' ' ' VAL . . . . . . . . . . . . . 4.2 p -88.23 0.37 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 186' ' ' THR . . . . . . . . . . . . . 8.7 m -115.65 -40.86 3.31 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.467 -1.396 . . . . 0.0 113.927 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -84.0 162.75 20.3 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.866 0.757 . . . . 0.0 112.289 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 188' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -62.72 138.71 96.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 121.578 -0.702 . . . . 0.0 112.675 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 189' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.79 -44.98 43.85 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.846 2.364 . . . . 0.0 114.077 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 190' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -65.18 -25.38 67.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.273 -0.892 . . . . 0.0 113.251 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 191' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -75.88 -47.2 26.38 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.54 1.136 . . . . 0.0 110.835 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 192' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.87 -40.53 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.91 1.232 . . . . 0.0 110.829 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 193' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -61.74 -26.46 68.08 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.059 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 194' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -71.37 -41.44 69.68 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.978 1.717 . . . . 0.0 111.86 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 195' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.079 0.399 . . . . 0.0 110.586 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 196' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.2 -43.25 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 118.581 -0.724 . . . . 0.0 111.363 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 197' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.63 -38.48 72.16 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 120.631 1.56 . . . . 0.0 112.359 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.42 -23.32 40.42 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -81.53 -41.84 21.07 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.305 0.957 . . . . 0.0 111.33 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.4 -39.19 91.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.949 1.3 . . . . 0.0 111.119 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 201' ' ' SER . . . . . . . . . . . . . 80.0 p -75.53 -2.42 28.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 202' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -80.73 -3.67 51.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.83 -1.169 . . . . 0.0 112.753 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 203' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -139.11 -34.11 0.6 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 204' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -111.85 162.99 14.7 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.52 116.84 19.18 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 150.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 206' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.99 111.74 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 207' ' ' ILE . . . . . . . . . . . . . 36.6 pt -97.48 -22.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.598 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 208' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -153.95 151.78 29.81 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.844 1.202 . . . . 0.0 113.635 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 209' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -138.26 137.17 37.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.481 2.712 . . . . 0.0 108.862 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 210' ' ' LEU . . . . . . . . . . . . . 7.2 tt -143.01 136.17 28.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.896 1.678 . . . . 0.0 110.276 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 211' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -93.23 142.95 26.74 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.109 0.964 . . . . 0.0 109.829 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 212' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.11 -4.42 49.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 213' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -57.97 141.27 81.24 Favored Pre-proline 0 CA--C 1.55 0.957 0 O-C-N 120.714 -1.241 . . . . 0.0 109.892 162.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 214' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -97.04 20.3 29.03 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.839 1.335 . . . . 0.0 114.225 11.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 215' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.08 -77.38 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.15 0.886 . . . . 0.0 109.824 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 216' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -117.01 134.6 54.54 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.637 -0.665 . . . . 0.0 111.371 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 217' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -97.39 142.1 29.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -164.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 218' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 60.2 17.85 7.32 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.411 1.884 . . . . 0.0 114.391 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.33 143.13 39.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.03 2.132 . . . . 0.0 109.326 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 220' ' ' ALA . . . . . . . . . . . . . . . -135.96 160.08 39.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.747 1.619 . . . . 0.0 110.873 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.75 129.35 51.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 222' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -113.31 147.55 37.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.434 1.494 . . . . 0.0 111.159 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 223' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.54 137.83 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.756 1.223 . . . . 0.0 110.01 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 224' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.92 156.44 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.866 1.267 . . . . 0.0 113.956 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 225' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -119.56 137.45 53.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.423 1.889 . . . . 0.0 110.819 167.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 226' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -92.7 128.15 45.2 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.706 1.602 . . . . 0.0 107.494 158.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 227' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.871 3.047 . . . . 0.0 114.501 -160.092 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 16.1 t80 . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.65 147.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.471 1.032 . . . . 0.0 111.243 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' SER . . . . . . . . . . . . . 13.2 t -150.57 159.62 44.37 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.972 2.109 . . . . 0.0 110.212 169.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -136.32 151.65 49.83 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.991 -1.068 . . . . 0.0 113.034 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -136.16 -179.06 5.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.581 1.153 . . . . 0.0 111.533 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -49.66 -23.48 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.777 2.031 . . . . 0.0 115.735 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -101.8 -20.79 14.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.27 -163.02 36.57 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 117.766 1.866 . . . . 0.0 117.766 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.36 134.32 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 127.839 2.456 . . . . 0.0 109.585 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.14 137.42 47.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 110.14 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.79 54.1 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.84 0.856 . . . . 0.0 112.549 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.17 151.25 48.59 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.477 1.511 . . . . 0.0 112.308 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -178.1 4.36 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.413 1.085 . . . . 0.0 113.35 175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.83 -20.6 65.92 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -88.79 -35.0 16.88 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.974 1.309 . . . . 0.0 112.392 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 19.12 4.3 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.172 1.844 . . . . 0.0 114.856 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -92.83 140.07 29.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.155 1.382 . . . . 0.0 111.23 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.87 131.98 43.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.244 1.018 . . . . 0.0 111.664 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' ILE . . . . . . . . . . . . . 81.4 mt -97.74 -50.43 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.55 1.94 . . . . 0.0 110.797 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -161.02 154.7 22.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.729 1.611 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 152.26 49.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.403 1.081 . . . . 0.0 112.548 164.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -140.39 145.05 36.58 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.018 1.327 . . . . 0.0 110.491 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -107.72 156.94 18.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.449 1.1 . . . . 0.0 112.126 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.06 138.67 57.33 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' THR . . . . . . . . . . . . . 77.8 p -90.42 -37.05 14.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.016 2.126 . . . . 0.0 112.852 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -87.58 -178.47 6.12 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.375 1.87 . . . . 0.0 111.236 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -65.67 123.0 83.46 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.124 -1.61 . . . . 0.0 108.374 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.85 -33.51 84.39 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.615 2.21 . . . . 0.0 114.753 -156.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -61.81 -29.2 70.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.621 1.1 . . . . 0.0 113.392 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -68.01 -35.76 78.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.268 1.027 . . . . 0.0 111.707 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 31' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.79 -39.76 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.832 0.853 . . . . 0.0 110.715 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.29 -43.21 98.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.146 -0.93 . . . . 0.0 112.03 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -58.84 -41.99 88.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.384 1.447 . . . . 0.0 112.117 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 34' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -62.49 -52.43 63.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.154 0.982 . . . . 0.0 111.625 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 35' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.59 -26.49 65.41 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 36' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.0 -28.8 63.63 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.342 0.973 . . . . 0.0 112.182 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 37' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -87.89 -11.55 47.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 167.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.81 13.37 69.75 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.8 1.667 . . . . 0.0 114.969 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.09 136.29 46.54 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.768 1.284 . . . . 0.0 110.177 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -95.17 137.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.493 0.717 . . . . 0.0 112.218 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -122.7 167.04 13.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.608 1.563 . . . . 0.0 112.594 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 42' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -40.85 -40.91 1.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.258 2.223 . . . . 0.0 113.928 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.22 -38.39 90.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.051 1.74 . . . . 0.0 112.089 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -88.29 -34.6 17.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.043 0.937 . . . . 0.0 111.685 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 45' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -55.86 -31.94 63.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.277 1.031 . . . . 0.0 112.596 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.45 -45.25 88.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.601 0.76 . . . . 0.0 111.81 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tt -73.52 -39.25 64.92 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.693 0.797 . . . . 0.0 112.096 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 48' ' ' LEU . . . . . . . . . . . . 0.301 1.1 pp -72.15 -24.42 61.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.842 1.201 . . . . 0.0 113.596 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 49' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.37 -41.12 57.19 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.837 1.199 . . . . 0.0 111.551 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 50' ' ' SER . . . . . . . . . . . . . 28.7 t -53.61 -47.89 69.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 0.0 111.861 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.44 -23.26 46.69 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.628 -1.295 . . . . 0.0 113.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 52' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.36 -45.57 90.57 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.126 0.876 . . . . 0.0 110.651 164.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.23 -31.74 69.28 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.201 1.401 . . . . 0.0 112.996 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 54' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -74.98 1.2 13.48 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.611 1.565 . . . . 0.0 113.696 168.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.03 59.5 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 163.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 56' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.98 148.83 27.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.071 1.435 . . . . 0.0 113.314 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -121.77 -23.18 5.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.344 1.857 . . . . 0.0 114.043 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 58' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -84.43 44.73 1.06 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.991 1.316 . . . . 0.0 114.515 -163.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 59' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.61 78.4 0.18 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.037 1.735 . . . . 0.0 114.503 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.78 116.95 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.297 -0.877 . . . . 0.0 111.534 166.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.7 169.41 9.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.56 1.544 . . . . 0.0 111.409 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -95.79 3.04 54.1 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 63' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -136.5 128.32 17.06 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.597 1.09 . . . . 0.0 112.166 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.62 -37.96 53.99 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.945 2.43 . . . . 0.0 115.447 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.99 -34.07 61.92 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.526 -0.734 . . . . 0.0 111.293 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 66' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.66 -41.0 98.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.771 0.429 . . . . 0.0 111.192 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 67' ' ' SER . . . . . . . . . . . . . 26.1 m -62.14 -37.6 85.78 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.456 -0.777 . . . . 0.0 112.472 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 68' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -63.74 -53.59 48.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.114 0.87 . . . . 0.0 111.578 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -58.52 -34.03 70.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.169 0.895 . . . . 0.0 112.19 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.65 76.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 71' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -81.8 -16.4 51.05 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.808 -1.183 . . . . 0.0 114.024 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -70.29 -34.42 72.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.419 1.488 . . . . 0.0 111.752 161.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 73' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.81 10.26 2.35 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.693 1.597 . . . . 0.0 112.657 166.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.44 -6.95 82.92 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.899 1.714 . . . . 0.0 116.576 170.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -70.68 154.39 41.9 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.546 1.673 . . . . 0.0 112.896 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 76' ' ' SER . . . . . . . . . . . . . 24.5 m -71.77 41.99 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.953 1.701 . . . . 0.0 113.81 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.65 142.91 31.34 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -163.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 78' ' ' THR . . . . . . . . . . . . . 67.9 p -136.07 178.79 6.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.825 2.05 . . . . 0.0 111.163 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -137.2 133.63 35.38 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -155.82 122.49 5.25 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.092 1.357 . . . . 0.0 110.128 158.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 81' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -64.08 -52.98 51.78 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.77 24.73 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.686 2.924 . . . . 0.0 114.792 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -72.15 151.52 42.93 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.654 -1.279 . . . . 0.0 111.601 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 84' ' ' ILE . . . . . . . . . . . . . 10.7 tp -55.02 -26.91 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.37 -51.06 69.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.752 0.706 . . . . 0.0 111.831 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.21 69.93 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.482 0.563 . . . . 0.0 112.663 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 87' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -64.6 -42.78 95.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.589 0.756 . . . . 0.0 111.795 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 88' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -69.9 -52.85 21.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.408 1.083 . . . . 0.0 112.293 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.39 -41.45 76.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.972 1.309 . . . . 0.0 112.255 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 mtm-85 -88.48 -6.69 57.47 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 91' ' ' SER . . . . . . . . . . . . . 67.8 m -95.81 -32.5 12.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.412 1.005 . . . . 0.0 113.51 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 92' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -116.66 53.26 1.13 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.745 1.218 . . . . 0.0 112.26 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 93' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -57.52 -30.99 90.3 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.312 2.008 . . . . 0.0 112.479 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 94' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.56 -21.9 65.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.743 1.617 . . . . 0.0 113.353 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 95' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -76.12 -26.56 56.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 0.0 111.915 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 96' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.41 -20.97 12.72 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -168.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 97' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.07 -0.27 1.68 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.823 1.649 . . . . 0.0 114.519 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.94 -172.37 55.18 Favored Glycine 0 N--CA 1.476 1.342 0 O-C-N 120.827 -1.171 . . . . 0.0 113.986 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -71.84 -28.5 63.6 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.876 -1.367 . . . . 0.0 113.318 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 100' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -81.28 16.41 1.62 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.501 1.52 . . . . 0.0 112.424 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 101' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -57.86 -34.58 69.89 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.827 -1.171 . . . . 0.0 113.461 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.62 -29.18 61.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -64.58 -40.86 96.29 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.174 -0.954 . . . . 0.0 111.172 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -67.56 -47.89 68.51 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.634 0.774 . . . . 0.0 111.292 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -58.27 -45.1 88.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.157 0.983 . . . . 0.0 111.636 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 106' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -59.05 -52.61 65.02 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.374 0.67 . . . . 0.0 110.956 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 107' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -58.95 -45.8 89.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.351 1.46 . . . . 0.0 112.257 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.48 -34.63 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.646 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.09 -47.62 90.2 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.2 0.909 . . . . 0.0 112.627 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.23 -6.96 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.467 -1.02 . . . . 0.0 113.443 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.89 -49.35 6.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.324 1.05 . . . . 0.0 111.232 166.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 112' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.74 -41.28 95.06 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.577 1.151 . . . . 0.0 111.866 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 113' ' ' THR . . . . . . . . . . . . . 18.8 m -66.35 -22.82 66.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.647 1.179 . . . . 0.0 113.392 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 114' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -87.18 -25.48 24.04 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.437 1.017 . . . . 0.0 113.055 168.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 115' ' ' MET . . . . . . . . . . . . . 54.5 ttp -81.48 -37.65 27.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.44 1.096 . . . . 0.0 113.588 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -63.12 122.88 17.19 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.923 0.783 . . . . 0.0 111.298 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.34 146.37 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.889 1.676 . . . . 0.0 107.455 167.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 118' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -114.79 153.2 30.8 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.81 161.04 19.91 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.624 2.769 . . . . 0.0 111.663 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 57.4 171.27 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.061 1.745 . . . . 0.0 114.299 -169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 121' ' ' SER . . . . . . . . . . . . . 39.1 t -155.9 137.32 14.01 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.583 -1.323 . . . . 0.0 111.038 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.41 -40.58 97.79 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -158.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.39 2.97 54.79 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -68.02 -29.42 68.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -159.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -28.11 68.1 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.049 1.295 . . . . 0.0 112.954 174.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -76.15 -33.82 59.39 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.137 -0.977 . . . . 0.0 111.086 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 127' ' ' MET . . . . . . . . . . . . . 73.1 mtm -69.07 -22.91 63.98 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.413 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 128' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.04 -47.99 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.123 1.329 . . . . 0.0 110.284 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 129' ' ' ILE . . . . . . . . . . . . . 25.9 mt -66.55 -47.45 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.786 0.835 . . . . 0.0 109.799 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 130' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -64.04 -35.17 79.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.809 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.23 73.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.394 0.997 . . . . 0.0 112.732 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 132' ' ' ILE . . . . . . . . . . . . . 16.9 mm -63.8 -47.83 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.749 0.82 . . . . 0.0 110.903 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 133' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.62 -37.63 88.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.207 0.458 . . . . 0.0 111.364 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.86 78.94 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.185 -0.947 . . . . 0.0 112.804 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.29 -43.05 82.72 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.766 0.712 . . . . 0.0 110.587 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 136' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.14 -36.32 72.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.847 0.749 . . . . 0.0 112.303 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -64.47 -44.4 91.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.258 1.023 . . . . 0.0 111.637 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.83 -40.22 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.205 -0.934 . . . . 0.0 111.236 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 139' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.32 -36.61 82.72 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.293 -0.879 . . . . 0.0 112.454 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 140' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -70.07 -42.79 72.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.775 1.23 . . . . 0.0 112.336 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 141' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.99 -32.06 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 119.639 1.109 . . . . 0.0 112.963 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 142' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.48 -47.47 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.091 0.86 . . . . 0.0 109.913 170.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 143' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -60.08 -38.4 82.77 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.887 0.767 . . . . 0.0 111.821 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 144' ' ' LEU . . . . . 0.414 ' C ' HD23 ' L' ' 144' ' ' LEU . 6.9 tt -65.98 -53.83 33.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.973 1.309 . . . . 0.0 112.683 176.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 145' ' ' LEU . . . . . . . . . . . . . 59.0 mt -68.15 -31.11 70.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.145 0.884 . . . . 0.0 112.302 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 146' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.73 -30.28 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.136 0.88 . . . . 0.0 111.831 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.85 99.88 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.415 1.461 . . . . 0.0 111.383 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -44.8 96.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.607 0.763 . . . . 0.0 111.989 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 tp -62.16 -41.39 98.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.355 1.062 . . . . 0.0 112.101 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 150' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -64.23 -49.26 72.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 111.431 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 151' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -66.26 -34.61 78.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.66 0.663 . . . . 0.0 112.522 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 152' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -75.18 -50.56 15.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.596 0.758 . . . . 0.0 112.069 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 153' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.66 -18.39 64.27 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.096 -1.003 . . . . 0.0 112.667 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 61.6 m -61.22 -16.48 45.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 168.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 155' ' ' LEU . . . . . . . . . . . . . 77.9 mt -74.94 -9.89 58.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.552 1.069 . . . . 0.0 113.05 170.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -123.93 -36.78 2.67 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.993 1.317 . . . . 0.0 113.284 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 157' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -158.02 70.86 4.08 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 124.385 1.074 . . . . 0.0 113.834 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 158' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.16 -20.13 33.36 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.343 3.362 . . . . 0.0 115.701 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -50.66 -27.21 6.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.99 1.316 . . . . 0.0 113.947 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 160' ' ' LEU . . . . . . . . . . . . . 12.5 tp -68.74 -24.55 64.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.35 1.06 . . . . 0.0 113.563 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 161' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.01 -31.9 64.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -166.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 162' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.11 -14.5 20.41 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.231 -0.918 . . . . 0.0 112.863 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 163' ' ' LEU . . . . . . . . . . . . . 36.7 tp -76.5 -45.49 30.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.435 -0.791 . . . . 0.0 111.734 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 164' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.52 89.0 6.81 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.023 1.329 . . . . 0.0 112.04 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 165' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.54 -22.01 21.67 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.565 2.177 . . . . 0.0 112.96 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 166' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -76.59 97.24 4.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.63 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 167' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -40.09 -47.83 5.83 Favored Pre-proline 0 N--CA 1.477 0.917 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.82 -28.73 76.04 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 122.696 1.998 . . . . 0.0 114.883 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 169' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -71.6 -35.65 70.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.236 1.38 . . . . 0.0 111.634 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 170' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -64.37 -40.74 96.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.675 -0.641 . . . . 0.0 111.367 172.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 171' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.33 -48.11 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.485 -0.759 . . . . 0.0 111.335 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.0 78.96 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -58.38 -53.76 54.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.415 0.686 . . . . 0.0 110.868 170.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.97 -30.25 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.13 -0.981 . . . . 0.0 112.559 -176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 175' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -63.24 -49.15 75.25 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.11 0.868 . . . . 0.0 112.034 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 176' ' ' THR . . . . . . . . . . . . . 8.4 m -85.72 -37.4 19.42 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -167.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 177' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.73 -44.41 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.742 1.217 . . . . 0.0 111.324 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.71 -88.44 0.05 OUTLIER Glycine 0 CA--C 1.534 1.252 0 O-C-N 121.413 -0.804 . . . . 0.0 112.451 -171.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 179' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -85.51 123.43 30.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.417 1.487 . . . . 0.0 111.736 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -16.83 60.37 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -169.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.02 -5.8 58.64 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 182' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -104.13 18.66 21.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.978 1.311 . . . . 0.0 114.533 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 183' ' ' ILE . . . . . . . . . . . . . 23.2 pt -65.26 151.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.919 1.288 . . . . 0.0 113.677 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 184' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -151.81 -169.12 3.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.481 2.312 . . . . 0.0 109.431 168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 185' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.4 -39.01 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.834 -1.166 . . . . 0.0 113.786 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.87 -46.25 81.95 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.354 1.061 . . . . 0.0 111.347 -172.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 187' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.88 -11.22 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 188' ' ' LEU . . . . . . . . . . . . . 40.4 mt -101.6 -49.86 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.255 1.422 . . . . 0.0 110.307 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 189' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -66.8 -43.33 84.13 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.623 1.569 . . . . 0.0 111.865 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 190' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -33.64 74.96 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.674 -0.641 . . . . 0.0 111.687 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 191' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.83 -6.9 35.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.023 1.329 . . . . 0.0 112.822 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.18 27.36 60.1 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.672 -1.267 . . . . 0.0 113.644 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 193' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.83 143.0 53.0 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.863 1.332 . . . . 0.0 108.004 158.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 194' ' ' SER . . . . . . . . . . . . . 67.6 p -78.02 163.11 26.22 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.655 -0.653 . . . . 0.0 111.197 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 195' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.11 -29.72 63.77 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.873 0.844 . . . . 0.0 110.797 170.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 196' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -67.06 -12.83 61.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.751 1.621 . . . . 0.0 113.561 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 197' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -100.94 -28.91 12.5 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.604 1.962 . . . . 0.0 112.432 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 198' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.01 -23.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.852 1.261 . . . . 0.0 111.787 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 199' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -71.85 21.43 0.05 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.196 -1.565 . . . . 0.0 113.894 164.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 200' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -147.9 -175.85 5.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 131.171 3.789 . . . . 0.0 106.657 167.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 201' ' ' ILE . . . . . . . . . . . . . 88.8 mt 66.75 -66.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.4 -1.437 . . . . 0.0 112.216 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 202' ' ' LEU . . . . . . . . . . . . . 69.8 mt -61.1 -42.93 99.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.262 1.025 . . . . 0.0 112.598 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 203' ' ' GLU . . . . . 0.425 ' O ' ' HE3' ' L' ' 207' ' ' LYS . 0.4 OUTLIER -63.45 -11.91 27.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 174.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 204' ' ' ALA . . . . . . . . . . . . . . . -96.58 3.47 52.58 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.036 -1.04 . . . . 0.0 113.544 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 205' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -39.62 -45.73 1.69 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.967 2.107 . . . . 0.0 114.717 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 206' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -116.87 -23.01 8.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.883 1.273 . . . . 0.0 114.205 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 207' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' L' ' 203' ' ' GLU . 17.0 pttp -111.85 16.43 20.41 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.151 1.781 . . . . 0.0 114.642 -173.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 208' ' ' THR . . . . . . . . . . . . . 2.3 t -49.47 143.38 6.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.94 0.896 . . . . 0.0 110.251 158.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 209' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -71.44 -7.95 50.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 210' ' ' GLY . . . . . . . . . . . . . . . -76.19 172.81 54.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.934 1.254 . . . . 0.0 115.058 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 211' ' ' ALA . . . . . . . . . . . . . . . -96.65 -125.71 0.13 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.071 1.348 . . . . 0.0 112.177 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 212' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -147.91 107.35 3.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.185 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 213' ' ' MET . . . . . . . . . . . . . 59.2 mtp -81.06 146.55 30.56 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.359 0.6 . . . . 0.0 109.462 153.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 214' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 151.69 34.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 215' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -51.66 -33.05 31.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.559 1.944 . . . . 0.0 112.885 168.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 216' ' ' THR . . . . . . . . . . . . . 26.0 m -82.14 -33.83 29.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.54 1.536 . . . . 0.0 113.407 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 217' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.7 -35.1 27.05 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.689 0.795 . . . . 0.0 111.843 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -68.74 -11.54 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.464 1.105 . . . . 0.0 113.189 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 219' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -50.69 -42.41 56.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.22 1.408 . . . . 0.0 112.118 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 220' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.32 -27.91 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.536 -0.727 . . . . 0.0 112.024 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 221' ' ' VAL . . . . . . . . . . . . . 3.3 t -83.71 -33.53 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.238 1.015 . . . . 0.0 110.934 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 222' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.78 -46.4 90.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.887 1.275 . . . . 0.0 111.148 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 223' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.57 -43.69 89.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 112.021 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 224' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.54 -41.66 66.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.789 0.835 . . . . 0.0 112.033 171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.48 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 226' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.58 -34.66 76.19 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.585 1.084 . . . . 0.0 112.765 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -45.15 92.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.728 0.811 . . . . 0.0 111.281 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 228' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.01 -32.32 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.838 -1.164 . . . . 0.0 111.928 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 229' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.33 -31.83 73.09 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.53 -1.356 . . . . 0.0 112.382 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -28.95 69.99 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.76 -1.212 . . . . 0.0 112.493 169.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 231' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.48 -28.88 63.19 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.144 -0.973 . . . . 0.0 113.238 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 232' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.73 -35.38 79.98 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.536 1.516 . . . . 0.0 111.446 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 233' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.9 -42.22 99.7 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.269 169.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 234' ' ' LEU . . . . . . . . . . . . . 62.4 tp -59.19 -45.26 91.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.076 1.307 . . . . 0.0 112.519 172.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 235' ' ' ARG . . . . . . . . . . . . . 49.7 ttt-85 -57.89 -40.43 80.26 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.364 -0.835 . . . . 0.0 111.111 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -41.1 69.11 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.528 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 237' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -58.43 -37.25 75.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.299 1.44 . . . . 0.0 111.795 172.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 238' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.46 -40.02 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.379 0.672 . . . . 0.0 112.576 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 239' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.32 -36.33 83.76 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.604 1.093 . . . . 0.0 112.248 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 240' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.29 -25.06 66.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.925 0.89 . . . . 0.0 112.651 171.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 241' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -94.48 -30.29 14.5 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 242' ' ' ILE . . . . . . . . . . . . . 41.9 mt -57.39 -42.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.9 1.227 . . . . 0.0 110.543 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -50.75 72.66 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.47 0.308 . . . . 0.0 110.857 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 244' ' ' ARG . . . . . 0.422 HH12 ' CB ' ' I' ' 216' ' ' THR . 65.0 ttt180 -58.31 -32.12 68.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.731 1.612 . . . . 0.0 114.281 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 245' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.679 -0.638 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 246' ' ' MET . . . . . . . . . . . . . 23.6 mmt -80.84 -34.17 34.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.88 0.872 . . . . 0.0 113.135 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 247' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -92.52 16.68 11.42 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 248' ' ' ASP . . . . . . . . . . . . 0.273 6.8 t0 -74.64 31.42 0.09 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 m -82.97 -156.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.406 1.482 . . . . 0.0 109.112 145.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 250' ' ' ALA . . . . . . . . . . . . . . . -116.19 78.73 8.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 120.854 -1.154 . . . . 0.0 113.084 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 251' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -64.35 149.36 90.27 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.22 2.613 . . . . 0.0 111.594 161.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 252' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -67.72 -41.26 83.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.879 0.872 . . . . 0.0 111.579 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 253' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.31 -46.51 89.63 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.467 0.707 . . . . 0.0 111.92 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 254' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -62.25 -37.72 86.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.852 1.261 . . . . 0.0 112.313 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.3 58.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 256' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.21 -53.22 10.26 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.37 1.068 . . . . 0.0 112.205 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 257' ' ' VAL . . . . . . . . . . . . . 17.8 m -114.23 -2.57 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.79 143.68 6.34 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 122.113 0.84 . . . . 0.0 112.986 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 259' ' ' ALA . . . . . . . . . . . . . . . -54.69 -44.09 73.08 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -167.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 260' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.25 -33.0 72.8 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.997 -1.064 . . . . 0.0 112.767 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 261' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.56 -33.86 25.34 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.865 -0.522 . . . . 0.0 111.713 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.39 -48.88 79.85 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.401 0.546 . . . . 0.0 111.67 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 263' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.57 84.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.504 1.121 . . . . 0.0 112.215 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 264' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -62.92 -45.94 90.11 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.227 -0.921 . . . . 0.0 112.743 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 265' ' ' LEU . . . . . . . . . . . . . 66.7 mt -59.3 -44.99 92.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.366 0.985 . . . . 0.0 111.596 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 266' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.87 -43.14 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.725 0.81 . . . . 0.0 110.767 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 267' ' ' SER . . . . . . . . . . . . . 35.2 t -65.69 -34.15 77.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.688 1.195 . . . . 0.0 113.825 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 268' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.01 -30.14 26.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.299 0.64 . . . . 0.0 112.073 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.73 61.85 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 168.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.71 -10.38 66.49 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.897 1.713 . . . . 0.0 114.593 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.05 172.87 38.36 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.995 1.283 . . . . 0.0 112.798 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 272' ' ' LEU . . . . . . . . . . . . . 54.3 tp -77.88 -33.14 52.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.483 -1.01 . . . . 0.0 113.1 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 273' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -62.47 -44.78 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.916 0.78 . . . . 0.0 109.45 171.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 274' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -64.49 -45.19 88.38 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.077 2.151 . . . . 0.0 110.351 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 275' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.37 -46.23 84.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.078 0.951 . . . . 0.0 112.393 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.43 -24.22 67.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 277' ' ' MET . . . . . . . . . . . . . 27.3 mmm -82.85 -3.17 56.48 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.719 1.608 . . . . 0.0 113.957 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 278' ' ' MET . . . . . . . . . . . . . 65.5 mtt -91.06 155.33 44.9 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 279' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -82.38 159.93 17.29 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.584 2.856 . . . . 0.0 112.076 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -45.42 -48.02 13.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.575 1.55 . . . . 0.0 111.651 166.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 281' ' ' SER . . . . . . . . . . . . . 1.4 m -61.96 -5.46 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 282' ' ' THR . . . . . . . . . . . . . 62.6 m -113.72 -41.96 3.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.126 1.37 . . . . 0.0 111.206 168.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 283' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.83 -32.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.462 1.105 . . . . 0.0 111.667 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 284' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -56.44 -32.84 65.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.531 1.532 . . . . 0.0 113.927 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 285' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.74 6.81 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.089 1.356 . . . . 0.0 114.41 -165.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 286' ' ' LEU . . . . . . . . . . . . . 32.8 mt -52.41 125.83 17.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.547 0.739 . . . . 0.0 111.499 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 287' ' ' GLY . . . . . . . . . . . . . . . 83.66 1.73 90.0 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.459 -1.189 . . . . 0.0 115.839 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 288' ' ' ALA . . . . . . . . . . . . . . . -75.59 27.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.106 1.453 . . . . 0.0 112.937 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 289' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -42.96 80.84 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.692 -1.255 . . . . 0.0 113.065 -159.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 290' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -63.68 -21.93 66.64 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.84 -39.9 12.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.354 1.061 . . . . 0.0 112.151 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 292' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.51 -33.01 74.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.428 0.691 . . . . 0.0 112.447 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 293' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -64.83 -49.95 68.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.385 0.674 . . . . 0.0 111.971 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 294' ' ' ARG . . . . . 0.413 ' HD3' " H4'" ' B' ' 18' ' ' ' A' . 21.9 ptt-85 -68.84 -24.82 64.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 295' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -62.39 -50.0 73.26 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.469 0.708 . . . . 0.0 110.382 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.82 -27.38 57.89 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 297' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -78.85 -40.75 31.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.888 1.275 . . . . 0.0 112.581 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 298' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.77 2.99 2.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -156.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 299' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.82 65.34 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 121.131 -0.981 . . . . 0.0 114.184 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.27 150.03 48.93 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.105 0.962 . . . . 0.0 111.611 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 301' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -45.7 128.55 6.65 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.418 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 302' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.56 152.83 31.81 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.545 2.83 . . . . 0.0 115.414 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 303' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -65.68 127.89 18.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.677 2.252 . . . . 0.0 112.253 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 304' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -81.55 -25.51 35.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.095 1.758 . . . . 0.0 113.028 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 305' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -164.72 162.48 21.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.967 2.107 . . . . 0.0 111.468 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 306' ' ' GLY . . . . . . . . . . . . . . . -121.0 -136.49 5.09 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.271 1.415 . . . . 0.0 111.371 165.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 307' ' ' VAL . . . . . . . . . . . . . 28.6 m -51.1 -24.34 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 308' ' ' ILE . . . . . . . . . . . . . 47.0 pt -61.03 -11.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.601 1.56 . . . . 0.0 114.936 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 309' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.0 -23.31 53.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.519 1.508 . . . . 0.0 112.815 168.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 310' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.34 -13.11 60.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 311' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -77.92 126.35 84.08 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 120.046 1.293 . . . . 0.0 110.469 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 312' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.04 -30.64 71.0 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.745 2.296 . . . . 0.0 116.042 -164.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 313' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.66 72.04 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 314' ' ' ILE . . . . . . . . . . . . . 46.0 mt -82.13 -28.88 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 315' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -88.81 26.67 1.47 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.203 1.401 . . . . 0.0 114.044 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 316' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -143.64 48.14 1.44 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.799 1.639 . . . . 0.0 111.978 163.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 317' ' ' SER . . . . . . . . . . . . . 62.4 m -150.98 132.22 7.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.001 1.32 . . . . 0.0 112.825 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 318' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.62 152.93 31.71 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.453 3.435 . . . . 0.0 115.133 169.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 319' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -56.93 -39.66 74.91 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 320' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -43.91 -53.06 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.147 1.379 . . . . 0.0 112.152 168.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 321' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -91.15 -11.09 39.5 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 322' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -56.01 -49.95 72.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.594 1.543 . . . . 0.0 111.968 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 323' ' ' GLY . . . . . . . . . . . . . . . -68.87 -34.9 78.23 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.387 0.539 . . . . 0.0 113.768 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 324' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -68.29 -42.69 79.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.137 0.968 . . . . 0.0 111.506 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 325' ' ' ILE . . . . . . . . . . . . . 94.2 mt -70.63 -33.49 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.758 0.823 . . . . 0.0 110.869 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 326' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.02 99.22 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.2 0.909 . . . . 0.0 112.463 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 327' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -58.78 -48.56 80.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.867 0.867 . . . . 0.0 111.945 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 328' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.19 91.37 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 329' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.97 -44.56 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 111.224 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.59 84.22 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 331' ' ' GLY . . . . . . . . . . . . . . . -62.18 -38.09 95.6 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.697 0.665 . . . . 0.0 113.358 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 332' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 -36.63 44.35 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.953 0.877 . . . . 0.0 112.865 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 333' ' ' LEU . . . . . . . . . . . . . 36.4 mt -60.72 -37.86 83.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.198 0.908 . . . . 0.0 112.392 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 334' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.951 0.9 . . . . 0.0 113.075 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 335' ' ' ILE . . . . . . . . . . . . . 76.5 mt -77.18 -52.04 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.377 0.671 . . . . 0.0 109.71 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 336' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.29 77.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 337' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.12 72.76 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 338' ' ' ARG . . . . . . . . . . . . . 54.5 mtm-85 -81.47 -29.98 33.52 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.78 -1.105 . . . . 0.0 113.155 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 339' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.91 -48.82 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.202 0.91 . . . . 0.0 110.118 165.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 340' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.39 -28.93 70.03 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 341' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -98.43 -39.46 8.76 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 342' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -100.05 -32.08 11.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 343' ' ' SER . . . . . . . . . . . . . 97.1 p -117.41 -28.77 6.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 344' ' ' GLY . . . . . . . . . . . . . . . 70.1 23.42 77.19 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 119.839 1.199 . . . . 0.0 115.138 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 345' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -107.22 -177.88 3.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.425 1.89 . . . . 0.0 110.74 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 346' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -129.5 133.05 47.06 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.484 -1.385 . . . . 0.0 112.889 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 347' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.76 4.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.505 1.522 . . . . 0.0 113.758 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 348' ' ' ALA . . . . . . . . . . . . . . . -68.42 -25.46 65.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -158.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 349' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -67.77 -41.22 83.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.193 1.36 . . . . 0.0 111.709 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 350' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -66.78 -35.53 80.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 111.99 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 351' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.79 -43.24 99.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.459 1.027 . . . . 0.0 111.78 171.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 352' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -62.17 -37.44 85.28 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.059 0.944 . . . . 0.0 111.156 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 353' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -70.69 -40.94 72.61 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.126 1.37 . . . . 0.0 113.182 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 354' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -65.91 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.851 0.751 . . . . 0.0 110.917 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 355' ' ' LEU . . . . . . . . . . . . . 56.5 tp -63.35 -43.77 96.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.67 -0.644 . . . . 0.0 112.048 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 356' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.04 -37.36 84.65 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.973 0.806 . . . . 0.0 112.127 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 357' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.14 85.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.868 0.758 . . . . 0.0 112.561 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 358' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -66.75 -34.5 77.98 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.131 -0.981 . . . . 0.0 111.758 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 359' ' ' ILE . . . . . . . . . . . . . 65.8 mt -66.04 -46.03 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.392 -0.818 . . . . 0.0 111.048 171.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 360' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -62.19 -29.12 70.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 0.0 113.378 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 361' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.34 -47.53 19.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.805 1.642 . . . . 0.0 111.609 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 362' ' ' ILE . . . . . . . . . . . . . 88.5 mt -60.54 -37.32 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.901 -1.124 . . . . 0.0 111.024 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 363' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -64.88 -13.66 57.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.404 1.481 . . . . 0.0 114.988 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 364' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -99.65 -32.0 11.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.319 0.963 . . . . 0.0 112.027 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 365' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -70.38 -40.27 74.08 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 366' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 116.928 -1.511 . . . . 0.0 114.526 -167.653 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' M' M ' 1' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' M' M ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.06 160.63 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.978 2.452 . . . . 0.0 112.875 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 3' ' ' SER . . . . . . . . . . . . . 85.2 p -74.74 -8.66 57.09 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.571 1.949 . . . . 0.0 115.456 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -92.23 -17.15 25.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 m -84.08 91.59 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.51 1.05 . . . . 0.0 109.828 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -76.04 -38.88 56.65 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -167.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 7' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.4 147.88 38.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.325 1.05 . . . . 0.0 111.154 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.76 119.18 21.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.17 139.05 42.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.626 0.77 . . . . 0.0 111.74 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -65.3 178.92 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.347 2.698 . . . . 0.0 114.13 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -74.46 -29.99 61.69 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.318 -0.864 . . . . 0.0 112.722 163.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.35 176.1 7.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.304 0.642 . . . . 0.0 111.368 161.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 13' ' ' LEU . . . . . . . . . . . . . 51.2 mt 63.96 -55.06 0.23 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.5 1.92 . . . . 0.0 114.734 -168.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.63 80.91 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.138 1.336 . . . . 0.0 113.216 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -60.61 -32.56 71.69 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.44 -0.788 . . . . 0.0 111.654 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -76.7 -31.46 57.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.921 1.289 . . . . 0.0 112.271 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.1 90.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.467 0.707 . . . . 0.0 111.355 171.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.58 -46.06 91.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.906 0.883 . . . . 0.0 110.522 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -64.17 -25.86 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.59 -38.96 67.71 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.817 -1.177 . . . . 0.0 112.26 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 21' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.25 -37.29 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.006 0.922 . . . . 0.0 111.082 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 22' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.24 -10.68 11.49 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 23' ' ' ILE . . . . . . . . . . . . . 94.4 mt -120.98 -46.0 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.108 1.322 . . . . 0.0 112.762 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.35 69.63 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.885 -1.134 . . . . 0.0 113.069 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 25' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -45.0 -51.45 9.86 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 128.545 2.738 . . . . 0.0 114.803 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -113.33 -14.63 12.79 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 27' ' ' THR . . . . . . . . . . . . . 34.1 p -95.08 -8.01 37.84 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.56 -123.32 0.99 Allowed Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.046 1.308 . . . . 0.0 113.2 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 29' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -143.26 125.08 15.08 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.598 1.559 . . . . 0.0 111.498 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 30' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.06 155.63 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.044 1.738 . . . . 0.0 111.985 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 31' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -130.26 142.08 50.58 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.732 1.213 . . . . 0.0 110.127 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 145.35 37.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.966 1.306 . . . . 0.0 112.147 -166.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.77 151.48 14.09 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 123.909 0.755 . . . . 0.0 111.439 -164.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 34' ' ' THR . . . . . . . . . . . . . 4.3 m -70.39 -31.94 69.37 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.972 -1.311 . . . . 0.0 113.851 -170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 35' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -73.12 -36.64 66.77 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.031 1.287 . . . . 0.0 112.175 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 36' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.6 -33.67 58.41 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.663 -1.273 . . . . 0.0 113.706 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 37' ' ' THR . . . . . . . . . . . . . 81.9 m -53.47 -46.55 69.99 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.877 0.762 . . . . 0.0 109.777 167.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 38' ' ' THR . . . . . . . . . . . . . 69.5 m -63.93 -48.14 77.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.626 1.17 . . . . 0.0 111.466 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -58.27 -38.92 77.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.75 1.159 . . . . 0.0 113.193 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.81 -34.09 71.39 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.51 -41.48 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 110.508 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.97 -33.97 76.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.081 -1.012 . . . . 0.0 113.616 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -75.71 0.41 17.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.548 1.139 . . . . 0.0 113.366 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.04 10.28 61.56 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.558 1.075 . . . . 0.0 115.163 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 45' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -96.0 -20.05 19.0 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.9 139.9 56.49 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.749 0.704 . . . . 0.0 112.122 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -106.88 -21.02 13.15 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.372 1.469 . . . . 0.0 113.506 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 48' ' ' LEU . . . . . . . . . . . . . 46.7 tp -159.1 143.25 15.32 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.094 2.558 . . . . 0.0 108.628 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.54 139.25 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.255 1.022 . . . . 0.0 112.425 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 50' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.33 132.34 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.781 2.032 . . . . 0.0 109.161 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.54 142.78 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.994 1.318 . . . . 0.0 110.77 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.63 145.8 36.52 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.581 -1.324 . . . . 0.0 113.431 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 53' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.31 -2.41 45.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -122.84 24.62 8.98 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -166.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -79.59 135.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.109 1.364 . . . . 0.0 112.472 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.04 122.23 5.79 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.701 1.6 . . . . 0.0 111.186 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -64.66 140.16 40.77 Favored 'Cis proline' 0 C--N 1.351 0.679 0 CA-C-N 120.984 1.387 . . . . 0.0 113.235 -1.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.33 -24.29 67.23 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -67.53 -20.7 65.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.599 1.16 . . . . 0.0 114.102 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -37.03 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 120.212 1.369 . . . . 0.0 111.312 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 m -94.2 -14.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.94 -23.83 34.34 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -24.03 66.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.52 -43.7 85.07 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 116.83 -1.557 . . . . 0.0 112.972 -166.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 65' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.08 -55.62 2.15 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.15 1.9 . . . . 0.0 114.411 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 66' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.21 -32.86 51.15 Favored 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 122.561 1.951 . . . . 0.0 113.13 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 tp -69.98 -31.12 68.66 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 113.494 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -84.79 -31.26 24.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.807 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 69' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.92 -39.06 90.19 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.684 1.129 . . . . 0.0 113.126 172.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.17 -24.4 67.38 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.804 0.729 . . . . 0.0 112.382 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 71' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -109.56 10.22 25.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.554 1.942 . . . . 0.0 114.482 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 57.81 32.75 22.35 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.35 1.46 . . . . 0.0 114.862 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm -98.22 131.53 26.15 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.993 1.317 . . . . 0.0 110.115 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.2 144.37 46.3 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.956 2.437 . . . . 0.0 112.943 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -129.95 139.28 51.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.761 1.625 . . . . 0.0 112.724 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 tp -143.16 151.82 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.566 1.146 . . . . 0.0 111.633 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -113.32 148.91 34.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.368 1.067 . . . . 0.0 112.078 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.29 152.89 75.96 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 124.898 1.279 . . . . 0.0 113.161 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -62.0 -27.54 79.63 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 N-CA-C 119.296 2.768 . . . . 0.0 119.296 -162.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 80' ' ' SER . . . . . . . . . . . . . 44.4 m -158.49 136.88 10.89 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 121.852 2.115 . . . . 0.0 115.417 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 81' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -59.97 -32.75 71.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.022 1.729 . . . . 0.0 115.509 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -75.46 -39.17 59.04 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.298 -0.876 . . . . 0.0 111.786 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -67.57 -36.37 80.79 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.304 0.642 . . . . 0.0 111.294 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.16 -40.48 90.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.492 0.717 . . . . 0.0 112.371 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.52 97.71 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.359 0.527 . . . . 0.0 112.661 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.94 95.94 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.989 -0.712 . . . . 0.0 112.537 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.13 99.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.349 -0.845 . . . . 0.0 112.069 174.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -8.66 34.82 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.82 3.31 77.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.469 1.509 . . . . 0.0 115.447 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -88.53 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.23 1.515 . . . . 0.0 111.609 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -92.61 -29.52 16.1 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -84.31 -152.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.499 1.519 . . . . 0.0 111.77 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.9 171.16 8.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.698 1.599 . . . . 0.0 112.349 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.95 125.58 20.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.44 0.696 . . . . 0.0 110.211 164.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.73 69.07 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.46 0.704 . . . . 0.0 112.258 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 96' ' ' SER . . . . . . . . . . . . . 90.0 p -153.49 162.38 41.32 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -141.88 145.1 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.805 2.042 . . . . 0.0 109.843 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.63 140.65 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.383 1.473 . . . . 0.0 112.223 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 99' ' ' ILE . . . . . . . . . . . . . 19.6 mm -97.18 124.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.619 1.168 . . . . 0.0 109.502 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.01 -52.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.16 0.891 . . . . 0.0 110.415 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -118.91 112.6 36.42 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 108.165 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 102' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -61.94 -13.99 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.054 2.503 . . . . 0.0 116.167 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.7 -124.69 36.92 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 118.927 0.785 . . . . 0.0 112.165 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -9.03 57.93 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.91 18.08 9.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.004 1.322 . . . . 0.0 114.16 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 106' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -52.61 -49.48 64.97 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.439 1.472 . . . . 0.0 114.171 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 107' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.61 -42.25 74.64 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.385 0.993 . . . . 0.0 111.964 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 108' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.92 -36.23 78.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.997 1.319 . . . . 0.0 113.05 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -72.17 -30.38 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.653 0.781 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 110' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -73.22 -41.55 63.63 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.889 1.222 . . . . 0.0 112.175 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.62 -35.38 80.34 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.364 0.984 . . . . 0.0 112.867 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 112' ' ' ILE . . . . . . . . . . . . . 19.4 tt -74.65 -42.56 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.3 0.955 . . . . 0.0 111.993 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.61 91.7 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.883 1.22 . . . . 0.0 112.177 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 114' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.27 -47.79 78.2 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.819 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.84 -22.27 61.56 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.24 -38.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.776 1.231 . . . . 0.0 111.373 168.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 117' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -65.56 -29.49 70.11 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.149 -0.969 . . . . 0.0 113.303 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -55.46 -31.79 62.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.842 0.857 . . . . 0.0 112.976 165.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 119' ' ' LEU . . . . . . . . . . . . . 28.4 tp -93.12 -29.58 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.992 1.317 . . . . 0.0 113.47 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 120' ' ' MET . . . . . . . . . . . . . 49.2 mtp -60.91 -15.72 34.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.476 1.511 . . . . 0.0 114.443 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 126.438 1.895 . . . . 0.0 114.521 -168.151 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 m -147.65 149.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.648 1.179 . . . . 0.0 110.303 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 3' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -138.49 143.86 39.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.521 1.129 . . . . 0.0 110.728 169.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.58 131.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.643 1.177 . . . . 0.0 110.242 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 5' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -129.01 157.69 40.99 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.277 2.631 . . . . 0.0 109.897 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.15 153.25 40.81 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.368 -1.457 . . . . 0.0 112.512 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -107.43 176.95 4.99 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.431 1.092 . . . . 0.0 110.599 160.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -88.05 2.67 51.33 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 9' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -113.52 146.85 36.26 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.566 1.546 . . . . 0.0 110.796 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 10' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.29 142.4 85.86 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.416 2.077 . . . . 0.0 111.134 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.39 -7.73 4.59 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.81 139.55 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.407 1.483 . . . . 0.0 110.934 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -136.29 156.7 48.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.909 1.683 . . . . 0.0 110.642 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 140.95 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.274 1.83 . . . . 0.0 107.702 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.63 152.02 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.115 0.871 . . . . 0.0 112.693 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 16' ' ' ILE . . . . . . . . . . . . . 34.6 mm -113.43 142.04 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.785 1.634 . . . . 0.0 108.668 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -136.22 -176.89 4.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.695 1.998 . . . . 0.0 109.427 168.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 18' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -75.89 6.08 5.58 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -172.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -27.36 40.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.658 -1.276 . . . . 0.0 111.767 158.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.36 -12.8 68.19 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.863 1.697 . . . . 0.0 116.094 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -81.42 147.45 29.77 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.205 2.002 . . . . 0.0 112.967 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 22' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -69.83 115.91 9.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.515 1.126 . . . . 0.0 110.47 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -101.75 170.49 8.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.83 1.652 . . . . 0.0 110.505 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 pt -118.73 150.79 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.239 1.016 . . . . 0.0 113.096 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.77 171.8 18.32 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.783 1.633 . . . . 0.0 112.645 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 26' ' ' THR . . . . . . . . . . . . . 19.9 p -129.36 156.73 43.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.651 1.58 . . . . 0.0 111.126 168.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -76.08 129.86 37.45 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.356 -0.84 . . . . 0.0 109.898 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -71.94 121.69 19.53 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.819 0.736 . . . . 0.0 112.035 -169.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.14 -37.83 23.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.392 1.877 . . . . 0.0 114.103 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.46 143.08 28.56 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.898 1.279 . . . . 0.0 109.372 152.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.78 157.19 55.83 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.892 3.061 . . . . 0.0 114.022 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.73 -21.98 43.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.163 1.839 . . . . 0.0 114.746 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.68 141.68 31.31 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.151 1.475 . . . . 0.0 113.353 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 34' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -109.45 150.07 28.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.486 1.514 . . . . 0.0 108.683 153.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.27 -26.61 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.671 0.788 . . . . 0.0 112.976 -168.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -145.53 25.13 1.36 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.97 38.21 36.28 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.682 -1.261 . . . . 0.0 113.315 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -92.51 159.34 15.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.134 1.374 . . . . 0.0 114.586 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 39' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -70.53 137.84 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.004 1.322 . . . . 0.0 110.216 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.08 149.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.213 1.005 . . . . 0.0 111.638 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.74 115.25 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.621 1.569 . . . . 0.0 107.607 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 42' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -82.86 144.18 30.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 43' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -136.9 172.21 13.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.73 1.212 . . . . 0.0 110.543 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 44' ' ' GLU . . . . . . . . . . . . 0.251 6.4 pt-20 -67.29 90.17 0.22 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 123.055 1.407 . . . . 0.0 112.441 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.37 5.83 66.9 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 126.933 2.206 . . . . 0.0 115.621 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 46' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -145.17 169.91 17.26 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 119.887 1.844 . . . . 0.0 113.397 -166.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.36 136.96 33.7 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.468 -1.395 . . . . 0.0 111.451 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.15 143.51 50.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.007 1.723 . . . . 0.0 111.396 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.58 132.51 49.83 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.35 1.46 . . . . 0.0 111.818 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.11 144.93 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.042 0.937 . . . . 0.0 111.782 -168.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 51' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -111.74 73.16 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.914 1.685 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 52' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -65.25 126.9 92.29 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 121.317 -0.864 . . . . 0.0 111.616 -172.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 53' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.0 -36.64 9.81 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.54 2.16 . . . . 0.0 113.213 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -62.76 -15.09 51.91 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.532 1.133 . . . . 0.0 113.639 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 55' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -130.16 22.52 5.26 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.796 2.038 . . . . 0.0 112.448 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 56' ' ' SER . . . . . . . . . . . . . 2.3 m -161.93 103.96 1.17 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.566 1.146 . . . . 0.0 111.515 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 57' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -60.34 -30.04 69.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.06 1.344 . . . . 0.0 113.653 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -38.28 71.48 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.239 -0.913 . . . . 0.0 111.916 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -40.51 98.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.203 -0.935 . . . . 0.0 112.163 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.61 79.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 117.747 0.773 . . . . 0.0 112.495 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.59 76.1 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.245 -0.909 . . . . 0.0 113.327 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 62' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.27 -37.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.235 -0.916 . . . . 0.0 111.176 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 63' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.95 -36.14 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.277 -0.889 . . . . 0.0 111.16 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 64' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -77.03 8.48 3.81 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.1 26.11 53.61 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 166.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -47.27 126.18 9.04 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.438 1.495 . . . . 0.0 111.521 171.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -94.62 -45.8 7.22 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.097 0.959 . . . . 0.0 112.366 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 68' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -92.9 81.69 4.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 69' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.07 115.98 65.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.063 -1.023 . . . . 0.0 110.31 166.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 70' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -90.3 -15.91 1.83 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.351 2.034 . . . . 0.0 115.747 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -77.59 143.7 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.32 0.964 . . . . 0.0 110.695 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 72' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -139.19 154.79 72.48 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 126.048 1.739 . . . . 0.0 111.072 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -60.52 154.38 54.38 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.72 2.28 . . . . 0.0 111.898 166.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.41 -12.71 7.14 Favored Glycine 0 CA--C 1.539 1.569 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 75' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.83 -174.26 2.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.799 1.64 . . . . 0.0 111.346 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 76' ' ' SER . . . . . . . . . . . . . 95.9 p -131.19 146.04 52.18 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.001 1.32 . . . . 0.0 114.092 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.77 137.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.832 0.853 . . . . 0.0 112.71 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 78' ' ' LEU . . . . . . . . . . . . . 49.4 tp -97.96 113.41 25.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.713 1.605 . . . . 0.0 109.216 170.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 79' ' ' TYR . . . . . 0.486 ' CE2' ' HA ' ' N' ' 82' ' ' ILE . 1.7 t80 -99.33 128.87 45.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.608 1.163 . . . . 0.0 109.845 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 80' ' ' LEU . . . . . . . . . . . . . 62.9 mt -115.03 118.74 34.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.315 1.446 . . . . 0.0 110.562 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.35 39.24 5.71 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.982 1.277 . . . . 0.0 114.313 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 82' ' ' ILE . . . . . 0.486 ' HA ' ' CE2' ' N' ' 79' ' ' TYR . 16.7 tt -64.67 -28.83 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -166.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 83' ' ' ALA . . . . . . . . . . . . . . . 40.47 -130.07 0.38 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.56 1.544 . . . . 0.0 112.742 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -73.78 7.54 2.46 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.306 1.443 . . . . 0.0 114.787 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.32 18.39 74.14 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.424 1.33 . . . . 0.0 116.424 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 86' ' ' THR . . . . . . . . . . . . . 13.4 m -47.3 -66.43 0.41 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.388 1.594 . . . . 0.0 113.298 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 87' ' ' THR . . . . . . . . . . . . . 25.2 p -80.73 -23.87 39.16 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.995 -1.065 . . . . 0.0 112.079 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.33 -31.35 71.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 89' ' ' SER . . . . . . . . . . . . . 82.7 p -57.01 -42.81 81.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 112.543 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 90' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -75.98 -34.34 59.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.386 0.674 . . . . 0.0 112.181 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 m -71.84 -27.29 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.583 -1.323 . . . . 0.0 112.699 170.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 92' ' ' SER . . . . . . . . . . . . . 12.6 t -66.45 -34.06 77.09 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.742 1.155 . . . . 0.0 112.882 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 93' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -65.04 -47.68 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 0.697 . . . . 0.0 111.593 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 94' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.76 -36.74 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.135 1.374 . . . . 0.0 112.882 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.67 -26.72 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.674 1.19 . . . . 0.0 112.496 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.75 -167.89 40.81 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.232 0.92 . . . . 0.0 114.893 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 97' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -84.8 -16.72 40.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -101.25 9.63 41.59 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.238 1.015 . . . . 0.0 113.192 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 99' ' ' GLY . . . . . . . . . . . . . . . -117.07 173.07 14.53 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.236 1.874 . . . . 0.0 112.276 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 100' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -139.63 135.74 33.61 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -165.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 101' ' ' ILE . . . . . . . . . . . . . 20.0 mt -127.88 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.556 1.142 . . . . 0.0 111.438 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 102' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -102.01 136.9 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.894 0.878 . . . . 0.0 109.884 163.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.91 108.04 1.12 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.004 0.811 . . . . 0.0 111.857 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.41 136.37 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.329 1.051 . . . . 0.0 109.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 105' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -139.11 157.09 46.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 106' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -84.27 -35.87 23.06 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 107' ' ' SER . . . . . . . . . . . . . 13.4 t -120.96 136.98 26.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-N 119.658 1.117 . . . . 0.0 113.216 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 108' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.12 -32.93 63.11 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.237 2.625 . . . . 0.0 112.035 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -70.8 -29.49 65.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.642 0.656 . . . . 0.0 112.584 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -77.87 -39.05 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 110.497 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 111' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.67 -24.52 53.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.376 1.07 . . . . 0.0 113.761 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 112' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -48.74 -40.49 28.76 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.74 1.616 . . . . 0.0 112.47 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.06 -21.89 66.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 113.014 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 114' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.94 -22.83 22.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.416 1.487 . . . . 0.0 113.092 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 115' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.78 -44.68 99.86 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.422 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 116' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.09 -32.01 22.28 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.334 1.869 . . . . 0.0 112.641 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 117' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.51 -37.65 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.919 -1.113 . . . . 0.0 110.577 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 m -77.28 -10.3 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -77.74 2.42 16.99 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.072 1.305 . . . . 0.0 111.98 167.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 120' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -123.36 -49.96 1.9 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.575 1.55 . . . . 0.0 111.859 162.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 121' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -81.81 65.91 7.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.127 1.371 . . . . 0.0 112.305 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -67.34 5.05 0.81 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 123' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -85.82 -3.53 58.93 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 119.631 1.105 . . . . 0.0 113.903 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mt -109.42 139.85 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 110.209 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 125' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.38 124.57 29.92 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.323 1.049 . . . . 0.0 110.023 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.29 127.02 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.117 3.212 . . . . 0.0 111.652 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 127' ' ' ILE . . . . . . . . . . . . . 71.9 mt -131.72 136.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.102 1.361 . . . . 0.0 110.305 -171.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 128' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.03 115.77 30.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.368 1.067 . . . . 0.0 112.531 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.4 167.71 34.23 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.968 0.794 . . . . 0.0 114.489 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -70.55 106.79 3.59 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.63 -0.923 . . . . 0.0 111.891 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.17 19.61 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 132' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.7 -7.94 59.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.319 1.448 . . . . 0.0 112.588 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 133' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -132.93 73.48 75.54 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.0 2.12 . . . . 0.0 108.661 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 134' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -57.78 -13.9 16.03 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.065 3.177 . . . . 0.0 115.315 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 135' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -54.74 -31.58 58.62 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.444 1.898 . . . . 0.0 113.575 167.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.02 -23.87 21.7 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.481 1.912 . . . . 0.0 115.085 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 137' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.47 15.96 6.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.691 1.196 . . . . 0.0 113.012 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 138' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -52.07 -31.78 31.85 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.95 -2.66 46.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 140' ' ' LEU . . . . . . . . . . . . . 68.9 mt -110.7 -1.52 16.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.996 1.718 . . . . 0.0 113.641 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 141' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.89 179.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.659 1.183 . . . . 0.0 112.469 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 142' ' ' THR . . . . . . . . . . . . . 66.1 p -133.38 -179.93 5.81 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.276 1.831 . . . . 0.0 110.5 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 143' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -57.7 150.05 20.5 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.23 -0.919 . . . . 0.0 110.485 155.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 144' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.23 164.72 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.169 1.788 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -85.74 -30.81 22.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.581 1.152 . . . . 0.0 113.04 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 t -139.73 150.58 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.974 1.31 . . . . 0.0 112.188 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 147' ' ' ILE . . . . . . . . . . . . . 95.1 mt -115.14 142.94 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.99 1.316 . . . . 0.0 110.628 163.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 148' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -128.78 149.34 50.76 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.485 1.514 . . . . 0.0 111.15 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.18 135.41 41.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.346 1.458 . . . . 0.0 111.643 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -145.12 31.31 1.12 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.823 1.249 . . . . 0.0 111.36 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 151' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.42 -28.42 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.113 -1.617 . . . . 0.0 113.803 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.36 24.35 6.51 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 153' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -87.54 160.21 48.23 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 0.0 112.723 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 154' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.93 -27.93 37.42 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.536 2.824 . . . . 0.0 113.965 173.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 155' ' ' THR . . . . . . . . . . . . . 23.3 p -88.9 2.25 54.06 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.454 1.502 . . . . 0.0 114.61 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 156' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -57.06 -36.38 70.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.209 1.822 . . . . 0.0 114.535 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.84 74.76 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.908 -1.12 . . . . 0.0 113.078 174.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 158' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -64.05 -40.43 96.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.492 1.117 . . . . 0.0 111.672 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 159' ' ' ILE . . . . . . . . . . . . . 67.4 mt -57.09 -50.56 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.24 1.416 . . . . 0.0 110.317 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 160' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.79 -44.76 96.42 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.853 0.751 . . . . 0.0 112.108 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 161' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.07 -50.3 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.134 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -31.38 69.17 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.603 1.547 . . . . 0.0 112.053 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 163' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.31 -1.494 . . . . 0.0 112.683 169.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 164' ' ' ALA . . . . . . . . . . . . . . . -84.47 -13.42 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.654 -1.279 . . . . 0.0 113.941 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 165' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -79.56 -36.82 37.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.379 1.472 . . . . 0.0 110.922 162.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.33 -55.51 4.85 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 167' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.5 -21.25 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -159.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 168' ' ' LEU . . . . . . . . . . . . . 23.7 tp -80.86 129.27 34.44 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.046 1.294 . . . . 0.0 112.485 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 169' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -71.18 154.01 42.04 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.845 0.858 . . . . 0.0 112.23 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 170' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.44 137.6 58.29 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.325 -0.86 . . . . 0.0 109.731 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 171' ' ' GLY . . . . . . . . . . . . . . . 72.9 4.0 61.27 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -166.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 172' ' ' GLY . . . . . . . . . . . . . . . -78.25 168.0 53.66 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.595 1.198 . . . . 0.0 112.476 167.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 173' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.84 166.74 15.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.398 1.079 . . . . 0.0 113.243 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 174' ' ' GLY . . . . . . . . . . . . . . . -146.16 153.79 25.54 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.123 -0.986 . . . . 0.0 113.208 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 175' ' ' MET . . . . . . . . . . . . . 23.9 mtt -132.97 144.12 49.91 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.816 1.646 . . . . 0.0 110.64 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 176' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.25 135.04 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.282 1.433 . . . . 0.0 110.617 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 177' ' ' ALA . . . . . . . . . . . . . . . -108.6 75.1 0.95 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.965 1.306 . . . . 0.0 110.616 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 178' ' ' VAL . . . . . . . . . . . . . 24.7 t -67.99 107.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.93 1.292 . . . . 0.0 111.188 -166.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 179' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -95.11 85.2 4.26 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.653 1.581 . . . . 0.0 108.916 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 180' ' ' SER . . . . . . . . . . . . . 5.3 t -48.98 -46.54 43.89 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -152.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -14.93 54.62 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 182' ' ' SER . . . . . . . . . . . . . 26.7 m -72.03 -25.12 61.69 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.357 0.98 . . . . 0.0 112.804 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 183' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.66 -44.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 110.637 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 184' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -158.62 152.09 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.838 1.255 . . . . 0.0 110.458 166.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 185' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.84 19.04 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.2 1.4 . . . . 0.0 112.208 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 186' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 -39.62 15.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.236 1.415 . . . . 0.0 112.15 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -111.89 177.99 4.46 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.687 1.595 . . . . 0.0 113.62 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 188' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.89 133.5 95.28 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.972 0.909 . . . . 0.0 111.591 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 189' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -57.98 -30.33 89.59 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.834 2.356 . . . . 0.0 115.926 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 190' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -61.01 -37.47 82.63 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.31 0.959 . . . . 0.0 112.35 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 191' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -78.7 -30.59 46.11 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.323 -0.86 . . . . 0.0 111.671 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 192' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.68 -44.68 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.783 0.719 . . . . 0.0 110.46 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -58.21 -38.91 77.7 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.028 0.831 . . . . 0.0 112.043 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 194' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.53 -32.93 74.59 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 195' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -76.42 -30.4 57.42 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.925 0.784 . . . . 0.0 112.917 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 196' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.45 -39.74 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.713 -1.242 . . . . 0.0 110.463 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 197' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.4 -34.43 78.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.286 1.034 . . . . 0.0 112.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -22.51 60.07 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.686 1.13 . . . . 0.0 113.948 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.2 -43.66 27.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.165 0.986 . . . . 0.0 110.372 170.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 200' ' ' LEU . . . . . . . . . . . . . 21.8 tp -68.44 -46.15 70.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.504 1.121 . . . . 0.0 112.241 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 201' ' ' SER . . . . . . . . . . . . . 88.5 p -76.34 -6.96 53.89 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 202' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -68.92 -23.92 64.23 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.044 0.937 . . . . 0.0 111.622 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 203' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -120.93 -29.79 4.53 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 204' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -117.21 157.15 26.48 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 205' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -78.68 108.17 11.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 156.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 206' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.97 128.27 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.952 0.901 . . . . 0.0 109.355 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 207' ' ' ILE . . . . . . . . . . . . . 39.9 pt -116.81 -26.81 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 208' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -157.52 142.66 16.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.095 -1.003 . . . . 0.0 112.205 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.56 134.07 42.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.49 2.316 . . . . 0.0 109.074 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 210' ' ' LEU . . . . . . . . . . . . . 34.1 tp -142.3 138.5 31.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.146 0.979 . . . . 0.0 112.872 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 211' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -75.44 144.53 42.09 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.283 1.833 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 mp -104.38 5.43 34.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.78 1.232 . . . . 0.0 113.88 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 213' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.91 144.6 46.75 Favored Pre-proline 0 CA--C 1.55 0.959 0 O-C-N 120.511 -1.368 . . . . 0.0 111.112 162.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 214' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.79 -2.84 60.39 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 120.108 1.074 . . . . 0.0 114.4 0.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 215' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -71.91 -33.96 68.71 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.33 1.052 . . . . 0.0 113.092 -171.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 216' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -124.12 176.29 6.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.889 1.676 . . . . 0.0 112.733 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -126.93 132.11 50.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.564 1.546 . . . . 0.0 111.163 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 218' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 48.82 44.48 21.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.574 1.549 . . . . 0.0 113.181 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 219' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -133.59 131.69 39.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.244 1.417 . . . . 0.0 110.644 -167.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 220' ' ' ALA . . . . . . . . . . . . . . . -142.7 135.43 28.0 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 221' ' ' LEU . . . . . . . . . . . . . 62.4 tp -86.51 128.93 35.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.932 0.893 . . . . 0.0 109.72 170.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 222' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -113.32 147.12 38.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.214 1.006 . . . . 0.0 109.779 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 223' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.82 140.17 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.484 1.114 . . . . 0.0 111.369 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 224' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.2 162.98 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 113.632 -164.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 225' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -128.89 144.6 51.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.182 2.193 . . . . 0.0 111.538 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 226' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.3 117.88 69.18 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 117.055 -1.45 . . . . 0.0 111.158 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 227' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.185 3.257 . . . . 0.0 115.564 -179.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' W' W ' 1' ' ' ' U' . . . . . 0.405 " H1'" HD12 ' F' ' 296' ' ' LEU . . . . . . . . 0 O4'--C4' 1.427 -2.163 1 O4'-C1'-N19 113.543 5.343 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' W' W ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.043 1 O4'-C1'-N19 113.192 4.992 . 0.387 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' W' W ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.954 1 O4'-C1'-N19 112.55 4.35 . 0.168 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' W' W ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.975 1 O4'-C1'-N19 115.416 7.216 . 0.371 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' W' W ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.29 1 O4'-C1'-N19 113.076 4.876 . 0.097 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' W' W ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.339 1 O4'-C1'-N19 112.962 4.762 . 0.166 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' W' W ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 0 O5'-C5'-C4' 114.811 3.293 . 0.525 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' W' W ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 1 O4'-C1'-N19 113.361 5.161 . 0.439 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' W' W ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.404 0 O4'-C1'-N19 111.943 3.743 . 0.604 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' W' W ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 0 C5'-C4'-C3' 111.249 -2.834 . 0.651 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' W' W ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 0 O4'-C1'-N19 110.418 2.218 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.3 1 O4'-C1'-N19 113.161 4.961 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.733 1 O4'-C1'-N19 113.19 4.99 . 0.188 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.26 1 C5'-C4'-O4' 115.504 4.503 . 0.286 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.407 -2.034 1 O4'-C1'-N19 112.966 4.766 . 0.572 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.433 -1.691 2 C4'-C3'-C2' 98.325 -4.375 . 0.441 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 1 O4'-C1'-N19 113.825 5.625 . 0.631 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.546 2.751 0 O4'-C1'-N19 111.507 3.307 . 0.256 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.201 1 O4'-C1'-N19 112.903 4.703 . 0.659 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.053 1 O4'-C1'-N19 113.815 5.615 . 0.647 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.006 1 O4'-C1'-N19 114.289 6.089 . 0.485 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.276 1 O4'-C1'-N19 112.781 4.581 . 0.414 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.178 0 O4'-C1'-N19 111.463 3.263 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' Y' Y ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.157 3 O4'-C1'-N19 113.457 5.257 . 0.234 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.455 1 O4'-C1'-N19 113.702 5.502 . 0.154 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.881 1 O4'-C1'-N19 112.864 4.664 . 0.625 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.37 1 O4'-C1'-N19 113.327 5.127 . 0.545 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.411 -1.827 1 O4'-C1'-N19 115.449 7.249 . 0.367 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.268 1 O4'-C1'-N19 113.679 5.479 . 0.404 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 O4'-C1'-N19 113.657 5.457 . 0.698 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Y' Y ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.088 0 O4'-C1'-N19 112.032 3.832 . 0.542 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' Y' Y ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.311 0 C4'-C3'-C2' 98.879 -3.821 . 0.592 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' Y' Y ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.221 1 O4'-C1'-N19 112.871 4.671 . 0.637 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.293 0 O4'-C1'-N19 111.585 3.385 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' Z' Z ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.292 2 O4'-C1'-N19 114.286 6.086 . 0.234 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.423 1 O4'-C1'-N19 113.695 5.495 . 0.015 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.111 1 O4'-C1'-N19 113.095 4.895 . 0.06 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.436 1.829 2 O4'-C1'-N19 112.775 4.575 . 0.609 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.432 -1.766 1 O4'-C1'-N19 113.498 5.298 . 0.567 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 7' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.231 1 C3'-C2'-C1' 105.302 4.225 . 0.01 1L . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 1 O4'-C1'-N19 113.972 5.772 . 0.313 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 9' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.256 2 O4'-C1'-N19 115.032 6.832 . 0.608 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 10' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.499 0 O4'-C1'-N19 111.64 3.44 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' Z' Z ' 11' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.443 1 O4'-C1'-N19 114.202 6.002 . 0.694 1a . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_